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Abstract 
Aims and Objectives 
Medicinal plant (herbal medicine) value chains have generally been overlooked 
compared with food commodities. Not surprisingly, revenue generation tends to be 
weighted towards the retail end of the chain and consequently the farm labourers, 
farmers and processors of the crude raw materials (the primary producers) are the 
lowest beneficiaries. This project aims to investigate medicinal plant value chains and 
interpret the impact different value chains have on the livelihoods of primary producers 
in developing countries and for the first time analytically assess the quality implications 
for the manufacturers (secondary producers) and end users in Europe. 
Methodological Approach  
This interdisciplinary project uses a mixed methods approach. Case studies were 
undertaken on three separate sites in India. Data were initially gathered on medicinal 
plant value chains by means of semi-structured interviews and non-participant 
observation. Samples were collected from locations in India, China, Europe and the 
USA and analysed using nuclear magnetic resonance spectroscopy and high 
performance thin layer chromatography.  
Results 
There were benefits for primary producers that belonged to a vertically integrated value 
chain and resulting products were subject to a higher standard of processing and 
storage. The analysis demonstrated that there was variation in the chemical 
composition of the samples tested and that products obtained from a vertically 
integrated value chain were more similar chemically to fresh turmeric rhizomes than 
other samples tested. 
Conclusions  
By using analytical methods, it has been possible to correlate important variations in 
product composition for selected samples and identify strengths and weaknesses of 
some key value chains. Through establishing direct contracts with farmers in India, the 
vertically integrated value chain investigated was able to exert greater control over 
cultivation and manufacturing processes than found in other chains. Consequently the 
vertically integrated value chain is able to produce a higher quality product than 
generally found on the market. This results in a value addition that can be passed back 
down the chain for the benefit of the primary producers. 
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1.0 Introduction 
This study was initiated through collaboration between the former London School of 
Pharmacy (now UCL School of Pharmacy) and the Leverhulme Centre for Research on 
Agriculture and Health (LCIRAH). LCIRAH was established under a five-year grant 
from The Leverhulme Trust to build a new inter-sectoral and interdisciplinary platform 
for integrating research in agriculture and health, with a focus on international 
development goals. The over-arching aim of LCIRAH is to better assess the complex 
global issues surrounding the need to find sustainable food and agriculture systems 
which are able to promote health and well-being for all people. 
The Centre for Pharmacognosy and Phytotherapy, UCL School of Pharmacy, has had 
many years of experience in investigating medicinal plants, their traditional and modern 
uses and how their quality and safety can be best assessed. It was a logical step to 
form an interdisciplinary partnership with LCIRAH in order to blend this scientific 
perspective with the disciplines of economics and international development. 
The analysis of agriculture value chains, in the context of international development, 
has tended to focus on food crops, including, tea, coffee and cocoa and on cash crops 
e.g. cotton. The mass production of these consumables has provided large-scale 
employment for rural workers in less economically developed countries (LEDCs) 
(Kaplinsky, 2004).  
The impact on livelihoods has in some cases been positive but also there have been 
many concerns. These have been most clearly documented for the plantation 
production of export crops, and particularly for the tea industry. It is claimed that the 
employment and management of rural workers by international companies has led to a 
negative outcome, with workers’ wages being squeezed to a minimum (Hilary and 
Dromey, 2010, Fairtrade, 2010).  
Moreover, there is  concern that small farmers1 are often unable to gain access to 
value chains due to an inability to make the necessary connections to the lead firms or 
not being able to meet  the standards and/or the entry requirements set (Henson and 
Humphrey, 2010).  Another concern being that once integrated into a value chain, 
farmers may lose power within the chain (Oya, 2012). 
                                                          
1
 Those farmers with land of less than 0.4 hectare (one acre) in size 
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It is within this environment that I have investigated medicinal plant value chains2 
(MPVCs).  
MPVCs have rarely been examined in relation to international development and 
livelihoods and never before has any kind of analytical investigation been performed 
alongside more traditional methods of assessment.    
The central backbone of this thesis is underpinned by two published papers that 
describe the key elements of the work undertaken during my PhD, including the 
concepts of growing medicinal plants to improve livelihoods and the link between value 
chains and the production of a quality product (see appendix 1 and 2).  
The forerunner of these papers was a paper written prior to my PhD. This investigated 
the possibility of using a nuclear magnetic resonance (NMR) spectroscopy platform 
coupled with multi-variate analysis software to determine variation in the chemical 
composition of different saw palmetto (Serenoa repens (W.Bartram) Small) products 
(Booker et al., 2014). It was essentially a method development project which 
constituted a major part of my MSc in pharmacognosy. The results of the saw palmetto 
study demonstrated that it was possible to determine important differences in the 
products and that there was major variability between the products and the claims 
made on the labels.  
The PhD project that I began with LCIRAH, did not initially include any analytical 
component, and although being interdisciplinary in terms of bringing together expertise 
from several academic disciplines, was firmly rooted in the social sciences.  
The method development process focused on conducting fieldwork and accumulating 
data regarding value chains and the livelihoods of farm labourers, farmers and 
processors of the crude raw materials (the primary producers) in LEDCs.  
It was hypothesised that, consumers believe that through purchasing ethically sourced 
goods, they are making a contribution towards the welfare of primary producers in 
LEDCs and that the finished goods produced are in some way superior to others found 
on the market. In other words through fair trade, there is value addition. 
                                                          
2
 Value chain has generally superseded the term supply chain to indicate that as a product 
progresses from a raw material to a finished product, it may be subjected to various sequential 
inputs that add value to its market worth. 
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Although there has been limited work carried out previously concerning the value 
chains of medicinal plants (Wynberg et al., 2003, Kala, 2003, Alam and Belt, 2009, 
Shahidullah and Haque, 2010), my proposal was to analyse products that were 
produced through a vertically integrated value chain (VIVC)3 in order to provide 
evidence that there were tangible benefits for the consumer in addition to any benefits 
for the primary producers. This is the first time that this type of interdisciplinary 
approach to value chain analysis has been attempted and the results gained will help 
to determine the benefits and costs of certain kinds of industry arrangements. More 
specifically, the results will help determine whether the premiums paid to primary 
producers can be supported from an analytical perspective. Moreover it will provide 
evidence regarding the quality of products produced from these chains.  
From this point, my project developed two separate but interconnected arms, one born 
from the socio-economic sciences and one rooted in the natural sciences and 
phytochemical analysis. 
For the socio-economic arm, I conducted fieldwork in India to compare different value 
chains and determine how VIVCs may offer advantages to primary producers. The 
main driver for the fieldwork was to understand thoroughly and in detail how a 
medicinal plant could be affected through its progress along a particular value chain; 
what were the sources of the value addition and how this impacted on the various 
actors’ involved in the chain? During the fieldwork stage, I also collected product 
samples for analysis. The medicinal plant chosen as a case-study for the project was 
turmeric, Curcuma longa L. (Zingiberaceae). This was chosen following some initial 
research using an on-line questionnaire. 
For the analytical arm, it was necessary to further develop the method I used for saw 
palmetto analysis, in relation to curcuma species and turmeric products. Together with 
Professor Michael Heinrich, I supervised an MSc student (Chinenye Umealajekwu) 
who worked on developing a method for turmeric products. The MSc student submitted 
an initial 32 samples for 1H-NMR spectroscopy analysis and compared them using 
multivariate analysis software. This formed the basis of her MSc project. 
During my second fieldwork visit, I collected further samples for 1H-NMR spectroscopy 
and HPTLC analysis. This gave me a total of 52 samples for comparison.  
                                                          
3
 Where direct contracts are established that link wholesalers and manufacturers to farmers and 
primary producers. 
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I acquired some fresh turmeric rhizomes and with the knowledge gained from fieldwork, 
that turmeric is commonly stored for long periods of up to five years, I developed the 
hypothesis that the VIVC products examined would be more similar chemically to the 
fresh rhizomes than products obtained through the traditional market system and 
together with the ethnographical research regarding different value chains and how 
they impact on livelihoods, this forms the second central question of my thesis.   
In order to gain more detailed information on individual samples, I additionally analysed 
the turmeric samples using high performance thin layer chromatography (HPTLC). 
After some initial experiments, performed by scientists at CAMAG laboratories, in 
Muttenz, Switzerland, I travelled to CAMAG and performed a detailed analysis of the 
more variable samples as determined by the initial 1H-NMR spectroscopy and 
multivariate analysis experiments.  
1.1 Background 
This project specifically deals with MPVCs, but it is not possible to examine these in 
isolation without first considering value chains in general and how these sit within the 
global economic and political framework. 
Global economic integration (globalisation) is not a new concept. The imperialistic 
period from 1870s to 1914 is regarded by some as the first age of globalisation (Stone 
et al., 2000). However, some assert that it began as far back as 2500 BCE with the 
spreading of world religions, the building of empires and the establishment of trading 
cities that bridged continents (Al-Rodhan and Stoudmann, 2006). Whereas others 
argue that ‘historical globalisation’ is a term generally used to refer to the period post 
1492 and Columbus’s arrival in the Caribbean while on his quest to find spices in India 
(Hall, 2006). However, the history surrounding how and when globalisation arrived is 
not the only topic for contemporary debate and an equally contentious and important 
issue, and highly relevant to this project, is whether or not the impact of globalisation, 
particularly on actors in LEDCs has positive or negative outcomes.  
The Nobel-Prize winning economist Amartya Sen considers globalisation beneficial, 
arguing that,  
“Globalisation has enriched the world scientifically and culturally, and 
benefited many people economically as well”.  
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However others disagree and globalisation has been attacked by critics of free market 
economics, including the economists Joseph Stiglitz and Ha-Joon Chang, for 
perpetuating inequality in the world rather than reducing it (CR, 2013).  
One dimension of globalisation - trade in international commodities - has had a 
particular impact on the livelihoods of workers in LEDCs through changing domestic 
commodity prices and inducing the widespread reallocation of resources within national 
economies (O’Rourke and Williamson, 2000) and one key emerging area, where one of 
the  largest groups of workers have been affected - farmers and agricultural workers - 
can be seen in relation to the production of herbal medicinal products (HMPs) and 
associated commodities.  
Global value chain (GVC) analysis has been commonly applied to food sectors, 
including tea, coffee and cocoa (Fullbright, 2008, Gibbon and Ponte, 2005, Kaplinsky, 
2004) and on certain crops that provide a cash income e.g. cotton (Poulton et al., 
2004), but little work has been undertaken in this area regarding medicinal plants. 
There have been a range of concerns about the division of benefits in GVCs. And while 
VIVCs have been seen as providing greater support to primary producers (e.g. term 
contracts, technical assistance, inputs and credit), they have also been seen as a site 
of tension and struggle (Oya, 2012). 
Agricultural production is generally in developing countries, while consumption is both 
in developing and developed countries. Such a usage impacts on public health, both 
potentially in a beneficial but also detrimental way and it has a direct relevance in the 
context of ethnopharmacology, pharmacy and agrarian economics.  
While ethnopharmacology has historically been focused on the ‘traditional’ uses of 
‘medicines’ in LEDCs, it is now more and more accepted that the complex 
interrelationship between the producers, middlemen and consumers of these raw 
materials and products needs to be studied from a trans-disciplinary perspective 
(Heinrich et al., 2011). 
Ethnopharmacological research has generally focused on crude herbal drug material 
and their composition and effects or on the final products available to the consumer. 
There has been a limited focus on the interconnectivities that link producers, 
middlemen and consumers. It is an important area for research since the production of 
high value products is an emerging but poorly understood sector within many 
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developing countries, and particularly within India and China, both with a long history of 
trading in such commodities.  
Moreover, until now research studies in agrarian-economics has tended to focus on the 
production and delivery of food and cash crops and to a large extent value chain 
analysis has primarily been directed at the major products, e.g. tea, coffee and cocoa 
(Kaplinsky, 2004, Fullbright, 2008). The cultivation of medicinal plants may be a smaller 
industry compared with these ‘big three’ but it is an industry that provides employment 
to a large number of people in LEDCs and particularly those belonging to minority 
groups (Hamilton, 2004, Jha, 2006), and is a globally significant, but poorly recognised 
element of trade (see below). 
Traditional practices have chiefly involved collection of medicinal plants from the wild, 
with the rarest of plants often being the most sought after (Schippmann et al., 2006). 
However, many argue it is not the collectors who are the main beneficiaries but the 
middlemen who have a detailed knowledge of the market and who are able to sell the 
raw materials to the customer (Kala, 2003). 
According to the World Health Organisation (WHO), world trade in herbal medicine was 
estimated at US$83 billion in 2008 (Robinson and Zhang, 2012). Much of the trade in 
medicinal plants has been based within national market systems. While global trade in 
high value products like spices and medicines has a long history (e.g. the spice route, 
(Freedman, 2003)), over the last 30 years international trade has flourished and a main 
thoroughfare of this trade exists between Asia and Europe, the US and Australia. 
Although this global trade has potential benefits for the manufacturers and retailers of 
HMPs, what is less clear is the impact that international trade between these 
economically different geographical areas has on the livelihood of primary producers in 
LEDCs. It is argued that the adoption of the quality standards that are generally 
devised and implemented in more developed countries as a requirement to trade in 
HMPs will lead to benefits for those actors who are involved at the beginning stages of 
the value chain (Vasisht and Kumar, 2002) (although it may also lead to costs) 
(Henson and Humphrey, 2010, Patel, 2006).  
From a global perspective, Europe has been leading the way in terms of supplying high 
quality HMPs. Firstly with diverse national initiatives and with the development of 
quality standards, for example, in the European Pharmacopoeia and, in 2004, with the 
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introduction of the EU-wide, Traditional Herbal Medicinal Products Directive (THMPD), 
which requires well defined standards of quality and safety to be assured before a 
product can be released onto the market. Although as of December 2012, there has 
been over one thousand traditional use registrations licences granted in Europe (EMA, 
2013), there has been little interest in the scheme from Asian producers as it is often 
considered by stakeholders as being too costly to obtain product approval 
(Patwardhan, 2011). However in February 2012 the first product that was entirely 
produced in Asia (China), was approved for use in the Netherlands (Gilbert, 2011). 
Moreover organically produced medicinal herbs continue to be sought after for the 
export market and the Indian domestic market has also been developing an appetite for 
these niche products (Kumar Sharma, 2013). 
The situation is complicated further by the blurred boundaries between what constitutes 
a food (including health foods) and what constitutes a medicine. Such boundaries are 
often defined based on political decisions by regulatory agencies but are also driven by 
consumer choices. This is a reflection of a long and complex interface between food 
and medicine (Etkin and Ross, 1991) which is linked to legal, political, scientific, 
economic and socio-cultural debates. Therefore, compared with many food crops, 
medicinal plants may be more attractive economically (Alam and Belt, 2009, Sharmin, 
2004) 
Herbal medicines, nutraceuticals and functional foods have all been traded within the 
European community and beyond for hundreds and probably thousands of years 
(Freedman, 2003, Wicke, 1998). In modernity, the use of herbal medicines fell out of 
fashion, particularly during the 1960’s and 1970’s when pharmaceutical products were 
heavily promoted as being panaceas for health and dominated the market, particularly 
in the USA and Northern European countries (Walsh, 2010).  However, because of the 
high cost of pharmaceutical products, the rise in antibiotic resistance, and the common 
public perception that pharmaceuticals often have unpleasant side-effects, herbal 
medicines and other  complementary and alternative medicines began to make a return 
to favour (Ehrlich, 2011).  
HMPs are often regarded by the public as being safer than pharmaceuticals and free of 
side-effects (IpsosMORI, 2009). Unfortunately, poor quality control and lack of effective 
regulation has led to numerous cases of adverse reactions to HMPs, sometimes with 
serious or even fatal consequences (MHRA, 2008), confirming that these products are 
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not free of dangers and that there is an urgent need for high quality products, 
manufactured and administered by well qualified and well regulated professionals.    
Countries such as Germany have a strong tradition of using HMPs and have a well-
developed manufacturing industry within a well regulated system, where the majority of 
these products are mainly regarded as medicines and prescribed by bio-medical 
doctors (Harrison, 1998) or as over the counter (OTC) products, commonly sold in 
pharmacies. Whereas in the UK, a country also with a strong herbal tradition, an 
exemption in the 1968 medicines act, has resulted in herbal practitioners being the 
main prescribers of herbal medicines. What distinguishes UK herbalists from herbalists 
in other European countries is arguably in their level of training and level of 
professional (voluntary) regulation.  
In many parts of Europe herbal medicine is typically practised either as part of 
mainstream medicine, by bio-medically trained doctors or according to ‘traditional 
knowledge’ by practitioners who are generally self-taught or have gone through a form 
of apprenticeship. The typical route for UK herbalists is through academic qualifications 
set at BSc or MSc level (AGCAS, 2012), obtained alongside practical training as 
determined by the relevant professional bodies. This has allowed for a closer dialogue 
to develop between more bio-medically focused approaches to the study of plants and 
the medicines derived from these, leading to the emergence of new terms such as 
phytomedicines and phytomedicine practitioners.  
These terms suggest a move away from more traditional practices, that have 
sometimes been criticised as being non-scientific and non-evidence based, towards a 
more integrative approach that combines key elements from traditional knowledge and 
bio-medicine. 
Over-the counter type trade, however, has been generally delivered by a mixture of 
health food shops, supermarkets and internet trade which has left the consumers with 
little guarantees of the products being fit for purpose. The introduction of the European 
directive for herbal medicines, which came into effect in April 2011, following a five year 
transitional period, has resulted in an increase in product quality for those products sold 
through retail outlets but has had less of an effect on products available from outside 
the EU and marketed through the internet (MHRA, 2013a).  
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The effect of these new regulations on products originating outside of the EU and 
particularly in Asia has been substantial, with protests being voiced from trade 
associations and government officials. This has been particularly noticeable in China 
and India, two countries who have had a long history of trade in herbal medicinal 
products with the UK and the rest of Europe (Das, 2013, InfoseekChina, 2011) 
The main problems highlighted and voiced by manufactures are that the more 
sophisticated inputs involved in meeting the standards and the costs attached to these 
registered products are seen as being too high for many companies that operate within 
Asia and particularly within India (Patel, 2006).  
These concerns are similar to those held generally on the impact of standards (Henson 
and Humphrey, 2010).  
However, changes in regulatory requirements or the setting of higher entry bars, 
although presenting many challenges to the industry, can also offer opportunities. An 
increase in quality standards is often regarded as a positive step by consumers, 
particularly when related to food or medicines and these improvements in quality and 
safety can be regarded as adding value to a product. If companies are able to use 
these added requirements to their advantage it may be possible for new and more 
sustainable enterprises to be established, particularly if there is co-operation between 
Asian and European actors.  
The creation of VIVCs is one way to achieve this co-operation and for producers in 
LEDCs to gain access to highly regulated markets. The investigation of the different 
chains and the impact these chains have on producers and the resulting products, 
forms the main aims of this project, which investigates the link between the 
establishment of a VIVC and the impact this may have on the livelihoods of primary 
producers in India and the quality of a selected product produced through this chain.  
I use a mixed methods approach, employing fieldwork investigations and, for the first 
time, use analytical laboratory techniques to investigate different HMPs in relation to 
the value chain from which they originate.  
The provenance and traceability of the raw materials used in HMPs has always been 
problematic (Newmaster et al., 2013). It is common practice for plants to be collected 
from the wild or cultivated on small farms and then either stored, for sometimes long 
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periods, sold in the local market or auctioned at one of the designated auction sites 
(Alam and Belt, 2009, Kala et al., 2006, van de Kop et al., 2006). Middlemen are 
usually involved in the supply of plant material to herbal manufacturers (Shahidullah 
and Haque, 2010) and any information regarding its origin and primary processing is 
mainly lost. This lack of a traceable supply chain can lead to uncertainty (from buyers 
and regulatory groups) regarding the authenticity of products and the possibility of 
contamination or adulteration.  
The consequence of this situation can be that the buyer is forced to perform additional 
testing, leading to downward pressure on the seller to reduce the price of the crop or 
even that the material is deemed not of an acceptable standard for export. Conversely, 
in cases where the product is exported it can result in sub-standard material being 
available on the high street. 
An alternative to this approach has been the implementation of VIVCs where contracts 
are made between the primary producers in LEDCs and the secondary manufacturers, 
typically located in more economically developed countries. 
A VIVC can be defined as when ‘a lead organisation’ is responsible for two or more 
intertwined steps of the manufacturing or value chain process (Strategy-Train, 2009). 
Connection to a VIVC has advantages for the farmer in that a premium is paid for the 
crop above the market price. Moreover, order size and type of crop grown can be well 
defined in advance, allowing for an effective planting and cultivation strategy to be 
developed. For the buyer, the advantages include that the crop has traceability, a price 
has been agreed in advance, and so market fluctuations become less important, and 
greater confidence that good cultivation practice has been employed. However, in 
order for this to work well, good governance is essential. For the farmer, a certain 
amount of freedom is given up and the lead firm gains power in, and greater control of, 
the chain. Conversely, once tied into the chain, the buyer is ‘locked in’ for a specified 
time period and so can also lose a certain amount of operational freedom. Moreover 
the costs involved in effectively managing a VIVC can be high.  
India was chosen as a research site as it is a fast developing country with a long 
tradition of medicinal plant use. It has an established HMP manufacturing base and a 
thriving export market (Polshettiwar, 2006).  
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Following market research, using an on-line survey to investigate a self-selecting 
group’s knowledge, attitudes and preferences towards traditional Asian medicine 
(TAM) and Asian medicinal herbs, turmeric (Curcuma longa) was chosen as a suitable 
case study. 
Turmeric’s use as both food and a medicine presents an opportunity to show how a 
value chain may be different for a food and a drug and how investing in quality can lead 
to genuine value addition. There are concerns over the quality of material available 
commercially. It is acknowledged that the chemical composition is variable and miss-
identification of species and adulteration are frequently reported problems (Dixit et al., 
2009, Govindarajan, 1980). This situation is not conducive to the development of a 
sustainable export market.  
If it can be shown that the establishment of a VIVC can lead to a better and more 
consistent quality profile, if governance is appropriate, this could have a beneficial 
impact on primary producers. The contracted farmers can benefit from integration 
through having an assured income, receiving essential inputs, including training, and 
being paid a premium for producing crops using good agricultural practice (GAP).  
Primary producers may also realise some benefits; working in a more regulated 
industry and one that is integrated into a structured value chain, where the end retailer 
is able to use ‘fair trade’ as a means to market and promote products. These benefits 
are likely to be in the form of improved conditions, better training and more work 
stability; as in order to produce a quality product, it is necessary to have a workforce 
that is better trained in and is able to implement GAP and good manufacturing practice 
(GMP). This usually translates into having a work force that is experienced and well-
motivated.  
In order for these benefits to be realised and to be sustainable, there needs to be some 
evidence to suggest that the quality driven strategies, policies and practices that are 
implemented along the chain can lead to a final product that is ‘superior’ in a 
measureable way to other products on the market that are obtained through the 
traditional route of supply. A major objective of this study is to determine whether this 
evidence exists and what is the best way to measure it? 
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Rather than use a conventional approach, my aim has been to assess quality in the 
context of value addition. There are many products on the market, all claiming to have 
particular benefits. However, in an attempt to increase the concentration of one 
particular compound, other (important) compounds may be lost. Moreover, the safety 
implications of developing ‘high potency extracts’, may not have been full considered.  
Although curcumin has been focused on as being the main active ingredient found in 
Curcuma longa, the bio-availability of this compound is poor (Shoba et al., 1998). Other 
research has suggested that it is the combination of curcuminoids that is important 
(Ahmed and Gilani, 2013).  
Curcuminoids belong to the group of di-phenylheptanoids, having a phenyl-C7-phenyl 
skeleton. Typically these polyphenols are present in 3-15% of Curcuma longa rhizomes 
with curcumin as the principal compound. Commercial ‘curcumin’ is usually made up of 
a mixture of three curcuminoids made up of approximately 71.5% curcumin, 19.4% 
demethoxycurcumin and 9.1% bis-demethoxycurcumin (Li et al., 2011). 
There are also other groups of compounds present, e.g. volatile oils and 
polysaccharides that may have therapeutic effects. 
The main sesquiterpene constituents found in the essential oil include, ar-tumerone, α-
tumerone and β-tumerone. Tumerone being responsible for turmeric’s distinctive aroma 
(Ravindran et al., 2007). Other compounds that have been isolated from the essential 
oil include α-felandrene, 1,8-cineole, ar-curcumene, α-zingiberene, β-sesquifelandrene, 
(Z)-ç-atlantona and (E)-ç-atlantona (Chassagnez-Me´ndez et al., 2000) 
The main water-soluble components found in turmeric are polysaccharides. The 
polysaccharides present in turmeric have also been suggested as having some anti-
inflammatory action (Tohda et al., 2006).  
Turmeric has a long history of use as a food and medicine and has been used in its 
natural unprocessed form to treat a wide range of conditions. Often modern processing 
techniques can change the composition (and therefore the medicinal properties) of a 
raw herbal drug. I have used a concept of quality that compares products to the 
unprocessed, fresh material. This strategy allows for a product to be assessed in terms 
of its ability to retain compounds and importantly allows for a potential marketing 
structure that can be linked to ‘value-addition’ and ultimately, livelihoods.  
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In order to investigate the complex and variable phytochemistry across a wide range of 
samples, metabolomics offers some novel and scientifically robust opportunities. It 
provides what has been called a 'holistic view' of the metabolites of a set of organisms 
(Kim et al., 2011) and has been used in a wide range of research fields like plant 
biotechnology, ethnopharmacology, ecological toxicology and plant physiology e.g. 
(Verpoorte et al., 2005, Kim et al., 2011, Liu et al., 2011, Michl et al., 2011), and is 
ideally suited for comparing large number of samples as one would encounter them, for 
example, along a value chain.  
At the same time it is a method which as such is not validated and data can potentially 
be manipulated in a biased way, and so it needs to be compared to a standard method 
like HPTLC, widely used in the authentication and quality control of herbal substances 
(Reich and Schibli, 2007). 
I have used these analytical techniques in combination in order to provide a depth of 
information that is unique. Moreover, never before have the results of a laboratory 
investigation been directly linked to value chain analysis and ultimately the livelihoods 
of producers. 
 
2.0 Thesis statement 
The livelihoods of primary producers of herbal medicines, in India, can be linked to the 
type of value chain that they are contracted to. Moreover, the value chain and its 
endogenous variables have a direct impact on the quality of the final herbal medicinal 
product. 
 
3.0 Review of the current literature 
Literature was reviewed using the University College London School of Pharmacy 
(UCLSOP) Library databases, Embase and Web of Knowledge and performing on line 
searches using, Google, Google Scholar and Pubmed. Hard copies of books and 
journals were accessed via the UCLSOP library, the School of Oriental and African 
Studies (SOAS) library and the Libraries of The Royal Society of Chemistry (RSC) and 
The Linnean Society. Grey material was accessed from the internet and from local 
publications during the fieldwork stages. 
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3.1 Traditional Asian medicine  
TAM covers a wide range of treatment modalities from many different countries. Most 
Asian countries have a long history of using traditional herbal medicines, which are 
more recently becoming popular in the US and in Europe (IpsosMORI, 2009, NIH, 
2007, UOM, 2011). 
The two most well-known of these are traditional Chinese medicine (TCM) and 
traditional Indian medicine (TIM), the most commonly recognised sub section of TIM 
being Ayurveda4 (NIH, 2009). Although there are subtle and sometimes major 
differences between TCM and TIM, their underlying medico-philosophy is similar and 
distinguishes them from more orthodox bio-medical practice.  
According to many of the world’s medical traditions, including TAM, disease firstly 
begins with minor imbalances within the body. Often the body will correct these 
imbalances naturally through homeostasis and physiological regulatory processes. 
However, if the body is weak or continually subject to external influences, which can 
prevent a return to a healthy state, then over time, disease processes will manifest, 
eventually leading to symptoms that will be well recognised through bio-medical 
diagnostics. The primary focus of TAM therefore is to treat the individual before any 
major symptoms have arisen. In TAM philosophy, no one is considered in perfect 
health, just that some people are less sick than others. This sentiment is summed up in 
an ancient Chinese text; 
“Trying to cure disease once symptoms have arisen is like digging a 
well once you are already thirsty or forging a warrior’s spear once the 
battle has already begun...”  
Source: Yellow emperor’s classic of internal medicine (Anon., 947–951 CE) 
This is not to infer practitioners of TAM only deal with healthy individuals, but that the 
emphasis is ideally on prevention rather than on cure. This thread of traditional medical 
philosophy continues when treating those with symptoms, where a practitioner of TAM 
will attempt to establish the underlying cause of disease based on traditional medico-
philosophical principles.  
                                                          
4
 Ayurvedic medicine is the most common system of traditional medicine found in India and 
stems from ancient texts of the Hindu religion. Other Indian traditional medical systems include 
Unani, derived from Greek-Islamic medicine, and Siddha, the folk medicine of Southern India. 
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This, what is often perceived by the general public as a more preventative, holistic way 
of treating human beings, has become increasingly popular in North America, Australia, 
New Zealand and many European countries and has led to significant increases in 
exports of traditional Asian medicines (Vasisht and Kumar, 2002) along with other non-
plant based practices such as acupuncture, tai chi, yoga, and various forms of Asian 
massage and physical therapy.  
In the UK there are well over 10,000 practitioners of acupuncture alone, affiliated to the 
three largest professional bodies (The British Acupuncture Council, The British Medical 
Acupuncture Society and The Acupuncture Association of Chartered Physiotherapists).   
These health focused interventions have begun to develop an evidence base (Kayne 
and Booker, 2010), indicating that they may be useful in the following areas:  
Oral herbal preparations have been shown to be beneficial in the treatment of eczema, 
atopic dermatitis, allergic rhinitis, primary dysmenorrhoea and in alleviating short-term 
side effects of chemotherapy (Sheehan and Atherton, 1992, Hon et al., 2007, Xue et 
al., 2003, Kotani et al., 1997, Zhang et al., 2009). The British Medical Association 
concluded in their report on acupuncture that there was clear evidence for its efficacy in 
the treatment of nausea and vomiting post-operatively and during chemotherapy, back 
pain, post-operative dental pain and migraine (Silvert, 2000) and there is evidence that 
tai chi reduces injury through falls and improves mobility of the ankle, hip and knee in 
people with rheumatoid arthritis (Han et al., 2004, Wolf et al., 2003) 
However, poor practice and a lack of regulatory standards can also have the potential 
to do harm and there have been numerous instances of quality problems and poor 
practice, including heavy metal and pesticide contamination, misidentification of herbal 
ingredients and the addition pharmaceutical active ingredients (MHRA, 2013a). This 
has led to the UK government proceeding with plans to subject herbal medicine 
practitioners to further regulation and a new regulatory framework.  
On 16th February 2011, the Secretary of State for Heath, Andrew Lansley announced 
in a written statement to the UK Parliament, that all UK practitioners prescribing herbal 
medicines are to be statutorily regulated via the Health Professions Council. The 
Health Secretary went on to explain that,  
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“This would ensure that practitioners would meet specified 
registration standards, giving practitioners and consumers 
continuing access to unlicensed manufactured herbal 
medicines to meet individual patient needs after the introduction 
of new EU legislation after April 30th this year” (Lansley, 2011). 
This further regulation of the herbal profession will come with some expectations 
attached and the Medicines and Healthcare Products Regulatory Agency (MHRA), the 
UK’s medicines’ regulators, have indicated that they would like to see a positive list of 
plant medicines established that can be used safely in daily practice (MHRA, 2006). 
The plants and plant products that make up this list will be required to satisfy standards 
of quality and safety appropriate to the United Kingdom.  
For plant material obtained from outside the European Union, this is likely to present 
some challenges but also some opportunities for Asian producers to benefit from a 
regulated and quality driven medicinal plant industry (see chapter 1.0).  
However, there has been some opposition to the statutory regulation of herbalists, with 
objections being raised that it lacks a credible evidence base and may give false 
credibility to the profession (Ernst, 2012). This opposition, coupled with a lack of a 
single voice from the profession, with a proportion of herbalists themselves being ‘anti-
regulation’ (Jones and Evans, 2013) has led to a delay in the process. With further 
consultation planned, the prospect of full statutory regulation is far from being assured, 
with ‘softer’ regulatory options being considered.  
The government’s stance in May 2013 was, 
“The legislation around this policy is complex and there are a 
number of issues that have arisen which the government needs 
to work through. I appreciate that the delay in going out to 
consult on this matter is causing concern, but it is important that 
any new legislation is proportionate and fit for purpose” 
(Hansard, 2013) 
The outcome of these proposals will have a direct impact on the herbal profession and 
the HMP manufacturing industry in the UK and, to a lesser extent, the rest of Europe. 
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This in turn will impact on both home producers of medicinal plants but also suppliers 
outside of Europe and particularly in Asia. 
3.2 The value chain 
The global commodity chain literature has moved away from the term commodity chain 
or supply chain in favour of the term value chain. The latter is thought to better describe 
a wider variety of products and services, while also focusing on the distribution of 
benefits. As a result, the global commodity chain approach is now known as GVC 
analysis (Gibbon and Ponte, 2005).  
“Value chain analysis describes the activities within and attached to 
an organisation, and relates them to an analysis of the competitive 
strength of the organisation. Therefore, in economic terms, it 
evaluates that value each particular activity adds to the organisations’ 
commodities or services. This idea was founded upon the insight that 
any company is more than a random assembly of machinery, people 
and finance and only if these things are arranged into definable 
systems will it become possible to produce something for which 
customers are willing to pay a price. Therefore, it is argued that the 
ability to perform particular activities and to manage the linkages 
between these activities is a source of competitive advantage” 
(Recklies, 2001).  
Changes in production, distribution and finance systems, in synergy with the 
globalisation of markets and the spread of information and communication 
technologies, suggest that more attention needs to be paid to both external and internal 
linkages within a company structure. The concept of the value chain allows us to shift 
the focus from manufacturing only to the other activities involved in the supply of goods 
and services, including distribution and marketing.  
“Value chain research focuses on the nature of the relationships 
among the various participants involved in the chain, and on their 
implications for development. At any point in the chain, some degree 
of governance or coordination is necessary in order to take decisions 
on how the chain should be managed effectively” (Giuliani et al., 
2005).  
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However, value chain analysis has also been criticised for not giving enough 
attention to wider social, economic and political factors. Its strength lies in 
describing the value chain linkages but it does not explain how and why these 
linkages have developed. And so any research investigating the value chain 
should also include a wider exploration of these surrounding issues. 
3.3 The medicinal plant value chain 
Value chain analysis has been applied to a variety of consumer goods but only recently 
has it been applied to medicinal plant production, (Wynberg et al., 2003, Alam and Belt, 
2009, Kala, 2003, Shahidullah and Haque, 2010, van de Kop et al., 2006)   
By examining MPVCs, it will allow us to better understand the role of different actors 
and inputs in the chain and their influence over chain management. Understanding the 
process is a vital step towards suggesting any meaningful strategies for improvement. 
In one example of an investigation into new opportunities and challenges for Ayurvedic 
small businesses, Torri (2012) argues that the current structure of the supply chain, 
being one of high fragmentation, renders it unable to improve the livelihoods of 
producers and highlights the need for community based enterprise initiatives to better 
represent the rights of farmers and small scale producers at the community level.  
The cultivation of medicinal plants is a relatively new industry and wild collection 
represents the main route of supply in terms of the number of species collected 
(Schippmann et al., 2006, Kuipers, 1997). On many occasions, wild medicinal plants 
are preferred by traditional healers and consumers over the cultivated ones (Giblette, 
2006), as there is a general feeling that wild plant species are more clinically effective.  
Researchers, Kala et al. (2006) and Manish (2011) claim that worldwide, medicinal 
plant species are depleting at a rapid pace due to over-collection from their natural 
habitats. The collection and marketing of medicinal plants from the wild is an important 
source of livelihood for many of the poor in LEDCs. In Nepal, more than three hundred 
thousand households are engaged in the collection of medicinal plants (Alam and Belt, 
2009). It is claimed that up to 15,000 species of medicinal plants are globally 
threatened (Hawkins, 2008) and two ways are identified to conserve threatened 
species; firstly by tightening restrictions on collection practices, and secondly by 
cultivation on a large scale (Schippmann et al., 2002). 
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3.4 Medicinal plant value chains in Asia 
Kala et al. (2006) assert that the marketing system in India is largely unregulated and 
inequitable. The medicinal plant cultivators are generally the marginal farmers and 
labourers. They receive a cash income to meet their basic requirements for food, 
health and the education of their children. They are often unaware of the real market 
prices of many of the medicinal plant species. Often it is difficult for farmers to sell 
certain herbs due to their lack of knowledge of the marketing system and conversely 
many medicinal plants are destined to be traded through illegal channels. Other 
constraints are slow rate of production, a long gestation period, shortage of cultivation 
technology, low yields, unscientific harvesting, poor processing, lack of quality control, 
scarcity of good manufacturers and poor marketing infrastructure.  
In the paper by van de Kop et al. (2006), a review of fieldwork conducted in 
Uttaranchal, one of India’s poorest states, the authors document that resource-poor 
people collect plants from the wild to supplement their low income. They point out that 
high risks, transaction costs and a lack of trust amongst chain actors prevent small-
holder producers from taking up the cultivation of medicinal plants and suggest that 
public-private collaboration as a way of reducing these constraints and secure market 
accessibility for small producers.  
They analyse the opportunities for and the constraints on developing medicinal plant 
chains and aim to identify the role of medicinal plant chains in poverty reduction.  
Most of the medicinal plants in this area are collected from the wild. Permits are issued 
to co-operative groups in the area, which in turn employ contractors to organise 
collection. The contractors employ collectors, usually land owning farmers or landless 
labourers. The contractor can sell the collected plants either to the local co-operatives 
or directly to independent traders after paying royalties to the co-operative.  
The co-operatives sell either to local agents or wholesalers, traders in large cities, or to 
drug manufacturers. The traders supply the domestic market and international markets.  
The authors suggest that in the value chain, the collectors and local contractors are in 
a weak position as they cannot sell directly to the large trading companies in the cities, 
and depend on the local traders for marketing. This weak position often results in them 
receiving a considerably lower price than the true market price.  
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Cultivation is seen as a way of breaking free from some of these ties and small scale 
projects have commenced in the area. There are difficulties and risks attached to 
cultivation and public-private collaborations are suggested as a way of minimising 
these constraints. However, these collaborations have remained small and further 
promotion, regulation and investment is needed if these ventures are to produce a 
meaningful result (Alam and Belt, 2009).   
Alam and Belts work focused on a project in Uttarakhand, northern India, where 80% of 
the population rely on agriculture as their main economic activity and 40% of people 
live below the poverty line. It was proposed that the cultivation of a medicinal plant, 
kutki, Picrorhiza kurroa Royle ex Benth. Scrophulariaceae, would benefit the farmers 
financially, provide social benefits and help preserve wild species. The European buyer 
would also have a secure supply of the plant from a fully traceable source. Although 
the authors claim that this was the first initiative of its kind between Indian farmers and 
a European company, the VIVC investigated during the fieldwork stage of this project 
has similar contractual agreements in place with farmers in India. 
The Uttarakhand project produced disappointing results and in their paper the authors 
highlighted the reasons for this as being poor quality of planting material, planting on 
small, poorly irrigated plots, and the emergence of apples as a profitable cash crop, 
resulting in farmers switching from kutki to apples.  
Alam and Belt concluded that the cultivation of medicinal plants is more difficult than 
usually suggested in the scientific literature and government promotional material and 
stress the importance of agencies and non-governmental organisations (NGOs) taking 
these difficulties into account and take steps to minimise these. The authors further 
argue that a thorough technical and economic feasibility study of the value chain, long 
term involvement of governmental and NGOs, and an understanding of the prevalent 
farming system are necessary to ensure the success of the chain.  
Conversely, in a project conducted in Bangladesh, Shahidullah and Haque (2010) 
appear more optimistic with respect to the economic potential of medicinal plants and 
suggest vertical integration as a vehicle to benefit and empower producers and 
processors at the beginning of the value chain.  
The Bangladesh project indicated that the primary and wholesale secondary markets 
were dominated by middlemen and their study challenged the view that medicinal plant 
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cultivation was only appropriate for relatively well-off people with better access to land, 
capital and information.  
The authors built on previous work by  researchers van de Kop et al. (2006) and argue 
that some of the mechanisms employed in developing and sustaining institutional 
relationships may also apply equally well to defining the MPVC and list contracts, 
quasi-vertical integration (an especially close and long term relationship), tapered 
vertical integration (when a company sources inputs externally from independent 
suppliers as well as internally within the same company), cost plus agreements (where 
the contractor is paid a negotiated amount regardless of incurred expenses), joint 
ventures and strategic alliances as examples of these potential relationships.  
Moreover, they argue that the benefits of an integrated value chain are numerous.  
“It enables primary producers to become active participants in the 
process, it removes market access barriers, and it results in better 
commercialisation of products and is attractive to companies as they 
can have greater control over quality and supply.”  
In their study, Shahidullah and Haque, contrary to previous views, found that the 
cultivation or production of medicinal plants could play an important role in improving 
the livelihoods of those poor or very poor people who may own only small pieces of 
land.  
They argue that in order to sustain growth in medicinal plant production,  
“A fair distribution of the gross margin to the primary producers is 
necessary.”  
In the value chain system examined by Shahidullah and Haque (2010), it was found 
that downstream buyers, especially manufacturers and consumers pay most of their 
money for middlemen’s value additive opportunistic pricing due to inherent weaknesses 
in the chain.  
A vertically integrated chain, with only producers and processors as commercial actors 
and NGO’s as promoters could create a better and more equitable situation.  
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However, there are some studies that suggest that vertically integrated chains, 
particularly ones that are dominated by a powerful company can lead to negative 
effects on the livelihoods of small producers.  
This has been illustrated in the work of van Niekerk and Wynberg (2012), where the 
authors present evidence to suggest that (based on their assessment) the monopolistic 
behaviour of one large German company threatened the livelihoods of farmers in South 
Africa (for a single botanical drug) and that there were major inequalities between the 
bargaining powers of the local manufacturers and the primary producers.  
And so the literature presents a different and sometimes conflicting view of the 
potential of VIVCs. 
 3.5 Land and Livelihoods 
In the context of international development, a common view has been that the answer 
to global poverty lies in the promotion of farm-based activities and in the redistribution 
of land resources (IFAD, 2008) and this level of thinking has often set the trajectory for 
development interventions and the introduction of new and more efficient technologies 
for increasing output.  
However, this fundamental precept does not go unchallenged and Rigg (2006) 
presents the argument that non-farm activities are becoming central to rural livelihoods. 
Quantitative data exists to shore up this hypothesis. One African study conducted by 
the De-agrarianization and Rural Employment (DARE) research programme 
undertaken in six African countries during 1996 to 1998, found non-farm activities 
contributed to 60 to 80 per cent of rural household income (Bryceson, 2002) and in 
India, the National Council of Applied Economic Research conducted a study in 240 
villages across 16 states between 1971 to 1999 and found that the share of non-farm 
incomes increased from 19 per cent to 48 per cent of total income (Foster and 
Rosenzweig, 2004). As a result, there needs to be greater consideration of who farms 
and who is involved in non-farming activities.  
The commercialisation of non-timber forest products and in particular medicinal plants 
is a means for rural communities  to increase their incomes and consequently their 
standard of living but as pointed out by Wynberg et al. (2003),  
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“As well as bringing opportunities for rural growth, there are also 
pitfalls to be considered and the benefits obtained from 
commercialisation must be weighed against any negative impacts on 
livelihoods and cultures that are integrated within a social network of 
subsistence farming.”  
In India, approximately 84 per cent of rural households operate less than 0.4 hectare of 
land (Turner, 2004). During 1993 to 1994 and 1999 to 2000, the growth of jobs in the 
farm sector was only 0.2 per cent (Kisan, 2006).  
According to Mitra and Josling (2009), agricultural wage, which directly impacts on rural 
living standards, is a complex endogenous variable and is influenced by several other 
variables in turn. Rural-to-urban migration may cause labour shortages in rural areas, 
particularly during the peak agricultural seasons, and this tends to raise wages.  
Farm labourers, however, who find employment in less-developed regions and help 
other workers’ migrate by bearing the initial costs of migration, take for themselves a 
percentage of the workers income and thus the actual gains to work due to rise in 
demand, get substantially suppressed. On the other hand, the rural work market and 
the credit market are often interconnected, and thus it is difficult to make a meaningful 
separation between the wage earned from the work undertaken and the costs and 
benefits associated with long term loans received from the employer.   
There is little validated data in the literature on the production of cultivated medicinal 
species since these are not recorded at the grass root level for want of adequate 
knowledge and interest by the record keeping authorities. All species are considered as 
one commodity. The area of 2,720,150 hectares listed under important medicinal 
plants, are estimated on the basis of consolidation made from the fragmented 
information available in literature.  
The National Medicinal Plant Board, Government of India, has identified 32 prioritised 
medicinal plants. The cumulative annual demand of all thirty two plants was estimated 
to be 141,398 tonnes  during 2004 to 2005 (Commission, 2007). 
In order to have a point of reference when examining the effects that a particular value 
chain has on livelihoods, it was important to establish what the current literature 
revealed about current wage distribution and working practices and how different 
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endogenous factors may impact on livelihoods. Improving the rural wage in India has 
been found to be the single most significant factor in reducing poverty among the rural 
poor (the national minimum wage is 100rps, (US$1.6 per day)) (Singh et al., 2012).  
One of the case studies examined during the fieldwork stage cultivates medicinal 
plants organically and therefore the current literature available in this area is of 
particular importance.  
The value chain itself is one factor to consider, but what are the others?  
1. The size of farm 
It is known that plantation workers earn less than other farm workers but is this 
connected with the size of the farm?  
In India, small farms account for approximately 84 per cent of all operational holdings 
and are responsible for farming 42 per cent of the country’s total cultivated area 
(Turner, 2004). Small farms maximise labour use, add maximum value to their 
products, and have higher yields than large farms (i.e. are more efficient).  
2. The geographical location 
Some states are very poor and the wages reflect this - what evidence is available to 
back this up? Is there much difference in wages between Karnataka and Tamil Nadu 
and could this explain why the traditional method farm workers (case study 1) were 
paid more than the vertically integrated workers (case study 2)? Gujarat, a region in 
western India which achieved a 10 per cent annual growth in agriculture over the last 
decade, has a lower average wage for both permanent and casual rural labour than 
other Indian states such as Maharashtra, Andhra Pradesh, Tamil Nadu and The 
Punjab. It was also lower than the national average wage rate in 2007 to 2008. Farm 
labourers in West Bengal earn wages as low as 70 rupees (approximately US$1.0 per 
day) for male workers at high season (Barua, 2010).  
The difference in wages between genders in the northern states is much lower than in 
the states of southern India (Mahajan and Ramaswami, 2012).  
A relatively higher growth of real wages in the southern states and a negative growth of 
real wages in Punjab and, to a lesser extent, Haryana, is a reflection of the agriculture 
performance of these states. By and large, the investigation of figures suggests that the 
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increase of real wages for agriculture workers has been significant. Agricultural 
productivity however, increased only marginally during the 1990s. This further raises 
the issue of what exactly determines the real wages for agricultural workers in the 
country? (Jha, 2006). 
3. Wage variation within a state 
Barua’s survey found that wages in Nadia, West Bengal varied due to the season and 
ranged from 40 rupees in low season to 80 to 90 rupees per day for men and 35 to 50 
rupees for women. In Jalparguiri, West Bengal high season wages ranged from 70 to 
80 rupees per day for men and 50 rupees for women (Barua, 2010). 
4. The type of crop 
The type of crop being cultivated, e.g. organic, non-organic, niche product, rare plant, 
and CITES-controlled, can have significance to wages. There is evidence that higher 
wages are paid for picking difficult crops in harsh conditions e.g. tobacco.  
“The wages for agricultural workers (known as coolies) vary in men 
from 120 to 220 rupees per day and 80 to 100 rupees per day for 
women in the Tirupur region. One exception is in the area of tobacco 
growing where a male worker can earn up to 300 rupees per day. 
This is because the tobacco season is relatively short and the picking 
and processing is unpleasant” (Carswell, 2010). 
 “The organic farming movement in India suffers from lack of 
adequate institutional support in the areas of research, extension and 
marketing. Organic farming requires more scientific support than 
chemical farming. Internationally accepted certification procedures 
need strengthening and must be farmer-friendly and affordable. 
Organic farming zones could be identified, like some of the hill areas 
and islands where currently chemical fertiliser use is very low, and for 
medicinal plants where the use of chemical pesticides and fertilisers 
is not advisable. Food safety and quality specifications should 
conform to the Codex Alimentarius standards since there are 
occasional reports of heavy metals being present in organic foods. 
Subsidies or loans similar to those given to farmers to buy chemical 
fertilisers / pesticides should be available for organic manures like 
39 
 
farm yard manure, compost and bio-fertilisers and bio-pesticides also. 
Farmers engaged in organic farming should be linked to niche 
markets where they will obtain a premium price, in order to 
compensate for any loss in yield” (Kisan, 2006).  
 5. The value chain 
VIVCs can pay premiums (Fairtrade, 2010, Nelson and Pound, 2009). However, 
pressure on small farms in value chains to compete on the open market may 
encourage the exploitation of workers in terms of the wages smallholder-employers can 
offer; the working conditions they can provide; and the temptation to use child labour in, 
for example, cotton production for domestic and multinational firms in India (Nelson and 
Pound, 2009).  
There is an argument that contracting agri-business firms do not pay attention to or 
take responsibility for labour issues. They protest that they do not contract farmers 
directly because contract farming in India’s seed sector is conducted through seed 
organisers – which are usually small local companies, large farmers or farm produce 
traders. However, Singh et al. (2012) suggest that large agri-businesses leverage costs 
onto smallholders through mechanisms like contract farming, which is based on the 
exploitation of hired and family labour and that farm and allied labour is not seen as a 
stakeholder in agriculture at all and is treated as just an element of production. 
Therefore, the livelihoods and concerns of paid agricultural labourers are more or less 
ignored in discussions of smallholder agriculture.  
6. The value of the end product 
It has been observed in the grocery market that the end price of a commodity cannot 
always be positively correlated to producer income. For example, retail coffee prices 
have remained relatively stable, despite producer prices dropping to less than one third 
of their 1960 level leading to accusations of flagrant profiteering from the exploitation of 
millions of smallholders (DFID, 2004).  
7. Caste / gender 
Nearly 70 per cent of Indian rural women are employed in agriculture and they are 
responsible for 60-80 per cent of food production. Most of the women cultivators are 
involved in food crops rather than cash crops since cash crops need more marketing 
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efforts, which are traditionally taken care of by men. Most of the women farmers are 
marginal or small farmers, landless tenant farmers and farm labourers. They don’t have 
enough land to cultivate, have low capital and poor access to credit, and have less 
knowledge of, and limited access to, innovative technologies (Yashwanth, 2011).  
‘Scheduled tribes,’5 account for approximately nine per cent of the total population of 
the country. A majority of minority groups across the country are dependent on forests 
and animal husbandry for their livelihoods. These include cultivation (shifting cultivation 
in many cases), collection of fuel, fodder and a range of non-timber forest produce. 
According to Kisan (2006), tribal farmers are among the most disadvantaged category 
of farmers.  
There is a significant gender gap in agricultural wages and working conditions in the 
developing world. In India in 2004 to 2005, women working on farms earned only 70 
per cent of what men earned. Over 80 per cent of women did not get the minimum 
wage, compared with 41 per cent of men (Singh et al., 2012).  
8. Do some of the farmers also own livestock? 
Livestock production is one of the important sources of livelihood for farmers in India. 
The contribution of livestock, especially in the drier regions, where crop cultivation has 
limited possibility, is very well recognised (FAO, 2013). Livestock, including poultry, is 
the second major land-based livelihood, contributing 26 per cent of the agricultural 
GDP in 2004 to 2005. It is clear that livestock and livelihoods are very intimately related 
in India and that crop-livestock integrated farming is a pathway to farmers’ well-being 
(Kisan, 2006).  
9. Seasonality 
It has been reported that farmers’ wages will vary according to the season. Barua’s 
survey found that wages in Nadia, West Bengal varied due to the season and ranged 
from 40 rupees in low season to 80 to 90 rupees per day in high season (Harvesting 
and sowing, where time bound work is crucial to end yield) (Barua, 2010). A quarter, 
(29 per cent), of households are engaged in agricultural labour, but this work tends to 
                                                          
5
 The Indian government has recognised a number of minority groups across India and has 
designated them as Scheduled Tribes. NCST (2005) National Commission for Scheduled 
Tribes.  Govt. of India,  [cited: 17-6-2013]. Available from http://ncst.nic.in/index.asp?langid=1.  
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be seasonal and the income accounts for only seven per cent of total income 
(Vanneman and Dubey, 2010).  
10. Farming is the sole income or only part of the income 
Non-farm employment is considered to be particularly important to the landless and 
small and marginal farmers (Coppard, 2001). The non-farm sector in rural India has 
grown steadily in the period since 1983, with some acceleration during the late 1990s 
and into the 2000s, but levelled off again in the period post 2004 to 2005. This process 
of transformation has contributed to declining rural poverty both directly, through 
employment generation and also indirectly through its impact on wages (Himanshu et 
al., 2011). 
This review suggests that the nature of the crop, the value chain, the season, the 
location of the farm, its size and worker characteristics will all play a factor in the 
determination of wages. 
3.6 Medicinal plant production in China and India  
a) China 
China has a long history of using plants for medicinal purposes (Petrovska, 2012). 
There are hundreds of state-owned and increasingly shared ownership companies 
producing traditional Chinese medicines, many of which export their products 
internationally (PMMI, 2001).  
China has partly addressed its own difficulties relating to the manufacture and supply of 
TCM products by modernising its traditional medicines profession with government 
sponsored GAPs and GMPs. All manufacturers of TCM products must comply with 
standards set down by the China Food and Drug Administration (CFDA) in order to 
gain GMP certification. Only around 1500 companies have achieved this standard.  
However, TCM products originating in China are of particular concern to the UK 
regulatory authorities and instances of poor quality and adulterated material are 
commonly reported (MHRA, 2008, MHRA, 2013b, MHRA, 2013c). 
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b) India 
Kala et al. (2006) assert that of the 17,000 higher plant species to be found in India, 
7,500 are known for medicinal uses, with Ayurvedic medicine claiming to use 2,000 of 
these. Most plants used in Indian systems of medicine are collected from the wild. 
More than 60 species are in great demand and the ‘tribal belt’ of India is abundant in 
these plants and minority groups mainly depend on this trade for their livelihoods 
(Patwardhan et al., 2005).  The annual turnover of the Indian herbal medicine industry 
has been estimated by different authors to be between US$377 million and US$1 
billion per annum  (Sharma et al., 2008, Kala et al., 2006), between 0.5 and 0.8 per 
cent of world trade.  
The globalisation of Ayurvedic practices gained momentum during the 1990s and 
onwards into the 2000s and Ayurvedic products are commonly used as food 
supplements in North America, Australia, New Zealand, Europe and Japan 
(Ravishankar and Shukla, 2007).  While Indian exports, valued at US$132 million in 
2008, contributed less than one per cent to the global herbal market, industry 
observers suggest that growth is rapid and that Indian companies are fast emerging as 
key international suppliers of medicinal plants (Seale, 2011).  
A  study commissioned by India’s National Medicinal Plants Board and conducted by 
the Bangalore-based institution, the Foundation for the Revitalization of Local Health 
Traditions (FRLHT) has estimated that 177,000 tonnes of medicinal plants are used 
each year by India’s domestic herbal industry, that 86,000 tonnes are used within rural 
Indian households, and that 56,500 tonnes are exported through international trade 
(Cavaliere, 2010). 
The structure of the industry is quite diverse. Herbal medicinal products are produced 
by several thousand companies in India, most of whom are quite small, including 
numerous neighbourhood pharmacies that compound ingredients to make their own 
remedies (Dharmananda, 2003). 
The products of these companies are included within the broad category of ‘fast 
moving consumer goods’ (FMCG) which mainly involves foods, beverages, toiletries, 
cigarettes, but may also contain certain types of pharmaceutical (LBS, 2009). Most of 
the larger HMP suppliers provide materials other than herbal medicines, particularly in 
the areas of foods and toiletries (Dharmananda, 2003).  
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The exact number of manufactures is unclear. Subrat et al. (2002) suggest that there 
are approximately 6,000 licensed manufacturers and about the same number of 
unlicensed ones, with about 70 per cent of the market share belonging to Ayurveda.   
Whereas Polshettiwar (2006) proposes that about 1200 licensed small manufacturers 
in India are on record, with about 20 well-recognised manufactures of HMPs and 140 
small to medium size manufactures.   
However, what is generally agreed is that the formal sector of the industry is dominated 
by less than a dozen major companies. In 2012, Emami was the leading company, with 
a market value share of 17 per cent, followed by Darbur with 16 per cent and Proctor 
and Gamble, the American multi-national consumer goods company, with 11 per cent, 
indicating an increase in market presence from non-Indian companies (Euromonitor, 
2013).  
However, according to Seale (2011), there are around 30 other companies that 
produce US$1 million or more in Ayurvedic products each year, including small 
pharmacies and family-owned enterprises that formulate their own products and guard 
their remedy recipes closely. But while Ayurveda has traditionally been the province of 
home remedies and naturalist producers, like everything in India, Ayurvedic and other 
traditionally based products are going increasingly high-tech (Seale, 2011).  
These manufacturers are supplied by local or national markets, directly from farms, or 
commonly through middlemen. The vast majority of medicinal plants used in India to 
make HMPs are still collected from the wild although there is evidence to suggest that 
some companies are developing more sustainable cultivation strategies (Cavaliere, 
2010). 
Exports 
Exports of Indian herbal products increased from US$69 million in 2005 to 2006 to 
US$128 million in 2009 to 2010, recording a compounded annual growth rate of 16.8 
per cent. North America, Pakistan, Germany, Japan, the United Kingdom, Spain, 
China, France, Vietnam and Mexico, were the top ten export destinations for India's 
herbal exports over the last three years.  
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The United Kingdom remained the fifth largest overseas market for Indian herbal 
products with exports worth US$3.7 million in 2007 to 2008, and US$5 million in 2008 
to 2009. The UK had a 2.5 per cent share in the country's total herbal exports in 2009 
to 2010 (Scindia, 2010).  
If these figures are accurate, it indicates that UK imports in 2009 to 2010 declined to 
around US$3.2 million, possibly as a result of the implementation of the THMPD which, 
it has been argued, raises the entry bar for producers of these types of plant based 
medicines to enter the European market (Patwardhan, 2011).  
Professional practitioners of TIM, including Ayurveda, are scarce in the UK compared 
with Western herbalists or TCM practitioners and Indian HMPs are generally sought out 
by the general public in retail health food shops or using online websites. Ayurvedic 
products are also available as food items in supermarkets in the form of teas. This is a 
juxtaposition of how these plants are administered in India, where many herbal 
products are regarded as potent medicines often superior in efficacy to 
pharmaceuticals and with fewer side-effects (Patwardhan et al., 2005). 
Despite some healthy growth in Indian HMP exports, adulteration and contamination 
are commonplace and so the supply of good quality raw materials is limited 
(Patwardhan et al., 2005). This has in turn stunted the industry’s growth in previous 
years. A national organisation, The Ayurvedic Drugs Manufacturers Association is 
reportedly taking a pro-active role to improve quality and research but has so far been 
unable to make any significant change.  
More and more species are being gradually added to the Indian herbal materia medica 
and the standards for purity and identification do not always keep pace with this 
expansion process (Kala et al., 2006). This potentially lucrative position has led to the 
over-exploitation and depletion of medicinal plants. 
Kala et al. state that more than 95 per cent of the 400 species used in the herbal 
industry are wild collected and argue that developing agro-technology should be a 
research priority. It is argued that farming will foster the production of uniform material 
from which standardised products can be readily obtained. Moreover by cultivating 
plant species, identification can be controlled from the seed stage.  
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One feeling is that the medicinal plant sector can be improved if the agricultural support 
agencies would come forward to help strengthen the medicinal plant growers and if 
research institutions would aid the plant growers by improving their basic knowledge of 
plant cultivation practices (Kala et al., 2006).  
Vaidya and Devasagayam (2007) are more positive about the condition of the industry 
and propose that evidence-based herbals are widely used and manufactured, as per 
the guidelines, by a well-organised industry and suggest that newer approaches, 
utilising collaborative research and modern technology in combination with established 
traditional health principles will yield rich dividends in improving health.   
However, as indicated below (see 3.8, The tea value chain and 3.9, The ginseng value 
chain), there is some debate and no firm resolution concerning the long term effects of 
a move to cultivation, the impact of closer regulation and of the implementation of 
VIVCs. 
Table 1 Estimated annual values of Herbal medicines and foodstuffs 
Global value of herbal medicine US$83 billion (2008) 
Value Indian herbal Trade US$1 billion  (2006) 
Value of Indian herbal exports US$128 million (2010) 
Value of UK imports of Indian herbal medicine US$5 million (2009) 
Value of herb trade at Bozhou market, China US$735 million (2011) 
Value of Canadian ginseng trade US$68 million (2001) 
Value of USA turmeric imports US$4 million (2008) 
(Source: (Robinson and Zhang, 2012), (Sharma et al., 2008, Kala et al., 2006), 
(Scindia, 2010), (Brion, 2011), (UPA, 2003), (Hallquist et al., 2010). 
According to Patwardhan et al. (2005), India should take the lead from China in 
developing a more quality-driven ethos towards medicinal plant production. However, 
Gong (2006), points out that despite the fact that China outpaces India in economic 
development, the Indian pharmaceutical industry excels in the international market 
while Chinese companies lag behind and argues that the critical success factors of 
Indian pharmaceuticals can be explained from both the macro level of the industry 
environment to the micro level of enterprises (see table 2).  
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Table 2 Success Factors for the Indian pharmaceutical industry (Gong, 2006) 
Macro Level Micro Level 
The development of the pharmaceutical 
industry is driven by societal development 
and innovation 
Well-established privately owned enterprises 
(POE’s) are commonplace in India 
The Indian government provides incentives 
for exporting active pharmaceutical 
ingredients and reduces taxation to promote 
trade 
Resources are well utilised and enterprises 
are efficiently managed 
To Investors India is more attractive than 
China because of better corporate 
governance, more regulated finances, more 
transparent IPR protection, and a more 
business friendly legal system. 
Indian companies have a longer history and 
deeper understanding of International 
markets than their Chinese counterparts. 
Exceptional patent protection exists in India Indian companies place a high priority on 
applying technologies and expertise to 
business management. 
Pharmaco-economic studies on TIM and TCM are rare but can help in understanding 
cost-effectiveness and cost benefit of traditional medicine. Patwardhan et al. (2005) 
argue that in all such attempts, Chinese medicine regulation can help India at various 
levels, including with policies, quality standards, research models and integration into 
the health system.  
There is no doubt that China has a lot of experience in this arena but it may also be 
productive for India to make collaborations with the countries in which their products 
are destined in order that they can fully comply with international standards and 
regulations.  As discussed above, India has already achieved this in the allopathic 
pharmaceutical arena where it appears ahead of China in terms of its achievements. 
 3.7 Supply, demand and sustainability 
As experienced in connection with the expansion of traditional medical systems 
globally, rapid growth in the TAM industry has led to the over-exploitation and depletion 
of medicinal plants, not only affecting bio-diversity and the ecology but also having a 
serious detrimental impact on the livelihoods of the indigenous forest peoples. 
It has been estimated that over 2000 medicinal and aromatic plant species are used 
commercially in Europe, of which 1200 to 1300 are European native species. 
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Approximately 90 per cent of the European species are collected from the wild, with 
eastern Europe and the Mediterranean regions being the main suppliers (Lange, 1998). 
In India it has been estimated that approximately 7500 species are used for medicinal 
and veterinary purposes (Uniyal et al., 2000). Over 10,000 species are used 
medicinally in China (He and Cheng, 1991), with 1,000 species commonly used in 
medicinal preparations, of which 80 per cent are wild-collected (He and Sheng, 1997)6. 
Kala et al. (2006) state that more than 95 per cent of the plant species used in the 
herbal industry are wild collected and argue that developing agro-technology should be 
a research priority.  
“Farming will foster the production of uniform material from which 
standardised products can be readily obtained. Moreover, by 
cultivating plant species, identification can be controlled from the 
seed stage. The medicinal plant sector can be improved if the 
agricultural support agencies would come forward to help strengthen 
the medicinal plant growers and if research institutions would aid the 
plant growers by improving their basic knowledge of plant cultivation 
practices.”  
Opportunities for governments to develop legislation to control and monitor harvest and 
trade of medicinal plant species and to consider conservation and sustainable use of 
medicinal plants as a priority in establishing protected areas have been greatly 
improved through the addition of medicinal plant species to the Convention on 
International Trade of Endangered Species (CITES) and the entry into force of the 
Convention on Biodiversity (CBD) (Schippmann et al., 2006). 
The following case studies consider some aspects. The debate centres on how private 
companies and other agencies are likely to be able to support agricultural initiatives 
and whether this leads to better pay and conditions. 
 
                                                          
6 These figures are difficult to obtain and to validate and thus there may well be a high degree of 
conflicting data. 
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3.8 The tea value chain 
The tea industry, including green tea and other niche products, provides a good 
example of how value may be added to a product. As with turmeric, it has uses as a 
food, a medicine and also in the cosmetic industry (Cabrera et al., 2006, Katiyar et al., 
2000). It is a product that has a history of being exported and has been subject to value 
chain analysis. Moreover the cultivation of this product can have a considerable impact 
on the livelihoods of farm workers in LEDCs (Agrifood, 2004). 
It is widely reported that tea cultivation in the countries where it is prevalent has 
historically demonstrated a positive impact on the economy of the poorer rural areas 
(Fairtrade, 2010, Groosman, 2011). 
Tea cultivation often requires companies to provide employment to large numbers of 
the least privileged segments of society, mostly in remote areas where there is little 
other infrastructure. As a result, roads, electricity, water, etc., become more widely 
available to the general populace in these isolated districts.  
In India for instance, the major tea plantation companies provide affordable housing, 
medical care and education to their employees and their employees’ families. Wage 
agreements are usually industry-wide and salaries are above the national average 
(Menon and Rodgers, 2008).  
Green tea production is chiefly located in south-east Asia and particularly in China, 
which is responsible for 75 per cent of all green tea produced (Groosman, 2011). 
Although much of Chinese tea production is conducted on small farms rather than large 
tea plantations, according to Liu (2010), Unilever has invested tens of millions of Yuan 
in establishing a research centre for tea and traditional Chinese medicine in Anhui 
province. The plant has a production capacity of more than 100 million Yuan (US$16.5 
million) every year.  
Although this seems to be a beneficial situation for rural workers, as outlined below, 
there is a counter argument suggesting that it is the tea companies who are the biggest 
winners through their exploitation of the farmers and their’ workers, who have few 
alternatives other than to subjugate themselves either to the multi-national or state run 
companies, finding themselves increasingly dependent on a wide range of exterior 
inputs ranging from seed to fertilisers to pesticides.  
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The bargaining power of producers at the cultivation end of the value chain appears 
relatively weak compared to the processors and retailers who are able to exert control 
on both the price paid for the raw crops and the essential inputs needed to produce 
economically viable yields (Hilary and Dromey, 2010).  
One initiative that is claimed to have a beneficial effect on both the incomes of farmers 
and the quality of produce is the Fairtrade® initiative (Fairtrade, 2010).  
This has been particularly noticeable in the tea and coffee markets and the broad 
based aim of the Fairtrade® movement is to offer a better deal for farmers by paying 
above the market rate for the commodity in question and in return the farmers are 
expected to adhere to the Fairtrade® policies on production and follow quality-driven 
requirements in key areas, particularly in the cultivation and collection stages.  
Although basically, this is a positive step forward, the scheme is far from a panacea as 
it only represents a small section of the total market and may be more suitable in some 
countries than others (Nelson and Pound, 2009).  
Fairtrade® schemes tend to favour larger companies and have little influence on the 
wages of the workers. The market-price for tea in China and the ‘Fair’ price, according 
to the Fairtrade® database was US$1.20 per kg and US$1.70 respectively.  According 
to Hodge (2009), even low quality Chinese tea typically costs more than US$1.70, 
indicating that the bar is set very low for Fairtrade® certification. Hodge asserts that in 
China, Fairtrade® is not relevant at all in relationship to good quality tea and argues 
that the producers of this level of quality tea do financially well compared to peasant 
farmers that are growing other crops. Chinese agriculture tends not to be based on the 
corporate, plantation model, as it is in the rest of the world and, therefore, many 
Fairtrade® initiatives are less implementable into the Chinese framework than they are 
for the huge plantations of Africa and South America.  
Although consumer support is needed, it appears that the issues are much more 
complicated than just price. Since virtually all farming in China is done by small 
farmers, the organisational issues are very different than for an international plantation 
model. This view appears to have some credibility; the Fairtrade® website has little 
mention of Chinese Fairtrade® tea whereas it does list bean products from Inner 
Mongolia as one of their success stories in terms of supporting poorer communities. 
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However, in terms of using Fairtrade® as a vehicle to help develop organic, sustainable 
farming, there are a few small specialist farms in China beginning to emerge.  
Moreover, in a ten year review of the Fairtrade® literature conducted by Nelson and 
Pound (2009), the authors conclude that although the evidence base is patchy, there 
are producer and gender inequalities and Fairtrade® has not shown to be a solution to 
rural poverty. The information gathered indicated that Fairtrade® was valuable in 
providing organised small export producers with the stability and security they needed 
to make longer term investments and that most Fairtrade® cooperatives are becoming 
stronger, particularly where producer ownership further along the chain is achieved.   
One of the major reasons for the price of some tea being kept so low is due to the 
domination of the tea sector by a few companies and it is seen in the breakdown of 
who accrues the largest share of the value chain that the highest earners are the 
traders and retailers. According to the Fairtrade (2010) statistics, approximately 40 per 
cent of the retail price of tea accrues to the tea traders and manufacturers, and a 
further 40 per cent goes to the processors and blenders, packagers and retailers, 
based mainly in rich countries. In tea-producing countries, around 15 per cent of the 
retail price goes to the plantation and factory, and less than one per cent to the auction 
broker. The plantation worker is likely to earn one per cent or less of the retail value.  
This un-appreciation and under-investment of the agricultural workforce as a valuable 
human resource is not only grossly unfair and a cause of huge social inequity, but may 
also lead to quality problems that will be carried through the length of the production 
process, potentially resulting in a finished product that will be difficult to sell as an aid to 
health in the hugely competitive functional food and nutraceutical arena (see below).  
The future for the growth of tea and particularly green tea production is inextricably 
linked to its health claims, but it is not only the health of consumers in Europe that are 
affected, but also the workers and farmers in the countries of origin. In Vietnam, tea 
producers often benefit from better living standards than producers of other crops, with 
reports of incomes doubling through tea production, this benefit appears mainly 
dependent on the ability of producers to connect to a value chain, which in turn opens 
up access to a more lucrative export market (Agrifood, 2004). 
However, one of the more concerning reports suggests that the over-use of pesticides 
by producers in Darjeeling, India leads to pesticide residue rates, which far exceed 
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international limits, exposing tea pickers to high levels of toxins that are hazardous to 
health  (Gurusubramanian et al., 2008).  
One pesticide, which is of particular concern, is the organo-chlorine pesticide (OCP), 
Endosulfan®. Although Endosulfan® has been banned or severely restricted in more 
than 60 countries, it is still widely used in many LEDCs, including India and China, due 
to its high effectiveness and low application cost. Endosulfan® is a ‘persistent organic 
pollutant’ (POP) as defined under the Stockholm Convention: it is persistent in the 
environment, bio-accumulative, demonstrates long range environmental transport, and 
causes adverse effects to human health and the environment (PAN, 2008).  
One central question is how can the tea industry be sustainably developed to optimise 
the health benefits at both ends of the value chain? Workers and small farmers have 
historically been weakened and marginalised and today hold a relatively minor position 
in the tea value chain.  A downward pressure on the price paid for tea to the farmers 
and subsequently on the daily wages of the workers, causes poverty and distress 
among hundreds of thousands of people whose living depends entirely on tea 
production. At the same time traders and tea packers are continuing to realise large 
profits. It is claimed that large companies have a policy of deliberately reducing 
differences in quality among the different teas produced all over the world, enabling 
teas to be purchased at the lowest cost and maximising profits from the blending, 
packaging and marketing stages which tend to be in the hands of the large tea 
oligopolies (Oldenziel, 2006). 
3.9 The ginseng value chain 
Another value chain, which has been well documented, and that gives a good account 
of how value can be added to a product, is that of Panax ginseng and some related 
species. It is of particular relevance to this project as the literature shows that buyer 
perceptions of what constitutes a good quality and desirable product can make huge 
value additions to a product. Moreover it is seen through examination of this literature 
that the lead firms in a value chain are not always at the retail end of the chain and 
more power can sometimes be held by farmers. 
During the 14 year period from 1989 to 2003, approximately 17 tonnes of dried 
American ginseng (Panax quinquefolius L.) root were harvested from Pennsylvania. 
Using a conservative price of US$600 per kg paid to collectors, the contribution from 
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the ginseng trade to Pennsylvania’s economy can be estimated at more than US$10 
million during this period and this figure does not include income received from 
downstream and value added processing (Burkhart and Jacobson, 2004). In 2012 the 
USA exported approximately 20 tonnes of wild or wild-simulated7 American ginseng, 
worth US$27 million (Schulz, 2013). When the market was at its peak, ginseng root 
was one of the world’s most profitable legal crops (in terms of its value per kg), selling 
for as much as US$770 per kg for semi-wild woodland crops (UPA, 2003).  
Ginseng values are dependent on the production method. The lowest investment and 
production costs are for wild-simulated ginseng, while the greatest expenses are 
required for intensively cultivated field grown ginseng under artificial shade. Wild 
ginseng is considered the most profitable, selling for US$990 per kg of dry weight in 
1999, compared with wild simulated at US$550 per kg and woods cultivated at US$330 
per kg. This translates to revenues of US$ 17,700 per hectare for wild-simulated over 
an eight to ten year period and US$31,500 per hectare for woods-cultivated over a five 
year period and so although the wild-simulated approach requires less input, the longer 
cultivation period reduces overall revenue (Burkhart and Jacobson, 2007).  
Field cultivated ginseng had a value of under US$44 per kg in the same year (Lucio, 
2002). This difference in price is at first difficult to comprehend but it may be linked in 
some way to the ginsenoside content of the herbal material and consequently its 
effectiveness. The potency of herbal products can vary from manufacturer to 
manufacturer and from batch to batch, partly because of non-standard processing 
methods but also due to the variability of cultivation conditions e.g. soil, temperature, 
moisture, length of cultivation and harvest season (Yuan et al., 2002).  
Asian buyers consider wild ginseng to be more potent than cultivated ginseng and 
connect value to morphology (wild roots look more human in shape). Consequently the 
root value is highly dependent on its appearance. However, in a study conducted by 
Schlag and McIntosh (2006), the authors fail to find a significant difference between 
wild and cultivated plants with reference to total ginsenoside content. This could 
indicate that Asian traditional beliefs surrounding ginseng are based on the subjective 
value of a wild crop or linked to experiences of taste, colour etc., or it could mean that 
total ginsenoside contents is not a clinically relevant measure of ginseng potency and 
other metrics such as relative ginsenoside composition may prove to be more 
                                                          
7 Plants are cultivated in areas and under conditions that reproduce as closely as possible a 
wild environment 
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meaningful. In the Schlag and McIntosh study, significant variations were found 
between the ginsenoside composition of wild and cultivated ginsengs and two distinct 
chemotypes were identified. However, chemotypical differences in composition were 
also observed between wild ginsengs grown in different areas of the US and so it is not 
such a simple picture of wild versus farmed. 
 Whereas the price paid for semi-wild ginseng has doubled from 1999 to 2009, the 
price for farmed ginseng has dropped by 75 per cent. Current prices for farmed roots 
are below the cost of production and consequently the artificial shade cultivated 
industry in North America is in a state of collapse. One of the primary reasons for this 
decline in prices in North America is increased cultivation of Panax quinquefolius in 
China. It is unlikely that this situation will extend to wild-simulated ginseng or even 
woods-cultivated as China has long since gone through a process of deforestation.  
Although high yielding, the main problem for farmed ginseng is that it is susceptible to 
disease and requires the heavy use of pesticides and fungicides in order to thrive 
(Hankins, 2009). This can be a real drawback when presented as an aid to good 
health, especially in a market that historically sets high entry bar standards for non-EU 
commodities. China seems to be responding in typical fashion and along the highways 
you can now see small trees several rows deep. These are part of China’s reforestation 
programme and once they reach a suitable age they are transferred to where forests 
once stood for re-planting. It may take some time for these new forests to mature, but 
there is a real prospect of wild ginseng growing once again in the country that made it a 
global commodity.  
3.10 Curcuma longa L. Zingiberaceae (Turmeric) 
The ancient peoples of India called turmeric the Oushadhi – The medicinal herb 
(Ravindran et al., 2007). Turmeric is probably native to south-east Asia. Although many 
related species of the genus Curcuma occur in the wild, turmeric (Curcuma longa) is 
not known to occur in the wild and is only cultivated. The name ‘turmeric’ may originate 
from the old English word, tamaret, possibly coming from the Latin name terra merita, 
becoming terre merite in French – deserving earth (Dictionaries, 2013). In English it 
was also known as yellow root or Indian saffron (Ravindran et al., 2007).   
Annual Indian production of turmeric for export was approximately 44,000 tonnes for 
2007 to 2008 (Hindu, 2008). India produces most of the world’s turmeric crop and 
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consumes 80 per cent of it (Prasad and Aggarwal, 2011). Indian turmeric is regarded 
by many as the best in the world because of its high curcumin content with the 
Alleppey variety being highest at over six per cent (Ravindran et al., 2007). The earliest 
reference to turmeric is in the Atharvaveda (ca. 6000yrs B.P.) where it is prescribed for 
jaundice and used in the treatment of leprosy. It is probable that true turmeric, 
Curcuma longa, came to India from Cochinchina (present day Vietnam) either through 
migration of peoples or with the spread of Buddhism. To the classic Indian cultures, 
turmeric was not a spice but a dye and a medicine used to treat many ailments (Food-
History, 2010). 
3.10.1 Important related species 
According to the Kew Gardens database (The Plant List), there are 92 species with 
accepted names in this genus (Kew, 2013). The presence of this large genus 
containing similar looking plants highlights the potential risks of confusion and possible 
adulteration between species.  
Curcuma amada Roxb., (mango ginger), is endemic to South Asia and found wild in 
northeast and southern India. It is cultivated for the edible ginger-like rhizome which 
has a flavour like green mango. Although mainly used in food preparations, it also has 
been used in TIM for digestive disorders and as an anti-inflammatory and it has been 
found to have similar biological properties to Curcuma longa. The major chemical 
components include starch, phenolic acids, volatile oils, curcuminoids and terpenoids 
(Policegoudra et al., 2011) 
Curcuma angustifolia Roxb., (wild or Indian arrowroot) is native to India and found wild 
in Bengal, north-east regions of India and western coastal plains and hills. It is also 
abundant in Madhya Pradesh, Chhattisgarh, Orissa, Andhra Pradesh and the hills of 
Tamil Nadu and Kerala. It was cultivated as a source of arrowroot starch, which is used 
as a food and medicine. Different parts of the plant have been used as a dietary aid, in 
gastro-intestinal disorders, including intestinal parasites, and to treat painful, inflamed 
or irritated mucous membranes (Sharma, 2011). 
Curcuma aromatica Salisb., (wild turmeric) is distributed from China southwards to Sri 
Lanka, it grows wild in many parts of India and is cultivated in Andhra Pradesh and 
Orissa. It gives out a strong camphoraceous smell. It is valued as a dye, medicine and 
cosmetic (Ravindran et al., 2007). 
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Curcuma caesia Roxb., (black turmeric, black zedoary) is native to north-east India. 
The rhizome has a deep bluish black or grey-black colour. It is used in folk medicine to 
treat tumours, skin conditions, asthma and bronchitis (Das et al., 2013). 
Curcuma zanthorrhiza Roxb., (Javanese turmeric) is monographed in the British and 
European Pharmacopoeias. The largest of the curcuma species, it is indigenous to 
Indonesia and is used as a food and for medicinal purposes (Ravindran et al., 2007).   
Curcuma zedoaria (Christm.) Roscoe, (the long and the round zedoary) mainly occurs 
in the northeastern and western coastal regions of India. It is used in traditional 
medicine as a stimulant and carminative (Ravindran et al., 2007).   
3.10.2 Typical chemical composition of Curcuma longa 
Moisture   6-13 % 
Carbohydrates 60-70 % 
Protein   6-8 % 
Fibre   2-7 % 
Mineral matter  3-7 % 
Fat   5-10 % 
Volatile oil  3-7 % 
Curcuminoids   2-6 % 
 
Nutritional composition per 100 g 
Moisture  6 g 
Food energy  390 kcal 
Protein   8.5 g 
Fat   8.9 g 
Carbohydrate  69.9 g 
Ash   6.8 g 
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Calcium  200 mg 
Phosphorous  260 mg 
Potassium   2500 mg 
Iron    47.5 mg 
Thiamine  0.09 mg 
Riboflavin  0.19 mg 
Niacin   4.8 mg 
Ascorbic acid  50 mg 
Phytosterols, tocopherols and fatty acids have also been identified.  
3.10.3 Cultivation 
Curcuma longa, a perennial herb, is cultivated extensively in India and China and other 
countries with a tropical climate (Velayudhan et al., 2012). The rhizome is used 
medicinally. It is usually boiled, cleaned, and dried, yielding a yellow powder. Dried 
Curcuma longa is the source of the intensely yellow coloured spice turmeric and is 
used extensively in foods as well as having a long tradition of use in the Chinese and 
Ayurvedic systems of medicine (Ravindran et al., 2007).  
The growing area in India for turmeric rose from 150,000 hectares in 2002 to 2003 to 
194,000 hectares in 2007 to 2008 and production increased from 526,000 tonnes to 
892,000 tonnes in the same period. However from 2007 to 2008, turmeric output 
started declining as farmers shifted to other remunerative crops e.g. cotton and sugar 
cane (ICEX, 2010). In 2008, the USA imported over 4 million kg of turmeric, worth 
approximately US$ 4.2 million (Hallquist et al., 2010).  Andhra Pradesh is the main 
cultivation region within India, accounting for 47 per cent of area and 63 per cent of 
production (Deepa, 2010) (see fig. 1). Tamil Nadu is the second biggest producer and 
also is the leader in terms of yields. The city of Erode, Tamil Nadu, is regarded as the 
most important trading centre of turmeric in Asia. There are a number of cultivars 
available in India and they are recognised chiefly by the name of the locality where they 
are cultivated.  
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Figure 1 2006 - 2007 Regional turmeric production in India / tonnes (Source ICEX, 
2010)  
Turmeric requires a hot and moist climate, a good water supply and well-drained soil. It 
thrives best on loamy or alluvial, loose, friable and fertile soils (ICEX, 2010). Turmeric 
is ready to harvest in eight to nine months after planting. In India the harvest season 
typically begins in February. Care must be taken not to cut or bruise the rhizome. 
Harvested rhizomes are cleaned by washing with water, and dried as soon as possible 
to minimise contamination, mould growth and fermentation (DEA, 2010).  
Processing typically consists of 3 stages: curing, drying and polishing.  
Curing essentially involves boiling fresh rhizomes in water for about an hour, until soft 
before drying. Boiling destroys the vitality of the fresh rhizome, removes the raw odour, 
reduces drying time, reduces the microbial load and produces a more uniformly 
coloured product. Curing should be done within two or three days of harvest to avoid 
spoilage (Prasad and Aggarwal, 2011).  
Sodium bicarbonate is sometimes added to the water to make it slightly alkaline in 
order to improve the colour. Lead chromate has also been used but this method is now 
discouraged due to the health implications. According to Ravindran et al. (2007), 
although curing does not affect the volatile oil content, the curcuminoid content may be 
reduced. The cooked rhizomes are allowed to cool and spread out to dry in the open, it 
may take 10 to 15 days to become completely dry (5-10 % moisture).  
Tonnes 
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Slicing the rhizomes prior to drying reduces drying time and produces turmeric with 
lower moisture content and higher curcuminoid extractability (Douglas et al., 2006).  
In most areas the rhizomes are dried in the sun but mechanical driers are also used in 
regions with high humidity. Artificial drying gives a brighter product than sun drying. 
Improper drying can lead to microbial growth and infestation by storage pests. 
Fumigation is sometimes used if the rhizomes are to be stored for a long time. Dried 
turmeric has a rough appearance and dull surface colour. The outer surface can be 
polished to give a better finish. Polishing is undertaken by growers on a small scale, 
but largely by dealers or exporters in commercial quantities (NABARD, 2007). 
To improve the surface colour, the dried rhizomes are sometimes coated with turmeric 
powder in the course of polishing. The use of lead chromate, once practiced to achieve 
the same result, has now been reportedly abandoned due to potential toxicity but a 
more common practice is the adulteration with related curcuma species (Jansen, 
2005). 
In India, in the Sangli district of Maharashtra, another of the country’s key centres for 
turmeric trade, the local spice merchants follow a centuries old tradition of storing 
turmeric in pits. The bags of turmeric are put into the pits and covered with soil where 
they can be left for up to four years, and according to Babu et al. (2013), with little 
change in quality. As with tea and ginseng, chemical treatment is often used to prevent 
decay of material upon storage.  
The chemicals recommended by The Spice Board of India for the treatment of turmeric 
seed material are Quinalphos® and Mancozeb® (Kandiannan et al., 2009). 
Quinalphos® is a highly toxic organophosphorous compound, it is an endocrine 
disruptor and cholinesterase inhibitor and has been banned in most developed 
countries (PAN, 2010b). Mancozeb® is also a cholinesterase inhibitor, is teratogenic 
and has been linked to thyroid cancer (PAN, 2010a).  
As seed material treatments, these do not present so much of a problem but 
contamination of the turmeric rhizomes with these chemicals clearly presents a 
potential risk. 
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Table 3 Major turmeric regions and examples of local varieties 
Growing Region 
 
Variety Features 
Andhra Pradesh Amruthapani 
 
 
Armoor 
 
Duggirala 
 
Tekkurpeta 
 
Medium duration crop (8 months), highly 
resistant to leaf spot but susceptible to leaf 
blotch.  
Long duration crop (9months) Resistant to leaf 
blotch. Popular variety 
Long duration crop (9 months) tolerant to leaf 
blotch. Major regional variety. Larger rhizomes 
Long duration crop (9months) Resistant to leaf 
blotch. Popular variety. Good colour 
Bengal and Assam Pattant 
 
Deshi 
Best colour and aroma amongst regional 
varieties 
Regional variety 
Kerala Moovattupuzha 
 
Alleppey 
High colour variety, generally marketed as 
Allepey type 
High colour variety. High curcumin content 
Maharashtra Rajapuri 
Waigon 
Major regional variety 
Major regional variety 
Tamil Nadu Chinnanadan 
 
Erode Local 
 
Salem 
 
Roma 
Generally marketed as Madras type, popular 
variety 
Major regional variety, generally marketed as 
Madras type 
Good quality variety 
 
Good quality variety 
Source: (NMCE, 2010)  
In domestic and international markets, Salem turmeric (Tamil Nadu) is established as 
the best quality and is more expensive than other varieties. The superior quality is 
reportedly due to good soil conditions and less cross contamination (NMCE, 2010). 
This discussion implies that a study of turmeric economics in India should be open to 
issues of contamination linked to processing. 
3.10.4 Cultural and religious use 
Turmeric is used in various rituals and ceremonies throughout India. It is associated 
with the cleansing of the body and is commonly used by women on the last day of 
menstruation where is applied as a paste before a bath in order to purify themselves 
and regain ‘touchability’ and a bride must take a turmeric bath and sprinkle the wedding 
clothes with a turmeric solution before the marriage ceremony can take place 
(Velayudhan et al., 2012). 
60 
 
3.10.5 Local and traditional use 
It is traditionally indicated as an anti-inflammatory and for the treatment of flatulence, 
jaundice, menstrual difficulties, haematuria, haemorrhage, and colic. As an external 
treatment, it is used in poultices to relieve pain and inflammation (Thorne, 2002). 
In China, different parts of the root and rhizome are accorded different medicinal 
properties. Turmeric rhizome (jianghuang) is oval in shape and yellow in colour, with 
numerous secondary garlic bulb-like projections. The root tuber, (yujin), although 
similar in action, is regarded as having an additional calming effect. Yujin is normally 
Curcuma aromatica but the root tuber of Curcuma longa is sometimes used as a 
substitute. Jianghuang is used to invigorate the blood, relieve menstrual cramps, and 
treat the pain and swelling associated with trauma.  Yujin is said to be cooler in action 
and used more to break up blood stasis and relieve constrained liver energy. Another 
species, Curcuma zedoaria (ezhu) is also used medicinally in Chinese medicine for 
removing blood stagnation and regulating qi flow and is indicated for use in treating 
abdominal pain and dysmenorrhoea (Bensky and Gamble, 1993). 
3.10.6 Medicinal properties and research 
Current research has focused on turmeric’s antioxidant, hepato-protective, anti-
inflammatory, anti-carcinogenic, and antimicrobial properties, in addition to its use in 
cardiovascular disease and gastrointestinal disorders (Thorne, 2002). 
There have been many claims made about the therapeutic value of Curcuma longa 
(turmeric), Curcuma aromatica (wild turmeric) and Curcuma zanthorrhiza (Javanese 
turmeric) and these plants have been subject to various in-vitro and in-vivo 
investigations, including some intervention studies. Particular reference has been made 
to Curcuma longa and its application as an anti-inflammatory and cancer preventative. 
(Jurenka, 2009, Kim et al., 2012, Sandur et al., 2007) suggest that turmeric can 
effectively block the proliferation of tumour cells through the suppression of NF-kB and 
STAT3 pathways. Another mechanism for chemoprevention has been linked to NRF2 
and its ability to regulate reactive oxygen species and reactive nitrogen species 
(Shureiqi and Baron, 2011) although some caution is needed as NRF2 has also been  
linked to oncogenesis because of its ability to create a more favourable intracellular 
environment for the survival of tumour cells (Sporn and Liby, 2012). 
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It has been established that curcumin, often cited as the main active ingredient, 
modulates the inflammatory response by down regulating the activity of 
cyclooxygenase-2 (COX-2), lipoxygenase-5, (LOX-5) and inducible nitric oxide 
synthase (iNOS) by inhibiting the production of  the inflammatory cytokines, tumour 
necrosis factor-alpha (TNF-α), interleukin 1, 2, 6, 8, and 12, monocyte chemo-attractant 
protein (MCP) and migration inhibitory protein (MIP); and by down regulating mitogen-
activated and Janus kinases (Abe et al., 1999). 
Curcumin may be of use in the prevention and treatment of cognitive decline, including 
Alzheimer’s disease (AD). The mechanisms for this remain unproven but apart from its 
anti-inflammatory action, curcumin has been shown to induce hemoxygenase, a protein 
that protects the cell from oxidative stress, reduce cholesterol, reduce levels of metals 
that may cause neuro-toxicity and reduce beta-amyloid plaques, the most prominent 
characteristic feature found in AD. It may also possess an anti-depressant action, most 
likely due to inhibition of monoamine oxidase (Mishra and Palanivelu, 2008, Howes and 
Houghton, 2003).  
However, Ahmed and Gilani (2013) assert that whereas curcumin is often cited as 
being the most important therapeutic agent, careful scrutiny of the literature reveals 
that a mixture of the curcuminoids found in turmeric offers better medicinal value than 
curcumin alone.       
Although curcumin appears promising in many therapeutic areas, it is recognised that 
the clinical effectiveness of curcumin is hampered by its poor bio-availability and large 
prescribed doses, e.g. 8 g / daily are required to achieve any therapeutic benefit 
(Jurenka, 2009). This has also led to the development of high potency curcumin 
extracts and various chemically modified spin off products purported to be more easily 
absorbed. The product development strategies include combining turmeric with pepper 
to inhibit glucorinidation (Shoba et al., 1998) and increase thermogenesis (Westerterp-
Plantenga et al., 2006) and embedding curcumin into a lipophilic phospholipid to 
improve bio-availability (Mignet et al., 2013). 
Curcumin is often regarded as being responsible for the therapeutic effect of turmeric. 
However, this does not explain the use of turmeric in TCM, where aqueous decoctions 
are the main phytopharmaceutical preparations used. As curcumin is poorly soluble in 
aqueous solution, any therapeutic effect must be due to other, more polar compounds 
found within turmeric which are more readily soluble in water.  
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This hypothesis is backed up by some research conducted by Japanese researchers 
on the anti-inflammatory effects of different turmeric species. The researchers found 
that the optimum results, in their in-vivo study, were obtained with Curcuma 
phaeocaulis, a curcuma species that contained less curcuminoids than the other 
species in the study. Consequently, the authors proposed a curcumin-independent 
pathway in the anti-inflammatory process, and identified Curcuma phaeocaulis as a 
potential COX-2 inhibitor and suggested that curcuminoid content does not relate to 
inhibition of inflammation (Tohda et al., 2006). Moreover, in a 2012 clinical trial 
examining patients with osteo-arthritis of the knee, researchers reported an anti-
inflammatory action for an aqueous, polysaccharide extract of Curcuma longa (Madhu 
et al., 2013).  
In an assessment report conducted by the EMEA (2010), the overall conclusions were 
that there was insufficient data to support a “well established use” indication for any of 
the conditions claimed but considered it suitable for classification as a traditional herbal 
medicinal product with plausible indications in the treatment of dyspeptic complaints 
and possibly for skin complaints if sufficient data regarding the preparation and 
posology were presented.  
3.10.7 Quality assurance 
Dried and fresh turmeric rhizomes are generally free from adulteration. The major 
quality problems are more evident in the powder, which is prone to adulteration, and in 
which various quality deficits have been identified (Dixit et al., 2009, Govindarajan, 
1980). These include adulteration with species other than Curcuma longa; mixing with 
low curcumin content powders and the addition of starches or artificial colours. 
Officially only Curcuma longa is allowed in the production of turmeric but there have 
been reports that the related species of C. aromatica, C. amada, C. malabarrica and C. 
zedoaria or their left-over matrices after extraction have found their way to the retail 
market (Dixit et al., 2009) and a survey conducted by Dixit et al. (2009) demonstrated 
that the curcumin content of branded turmeric powders ranged from 2.2 to 3.7 per cent 
and non-branded loose powders ranged from 0.3 to a maximum of 2.6 per cent. 
Moreover none of the branded powders contained artificial colourings whereas 17 per 
cent of the non-branded powders contained metanil yellow, a non-permitted food 
colouring that has been shown in animal studies to cause testicular damage (Kaur et 
al., 2010).  
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Lead chromate, causing anaemia, blindness, and other disabilities, is another 
contaminant that has been found added to the powder or even painted on the root 
(Ashfaq and Masud, 2002).  
Turmeric used with a ‘medicinal’ claim has its own quality problems and in 2009 The 
Food Standards Agency (FSA) issued a warning to the UK public to avoid a brand of 
turmeric food supplement after it was found that it contained a drug called nimesulide. 
This drug was linked to two deaths and several liver damage cases in Scandinavia. 
The product in question, branded as Fortodol® or Leppin Miradin®, was being sold in 
the UK via the internet as a food supplement, often accompanied by unsubstantiated 
claims to relieve arthritis, muscle pains and headaches (Starling, 2009).  
Angles et al. (2011) highlighted that the main reason that less than ten per cent of 
Indian turmeric was exported was due to quality related issues and particularly the 
over-use of chemical treatments and related post-harvesting processing deficiencies 
and suggested that more importance should be directed to research and development 
in this area. 
3.10.8 Intellectual property and ‘biopiracy’ 
Biopiracy refers to the appropriation of the knowledge and genetic resources of farming 
and indigenous communities by individuals or institutions that seek exclusive monopoly 
control (patents or intellectual property) over these resources and knowledge (ETC, 
2014). 
In 1995, a US patent was granted to the University of Mississippi Medical Health 
Centre for turmeric for its use in wound healing. The university claimed that its use as a 
vulnerary was novel. The claim was challenged by the Council of Scientific and 
Industrial Research (CSIR), India and after a long legal battle it was acknowledged by 
the courts that this use had been described and documented previously in ancient 
Ayurvedic texts and consequently the patent was revoked in 1997 (Velayudhan et al., 
2012). 
The European Parliament has adopted a resolution in an attempt to prevent the 
plundering of the medicinal plants found in some LEDCs by multi-national companies 
without sharing the profits with the indigenous people. 
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“Biopiracy - the practice of patenting and marketing the use of 
traditional knowledge and genetic resources of indigenous peoples 
without authorisation from source countries - can impede the 
economic progress of developing countries and runs counter to EU 
development policy goals, says the resolution, which notes that 70 
per cent of the world’s poor depend directly on biodiversity for their 
survival and well-being”  (Krivade, 2013). 
3.11 Metabolomics and nuclear magnetic resonance spectroscopy  
Metabolomics is the term used for the comprehensive, nonbiased, high throughput 
analyses of complex metabolite mixtures such as those typically seen in plant extracts. 
Achieving a broad overview of metabolic composition requires the establishment of a 
fully integrated approach for the optimisation of sample extraction, metabolite 
separation / detection / identification, automated data gathering, processing and 
analysis, and quantification (Hall et al., 2002). Metabolomics has become a well-
recognised method for the study of all types of organisms; and complements the data 
obtained by the other, omics-technologies: genomics, transcriptomics and proteomics 
(Schripsema, 2010).  
One of the main problems associated with metabolomics is that the metabolome 
consists of a wide range of compounds at very different concentrations and with 
different polarities and other chemical characteristics. At present, there is no single 
solvent capable of solubilising the whole range of chemical constituents. The choice of 
extraction solvent is thus limiting the view on the metabolome. In general, metabolomic 
studies should be designed to detect as many metabolites as possible in an organism 
(Kim and Verpoorte, 2010).  
It is widely accepted that a single analytical technique will not provide sufficient 
visualisation of the metabolome and therefore, multiple techniques are needed for a 
comprehensive view. However, practical reasons can force us to choose an optimum 
analytical tool for metabolomic profiling. Consequently, it may be preferable to use a 
wide spectrum chemical analysis technique, which is rapid, reproducible, and stable in 
time, while needing only the very basic sample preparation. NMR spectroscopy is 
potentially an analytical tool that could meet these requirements (Choi et al., 2004). 
NMR spectroscopy is a physical measurement of the resonances of magnetic nuclei, 
such as 1H, 13C, or 15N in a strong magnetic field.  
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Each compound has a highly specific spectrum. The only variables are the solvent 
used and the magnetic field strength (Verpoorte et al., 2005).  
NMR spectroscopy is an effective tool for the quality control of medicinal plants or 
HMPs (Shyur and Yang, 2008). The advantages of NMR spectroscopy over other 
techniques such as mass spectrometry (MS) for metabolomics applications include the 
relative ease of sample preparation, non-destructive analysis, potential to identify a 
broad range of compounds, enhanced capacity for definitive chemical compound 
identification, and provision of structural information for unknown entities (Zulak et al., 
2008).  
Recent advances in analytical chemistry, combined with multi-variate analysis 
techniques, have brought us closer to the final goal of metabolomics: the 
comprehensive evaluation of all the metabolites, both qualitatively and quantitatively in 
living organisms.  
NMR spectroscopy and MS have been successfully used for metabolic fingerprinting 
analysis. These two techniques have their respective advantages and limitations; 
however, as a tool for metabolomics, NMR spectroscopy has some unique advantages 
over MS-based methods. It can provide a detailed analysis on the bio-molecular 
composition very quickly with relatively simple sample preparation. It is a universal 
detector for all molecules containing NMR-active nuclei. Using a proper internal 
standard, the real concentration of metabolites can be easily calculated and because 
NMR spectroscopy is based on the physical characteristics of compounds, it has very 
high reproducibility (van der Kooy et al., 2009). In any metabolomics application, the 
robustness and reproducibility of data collection is vitally important.  
1H-NMR spectroscopy is an ideal tool for large scale plant metabolomics data 
collection. In a study by Ward et al. (2010), it was concluded that “with attention to 
experimental design and careful set up, data collection for large scale plant metabolite 
fingerprinting using 1H-NMR  spectroscopy can be carried out as a dispersed activity 
across laboratories, using different NMR spectroscopy instruments.” Moreover, a 
number of techniques have now been devised to develop 1H-NMR spectroscopy as a 
fingerprinting tool for the quality assessment of crude plant materials.  
Multivariate or pattern recognition techniques such as principal component analysis 
(PCA) are valuable techniques for the analysis of data obtained by 1H-NMR 
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spectroscopy. In combination with PCA, 1H-NMR  spectroscopy has been applied to 
the metabolomic profiling of plants and herbal medicines (Kim et al., 2005). In the case 
of feverfew, 1H-NMR spectroscopy and principal component analysis was used to 
differentiate between 14 commercial batches of samples based on their multi-
component metabolite profile (Bailey et al., 2002). In the case of Hypericum 
perforatum, (St John’s Wort) principal component analysis of the NMR spectra from 
different commercial extracts was used to differentiate between various preparations 
according to their metabolomic profile. This included differentiation between various 
batches obtained from the same supplier. This  highlighted the potential to use the 
method for assessing whether the species extract variability versus the manufacturing 
process accounts for the variability (Heinrich, 2008). Further studies carried out on 
herbal tinctures have shown that 1H-NMR  spectroscopy and adjuvant techniques can 
potentially be applied to the quality control of plant extracts, including batch-to-batch 
consistency and stability studies (Politi et al., 2009). 
3.11.1 Metabolomic analysis  
Metabolomic analysis consists of three separate experimental parts. First, the sample 
preparation, followed by the collection of data using analytical chemical methods and 
the third and final step is data analysis using defined chemo-metric methods. Whereas 
the data collection step is generally automated for high throughput analysis, sample 
preparation is still mostly manual, resulting in high operating costs. Thus, in order to 
handle large numbers of samples simultaneously and to minimise the risk of sample 
degradation, it is important to keep the procedure as simple and fast as possible (Kim 
and Verpoorte, 2010). 
Data collection and spectral processing are also important to ensure that, for example, 
replicate samples provide identical 1H-NMR spectroscopy fingerprints. In practice small 
differences in line shape and chemical shift will be observed. The differences in line 
shape can be minimised by using exactly the same sample volume in identical NMR 
spectroscopy tubes and by optimising the magnetic field homogeneity before data 
acquisition. To compensate for differences in line width, the line-broadening parameter 
can be varied during processing. To minimise the misalignment of NMR spectroscopy 
signals, there should be strict control of sample preparation (Schripsema, 2010).  
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3.11.2 1H-NMR spectroscopy measurement  
Following the sample preparation, they are submitted for 1H-NMR spectroscopy 
analysis. It is possible to submit liquid samples in non-deuterated solvents but in this 
case a small quantity of deuterated solvent must be added to provide the lock signal for 
1H-NMR spectroscopy, and during the measurement, solvent suppression is applied. 
When the samples are dry they are dissolved in deuterated solvents. For hydrophilic 
extracts usually water-D2O, methanol–D4 or a mixture of the two is used. For lipophilic 
extracts, chloroform-CDCl3 or Dimethyl Sulphoxide-(CD3)2SO can be used 
(Schripsema, 2010).  
3.11.3 Data processing and multivariate statistics 
Because metabolite profiling is cheap once the hardware platforms have been 
established, it can be applied to a large number of samples to generate huge amounts 
of data. The bottleneck comes in finding ways to combine and interpret this data 
(Kopka et al., 2004).   
Multivariate statistics commonly refers to PCA, which is the main technique employed 
by many analysts (Hall et al., 2002). PCA is a math based method of reorganising 
information found in a data set of samples. It can be used when the set contains 
information from only a few variables but it is most useful when there are large 
numbers of variables, as in spectroscopic data. What PCA does is to discover new 
variables, called “principal components” (PCs) which account for the main variability of 
the data (Davies and Fearn, 2005). Data is represented in nth dimensional space, 
where n is the number of variables, and is reduced into a few principal components, 
which are descriptive dimensions that describe the maximum variation within the data.  
The principal components can be displayed in a graphical fashion as a ‘scores’ plot. 
This plot is useful for observing any groupings in the data set and, in addition, will 
highlight any outliers that may occur due to errors in sample preparation or 
instrumentation parameters. PCA models are constructed using all the samples in the 
study. Coefficients by which the original variables must be multiplied to obtain the PC 
are called ‘loadings’. The numerical value of a loading of a given variable on a PC 
shows how much the variable has in common with that component.  
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Thus for NMR spectroscopy data, loading plots can be used to detect the spectral 
areas (groups of metabolites) responsible for the separation in the data (Ward et al., 
2010). An important feature is that directions in the scores plot correspond to directions 
in the loading plot and vice versa. For example samples with negative scores are 
associated with negative peaks in the loadings plot (Michl et al., 2011). 
3.12 High performance thin layer chromatography 
HPTLC is a chromatographic technique that utilises the capillary action of a solvent 
(mobile phase) and a stationary phase to separate compounds in a sample mixture 
(Chromadex, 2011). According to the American Herbal Pharmacopoeia, it is an 
invaluable tool used in quality assurance for the assessment of plant materials and 
allows for the efficient and cost-effective analysis of a broad number of compounds 
(AHP, 2011).  
Much like HPLC grew out of improvements in column chromatography, HPTLC grew 
out of improvements in the quality of sorbents and consistency of plate manufacture, 
use of optimised techniques and equipment for sample application, plate development, 
detection reagent applications, densitometric scanning and a greater understanding of 
chromatographic theory (Sigma-Aldrich, 2013). In comparison to more widely used 
column chromatography, Reich and Schibli (2007) argue that HPTLC offers some 
distinct advantages: 
 Visual results 
 Simplicity 
 Parallel analysis of samples 
 Rapid results 
 Flexibility 
 Single use of plate 
 Multiple detection 
 Cost efficiency 
However, some limitations also have to be recognised, including that it requires more 
manual input, the separation power of HPTLC is lower than that of High Performance 
Liquid Chromatography (HPLC) and because it includes several drying steps, it is not 
suitable for samples that need to remain in solution. Moreover there are relative 
strengths and weaknesses of 1H-NMR spectroscopy and HPTLC with reference to the 
analytical investigation of herbal value chain products (see Table 4). 
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Table 4 Comparison of key strengths and weaknesses of 1H-NMR spectroscopy and 
HPTLC 
1H-NMR spectroscopy HPTLC 
Equipment expensive Equipment relatively cheap 
High throughput technique with sample 
preservation 
High throughput technique with sample 
preservation 
One system needed to view entire range 
of extractable metabolites.  
Three systems needed to view entire 
range of extractable metabolites. 
Multivariate analysis is able to group the 
samples according to the metabolite 
composition. 
Grouping of samples is achieved manually 
by visual inspection. 
Multivariate analysis can be confounded 
by multi-ingredient samples leading to 
errors in groupings. 
Separate systems and visual inspection 
reduces grouping errors. 
Manipulation of data allows for individual 
samples to be compared in detail against 
other samples or to the whole group. 
Comparisons are generally achieved 
visually.  
 
3.13 Summary of the literature 
There is a plethora of literature for Curcuma longa, TAM, and to a lesser extent value 
chains, which tend to be focused particularly on food crops and high-value 
commodities such as tea, coffee and cocoa and on cash crops e.g. cotton. There is a 
limited range of literature available concerning MPVCs in India and the impact that 
gathering or cultivating these crops has on livelihoods (e.g. Alam and Belt, 2009, Kala 
et al., 2006, van de Kop et al., 2006).  
The literature is somewhat contradictory and highlights both positive and negative 
outcomes for the primary producers of medicinal plants, however, some reasons for 
poor performance have been identified and suggestions made for future work.   
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The literature search suggests that very little has yet been published on the effect that 
different quality requirements and regulations may have on the MPVC and the impact 
that the farming medicinal plants may have on the livelihoods of the primary producers 
in LEDCs.  
Value chain analysis has been applied to a variety of consumer goods. It was found 
that there was a gap in the current literature with respect to MPVCs and particularly the 
impact that these heterogeneous chains have upon livelihoods.  
In particular, the literature review raises the following questions with respect to value 
chains: 
How easy / difficult is it for farmers and particularly small farmers to access organised 
value chains? 
Once access has been gained to a value chain, are their real benefits for the farmers or 
does it lead to greater subjugation of farmers by the lead companies? 
Once established, are the lead firms able to control the supply chain satisfactorily?   
A European directive has been introduced for the registration of herbal medicinal 
products but it is not well understood what the impact of this directive will be on the 
livelihoods of producers. Moreover, it is not well documented how the variability of 
starting materials and HMPs within these value chains could affect the health, both 
positively and potentially negatively, of consumers in Europe and how this variability 
might be measured analytically. 
Literature is available on 1H-NMR spectroscopy and HPTLC and their application to 
chemical and metabolomic studies. The literature provides explanations of the differing 
techniques and discusses their advantages and limitations from an analytical 
perspective.  
Analytical techniques, including metabolomic studies, have been widely used in quality 
assurance and drug discovery but their use in connection with the assessment of the 
validity of a particular product supply route is a new area and never before have these 
techniques been documented as having a role to play in the investigation of MPVCs.  
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4.0 Aims, hypotheses and research questions  
Aims: To investigate MPVCs and interpret the impact different value chains have on 
the livelihoods of primary producers in developing countries and ultimately on the 
health of consumers in Europe.  
Hypothesis 1 (H1): The establishment of a VIVC can have a positive impact on the 
livelihood of primary producers of HMPs in India. 
Hypothesis 2 (H2): Differences in the composition and concentration of products 
obtained through separate value chains can be determined through analytical 
techniques. 
Hypothesis 3 (H3): Differences in the concentration and composition of the products 
studied can be correlated to the quality of products found in the value chain. 
Research questions:  
 What examples of value chains can be found in India? 
 What impact does the implementation of a VIVC have on the livelihoods of 
primary producers of medicinal plants in LEDCs? 
 What impact do different value chains have on product quality? 
 
5.0 Research strategy 
5.1 Summary of research methods 
Stage 1: At the beginning of the project a survey was carried out to identify potential 
plant candidates to be used in the case studies. This survey was developed using on-
line software and distributed via electronic means (email, social media sites, interest 
group websites). A web-based survey was chosen in preference to more traditional 
methods, e.g. focus groups, face to face interviews, as it is relatively in-expensive to 
implement and manage and can acquire a large and diverse range of participants over 
a short time frame (Couper and Miller, 2008). I discovered that there was a company in 
the UK that had an established vertically integrated value chain and I approached this 
company in order to gain access to its suppliers in India. I would compare this chain 
against two other examples of supply. 
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Preliminary fieldwork study 
Before I began the main fieldwork I decided to conduct a pre-fieldwork study at a well-
established site in Anhui province China. I visited one of the largest medicinal plant 
trading centres in China, a HMP manufacturer and a university that was involved in 
providing assistance to local farmers regarding medicinal plant cultivation. This 
preliminary fieldwork acted as a bench-marking exercise and enabled me to gather 
important information about the current trends in cultivation and what was achievable in 
the long term. The herbal trade in China was an appropriate benchmark as modern 
Chinese companies are further advanced in implementing the infrastructure required to 
produce quality herbal medicines and have developed trade links with international 
companies using a vertically integrated model of supply. This is opposed to the 
instances of adulterated material found on the UK market (see 3.6), which is primarily 
the result of illegal activity. 
The methods used to interrogate the hypotheses H1, H2 and H3 are split into two 
separate but connected stages (Stage 2 and Stage 3). Firstly the methods used to 
answer H1 used a case study approach employing semi structured interviews (see 
appendix 1) and non-participant observations. Semi-structured interviews are useful in 
obtaining general and specific information from a sample of the population and gaining 
a range of insights on a specific issue. This methodology had advantages over a fully 
structured approach in that it was less intrusive, encouraging two way communication. 
It was able to both confirm what was already known and provided an avenue for 
learning with the interview subjects being able to provide the reasons behind their 
answers as described by FAO (1990). As previously outlined by Handley (2012), 
observational methods offered an objective insight into what people do rather than 
what they say they do. “Thoughtful and judicious use of observational methods 
provides one of the most effective ways to begin to understand what goes on in 
naturalistic settings.”  Moreover, an observational and interview approach is in line with 
what would be regarded as ‘best practice’ in research connected with GVC analysis 
(Kaplinsky and Morris, 2001). This recommends that actors at various stages of the 
value chain are interviewed in order to establish value chain dynamics. 
H2 and H3 were answered using a combination of analytical techniques. 1H-NMR 
spectroscopy coupled with multivariate analysis and HPTLC. 
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Stage 1: Initial on-line survey to identify potential case study candidates and pre-
fieldwork in China 
Stage 2: Qualitative work using a triangulated approach to answer H1 
 
 
 
 
 
 
 
 
 
Stage 3:  Analytical techniques to answer H2 and H3 
 
 
 
 
 
 
 
5.2 Ethical approval and permissions 
Ethical approval for the online questionnaire was given by the London School of 
Pharmacy on 15/3/2011 and approval for the fieldwork study was given on 25/11/2011 
(Research Ethics Committee References REC/B/10/07 and REC/B/11/01). 
Representatives of The School of Pharmacy in Udhagamandalam, Tamil Nadu agreed 
to organise and collaborate on a fieldwork visit to a farm in Erode, Tamil Nadu, and 
introduced me to various company directors and NGO officials who agreed to be 
interviewed.  A company in Bangalore gave permission for me to spend time at their 
Case studies   
Non-participant 
Observation 
Semi-structured 
reflective interviews 
Laboratory Analysis 
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company and on their farms near Shimoga, Karnataka conducting interviews and 
observing farm practices. A professor at the University of Bundelkhand organised a 
visit to farms in Jhansi, Uttar Pradesh and introduced us to farmers who gave their 
permission to be interviewed.  
5.3 On-line survey to identify plant candidates 
Plant candidates were selected for case history analysis 
I designed an on-line survey which was distributed by direct emailing, by placement of 
a link on discussion forums and through social networking sites. The survey questions 
were designed to find out how much knowledge a selection of people (mainly in the 
UK) had about traditional herbal medicine and in particular TIM.  
The survey asked which herbs from India and China were used as medicines and what 
conditions were treated using herbal medicine. It asked the participants to give their 
views on any concerns they had about traditional systems of medicine such as TIM and 
TCM. 
5.3.1 Inclusion and exclusion criteria 
The inclusion criteria were that the plants should be of economic importance in their 
country of origin and are a species that is widely cultivated. They should have a 
plausible medicinal use and they should have a history of distribution within the 
European market.  
The Exclusion criteria were for non-plant based medicines, plants listed on schedule 1 
of The Convention on Trade in Endangered Species (CITES)8, and Asian plants that 
were already widely grown and distributed within European countries. 
 
 
 
 
                                                          
8
 CITES schedule 1 prohibits all trade in the named species whereas schedule 2 allows trade 
with the appropriate certification.  
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6.0 Socio-economic methods and approach 
6.1 Preliminary Investigation in Anhui province, China 
I visited Bozhou, Anhui, China, in April 2011 to assess and document current practices 
and policies involved in the supply of Chinese medicinal plants to the internal and 
export markets. I compared and contrasted the traditional free market approach to 
trade with more recent initiatives that use a vertical integration strategy to make direct 
links between the farmers and the manufacturers.  
6.2 Fieldwork in India 
6.2.1 Sampling strategy 
Case Studies: Three case studies were used for comparison. It was important to 
identify sites that had experience in the cultivation and trade of the plant product 
identified through the on-line survey (Turmeric, see 7.1).  
The first case study examined a farm site located near to Shimoga in the state of 
Karnataka. This was an example of a farm that was in a chain, vertically integrated at a 
national level to a primary manufacturing site in Bangalore and internationally to a 
secondary manufacturing site in the UK). The second case study examined a farm site 
near to Erode in the state of Tamil Nadu. This site grew plant material that would be 
sold through middlemen at an auction house and represented the traditional route of 
supply where the plant material could be bought by any buyer for a multitude of 
purposes, including being purchased by a local manufacturing unit and once traded the 
traceability of the material was generally lost. The third site was farm in Jhansi, 
northern India that sold turmeric only to local market traders and had no connection 
with, and little understanding of, the industrial chain. At this site there was also a large 
farm that grew European herbs for the extracts industry which served as a good 
comparator.  
Although arguably there would be less confounding information if all three of the sites 
were in the same state, these farms provided a good comparison between an 
integrated and non-integrated approach, organic and non-organic, high output versus 
low output and were located in states within southern and northern India, which allowed 
for a wide angled view of the current situation and broad interpretation of the available 
data.  
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When choosing the sites several factors were considered to be of prime importance.  
Firstly, I wanted to examine regions that had a large trade in turmeric. Tamil Nadu and 
Karnataka are major growing areas for this crop (see Fig. 1) and Erode is regarded as 
the main trading city for turmeric in southern India.  
My core sample was comprised of farmers, farm workers, processors and market 
traders, (a wide range of people were secured using primary respondents to 
recommend subsequent interviewees, i.e. through ‘snowballing’). The sample size 
aimed for was 20 to 30 respondents or once data saturation was reached.  
Factors that were considered during the sampling stage were: age, gender, social 
class, experience, training, occupational group, ethnicity and situational context but I 
was limited to what personnel were available at the three sites and who I could 
communicate with effectively in English. I limited my interviews to the farmer level as it 
was not easy to communicate with the farm workers due to their level of spoken 
English, my level of Hindi, and almost no knowledge of the regional languages9. It was 
possible, however, to get an impression of their working conditions through observation 
and I was able to gain more detailed information about the pay and conditions of the 
farm workers through interviews with farmers and other actors in the chain. I used a 
peripheral sample as opportunities presented; this included other rural workers, 
regulators, NGO’s, exporters, and retailers. For more information on the research 
objectives and the prompts used for semi-structured interviews see appendix 3. 
It was important to visit the sites during times of high productivity. The busy period for 
turmeric production runs from November through to April. This is the period where the 
majority of harvesting, drying, processing and trading takes place. I initially visited for a 
period of two months in January and February 2012, where I was able to visit the sites 
in southern India (Shimoga and Erode) and then followed this up with a second two 
month visit in October and November 2012, revisiting the primary manufacturing site in 
Bangalore and then travelling to northern India to visit farms in Jhansi, Uttar Pradesh. 
During the second visit I aimed to gain more detailed information from the initial sites 
and also to conduct interviews at the third site in the north of India for a comparison. In 
addition to my three main sites I also visited herbal companies, Ayurvedic hospitals and 
trade fairs to find additional or comparative information.  
                                                          
9
 Hindi is only spoken widely in the North of India and in the state of Karnataka the local 
language spoken is Kannada. 
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Experiences were sourced primarily through interviewees and observations but 
additionally through texts and records and I made notes from the local newspapers of 
any news stories relating to export trade, agriculture and herbal medicines. 
6.2.2 Data recording and storage 
I chose several techniques to record the data. My main method of recording the data 
utilised a notebook. Here I recorded information that I gained from the observations. I 
recorded this according to the time, place and the nature of the observation. I also used 
the notebook during the semi-structured interviews. I would record the person’s name, 
their position, the site or institution visited and the date of the interview. I made 
extensive use of photographs as a record of observations and sometimes I made brief 
video clips, all with the permission of the subject(s). On occasion I used a voice 
recorder, although I found that there was some resistance to recording an interview in 
this fashion. Written data were stored in a locked office at the UCL School of Pharmacy 
and electronic data were stored on a password protected laptop computer. 
6.2.3 Data analysis 
Information was gathered firstly by reviewing the literature on Ayurvedic plants, value 
chains, crop production and agrarian economics. An initial step was to identify 
important plants that could be used as case histories for the project. From the 
preliminary fieldwork in China and the fieldwork in India it was necessary to interpret 
the findings in order to discover what had been learnt. This was achieved through 
reviewing the observational and interview data systematically and transposing the data 
into the relevant categories of analysis. This constituted using a content analysis 
approach for individual questions and an interpretive content analysis of complete 
interviews. I used a triangulation approach whenever possible using the testimony of 
different actors on the same subject material. For the analysis of the observations I 
made on the different study sites, I formulated these into a table for ease of reference. 
Case study analysis was used to compare one case study site against another. 
6.2.4 Health and well-being survey 
At the outset of the project it was intended that as a follow up strategy, I would use a 
questionnaire approach to elicit information regarding the relative health and well-being 
of the farm workers involved in the production of medicinal plants. As the first part of 
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the study got underway it became apparent that logistics of performing a survey of this 
nature would be problematic in India due to time factors and government restrictions on 
performing this kind of study. Moreover it was agreed that the most valuable 
information regarding the value chain came from the farmers, the primary processors 
and secondary manufacturers as these were the groups that were directly linked into 
the chain and who were most affected by changes in value chain structures. This 
approach is also supported by ‘best practice’ on value chain methods (Kaplinsky and 
Morris, 2001) 
6.2.5 Positionality 
I was able to gain access to the farms through having contacts in India and China. My 
contacts were usually involved within the chains at the farmer and primary producer 
level and it was through these chain actors that I gained the majority of information 
about the farm workers regarding their pay and conditions. I was able to corroborate 
this information in part by gaining access to wages documentation. Being from a 
developed country and performing interviews in developing countries poses some 
cultural barriers that need to be overcome with care.  
“Conducting international fieldwork involves being attentive to 
histories of colonialism, development, globalization and local realities, 
to avoid exploitative research or perpetuation of relations of 
domination and control. It is thus imperative that ethical concerns 
should permeate the entire process of the research, from 
conceptualization to dissemination, and that researchers are 
especially mindful of negotiated ethics in the field” (Sultana, 2007). 
It was necessary to spend time interacting with the participants in order to gain their 
trust and attempt to break down some of the barriers that separated us. This was not 
generally directed towards the project itself but comprised of talking in more general 
terms about the differences between countries, family life, education, health and even 
football. In a broad sense I think I achieved a position where the participants felt 
comfortable with my comings and goings, my sometimes strange questions, and my 
constant note taking and photographic documentation. I felt that the participants in the 
study offered information freely, however, because different levels of management 
were perceived as being involved in the process and I was perceived as being 
connected in some way to actors in the higher management positions or to university 
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faculty, it is unlikely that I was given the most negative aspects of employment on the 
farm or in a factory or heard grievances regarding poor pay and / or working conditions.  
 
7.0 Socio-economic findings 
7.1 On-line survey  
Overall 230 reponders participated to the on-line survey, but not all answered all 
questions. The survey ran over a two year time frame and I was able to gather 
information regarding the attitudes and beliefs of a self-selecting sample group 
regarding herbal medicine and HMPs  and more specifically, TIM and its supply chain. 
Over 85 per cent (of 230 respondents) had tried some form of herbal medicine with 
over a quarter using herbal medicines or using herbs in cooking but for health reasons, 
at least monthly (Fig. 2). 
 
Figure 2, Overall usage of herbal medicine, n = 230 
Fewer respondents, however, had used Indian herbs or HMPs, with almost 53 per cent  
(of 226 respondents) having never used them (Fig. 3). This could be to a lack of 
knowledge, problems obtaining these herbs or it could be due to fears and concerns 
over the quality and safety of HMPs originating from India (see Figs 10 and 11). 
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However, only approximately 15 per cent (of 225 respondents) would never try Indian 
herbal medicine, and almost 50 per cent would use them (Fig.4). This information 
supports the hypothesis that there is a demand for Indian HMPs providing that the 
quality and safety can be better assured (e.g. by complying with the THMPD) and that 
the consumer has sufficient information to choose the appropriate product.  
 
 
Figure 3, Usage of Indian medicinal herbs as an aid to health, n = 226 
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Figure 4, Future attitudes towards Indian products, n = 225 
 
 
 
Figure 5, Perceived benefits of Indian herbal medicine, n = 203 
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Respondents (203) perceptions of the health benefits of Indian herbal medicine 
suggested that the main area of treatment was digestive problems, followed by cold 
and flu type conditions (Fig. 5). These are two treatment areas that are feasible to 
satisfy the conditions regarding ‘indications’ for a traditional herbal product registration 
(THR). 
Turmeric is mainly used for the treatment of digestive problems and inflammatory 
conditions. It also has a history of traditional use for the treatment of sore throat and so 
the results of this question helped to strengthen the case for using Curcuma longa as a 
case study and when respondents were asked to name the most important Indian 
medicinal herbs, turmeric was by far the most frequently mentioned (Fig. 6) 
 
Figure 6, The most important Indian medicinal herbs, n = 191 
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Figure 7, Asian country suppliers of HMPs, n = 229 
China was the most well-known about Asian country for supplying HMPs to the UK 
(Fig. 7) with almost 85 per cent (of 229 respondents) recognising it. India was second 
choice with approximately 65 per cent. This information helped me to decide on India 
and China as sites for fieldwork and pre-fieldwork for the study. 
Out of 209 respondents, 20 per cent said they obtained their Indian herbal medicines or 
medicinal spices from a supermarket (Fig. 8). This was followed by health food shop 
(18 per cent) and then friends and family bringing products back from India (nine per 
cent). It is likely that the supermarket is used for culinary herbs that can also be used 
medicinally, e.g. ginger, garlic, turmeric, and the health food shop is used for more 
medicinal products e.g. ashwagandha, neem, holy basil. Less than four per cent of 
respondents indicated that they used the internet as a source of supply which is in 
some ways surprising. However, the internet is mainly used for HMPs rather than fresh 
or dried herbs and spices and moreover there are sometimes concerns over the quality 
of products obtained from this source, which may be some of the reasons for the 
relatively low figure. 
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Figure 8, Sources for the supply of herbs, spices and HMPs, n = 209 
 
Powders, fresh herbs and dried herbs are the most popular forms of consumption, 
whereas capsules and tablets are used slightly less (Fig. 9), indicating that the 
preference may be to use these products within cooking rather than having to take a 
daily dose of a HMP. This correlates to some local and traditional practices for the use 
of the fresh and dried herbs and spices, e.g. turmeric is taken with milk for a sore 
throat, or is mixed with other spices to form curry powder to promote general health 
and well-being, garlic is mixed with honey for a sore throat or used raw for its 
circulatory effects, and fresh ginger is used to treat common cold and it is used in its 
dried form to alleviate feelings of nausea.  
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Figure 9, Dosage form for Indian HMPs, n = 211 
 
Some of the most telling information regarded issues of quality and safety. When asked 
whether they had any concerns over quality and safety of Indian herbs or HMPs, only 
19 per cent (of 76 respondents) indicated that they had no concerns (Fig. 10), with 50 
per cent having concerns regarding quality and safety. Interestingly, only 12 per cent of 
responders were concerned about efficacy and when asked for their own comments 
regarding Indian herbal medicine, 50 per cent (of 49 respondents) regarded it as being 
very effective (Fig. 11).   
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Figure 10, Quality and safety concerns regarding Indian HMPs, n = 76 
 
 
 
Figure 11, Comments on Indian herbal medicine, n = 49 
 
 
The online survey helped me to establish turmeric as my case study. Moreover the 
results of the survey helped in the development of the aims and objectives of the study.  
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The survey demonstrated that the belief in TIM effectiveness was high and a high 
percentage of people indicated they would consider using TIM for a range of medical 
conditions. 
However, there is a lack of knowledge about using these products and there are 
concerns over the safety and quality of the products supplied to the UK. 
7.1.1 Limitations of the survey 
The on-line survey recruited 230 respondents. However, certain questions, mainly 
relating to safety and quality, had a relatively low response rate. 
The survey design allowed for self-selection convenience sample of participants which 
could potentially lead to a voluntary response bias in the results.  
Selection bias was apparent and there was under-coverage and over-coverage of 
certain groups. Because the survey was on-line, the percentage of older respondents 
was relatively low with over 90 per cent being less than fifty four years, whereas the 
percentage of student respondents was relatively high (45 per cent). 
There was a good ethnic mix in the survey, with 58 per cent of respondents describing 
themselves as ‘white’, and the rest being made up from different ethnic groups.  
For the full survey and a more detailed account of the demographic information, see 
appendix 4 
The online survey was an effective and rapid method for determining suitable plant 
candidates for the case study.   
Turmeric was chosen as the case study based on the survey results.   
7.2 Preliminary Investigation in Anhui province, China 
Although the main fieldwork connected with this project was in India. I decided to carry 
out some preliminary investigations in China prior to visiting India in order to be able to 
assess what the current trends were within the market, particularly in the area of 
integrated value chains. China would make a good ‘benchmark’ as it has a more 
developed herbal medicine industry than most Asian countries, particularly if Taiwan is 
included. I was especially interested in the links between these two locations, 
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separated by both geography and ideology, but in many ways similar and emanating 
from the same cultural roots. I wanted to discover what formal and informal links had 
been established between a Taiwanese company, who trade internationally, and the 
provincial farms, primary processors and herbal markets in China. To what degree any 
vertical integration had been established between the company and primary producers 
and whether this had an impact on local livelihoods?  
I wanted to get a general background as to what plants were grown and how 
government and academic institutions were involved (if at all), and if any GAP 
standards were being implemented. Through this preliminary fieldwork I would be able 
to make better informed comparisons during my fieldwork in India. 
7.2.1 Botanical diversity and cultivation of Anhui  
As of 2005, there were 3,482 species of plants and fungi listed for Anhui province 
giving it a ranking of sixth most populated for China as a whole. Cultivated herbs are 
prominent in the north, whereas wild harvesting is more prevalent in the central 
mountainous regions, together with some cultivation. Wild harvesting is mainly found in 
the south particularly around the area of the Yellow Mountain (Chang, 2011). To 
support wild harvesting, seeds are sometimes collected from the wild and propagated 
in the laboratory (see fig. 12). Seedling plants are then returned to the wild to grow.  
Selected medicinal plants and fungi of Anhui Province:                    
Atractylodes macrocephala Koidz. Asteraceae, is endemic to China. It is found in the 
areas of Bozhou, Huoshan, Ninguo, Shexian and Chimen. It is cultivated or grown 
using wild-simulated cultivation. Atractylodes macrocephala has become extinct in the 
wild in Anhui province due to over-collection. 
Chaenomeles speciosa (Sweet) Nakai, Rosaceae, is a native plant and is found in 
Shuanchen 
Cornus officinalis Siebold et Zucc., Cornaceae, is a native plant, found in Jinzhai, 
Huoshan, Yuexi and Shitai 
Crataegus cuneata Siebold et Zucc., Rosaceae, is native to China and is found 
growing in Northern Anhui 
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Dendranthema grandiflorum (Ramat.) Kitam., Asteraceae, is a Di Da herb of Bozhou. 
(Di Da herbs are regarded as the highest quality) There are 4 types and it is found in 
Bozhou, Chuzhou and Shexian. 
Dendrobium catenatum Lindl., Orchidaceae, is endemic and grows on stone. It can be 
cultivated. Wild varieties are found in the Huoshan area, growing at 800 metres, but it 
is very rare to find. (CITES 10controlled). Wild species are collected for their seed. The 
seed is propagated in the laboratory and then the plant is returned to the wild (see Fig. 
12). In TCM it is used as a ‘yin tonic’ and is used to treat febrile diseases. 
Eucommia ulmoides Oliv., Eucommiaceae, is endemic to China and is cultivated in 
Anhui and Beijing. 
The fungus, Ganoderma lucidum (Leyss. Ex Fr.) Karst, Ganodermataceae, is cultivated 
and the fruiting body and spores are used in medicine. 
Gastrodia elata Blume, Orchidaceae, is a native plant and is cultivated in the Jinzhai 
and Huoshan regions. It has a symbiotic relationship with bacteria and the mycelia 
surrounding the maple tree. It is pollinated by hand and can be harvested within one 
year. 
Isatis tinctoria L., Brassicaceae, is a native plant and is naturalised elsewhere and 
widely distributed throughout the northern hemisphere. It is cultivated in the Bozhou 
area. The price of this herb has increased dramatically due to outbreaks of Influenza 
that have significantly increased demand. 
Magnolia biondii Pamp., Magnoliaceae, is cultivated in Huaining 
Magnolia officinalis ssp. biloba (Rehder & E.H. Wilson) Cheng & Law in W. C. Cheng, 
Magnoliaceae, is found in Qianshan 
Morus alba L., Moraceae, is a native tree with many of its parts being used in Chinese 
medicine. It is found widely in Anhui province. 
Paeonia lactiflora Pall., Paeoniaceae, is a native species and is cultivated widely in 
China. The ‘shaoyao’ (peony) of Bozhou is known as ‘boshao’. It is harvested after four 
years of growth.  
                                                          
10 CITES Appendix II - Trade controlled to avoid use incompatible with species survival 
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Its quality standard is measured in terms of its paeanoflorin content which is set at a 
minimum of 1.6 per cent. The levels of paeanoflorin can deteriorate due to improper 
storage or processing. 
Paeonia ostii T.Hong et J.X. Zhang, Paeoniaceae, is endemic. It is native to Henan 
province and cultivated in other provinces.  It is cultivated in Bozhou and wild-simulated 
in the mountains of Tongling. Cultivation is strictly controlled. The colour of the 
medicinal plant is white and the coloured varieties are used for exhibition purposes. It 
flowers in mid-April and is harvested after 4 years. It is known as mudanpi used in TCM 
and used as a regional alternative to Paeonia suffructicosa. 
Peucedanum praeruptorum Dunn, Apiaceae, is endemic and is found in the 
mountainous areas of Anhui. 
Platycodon grandiflorus (Jacq.) A.DC., Campanulaceae  is a native plant found in 
several areas of Anhui province and it is cultivated in the Bozhou area. It is a medicinal 
herb that can also be grown as a food crop, although these two practices are normally 
separated. 
Wolfiporia extensa (Peck) Ginns Polyporaceae is found in the south-west of Anhui. 
This fungus is cultivated by burying pine tree bark. The bark is cut into pieces and 
inoculated with the poria fungus and is then buried in sand. The fungus then grows 
through and out of the bark and is ready for collection after six months. 
Pseudostellaria heterophylla (Miq,) Pax, Caryophyllaceae, is a type of ginseng, native 
to China and is found growing in the mountains of Anhui. 
Trichosanthes kirilowii Maxim., Curcubitaceae,  is a native plant and is widely 
cultivated. It is grown in the Bozhou area of Anhui province. 
Ziziphus jujuba Mill., Rhamnaceae, is native to China and cultivated in many parts of 
the world. 
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Figure 12, Laboratory cultivated Dendrobium catenatum Lindl. (Seeds are collected 
from wild specimens) 
7.2.2 Trade in Chinese medicinal herbs 
In Bozhou, the land is flat and fertile. One million people in the Bozhou area are 
involved in the production of traditional Chinese medicines. In the Chinese 
Pharmacopoeia, four medicinal plants are named after the city of Bozhou; boshao 
(peony root) boju (chrysanthemum flower) bosanpi (mulberry bark) and bohuafen 
(trichosanthes root), about 75 per cent of China’s baishaoyao is produced in Bozhou. 
The city has the largest specialised TCM market and trading centre in China (Fig. 13). 
It occupies 80 hectares, with building areas of over 10,000 square meters (Brion, 
2011). 
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Figure 13, The main trading building at Bozhou Herbal Market 
Farmers bring their dried herbs to Bozhou from all over Anhui province and beyond. 
The market traders are most commonly the farmers themselves who are each allowed 
to produce one tonne of dried herbs per year (Fig. 14). 
 
Figure 14, A local farmer trading his herbs at Bozhou market 
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Information on market trading trends is distributed by Bozhou market to help farmers 
make the best choice as to what to plant for the following year:  
e.g. Baizhi (Angelica dahurica (Hoffm.) Benth. & Hook.f. ex Franch. & Sav., Apiaceae 
“It is not only used as a medicinal herb but also can be used as an 
ingredient for cooking so the demand is increasing in large amounts. 
Its seeds can be planted in spring but the quality of the plant will not 
be that good. Planting in August and September is much better. Use 
3 kg of seed per metric unit (MU) and it takes one year to produce; 
output is about 500 kg per MU. At present this herb’s price is 15 Yuan 
per kg and income is about 7,500 Yuan” (Guangqian, 2011). 
Detailed information is also provided concerning the planting growing and harvesting 
conditions for selected herbs together with projected figures of income, 
e.g. Analysis of  chaihu cultivating technique, effect and profit,   
“Chaihu (lit. kindling of the barbarians11) has the alternative names of 
zhuyechaihu, beichaihu (northern chaihu), nanchaihu (southern 
chaihu), hongchaihu (red chaihu) and xiaochaihu (small chaihu). This 
herb is of the umbelliferae family.  
It is used in TCM to expel pathogenic factors in order to reduce fever, 
sooth the depressed liver and invigorate the Spleen-yang. Indications: 
common cold, irregular periods, stagnation of Liver-qi. It is mainly 
distributed in Hebei, Henan, Shanxi, Gansu, Hubei and Dongbei. 
It is a perennial plant and grows up to 45 to 70 cm in height. Its root is 
straight and some of the root has branches. Bunches of canes grow 
straight up and branches are on the top in a Z shape. 
It likes a warm and damp environment. It is cold and draught resistant 
but does thrive in waterlogged places.  Deep loose and rich soil is 
better for production; organic sandy soil is the best.  
                                                          
11 In ancient China, ‘barbarians’ were considered anybody who originated outside of ‘the middle 
kingdom’  (China) HUANG, Y. (2013) Perceptions of the Barbarian in Early Greece and 
China CHS Research Bulletin, 2 (1).. 
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However, saline and low-lying land is not suitable. It requires a high 
altitude area, with well drained, deep loose and rich organic soil. It 
needs intensive cultivation. Put in a lot of base fertiliser while turning 
over the soil. Complex fertiliser 3,000 to 5,000 kg, mixed carbon 
fertiliser, potash fertiliser 50 kg per MU and urea 20 kg per MU. Make 
a high bed whilst waiting for cultivation. 
Seeds should be planted in spring or autumn. Seeding in spring will 
produce results around early April and in autumn before frost arises. 
Seeding in autumn is better. Seed at 3 kg per MU. Water it when you 
put the seeds in which will allow the seeds to sprout easily. 
As the baby plants are growing up, pay attention to weeding. To avoid 
weeds growing you can use herbicide before putting the seeds in if 
cultivating over a large area. During the rainy season keep good 
drainage. If there is drought, keep watered. During next spring you 
should fertilise once again using urea 10 kg and potash fertiliser 10kg 
per MU). In the winter clean the field to get rid of dead branches and 
leaves. Also add some more homemade compost.  
The main disease for chaihu is root rot. This can be prevented by 
applying 65 per cent daishengmengxin spray. In the early stages you 
can use duojunlung spray as prevention. The main pest is aphid, 
which can be treated by using tachongjin (aphid clear away). With 
underground pests you can use xinliuling together with poison bait. 
Usually after one to two years growing, the above ground part will 
wither away in the autumn. That means it is the time to harvest. 
Firstly cut the above ground part, and dig up the roots, remove earth 
from the root and dry it in the sun.  
Income per MU:  
150 kg x 40 = 6,000 Yuan, stem and leaves 300 x 2 = 600 Yuan,  
Total Income 660 Yuan 
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Costs per MU: 
Seeds: 3 kg x 70 = 210 Yuan; fertilisers: 50 x 4 = 200 Yuan;  
machine: 30 Yuan; labour: 100 Yuan; pesticides: 10 Yuan  
Total cost: 550 Yuan 
Net benefit: = 6600 - 550 = 6050 Yuan per MU” 
(Guangqian, 2011). 
For a full account of prices and market trends for herbs sold in Bozhou herb market 
(2011), see appendix 5. 
7.2.3 Anhui University of TCM 
“Anhui University of TCM is the main TCM University in Anhui. It has 
produced 7,000 pharmacy graduates and currently has 2,000 enrolled 
students, 180 staff and 18 professors. It has five undergraduate 
programmes in pharmacy and four post graduate programmes 
including a PhD programme. The university has generated over 3,000 
papers and has a focus on Chinese pharmacy development. It has an 
extensive herbarium containing more than 90,000 specimens of 
approximately 3,000 different species” (Chang, 2011).  
Pharmacognosy is a speciality of the university and a variety of modern and traditional 
techniques are used. Voucher specimens are kept within the university for many of the 
herbarium species (Fig. 15) 
“There are 50 pharmaceutical companies in Anhui province and the 
university has associations with some of these companies. The 
university is involved in the modernisation and development of TCM 
including research into active plant ingredients. They work closely 
with the sourcing companies and local pharmaceutical companies, 
providing technical knowledge and expertise. In return the university 
is supported through some industry funding” (Chang, 2011).  
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Figure 15, Herbarium voucher specimen at Anhui University 
“Although China has been trading medicinal herbs with the 
outside world for hundreds and probably thousands of years, 
much of this business came to an end during the latter part of 
the 20th Century while China was under a stricter communist 
regime. Although trading probably continued during more 
informal channels during this time, trade in Chinese exports of 
medicinal herbs began again officially in 1984, through the 
establishment of government sponsored Chinese export 
companies. Joint venture companies; often being collaborations 
between Chinese and Japanese partners, have been emerging 
in the arena of medicinal herbs since the 1990’s. For 
Taiwanese companies, trade has had its difficulties and during 
the 1980’s when trade restrictions were stringently enforced 
between the Island and mainland China, the Taiwanese were 
forced to source herbs through intermediary suppliers, chiefly 
located in Hong Kong. It has only been since 2000 that it has 
been possible for Taiwan to import herbal raw materials directly 
from China. For hundreds of years, buyers have obtained their 
herbs chiefly from the herbal markets” (Interview with WCC, 
2011).  
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There are 17 major herb markets in China, the largest of these can be found in the city 
of Bozhou, Anhui province. Farmers, wild-pickers and market traders gather here from 
all over Anhui province and beyond to sell their herbs. There are 6,000 market stalls, 
trading 5,000 tonnes of Chinese herbs, consisting of approximately 2,000 species to 
the 50,000 people who visit the market each day. The daily turnover is estimated to 
exceed US$1.2 million, and annual turnover US$735 million (Brion, 2011).  
This centralised market approach is the traditional way of buying herbs throughout 
China. Prices are fixed and advertised and bargaining is not allowed under Chinese 
agricultural law (PRC, 1993). (Although bargaining was observed during the visit) 
The quality of the herbs is determined by traditional organoleptic methods such as size, 
shape, aroma and taste, and little attention is paid to the active constituents, marker 
compounds, or chemical impurities. Although it is often the farmers themselves that are 
also the market traders, little attention is paid to documenting the source of the herbs or 
documenting any processes that may have been applied to them. Apart from the usual 
drying stage, Chinese medicinal herbs may be subjected to a variety of pre-processing 
requirements including cutting into precise shapes, sieving, washing, stir-frying, 
charring, steaming, boiling and baking. Traditionally much of this work takes place on 
site and it is a common occurrence to see herbs laid out over the pavement or highway 
to dry in the sun after being washed in the local water supply. The pre-processing 
stages such as stir frying, boiling, baking, may take place in the farmer’s home or in 
roughly converted production areas. 
Comment on the current market trends in Bozhou, 
“I have checked the price trend of forty herbs during the years 
2008 to 2009. Their price wandered in low valleys for around 
two years. With other agricultural products increasing their price 
and with increasing labour costs, a lot of farmers gave up or 
reduced cultivating medicinal herbs. In 2009, crop outputs were 
not large amounts. Additionally, drought, floods and freezing 
temperatures caused havoc resulting in even lower output. In 
2010, all herb prices rose” (Zhen, 2011). 
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7.2.4 Developing an international quality strategy  
In order to satisfy the requirements of an international market, some companies have 
found it necessary to put in place systems that help address the quality concerns of 
foreign customers. Taiwanese herbal product manufacturers, which supply herbs to 
distributors in many parts of the world have had to find an alternative strategy from 
buying herbs at local or provincial herbal markets in order to better assure their 
customers that they can source good quality herbal ingredients that can be traced back 
to the areas of cultivation. The belief is that by having direct links to the farms it is 
easier and less costly to assure the quality and traceability of the herbs in comparison 
to using the herbal markets that tend to dominate herbal medicinal trade. In China it is 
difficult for non-Chinese organisations to make direct links with individual farmers and 
so herbal sourcing companies have emerged to provide this missing link in the export 
market supply chain. Anhui Tienho Herb Sourcing Company (ATHSC) is a company 
such as this. ATHSC has been exporting herbs from China for the last 20 years. Firstly 
to herbal manufacturers based in Japan and for the last 5 years to a company in 
Taiwan. They supply processed and un-processed medicinal herbs, plant extracts, 
essential oils and some functional foods. Their main focus is on herbs from Anhui 
province but they also gather herbs from all over China subject to customer demand. 
ATHSC appear to have built good relationships with local farmers and local people are 
employed to work on the land (Fig. 16).   
 
Figure 16, Field worker in Bozhou harvesting mature plants 
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Figure 17, an employee of ATHSC in the warehouse 
The production workers (see Fig. 17) are employed to work seven hours per day for six 
days of the week. Much of the work involves manual sorting of herbs (Fig. 18). 
Industrial equipment is used for washing herbs, drying, cutting, sieving and pre-
processing. 
 
Figure 18, ATHSC factory employees sorting Ziziphus, suan zao ren 
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The management at ATHSC attempts to draws a clear distinction between the quality 
of their herbs and the herbs that can be obtained through the market place (see Figure 
20).  
Company staff together with academic staff from Anhui University, pay regular visits to 
the herb markets to take samples of herbs for comparison. 
The company claim to pay above the market price for the herbs that they source and in 
return they require farmers to pay close attention to quality requirements. They require 
that herbs are sourced at particular times of the year and sometimes in conjunction 
with chemical test data. For example, Paeonia lactiflora is harvested once the 
customer’s requirement, of not less than 3.0 per cent paeoniflorin, is achieved (the 
national requirement being not less than 1.6 per cent). The company believes that the 
increased requirement helps to ensure that quality is preserved through storage and 
pre-processing. This scientific measurement of quality is a new concept for many of 
those involved at the early stages of the supply chain.  
Some quality control testing is performed in-house, including authenticity, loss on 
drying, sulphated ash, essential oil, sulphur dioxide, total heavy metals and assay. 
Whereas more complicated tests are contracted to specialist laboratories, including 
microbial analysis, aflatoxins, residual pesticides and specific heavy metals.  
The crop suppliers are audited by ATHSC annually and the factory is required to 
comply with Chinese standards of GMP as laid down by the CFDA. 
Approximately 95 per cent of the herbs sourced by ATHSC are destined for the export 
market, mainly Japan and Taiwan, and a few other Asian countries. However, 70 per 
cent of these exports are destined for a Taiwanese company, making them by far the 
biggest customer. The Taiwanese company, Sun Ten Pharmaceutical Co. Ltd (STPCL) 
has built up a relationship with ATHSC over a number of years and now invests in the 
company’s infra-structure and training programme. Even though there is a mutually 
advantageous collaboration apparent, with the STPCL owning about 70 per cent 
shareholding, there are still problems to overcome.  
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“Taiwanese board members can only have involvement if they are US 
residents as in the strained political climate, government policy does 
not allow for Taiwanese citizens to be board members of companies 
in China even in joint partnerships. STPCL has been developing a 
working partnership with ATHSC and Anhui University of TCM for 
over 5 years.” (WCC, 2011). 
ATHSC’s strategy is to develop a strong link between STPCL and the Chinese 
mainland suppliers, a strategy that appears to be providing mutual benefits.  
Fig. 19 shows the supply chain for the herbal medicinal products and the links between 
the different parties involved. It can be seen that STPCL is selling some of its products 
on the Chinese market as functional foods which is seen as a major step forward for 
the future development of herbal medicinal trade between Taiwan and the mainland. 
 
Figure 19, The Taiwan-Anhui supply chain  
CHINA 
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The herbal medicinal supply chain for STPCL involves fewer outsider businesses than 
the traditional route (Fig. 20). This strategy helps to promote inter-participatory 
cohesion and helps keep the total costs to a minimum through exclusion of the market 
and wholesaler stages. Importantly, it allows for better defined and transparent 
traceability for the herbs used in the manufacture of HMPs. The flow diagram highlights 
how food manufacturers are placed within the supply chain. 
 
Figure 20, Different routes of supply to the consumer 
Economic considerations 
The price of a herb obtained from ATHSC is dependent on several factors: 
1. The quality of the herb 
2. The season and subsequent yield 
3. Pre-processing requirements 
4. Quality control costs 
5. Increased demand (influence of viral epidemics / pandemics) 
6. Competition from food companies (super foods) 
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Quality requirements are determined by STPCL, and the supplier will aim to source 
herbs that meet these requirements. ATHSC has some input on which fertilisers, 
pesticides and herbicides should not be used but it is the local government authority 
that normally advises on which products should be used preferentially.  
The Brion Research Company, Taiwan (BRCT) has had some difficulty ascertaining 
the precise details regarding pesticide type and usage and this is an area that merits 
further investigation. Over the last five years, the price of crude herbs at the start of the 
supply chain has risen dramatically partly due to the emergence of sourcing companies 
who are contracted by food manufacturers. The quantities of herbs required are often 
very large compared to the medicinal herb market and it appears less likely that the 
buyers will require the producers to adhere to the detailed specifications that are 
mandatory for many medicinal plants.  
Herb prices are also affected by market shocks. It is difficult to plan for many of the 
market shocks that have an effect on supply e.g. Influenza outbreaks, the transient 
popularity of ‘super foods’, droughts, tsunamis etc. These shocks can impact the 
market in variable ways. The so-called super foods easily go out of fashion and flu 
epidemics are unpredictable. Therefore, planning a cultivation strategy can be a risky 
business (Canada, 2012).  
Some of these risks are unavoidable and the suppliers can develop strategies for 
minimising the impact of sudden changes in the market such as to source a wide range 
of herbs from several different areas. Some sourcing companies deliberately buy the 
same herb from different areas, when available, in order to protect supply when a poor 
season in one region of China produces poor yields.  
It is probably the farmer who only cultivates one or two types of crop, who is most at 
risk from shocks and market fluctuations. Herb companies that have managed to 
establish direct relationships with the farmers or specialist sourcing companies are able 
to offer an added benefit in this arena as the sourcing company is committed to 
delivering a certain quantity of herbs to a required specification and so this allows the 
crude herb supplier to plan more effectively for future cultivation or gathering. 
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7.3 Fieldwork in India 
Table 5, Coding for respondents and sites  
Coding Name and/or title Site (Site coding) 
BM Biolab Manager Phalada Agro, Bangalore, India (PA) 
BH Ben Heron,      Operations 
manager 
Pukka Herbs, Bristol, UK (PH) 
CD Company Director Erode, Tamil Nadu Company (ETNC) 
CMN CMN Shastry,    Managing 
Director 
Phalada Agro, Bangalore, India (PA) 
DMPF Director of Medicinal plant 
farm 
Medicinal plant farm (Dodabetta) (MPFD) 
GK Girindhar Kinhal Indian Forest Service (IFS), Bhopal 
HH Himalaya Herbs Trivandrum Ayurvedic Festival (TAF) 
MD Mr. Danesh,  
Farm Manager 
Hosagunda Farm, Karnataka, India (KF) 
PD Professor Dhanabal Tamil Nadu Farm, Tamil Nadu, India (TNF) 
PLW Professor Liz Williamson Reading School of Pharmacy 
PPM Production manager Phalada Agro, Bangalore, India (PA) 
PRM Retail Manager  Phalada Agro, Bangalore, India (PA) 
RS Rambir Singh 
University lecturer 
University of Bundelkhand, Jhansi, India 
SGP SG Phytopharma Trivandrum Ayurvedic Festival (TAF) 
SK Accounts Manager Phalada Agro, Bangalore, India (PA) 
SP Sebastian Pole, Herbal 
Director 
Pukka Herbs, Bristol, UK (PH) 
TW Tim Westwell,                         
Managing Director 
Pukka Herbs, Bristol, UK (PH) 
VO Vanya Orr                 
Director 
The Earth Trust 
 
 
Case Study 1, The Traditional Chain (Tamil Nadu) 
Case Study 2, The VIVC, Karnataka 
Case Study 3, The Jhansi Chain 
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Introduction 
The central theme of my fieldwork was to understand in detail how the participation in 
different value chains may impact on livelihoods and how the quality of starting 
materials and HMPs may vary in these chains. This enabled me to investigate and 
document the cultivation of medicinal plants, including turmeric, primary processing 
and storage procedures and (for some value chains) secondary processing of plants 
into finished HMPs. Undertaking this exercise enabled me to compare and contrast 
different value chains of turmeric and obtain a deep understanding of the processes 
involved that have an impact on livelihoods and product quality.      
Through networking and by developing a range of contacts within the UK, with people 
who have interests in, or knowledge of the HMP industry in India, I was able to gain 
access to several study sites. It was important to compare a VIVC (case study 2) 
against a traditional chain (case study 1) these chains represent industrial scale 
operations that either produce HMPs for the domestic market or produce products for 
export. The third case history provides an example of smaller, non-industrial chains, 
providing fresh turmeric to the local market. The farmers interviewed in this chain 
provide an alternative scenario to the first two case histories, which describes a 
situation where farmers would like to add value to their products but lack the necessary 
inputs, skills and contacts that would be needed to make this possible and sustainable. 
Professor Liz Williamson (PLW), School of Pharmacy, Reading, introduced me to a 
Professor in Udhagamandalam (PD) (see Table 5) who part-owned a turmeric farm. PD 
and his two brothers were able to provide a detailed account of how the supply chain 
was organised in Tamil Nadu. Moreover, they introduced me to other actors in the 
chain, including the manager of auction house, the owner of a storage facility and the 
managing director of a secondary manufacturing unit.  The managing director of PH, 
(SP), provided a valuable source of information and facilitated introductions to key 
personnel in India. PH retains an employee in India (BH) who was able to arrange my 
visits to the VIVC farm and manufacturing site.  
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Research was carried out on the Indian sites (Fig. 21) over a period of approximately 
four months during 2012. This generally entailed travelling to different sites by road, rail 
or by air and staying within farm dwellings or in accommodation in close proximity to 
the manufacturing sites. Whilst on the farms, I was able to spend time interviewing the 
farmers and / or farm managers. Although the farm workers spoke little, or often no 
English, I was able to get a general impression of their daily routine through 
observation, much of which I recorded through photographic images. Within the 
manufacturing units, the level of English spoken was much better than encountered on 
the farms and I was able to conduct interviews with many of the senior and middle 
management. 
7.3.1 Case study 1: The Tamil Nadu Chain 
Erode and the PD Farm, January 29th to January 31st 2012 
Professor of Phytomedicine, (PD), grew up on the family farm where his two brothers 
still work and reside (see Fig. 22). PD’s father died in 1996 and the brothers took over 
the running of the farm, which has been in the family for three generations. The farm is 
12 hectares (30 acres) in size, each brother owning four hectares and the two resident 
brothers manage PD’s plot.  
 
Figure 22, The PD family at the Tamil Nadu farm 
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Each brother has his own house on the farm, which is comfortable and furnished, with 
modern appliances including TV, computer and broad band internet. Cows and 
chickens are kept on the farm for domestic purposes.   
Most of the farms in the area tend to grow the same crops. These tend to be those 
crops that can be grown relatively quickly, that are relatively disease resistant and that 
have a potential for selling on. There is a sugar processing centre close to Erode which 
provides an avenue for the sale of sugar cane (see Fig. 23). 
“The main crops are sugar cane and turmeric. The sugar cane is 
harvested after 10 months and local labourers are employed to gather 
the crop.  
  
 
Figure 23, Gathering the sugar cane (the leaves are removed before the cane is cut) 
 
Afterwards, the harvested crop is passed to a local sugar factory for 
processing. Sugar cane is the main crop in the area of Erode. This is 
due to it is being quite resilient and largely resistant to disease; it 
represents a low risk crop with good yields.” (PD) 
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These are not the only crops grown and market forces determine which others are 
grown. There is a strategy for planting, chiefly based on which crops have done well 
the previous year.  
“Other crops that grow in this area are tapioca, coconut, rice, bananas, 
papaya, maize and okra. The dominant crops tend to reflect market 
prices - so if the price is good for one year, more of these are planned 
for the next.” (PD)  
However, this often has the effect of over supplying the market, resulting in a decrease 
in value. Some crops have a fast turnaround, e.g. okra is ready for harvest after three 
months, so that four harvests per year are possible. The farm itself does not engage 
directly in cultivation of medicinal plants (although the turmeric, cultivated primarily as a 
food crop, has the potential to be used in medicines further along the chain). The 
reason for the reluctance to cultivate medicinal plants is partly because of the brothers’ 
view that the market is subject to many variations, and therefore the risks are too high. 
They were not informed about any buy back or voucher schemes such as those 
implemented in the Karnataka state. PD had never heard about the possibility of taking 
out insurance for failed crops. The government in India pays little attention to helping 
farmers financially but there are some benefits available. 
“The involvement of the government is very low, but they provide free electricity 
for the irrigation of the fields.” (PD) 
The cultivation of turmeric on this farm requires different inputs at certain stages. 
Although the farm is not a vertically integrated farm, it is necessary for the farmers to 
make horizontal linkages with different actors. Theses linkages provide sales revenue 
and income for the goods and services providers. 
“Turmeric can suffer from leaf rot and thin rhizomes, so different proprietary herbicides, 
fungicides and pesticides are used alongside fertilisers, including potash, urea and 
manure.  After harvesting, the turmeric is boiled using a mobile steam generator (Fig. 
24), which is hired from a third party. Manure is added to give a good colour. The 
boiling decreases the microbial load and helps to remove water from the roots and 
rhizomes. After the turmeric is boiled, it is dried in the sun for twenty days before it is 
polished (Fig. 25). The polishing gives the rhizome a more attractive colour and makes 
it more attractive to buyers.” (PD) (Fig. 26) 
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Figure 24, A farm labourer boiling the turmeric root crop 
 
The products that result from turmeric cultivation are the root tuber and the rhizome. 
Both of these parts are valued commercially although it is the finger-shaped rhizome 
that is mostly identified with as being authentic turmeric and it is this rhizome that is 
typically subjected to further processing. 
 
“Both the root and the rhizome are used and both can be re-planted but 
the root is more commonly used for seed stock. The rhizome is mainly 
ground to produce turmeric. The root tends to be used for paints and 
dyes but also for cosmetic purposes.” (PD) 
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Figure 25, A farm labourer processing turmeric 
 
Farm labour is notoriously under-paid, with many farm workers throughout India living 
on or below the recognised poverty line. The introduction of mechanised horizontal 
inputs can significantly boost employment and the wages of labourers.   
“For the boiling process 45 rupees are charged to the farmer for each 
barrow load - of which, 30 rupees are shared between the five operators 
and 15 rupees are given to the equipment hirer. The total output is 
approximately two hundred barrow loads per day and so each operator 
earns approximately 1,200 rupees (US$20) per day during the season.” 
(PD)  
A boiler of this type would be cost 2.5 lakhs (US$4,000). The polishing 
process also requires hired machinery. Approximately 80 bags, each 
weighing 90 to 100 kg, are polished every day. The farmer pays 100 
rupees per bag – of which 60 rupees goes to the farm labourers and 40 
rupees to the owner of the equipment. Therefore the processors earn 
4,800 rupees (US$80) or 1,000 rupees each (US$16) per day. 
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Figure 26, Farm labourers polishing turmeric rhizomes 
 
The usual local wage for farm labourers is 200 to 300 rupees (US$3-5) per day 
(depending on the season) and 100 to 150 rupees (US$1-3) per day for women 
workers. 
In 2010, the auction price of turmeric reached up to 18,000 rupees per quintal (100 kg), 
but in 2011, it fell to 4,000 rupees per quintal. At this price it is difficult for farmers to 
realise any profit and so they may choose to store the crop until the market price rises. 
The brothers would not consider cultivating medicinal plants at the current time but 
would consider distributing un-polished turmeric to a herbal medicine manufacturer, if 
requested. 
Most of PDs relatives, who still live in the area, are farmers. I visited some cousins who 
also grow sugar cane, turmeric and other crops but also have diversified with a clothing 
manufacturing unit on the farm site. 
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They buy cotton from Gujarat and use this to produce shirts and other garments, which 
they sell all over India. One of the cousins works in Hyderabad in information 
technology (IT). 
PD also has a friend who was originally a pharmacist – but is now a full time farmer. He 
grows sugar cane, turmeric, coconuts and well as organic bananas. He doesn’t grow 
organic turmeric, and explained, 
“That would not be profitable, because the yields are too low. I 
would like to produce for export, because at the moment the 
domestic price for turmeric is so low that the costs for 
production are disproportional to the profit. Even on the 
contrary, they would exceed this.” 
Moreover, he described the problematic situation regarding the middlemen, who are 
auctioneers and storers’ of turmeric, as well as the attitude of the government: 
“On the one hand there are the middlemen, who take the whole 
profit and on the other hand the government, which do nothing 
to stabilise the price.  
There is some potential to distribute directly to medicinal plant 
companies but they are currently over supplied.”  
At the government regulated market (Fig. 27), each farmer sells about 2,000 bags of 
turmeric per day, for about 4,000 rupees per bag, depending on quality. The auction 
market takes two per cent of the sale price as commission. 
Samples are displayed for buyers, prior to the auction, for organoleptic inspection and 
subsequently they will bid for each lot.  
“But as a buyer you are aware of which farm the lot comes from 
but have no knowledge about how it was grown.” (PD)  
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Figure 27, The state regulated auction house in Erode, Tamil Nadu 
 
Farmers, who do not want to sell immediately, send their harvest to a storage unit. The 
storage unit is leased for two lakhs (US$3,200) per annum and an additional 15,000 
rupees per month (US$240) are paid to the landlord owner of the property.  
In Erode there are about 350 storage facilities of this type. 
The turmeric can be stored in this type of facility for up to five years (Booker, 2012, 
fieldwork interviews). When the crop is sold, the storage unit receives two per cent of 
the sale price as commission.  
The turmeric is stored in jute sacks (Fig. 28) and there is evidence of weevil infestation 
and fungal moulds and so there are some risks involved in storing crops in this kind of 
facility particularly as the owner accepts no responsibility for any spoilage.  
 
Figure 28, Turmeric stored in jute sacks and treated with pesticides to minimise 
infestation and microbial growth. 
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I visited the largest manufacturer of herbal medicinal products in Erode, Tamil Nadu 
(ETNC) and I interviewed the company director (CD). The parent company is well 
established in the cattle, poultry feed and dairy sectors. There is a powdered egg 
facility, producing 15 lakhs (1.5 million) eggs daily that are exported to Europe. This 
company is not connected to Case study 1, but is an example of a company involved in 
a traditional chain. The company preferred to remain anonymous. 
ETNC produces HMPs and retains 250 employees. It produces Ayurvedic, Siddha and 
Unani medicines – medicated oils, liquid formulations as well as tablets, capsules and 
bhasmas12 (Fig. 29). All products are produced from raw herbs and powders. This 
manufacturing unit does not produce plant extracts.  
 
 
Figure 29, Ayurvedic medicine manufacture 
“80 per cent of the raw materials are wild-collected, another 20 per 
cent is cultivated, of which ten per cent is organic but not certified.” 
(CD) 
 
                                                          
12
 Bhasmas are Ayurvedic medicinal products that contain a calcined mixture of plants, gems 
and metals (some of which are known to be toxic). 
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 The company produces, what the director describes as ‘classical generic formulations’, 
which make up 80 per cent of products and branded proprietary medicines 20 per cent.  
“The focus is on producing old formulations with modern quality 
assurance. The company also has a clinical side and owns an 
Ayurvedic / Siddha hospital in Erode dealing with both out-patients 
and in-patients. It has one hundred patients being treated exclusively 
with traditional medicines including bhasmas.”  (CD) 
The company tests for liver toxicity and, according to the director,  
“There have been no reported cases of abnormal liver enzymes.” 
(CD) 
The company was started as a charity using 15 crore rupees (US$2.4 million) funds 
from the parent (farming) business and 5 years ago the turnover was three crore 
rupees (US$490,000). Now it is breaking even with a turnover of 13 crore rupees 
(US$2.1 million) and has its main sales area in South India in the states of Tamil Nadu, 
Karnataka and Kerala.  
There is currently no export of HMPs because it was difficult for the company to find an 
organised supply chain that would satisfy the needs of exportation. It would need the 
same kind of traceability as they have for their egg powder production. 
At the moment the plants are bought from traders who supply 250 different herbs. 
Samples are identified and approved for quality using the services of the company’s in-
house QA and pharmacognosy laboratories. Incoming raw material is cleaned to 
remove foreign matter and then placed into drums. It is more problematic for external 
testing as the director states that:  
“There is no transparency within the industry and testing for heavy 
metals, pesticides etc., can be very expensive, and so these tests are 
not carried out routinely.” (CD) 
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7.3.2 Case study 2: The vertically integrated value chain  
January 19th to January 25th 2012 and October 9th to October 14th 2012 
This case study represents the VIVC that is operated between a farm in the state of 
Karnataka, India (KF), a primary manufacturing company in Bangalore, India (PA) and 
a retail company in the UK who undertakes the secondary manufacture of HMPs (PH).   
My main interviewee on the farm was MD who was able to provide me with more 
detailed information on employment structures, procedures and practices and how the 
farm linked in to other actors within the value chain. 
a) The Farm (KF)  
KF is a 12 hectare farm, set in 180 hectares of forest that is managed by the Sri 
Umamaheshwara Trust.13 The farm is owned by CMN and is managed on a day to day 
basis by MD, the farm workers vary in number depending on the season.   
The farm workers 
Farm work is the biggest area of employment for the state of Karnataka. The work 
force comprises both residents of the state and migrant workers from other nearby 
states. The 2001 census accounts for about 56 per cent of employment as farmers and 
agricultural labourers (HDR, 2005).   
On 20th January 2012, there were about ten farm workers on the KF site, five women 
were involved in weeding the gotu cola (Centella asiatica ( L. ) Urb. Apiaceae) field 
(Fig. 30) and three male workers were involved in harvesting and processing of Areca 
catechu L. Arecaceae (Fig. 31). Other workers divided their time between weeding, 
harvesting, sorting, cleaning and drying although only the male workers were involved 
with the harvesting of the areca catechu (which often requires the ability to climb trees) 
and its processing, where it is cooked in a pot for several hours. 
                                                          
13
 12 hectares is large by Indian standards where an average farm is normally less than 0.4 
hectare.  
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Figure 30, Workers at KF weeding the Gotu Kola field 
 
 
Figure 31, A farm worker undertaking processing of betel nut (Areca catechu L. 
Arecaceae) 
The farm labourers begin work at eight o’ clock in the morning and work through until 
lunch. They are managed on a day to day basis by MD, the farm manager. MD lives 
and works on the farm and it is his full time occupation. He is currently single, but plans 
to get married later in 2012 and hopes that his wife will come to stay with him on the 
farm.  
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The other farm workers either live on the farm or in close proximity (up to 1km away) 
and also work on other farms as demand dictates. The farm register recorded between 
six and fourteen farm workers attending the farm each day. The length of time that 
workers had been on the farm varied and some were relatively new to the farm, other 
workers, however, have been employed on the farm for many years and have children 
who also work on the farm.  
“They either stay for a half day or full day, depending on what 
work is required, and are paid on a daily rate. I haves no plans 
to move away from the farm and when I get married later this 
year, my wife will come to live with me on the farm. The longest 
serving employee has been on the farm for 15 years and has a 
son and daughter who also work on the farm. 
I have been on the site for six years and two of the male 
workers have been on the site between six and eight years.” 
(MD). 
MD, the farm manager appeared well and healthy. His attire was clean and smart. He 
has a number of material possessions that could be interpreted as wealth indicators. 
There are other farm workers who also have been able to save some of their wages in 
order to accumulate some possessions. 
“I have a mobile phone, a motorbike and a car. One of the 
young farm labourers has a second hand motor bike and 
another labourer also has a motorbike” (MD) 
The farm work is varied and cultivating crops organically can be more labour intensive 
than conventional farming. The work carried out on the farm is divided up between 
male and female labourers. The men and women at KF are usually segregated in the 
workplace. This practice is typical throughout India for many types of employment, 
although I observed that the army and police force were noteworthy exceptions. At KF 
it appeared that the men and women had quite well-defined roles and this was 
confirmed by MD.  
Most of the farm labourers work permanently on the farm. Occasionally, short-term 
contractors are employed during periods of high productivity.  
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There is some variation between how males and females will find employment, with 
men tending to travel further to find work. Sometimes, when there are particularly busy 
periods, extra labour is recruited off-site, e.g. the Areca crop, which is a particularly 
labour intensive, is loaded onto a lorry and taken to the nearby village where women sit 
and take off the husks (Fig. 32).  
This work is physically demanding as the husks are tough and must be cut with a metal 
implement before shelling can take place. The women work under a shaded area 
outside of a large house. They sit and chat to each other while working, which helps to 
pass the time. 
“The women and the men share the work but the type of work 
that they do is often different, the men do more climbing and 
heavy work and also take care of the animals (cows and 
buffalo).   
When the seasonal work comes to an end, the women will find 
other agricultural work in the local area. The men may travel 
further afield to find work. When the Areca is harvested, extra 
processing is required off-site. This mainly involves the shelling 
of the raw fruit. It is then returned to the farm for processing.” 
(MD) 
 
Figure 32, Women from a nearby village help to process the Areca crop 
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The cook and her husband work on the farm and they have one son. When he finishes 
school, around four o’ clock, he comes to the farm to meet his parents. He speaks little 
English. The husband is a habitual betel nut user and the son likes to eat raw sugar 
cane and fresh coconut. The ten year old boy helps out with the farm work on 
occasion.  
“Both the cook and her husband work on the farm. They have 
one child, ten years old, who is in school. They live about one 
kilometre from the farm but often stay on the farm during 
harvest time.” (MD) 
By the time of my second visit the cook and her family had moved to the city. MD 
explained that the husband had found better paid employment. The cooking 
responsibilities were taken over by the wife of one of the Brahmin priests (SK). As well 
as taking care of feeding the priests, and some of the farm workers, she also manages 
the farm accounts.  
At the time of the interview (October, 2012) SK had one, three year old daughter, who 
was about to start school. SK lives with her husband in a house next to the main 
farmhouse. SK has knowledge of some medicinal plants and their uses. This 
knowledge had been orally handed down to her through a family relative, her aunt, and 
is based on the Ayurvedic system. She uses this knowledge to treat herself and her 
family when they are unwell. 
“My husband used to live in the farmhouse with another three 
priests but when we were married, a new house was built for 
us.  
I gained my knowledge of Ayurvedic medicine from an auntie 
who was an expert in their use. I use various plants from the 
forest for medicine. I mainly use the Ayurvedic medicines to 
treat my daughter when she is unwell.” (SK) 
Infrastructure, wages and working conditions 
The buildings are mainly brick built and sturdy looking in their construction. The 
accommodation is basic but clean and practical. My own accommodation, which was 
located about fifty metres from the main farmhouse, consisted of a large room with a 
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bathroom attached, there was another room of a similar size next door occupied by 
some Italian volunteers. The accommodation is used regularly by volunteer workers, 
mainly from Europe, who typically stay on the farm for a few months. They can choose 
to do farm work or to help with a temple restoration project that is taking place in the 
forest. In return they receive meals for the day and a place to sleep.  
 For all of the domiciliary buildings, there is hot water provided by log (or coconut) 
burners located on the outside of the building. The electricity comes from the mains 
supply but can be disrupted by power cuts and so a generator is kept on site as a back-
up. The ovens and hobs that are used for cooking are powered by gas. This is either 
bought in pre-filled cylinders, or is obtained as a by-product from the cows.  
In keeping with Hindu belief, all of the three meals served per day are vegetarian. 
There is a strong connection between the farm and the nearby Hindu temple, of which 
CMN (the Managing Director of PA), is a benefactor. The local Brahmin priests 
regularly come to the farm to eat at the communal meal times. On other days, 
particularly at the time of religious festivals, meals are provided at the temple, and the 
farm workers will join the priests and other members of the local community at these 
gatherings. 
The majority of workers are paid by MD on a daily basis and he receives his wages 
monthly. It is a long working week with few holidays. The men earn 150 rupees 
(US$2.4) per day and the women 100 rupees (US$1.6) per day. This is lower than the 
usual local rate of 250 rupees for men and one 150 for women but the farm workers at 
KF are hired under contract, which is atypical for farm labourers in India who would 
normally move from farm to farm as the work dictates. At KF, the workers are 
employed on a yearly basis for six days per week and so although the daily wages are 
lower, they have a guaranteed yearly income, without having to travel. The farm (and 
the factory further along the chain) benefit from this arrangement through having 
workers who are trained in GAP and have knowledge of crop cultivation that has been 
built up over a period of time.  
“If the workers stay until the afternoon, they eat in the 
farmhouse, otherwise they eat at home. 
The farm workers work six days per week and have four unpaid 
days per month off plus festivals.  
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The men earn 150 rupees (US$2.5) per day and the women 
100 rupees (US$1.6) per day. My wages are 7,500 rupees 
(US$120) per month. I manage the farm workers and also help 
out with the harvesting. During the Areca harvest time, two 
weeks in January, I sleep outside with the crop as there have 
been cases where the crop has been stolen during the night.” 
(MD) 
 “The farm workers on the estate are contracted for the entire 
year and paid for six days per week. Typically for the area farm 
work is seasonal and workers are only paid for days they have 
worked harvesting, spraying or planting. Organic and bio-
dynamic farming, particularly in the forest setting needs 
constant attention and management and so there is always 
work to be done throughout the year.” (SK) 
The farm is contracted to supply medicinal plants and spices to one company in 
Bangalore who in return offer some services to the farm.14 
“PA buys all the medicinal plants. They provide seeds and 
seedlings, training in cultivation, advice on good agricultural 
practice (GAP), good collection practice (GCP), and best use of 
organic inputs.” (MD)  
The farm has a computer where all accounts and records are kept, a 24 inch colour TV 
and digital box and internet access through Wi-Fi.  
The crops 
It is common for farms in India to produce more than one crop. This multi-cropping 
helps to ensure that there is employment for much of the year and also helps to protect 
against the impact that climatic shocks or diseases may have on individual crops.  
Moreover by having a selection of differing crops, it helps to even out fluctuations in 
market prices. 
 
                                                          
14
 The owner of the farm CMN, is also the owner and managing director of the company in 
Bangalore. 
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“As well as Areca and medicinal herbs the farm grows food 
crops. Chili, all spice, cinnamon, nutmeg, pepper, bananas, 
coconut and ginger, which are sold at local markets, small 
mangoes are grown on the farm to make pickle and also to sell 
at the market. The main farm crop is Areca catechu, then rice, 
coconut, spices, medicinal herbs. All of the rice is consumed on 
the farm. The Areca, coconut, bananas and pepper are all sold 
at markets in Sagar.” (MD) (Figs. 33 and 34) 
 
 
Figure 33, Pepper vines are grown amongst the Areca forest  
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Figure 34, Bananas are grown on the farm and sold in a nearby town 
 
In keeping with the organic and sustainable ethos that CMN encourages, there is much 
interest in finding ways to grow crops under the Areca forest canopy. Crops that are 
cultivated in this way are termed ‘woods-cultivated’ or ‘wild-simulated’ and can often be 
sold at a higher premium than other cultivated products. In this way it is seen as a form 
of value addition within the chain. These methods of semi-wild cultivation that can lead 
to value-addition of the product were highlighted in the literature review in relation to 
ginseng cultivation in North America.  
Some of these experiments are still at an early stage and not all of the seeds planted 
are expected to survive. Some of the experiments are more successful than others. 
One experiment with haritaki (Terminalia chebula Retz., Combretaceae), which took 
place in 2010, did not yield as many plants as hoped.  
“Some crops, such as haritaki, may take up to five years to 
harvest, whereas turmeric is ready in nine months. 20,000 
haritaki plants have been seeded in the woods. The haritaki 
planting had mixed success with many seeds not producing 
plants.” (MD) 
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In another experiment with Centella asiatica (gotu kola), shading is used with palm 
leaves to try and force it to grow quicker (Fig. 35). The shaded crops appeared to be 
growing better than the un-shaded.  
    
Figure 35, An experiment using shading techniques to promote plant growth 
After harvesting the crops are cleaned by hand, washed using a tiered system and then 
drained and dried. Initially in a drying room, before being laid out in the sun for further 
drying (Fig. 36). The turmeric rhizomes will be sent for further processing but the root 
tuber is mainly replanted for next season’s crop.  
The chosen plant of interest, Curcuma longa (Turmeric) is a major crop grown on the 
farm. It is also cultivated on neighbouring farms that are contracted to the VIVC. It is 
dried, as is typical for root crops, by being laid out in the sun (see fig 36). 
    
Figure 36, Turmeric after harvesting and being laid out in the sun 
Or sometimes, in the case of Areca, the drying takes place on the roof (Fig. 37).  
It is then processed on the farm before being shipped to the next actor in the chain. 
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Figure 37, Areca catechu drying on the farm house roof 
“Areca is pre-processed using a boiling method and dried in the 
drying huts before sending to the main processing unit in 
Bangalore.” (MD) (Fig. 38) 
 
     
Figure 38, Processing Areca catechu 
On the 21st January 2012, I observed harvesting of the Bacopa monnieri (L.) Wettst. 
Plantaginaceae (jala brahmi). The harvest was undertaken by the women workers; six 
local Indian women and one Italian volunteer. The process consists of harvesting the 
plants by cutting them close to the ground, removing foreign matter, sequential 
washing, draining and drying. The process steps are recorded on a GAP tag that is 
attached to the batch (Fig. 39). 
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 According to the batch record, this crop of jala brahmi was planted on 21/8/2010 and 
harvested on 21/1/2012. The harvest takes place over several days and the women 
often spend the whole day in the sun and heat in order to reach their target yield. 
“The seven women harvest 25 kg of wet plants per day.” (MD) 
      
     
Figure 39, Different stages of crop processing; collecting, sorting, sequential washing, 
drying and batch record attachment. 
 
Livestock 
On the farm, as in much of India, cows are regarded as an essential possession. 
Particularly on an organic farm, where chemical fertilisers are prohibited, cow manure 
becomes an essential requirement for healthy plant growth. 
There were six cows and two buffalo kept on KF. These were used both to provide 
essential food items used in daily meals, for agricultural use and as a source of energy. 
“The cows provide milk and curds and the cow manure is 
collected for fertiliser, it is mixed with water before irrigating the 
fields, and to make (methane) gas for cooking.”  (MD) 
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Organic farming 
 
Figure 40, Organic farm certification for KF 
The farm has been certified organic since 2004 (Fig. 40).  
Waste vegetable matter is composted and leaves are collected to produce leaf mulch 
fertiliser.   
Many crops are planted in the forest in a random fashion, the crops in the fields are 
manually weeded and those that grow in water do not require weeding. Organic 
farming encourages natural pest management and a resident wild bird population helps 
to keep the insects down as well as providing another source of fertiliser (Fig. 41)  
“All of the farms are certified by an International certification 
body similar to the soil association in the UK. There is a nursery 
where organic plants are propagated. These are given to the 
farmers for growing on and then the crop is bought from the 
farmer after harvesting.” (CMN) 
“There are no chemical pesticides or herbicides used on the 
farm.” (MD)  
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Figure 41, Fields are weeded by hand and birds help to fertilise the land and reduce 
the insect population 
b) The primary manufacturing site (PA) 
PA began trading in 1999 and in January 2012 employed 150 people. 
“We are currently making a modest profit but not enough to 
provide a margin of safety in a fairly high risk area. However, 
the company continues to grow by 20 to 30 per cent each year.” 
The factory workers  
The pay for factory workers is similar to that of farm workers (Fig. 42) although factory 
work is generally preferred as the working conditions within the factory are considered 
better than on a farm where temperatures can get very hot or it is very wet during the 
monsoon season. Moreover, within the factory hierarchy there are more positions of 
middle and senior management that attract a higher salary. 
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Figure 42, Factory staff at PA, sorting dried herbs 
“The staff at PA normally work a six day week, however, they can work 
seven days if they choose to. The work consists of sorting, cleaning, 
processing and packaging depending on customer requirements.” 
(CMN) 
“The workforce at PA, work a six day week (48 hours). The employees 
receive free healthcare, a company pension and free education for their 
children. Salaries range from 6,000 rupees (US$95) per month for a 
junior clerk to 16,000 rupees (US$255) per month for a manager.” 
(PPM) 
The products 
The company produces a range of products, all connected with the sustainable 
cultivation of organic herbs and spices. Apart from the medicinal herbs the company 
also produces a range of organic culinary herbs and spices (Fig. 43). 
Almost all of the spices and medicinal herbs are exported but since 2010 the company 
has been experimenting with a spice range for the growing domestic market.  
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“Medicinal herbs are produce exclusively for PH. 
Culinary herbs and spices are sourced locally but also farther afield e.g. 
saffron from Kashmir, mint, fennel, holy basil and mustard from Uttar 
Pradesh.” (CMN) 
 
Figure 43, Organic food products packed at PA 
Another important product for the company is organic compost. This is a mycorrhizal 
compost that is suitable for use with organic farming.  
Fertilisers are a major cost for farmers and most farmers produce their own through the 
use of decayed vegetable matter and through animal manures.  
“There are 2 sites for this, one in Shimoga, Karnataka and another in 
Mumbai. These two sites produce 3,000 to 4,000 tonnes of compost 
per annum. Some of it is destined for PAs own contracted farmers if 
they cannot make enough of their own but the majority is sold to the 
big organic farms throughout India.” (CMN). 
“Farmers are not obliged to buy pesticides / fertilisers from PA and 
the majority (80 to 90 per cent) choose to manufacture their own.” 
(PPM) 
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Figure 44, Production of mycorrhizal fertiliser 
There are also a range of (bio) - fertilisers, pesticides, fungicides and herbicides 
produced. These are also essential for the healthy growth of organic plants. Some can 
be made by the farmer but many of these products require complex bio-engineering 
with much of the initial development being undertaken by the Indian government. 
“Bacterial bio-fertilisers are able to symbiotically fix nitrogen in 
the soil. A phosphorous solubilising bacterium allows more 
readily uptake of phosphorus by the plants. Pseudomonas sp. 
is used to control disease. Aspergillus sp. aids in compost 
manufacture. The mother tinctures are developed by the 
agriculture department of the Indian government which PA 
purchase and then grow in the lab.” (BM) 
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Figure 45, Laboratory production of bio-(fertilisers, pesticides and fungicides) 
Turmeric 
Turmeric is one of PAs top selling products and is produced on several contracted 
farms, including HF. 
“Turmeric ranks within the top five of products produced by PA. 
We export 60 tonnes of turmeric, of which about three tonnes 
goes to PH. The remainder goes to another UK company (OHC 
organics), the USA, Germany and Austria. The usual variety 
grown is Roma with an average curcumin content of 2.7 per 
cent (as determined by PA). 
The company is keen to exploit new markets and has been investigating 
the potential of using different varieties of turmeric. 
We are now experimenting with a north-eastern variety, 
Kandama, which has high oil content. The domestic market is 
still relatively low with about 0.5 tonnes being distributed.” 
(PPM) 
Perhaps surprisingly, the more profitable business, in terms of margins, is 
the domestic one. This is mainly due to the extra costs involved in meeting 
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the standards required, (a problem highlighted in the literature review). 
However, in this case, the export market remains most profitable in total 
because of the high turnover. 
“Although the domestic share is relatively low, the returns to PA 
are slightly higher than with the export business (Figs. 46 and 
47). This is because even though PA receives a better price 
from the export buyer, there are additional costs to the 
company that reduce the net profit. These extra costs are 
mainly export duty and the additional testing that is required to 
ensure conformity to EU regulations and customer 
specifications. However, the majority of business lies with the 
export market.” (CMN) 
The costs of producing turmeric in this VIVC are relatively low when 
compared to the traditional method. One reason for this is that less 
processing is needed at the beginning stages (i.e. the boiling and polishing 
steps) as the appearance of the rhizomes, while being a major indicator of 
value for product sold at auction, becomes less important within a VIVC 
where an encapsulated or tableted HMP is the end result. 
 “It costs 20 rupees per kg to cultivate turmeric, this includes 
labour costs. This is probably lower than at other farms as all 
the primary processing (boiling only) is undertaken at the 
Bangalore site.” (MD) 
However, some additional costs become apparent when trying to sell a 
niche product within the domestic market. 
“The organic market is very small compared to the regular 
market and consequently retailers want to make a higher return 
and so demand a higher percentage of the retail price. In the 
medicinal plant sector, organic is in even less demand although 
some of the more progressive companies are beginning to 
consider organics in response to changing consumer demand.” 
(PRM)  
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There are also some other reasons why Ayurvedic medicinal preparations 
are less popular in the domestic market. 
“The majority of business for Ayurvedic products lies in the 
export market with only 10 to 15 per cent remaining domestic. 
Rural people with some knowledge of medicinal plants are 
unlikely to buy Ayurvedic preparations. This is partly due to the 
cost but also many of these plants are available in the wild. 
Home cultivation may also be employed, especially for food 
plants with medicinal qualities. In urban areas the situation is 
different. There is little knowledge amongst the general 
population concerning traditional medical uses of plants. 
Because of busy lifestyles, Western pharmaceuticals have 
become popular as they tend to act more rapidly and do not 
generally require that the individual modifies their lifestyle or 
dietary intake. Very little knowledge of Ayurveda has been 
passed down through the generations and my friends or I do 
not have a good knowledge of Ayurveda. In general, 
conventionally trained doctors enjoy a higher status than the 
Veydas who can be looked on with some suspicion.” (PRM) 
However, this picture is not a static one and there seems to have been some changes 
over the previous ten years and the impetus of this change may have come from the 
use of these medicines in more economically developed countries. This is coupled with 
a more relaxed regulatory system in India that allows for a wider interpretation of 
evidence of the effectiveness of HMPs. 
“Through mainly advertising and marketing campaigns, more 
people are becoming aware of the health benefits of certain 
plants. There is a view that if these plants are being used by 
people in Western countries then there must be some truth in 
the claims made for their effectiveness. Consequently there is 
an increasing trend for manufacturers to add these plants to 
food products and health drinks, including teas. The health 
claims that are permissible in India are more generous than 
what would be allowable in the EU.” (PRM) 
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The contract with the farmer 
HF has been contracted to PA for over ten years and it is necessary to build up these 
longer term relationships in order to build trust along the length of the value chain. One 
way of developing this trust is by ensuring good governance in financial obligations. 
However, particularly with newly contracted companies, break-downs in supply chain 
governance can occur. Because of this PA has had to find ways of ensuring adequate 
stocks are maintained. 
But for the farmers who remain loyal over time there are financial rewards. Incentives 
are offered to the farmers in the form of price premiums. These premiums are paid in 
recognition of the extra work it takes to be able to farm organically and using GAP.  
“Relationships are built up with farmers over time.  PA is now in 
a position where it can settle accounts immediately which is a 
good incentive for farmers to remain loyal.” (PPM) 
 “One of the main problems is when the farmer sells to another 
company who urgently needs the crop or sells it on the open 
market when the price runs high.” (PRM) 
 “We try to ensure that we have the crop in the warehouse 
before finalising the customer contract (Before final payment is 
made)” (PPM)  
“The farmer receives a 10 to 40 per cent premium for spices, 
foods and medicinal plants above the market price depending 
on the complexity of cultivation and the GAP processes that 
need to be used e.g. ginger 30 to 40 per cent, turmeric 10 per 
cent, coffee 10 per cent, pepper 20 per cent, white pepper 30 
per cent. The premium is adjusted depending on the 
conventional market price”. (CMN) 
Costs 
Pesticide testing is one of the biggest expenses particularly as customers demand that 
testing take place in EU certified labs. Historically it was found that Indian and EU labs 
would often give different results for the same batch of product.  
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A bigger problem than pesticides are heavy metals and microbial contamination. As the 
herbs come from different farmers, often supplying 5 to 10 kg of dried herb each, which 
is then blended. All it takes is for one farm to have a high microbial count and it can 
affect the whole batch. One solution would be to test each supplier but this would be 
costly. If a batch fails the microbiological test, it is steam or dry sterilised, either at the 
Bangalore plant or at a plant located in Turkey, which is equipped to deal with larger 
volumes. This isn’t ideal as it is costly and may change some of the herb’s 
characteristics 
The lead firm 
In any VIVC there is usually one lead firm who has the ability to govern the chain. 
Whether this actor is placed at the beginning, middle or end of the chain is often 
variable and depends on complex and multi-factorial inputs, including the type of 
commodity supplied, where it is produced and where it is destined. In the VIVC 
examined it appears that the distribution and retail company (PH) may be the lead firm. 
This relationship between PA and PH requires that a good line of communication is 
implemented and maintained between the two sites. This can be in the form of 
electronic means but face to face meetings are considered as being of vital importance. 
However, although PH may be the lead firm, a different firm may be responsible for 
governance of the actors at the beginning stages of the chain and so in turn PA has the 
power in the relationship with the farmer.  This situation has to be managed carefully as 
taking too much of a lead role can lead to problems if things go wrong.  
“PH has the power in chain by perhaps 60:40, they dictate 
which crops are grown and what amount. This is similar for the 
domestic market where the retailer has the power. We advise 
on which crop should be grown and the amount. However we 
are now careful not to dictate how the crops are grown or insist 
the farmer uses our products as this can lead to recriminations 
if the crop does poorly. We will offer advice but stipulate that the 
integrity of the crop is the farmer’s responsibility.” (PPM)  
“PH visits two or three times per year, either for business 
discussions or to carry out a customer audit.” (CMN) 
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c) The distribution and retail site (PH) 
PH is the largest supplier of Ayurvedic herbs in the UK. It was founded in 2001 by 
SP, an Ayurvedic practitioner, and TW. In the first year, turnover was £45,000 and by 
2005 it was £650,000 (Bristow, 2006).  In 2011 the company’s turnover reached 
approximately £7 million, generating profits of £150,000 (Check-Business, 2014) and 
by 2013 turnover reached £10 million (Bradley, 2012).  
It operates with 50 staff it has a range of products that include traditional Ayurvedic 
medicines, a range of 24 teas and a distribution network across Europe and beyond. 
Herbs and spices are obtained from 27 different countries. Most come from India where 
the company works directly with 500 farmers and every year, 100 tonnes of herbs pass 
through the warehouse (Bristol, 2009). 
The company maintains that working at this grass roots level helps ensure that the 
farmers get the best price for the goods that they grow. All finished product 
manufacture is undertaken in the UK at a registered facility with a Manufacturer’s 
Licence (S.A., 2013).   
“The herbs are sourced directly from the farming co-operatives 
that PH has helped to set up in India and Sri Lanka. This helps 
to ensure that the farmers are paid a fair wage. By employing a 
strategy of fairer pay to the lower end of the value chain, the 
company seeks to ensure that the workers are committed from 
the earliest stage to producing a quality product.” (SP) 
PH works with farmers living across the varied climates who are required to cultivate 
the different medicinal plants from the Ayurvedic pharmacopoeia. These include the 
humid tropics of Sri Lanka and South India, the dry plains of Madhya Pradesh and 
Gujarat and they are working with cultivation projects in the Himalayas to grow some of 
the rarer species (Jatamansi – Nardostachys jatamansi and Kutki - Picrorhiza kurroa). 
PH has been able to successfully cultivate and market Picrorhiza kurroa with the 
correct CITES certification. With respect to the VIVC, the lead company verified that it 
has been working with the other actors in the chain for some time.  
Any differences of opinion between PH and PA appear to centre on different 
interpretations of what constitutes ‘a good quality product and what constitutes ‘GMP.” 
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The manner, by which some of these issues have been managed, where PH has 
insisted on their quality requirements being met, adds weight to the view that PH is the 
lead company in this VIVC. 
In this case study, tangible benefits for the primary producers have been realised 
through the chain management being delivered by the lead company (e.g. regular 
orders, timely payments and access to an international market).  
This arrangement, where both actors in the chain benefit, provides another reason why 
the relationship is still intact after ten years and both companies continue to grow and 
prosper.  
“The product is exported to the USA where there is demand 
from practitioners, who are far greater in number than in 
Europe, but also the regulatory framework is pliable enough to 
allow its distribution as an OTC product. 
 PH has been working with PA for ten years and has built up a 
good working relationship, although it hasn’t always been easy 
and there have been some differences of opinion regarding 
correct working practices.  
It has been a challenge to persuade PA to adopt good 
manufacturing practices that comply with EU requirements, but 
notwithstanding, these changes were implemented and once 
the Indian company experienced tangible benefits of being 
linked into an integrated value chain, it was more amenable to 
change. 
 “The benefits are seen in terms of regular orders, high quantity 
orders, and stable prices. PH visits PA approximately four times 
per year to perform a customer audit and additionally to train 
staff on current EU requirements, GAP and GMP. “(SP) 
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7.3.3 Case study 3: The Jhansi Chain 
November 5th to November 7th 2012 
I visited two farms in the north of India. One of these farms represents the smallest 
commercial operation with fewer attached inputs than the other case studies. The 
second farm visited in Jhansi did not produce turmeric but it was useful to look at this 
site for comparison. 
The first farm was less than 0.5 hectare in size and produced peanuts (Arachis 
hypogaea) and turmeric. The second was an interesting contrast as it was a very large 
farm by Indian standards of around 120 hectares and cultivated chiefly European herbs 
for use in the pharmaceutical and cosmetic industries. The farmers on these sites 
spoke little English and so I used the services of a translator from a local University. 
Farm 1: The farmer and his family cultivate turmeric to sell in the local market. It is not 
boiled, polished or even dried but sold directly to market traders after harvesting. The 
farmers sell the crop to middlemen for 25 rupees per kg, which is less than either of the 
other case studies. This is the same price as you would find turmeric selling for in the 
local street market. 
Turmeric was not the main crop, in 2012 but this was Arachis hypogaea (peanut). 
Turmeric is always grown as a ‘standby’ crop, in case of a sudden rise in its market 
value, as was seen in previous years. Using this strategy, the farmers have some 
turmeric ready to sell and have enough seed stock in the form of the root tubers for 
replanting when necessary. 
A fairly small area of approximately 200 square metres can produce a yield of two 
tonnes of turmeric rhizomes. This high yield is due to the loose sandy soil of the area, 
which is ideal for growing root crops. 
The farmers adhere to a planting strategy that is directed by local brokers (middlemen). 
These brokers advise the farmers on which crop to plant and how much, based on their 
market predictions.  
The majority of the farm work is undertaken by family members and so there are no 
additional labour overheads.   
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The farmers expressed interest in processing crops to increase their value but had little 
idea on how they would go about this. There was no auction house in the area. 
Farm 2: Approximately 120 hectares in size, the main crop grown was Mentha piperita 
L. (peppermint) which was sold to a local distillation company for the production of 
menthol. The farmers were unsure exactly what the menthol was used for but thought it 
was purchased mainly by the pharmaceutical and cosmetic industries.  
The farm employed 35 permanent staff who are paid 150 rupees per day  
7.3.4 Secondary sites 
Although the farmers and primary producers were the main focus for the research 
interviews and observations; I additionally visited peripheral organisations and 
individuals in order to ensure a wide as possible representation of the research issues. 
Earth Trust – 1st February 2012 
VO has been working in India with The Earth Trust for the last twenty years and is 
currently project director. She is 78 years old and lives in Udhagamandalam, Tamil 
Nadu. The trust works with indigenous communities (scheduled tribes) and their 
strategy is focused on growing nutritious food crops and medicinal plants that can be 
used by these minority groups for maintenance of health and treatment of disease. 
The trust currently has three nurseries between 0.4 and 1.5 hectares in size. It has 
developed sustainable models for managing slopes, seed collection and organic 
production. The tribal people are using the medicinal plants for their own medical use 
and several plants have unique properties for curing specific illnesses. Surplus plants 
are generally given away to women for planting in their home gardens. All of the 
participants in the scheme originate from the local area. 
“The operation is quite low-key, however, the models we have 
developed could potentially be replicated anywhere and so there is 
real potential for expansion.” (VO) 
The trust operates a twelve module training programme in health studies which 
includes the use of traditional knowledge and medicinal plants. All of the people taking 
part in the scheme are women and adolescent girls.  
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“The men are less interested as there is little monetary gain to be 
had.” (VO) 
Twelve village health workers, with responsibility for over 50 villages, were given two 
year training in primary healthcare which included both western medical sciences and a 
respect for traditional beliefs.  
“Two years ago we helped them (the health workers) set up their own 
small enterprise group. They call themselves ‘The Thulasi Group’ and 
land was made available for a nursery. Developing the ‘Gardens for 
Health’ concept, we set up a herbal preparation unit where they make 
the medicines they need for their work. There is a monthly meeting 
where they present their work and discuss the advice and medicines 
they gave and the results of these interventions. A Siddha doctor 
attends these meetings as well as our health team members. A 
second unit is in its beginning stages with the Kurumba women at 
Chengalpuddur. Altogether seven units are planned around the Niligiri 
Ghats.” (VO) 
Another project is to develop forest gardens within tribal communities as part of a wider 
strategy to produce a sustainable model and engage young people in ethno-botanical 
projects and give them lessons in schools within Udhagamandalam.  
“Tribal elders are brought in to teach the children about the uses of 
medicinal plants. The school curriculum now includes modules on 
organic farming and environmental science.” (VO) 
The Earth Trust mainly relies on private funding and has a fund-raising centre, based in 
Winchester, UK. For a future project the Trust wants to acquire a piece of land in order 
to develop a medicinal plant garden using traditional knowledge from the Toda 
indigenous group. 
Global Ayurvedic Festival February 8th to February 12th  2012, Trivandrum, Kerala 
The suppliers at the festival were mainly based in the state of Kerala but sold their 
products all over India and to a lesser extent, internationally, mainly to the United 
States, where HMPs are mainly sold as food supplements and to Switzerland and 
Sweden who have sympathetic policies regarding international trade.  
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Sweden is easier to access than many EU countries as it has a policy of free trade and 
is against forms of protectionism allowing for easier access for exporters (MFA, 2011). 
Switzerland is not formally a part of the EU and so is not subject to the same European 
directives concerning HMPs and although they are well-known for producing and 
marketing high quality products, they are free to regulate HMPs according to their own 
regulatory framework.  
In general conversation with company representatives attending the festival, I 
discovered that the suppliers often deal directly with practitioners of traditional ethnic 
medicine (TEC) but also have some products that are suitable for OTC trade.  
These tend to be the external preparations, e.g. massage oils, hair applications and 
cosmetics and also functional foods, the most well-known being Chyawanprash, a 
mixture of up to 80 herbs and ghee (clarified butter) made into a type of jam with the 
main ingredient being amla, the Indian gooseberry, Embelica officinalis. The market 
size of Chyawanprash in 2010 was 4 billion rupees (about US$80 million) (Sagar, 
2011). 
Many of the company representatives claim to have contracts with the farms that 
produce the crops or collect them from the wild. Very few of the cultivated products are 
produced organically although the representatives agreed that this was a growing 
market for exported products and more recently in India. However it was felt that the 
main driver for the domestic market was still price and that Indian consumers were still 
reticent about paying a premium for organically produced products. 
One company, SG Phytopharma (SGP) employs approximately 60 employees and 
specialises in classical Ayurvedic preparations, including bhasmas. Some products 
take up to eight months to prepare when following the original guidelines but strict 
adherence is important to the Ayurvedic practitioners who constitute the main market 
for these items. The raw materials are either cultivated or collected from the wild. The 
company employs the services of a plant material distribution centre, who gather plant 
material from different farms and wild collectors. SGP planted more than 10,000 plants 
on the Sahyadri Range, west of Maharashtra. The company chiefly supply to India but 
have plans to expand into other Asian and African countries. They currently supply one 
anti-malarial product to Nigeria. 
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Himalaya Herbs (HH) is one of the largest manufactures of HMPs in India. The 
company own 80 hectares of farms growing herbs mainly for the US and the EU 
markets.  They are based in Bangalore, India and are currently building new production 
facilities in the USA. The company trades $60 million in herbal products across 56 
countries. They produce 10 million tablets each day. 
The company was founded in 1935 with 10 employees. Their first product was 
Serpina® Rauwolfia sepentina. It was used to treat hypertension and in 1954 the drug 
Reserpine was isolated from the plant. Now the company has 136 products in total, 60 
per cent of which are herbal medicines. 
15th October to 17th October 2012 Convention on Biodiversity, Hyderabad 
I attended the Convention on Biodiversity in Hyderabad in October 2012. This 
convention brought together interest groups from all over India and Internationally. The 
convention gave me an opportunity to interview another secondary sample group in 
addition to the primary responders and provided a good comparison of wages and 
conditions for other types of workers in different states of India. 
15th October 2012 
The Uttarakhand Bamboo project 
In Uttarakhand, there is currently a local government project to develop the Bamboo 
industry. Local government helps to provide loans to farmers and craftsmen and offer 
tax incentives. The average earnings for a skilled bamboo craftsmen/ house builder are 
500 rupees (US$8.0) per day.  
The Chenchus of Andhra Pradesh 
This indigenous group, undertake work to conserve the land and protect bio-diversity. 
Each group member earns 200 rupees (US$3.2) per day plus 20 kg of rice per month. 
In addition they receive free education for their children. The Chenchus are considered 
experts in their knowledge of medicinal plants and wild foods. They belong to a 
religious class of ancient Hindus. 
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16th October 2012 
Sushil Bajpur WOTR 
In the state of Maharashtra, indigenous groups are known to collect wild food but only 
in the region of 10 per cent is wild collected. In comparison, indigenous groups in 
Madhya Pradesh collect up to 40 per cent of their food from the wild. The 
Maharashtran groups grow rice, vegetables, and lentils for protein. Regarding livestock, 
there has been a problem with hybrid cows (Western varieties bred with older Indian 
stock) in that, although high yielding, they are also more susceptible to disease and 
consequently there is a drive back towards rearing traditional varieties of livestock.  
This demonstrates how in the drive for higher productivity, exogenous variables can be 
introduced that can exert serious negative consequences on the value chain. 
This move back towards traditional food sources can also be observed with crop 
cultivars, including rice, of which there are approximately 95,000 varieties.  
Only about ten cultivars are produced on a large scale by a few companies which 
dominate and control the market.  The less well known cultivars can be produced on a 
smaller scale and sold as special niche products of higher value, as seen with Navara, ‘ 
the medicinal rice of Kerala’ (Swaminathan, 2011). 
SP, managing director at PH 
SP has been leading a project to cultivate and market Picrorhiza kurroa in the 
Himalayan region (with the correct CITES certification).  
“The product is exported to the USA where there is demand from 
practitioners, who are far greater in number than in Europe, but also 
the regulatory framework is pliable enough to allow its distribution as 
an OTC product. It is likely that Picrorhiza products originating in the 
USA are available worldwide via internet sales. Practitioners of 
Ayurveda differ from TCM practitioners in that they mainly prescribe 
manufactured products and so have been more negatively affected 
by the implementation of the THMPD. One of PH’s criticisms of the 
THMPD is that it pays little attention to GAP and has no requirement 
for manufacturers to regularly audit their supply chain to farm level.” 
(SP) 
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17th October 2012, GK, IFS, Bhopal 
Application of Fairwild® standards, national, regional and local policy 
There are 68 million hectares of forest in India. Standards for forest management are 
working on a local level but not nationally on any meaningful scale.  The state of 
Madhya Pradesh is well developed with regard to the government’s involvement in the 
Fairwild® initiative. 
In India, there are 1,000 companies sourcing from the wild. Over the last ten years 
companies have diverted their practices towards the collection of medicinal plants. 
Manufacturers are recognising the importance to their businesses of conservation. This 
is a new development to tie business in with conservation. The main difficulty is in the 
implementation.  
A representative from the Darbur Company (RDC), one of India’s largest HMP 
companies explained some of the company’s sustainability objectives, 
“Darbur owns the world’s largest greenhouse. We produce 5,000 
saplings each year which are distributed free of charge to farmers 
with a buy back clause. We take these steps towards sustainability for 
the survival of the industry rather than through any regulatory 
pressure.” 
But it appears that consumers are largely unaware of the Fairwild® initiative. 
“Consumers know nothing about Fairwild® and need to be educated 
about how much of what they eat or use as medicine comes from the 
wild and the effects this may have.  More investment is needed and 
more dialogue with ministers. A ten year impact study should be 
performed following the example of Costa Rica where they have hard 
evidence that forest sustainability is possible.” (RDC) 
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31st October 2012 
Interview with the DMPF, Doddabeta (MPFD) 
The farm grows both European and Indian herbs and produce aromatic oils, which are 
sold throughout their five retail outlets in India; medicinal plants, which are sold as dried 
herbs to Indian distributors and some culinary herbs which are sold locally.  
“We tried exporting some herbs to Europe but had some problems. A 
whole shipload of herbs was rejected as it was discovered that one 
per cent was not organic.”  
The farm comprises approximately 12 hectares of certified organic fields and some 
further hectares, which cultivates non-organic herbs for the medicinal plant extract 
industry. The MPFD acts as an intermediary between tribal partners and industry 
buyers. The farm acts as an ‘incubator’ project with the aim that farmers will eventually 
acquire their own land. 
The farmers, 90 per cent of whom are women, take home 5,000 rupees (US$80) per 
month (approximately US$3.30 per day assuming working a six day week). The men 
tend to work away, earning money as agricultural workers or building labourers. 
The project has had some positive impact within the community resulting in fewer 
social problems. Children are for the first time, starting to receive some formal 
education. 
A total of 85 people work on the farm, and are made up of different tribal groups. 
“I have seen a change in attitude from the tribal members; there are 
less disputes and a better work ethic.” 
The farm was originally a cinchona farm used in the production of quinine. Due to the 
world wide problems of malarial resistance to quinine, the farm went out of business. 
However, there is once again an interest in cinchona as a source of quinine as it is 
believed that the malaria parasite cannot develop resistance so easily. 
 
 
149 
 
7.4 Analysis of the value chain 
The data obtained from the fieldwork study demonstrates that there are many different 
value chains surrounding a single product (turmeric). It is widely grown in India and is 
often treated as a commodity product and sold on to middlemen once the price is right. 
There is some reluctance to grow the product organically by some of our sample as it is 
seen as too high risk and would be a change from normal farming practice. However, 
the farms involved in the VIVC have deviated from normal practice and are no longer 
driven by the same market forces. This can mean that they may fail to make large 
profits should the price of turmeric suddenly rise but they benefit from having an agreed 
price paid with associated premiums.  
Although, in the VIVC case study, it cannot be shown that farm workers are better off 
financially in terms of their actual wage, they benefit through having constant 
employment and relatively good working conditions. Overall this means that throughout 
the year their gross salary can be higher than farm workers who have to seek out 
seasonal employment on different farms. 
It can be observed that the quality of turmeric on small farms could suffer due to lack of 
inputs such as proprietary fungicides. The larger farms are able to grow better quality 
turmeric by using chemical treatments. Turmeric can be stored for long periods using 
these chemical treatments.  
The VIVC turmeric is grown organically, treatments are used to keep the crop in good 
health but these must be approved for use in organic farming. The farmers are taught 
organic farming methods and GAP. Through this training a better quality crop can be 
produced and because the crop is not sold at auction, it can be quickly exported, 
minimising potential problems of growth of micro-organisms and the loss of volatile 
compounds. 
The export market versus the domestic market  
From the analysis of the turmeric chain it is evident that the profits that can be made in 
the domestic market can be higher than for the export market but the demand is much 
lower. This observation appears particularly relevant to the organic market which is a 
relatively new emerging market in India. However there appear to be differences in 
demand for these niche products in rural compared to urban areas.  
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Moreover, the popularity and trust in pharmaceutical medication alongside a decline in 
the use of Ayurveda and other traditional medical systems is likely to affect the 
domestic market for HMPs. At the time of this study PA was exporting 95 per cent of its 
organic spices and medicinal herbs. 
In the domestic chain (Fig. 46), the farm worker receives 7.5p per kg of turmeric 
harvested15. The farmer receives 70p from the PA. The farmer has paid the farm 
worker 7.5p and has additional overheads of 12.5p per kilo to cover the cost of seed 
and the inputs needed for successful cultivation. This leaves the farmer with a profit of 
50p per kg. Indian retailers pay PA £2.80 per kg. PA has paid the farmer 70p per kg 
and has additional overheads of £1.40 per kg.  
The overheads are mainly staffing and associated costs. This leaves PA with 70p per 
kg profit. The customer pays the retailer £4.00 per kg. The retailer has paid PA £2.80 
and has relatively small overheads of approximately 10p per kg. This leaves the retailer 
with a profit of £1.10p per kg of turmeric.  
For 1kg of turmeric 
 Farm worker                    Farmer                          PA                            Retailer                       Customer 
                           7.5p                              70p                          £2.80                             £4.00 
        7.5p                            62.5p                         £2.10p                          £1.20p 
                                            12.5p                         £1.40p                           10p*              
                                             50p                             70p    £1.10p 
Figure 46, Amount per kg paid for turmeric along the PA domestic value chain  
In the export chain (Fig. 47), the farm worker and the farmer receive the same amounts 
and any overheads are identical to the domestic chain. However PA is now selling the 
product to the buyer in the UK as part of the VIVC. PA receives £3.00 per kg from PH, 
they have paid the farmer 70p per kilo but in this case the overheads are higher to the 
amount of £1.70 per kilo.  
                                                          
15
 In relation to the VIVC, I have converted Indian rupees to pounds sterling rather than US$ for 
clarity and ease of reference. 100 rupees is approximately equivalent to £1. 
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This higher amount is with respect to the additional testing that is needed for products 
to be accepted into European countries. This leaves PA with a profit of 60p per kg. The 
retailer pays PH £238 per kg. PH has paid PA £3 per kg but operating within the UK 
has a high level of overheads in order to place the finish product on the market of £223 
per kg (including staffing costs).  
This leaves PH with a profit of £12 per kg. The retailer is paid £340 per kg by the 
customer. The retailer has paid PH £238 per kg and has modest overheads of £5.00 
per kg, leaving the retailer with a profit of £97.00 per kg.  
Farm worker                Farmer                   PA                 PH(UK)                Retailer                 Customer 
                            7.5p                     70p                £3.00p                 £238                    £ 340 
     7.5p                          62.5p                   £2.30p                 £235                 £102 
                                        12.5p                  £1.70p                 £223                 £5.00p* 
                                        50p                       60p          £12.00p             £97.00p 
Figure 47, Amount per kg paid for turmeric along the PA export VIVC  
These figures have been produced primarily from fieldwork data but I have also used 
an estimated figure* (based on the cost of shelf-space) concerning the overheads for 
retailers as these can vary depending on size of premises, number of staff and running 
costs. 
Using the information gathered from the visit to the Chinese herb market in Bozhou, on 
turmeric cultivation and the using information gleaned from the turmeric products 
sampled, I have highlighted two separate value chains. One follows the practitioner 
route of supply16 and the other concerns the production and delivery over the counter 
(OTC) products. The herbal practitioner value chain (Fig 48)  begins with the herb 
grower in Asia and finishes with the consumer in the Europe, As the herb material 
moves along the chain value is added in terms of costs to the producer and it is the 
consumer who will eventually pay for these costs along with any profits added. (Prices 
based on average values, November 2011, for 20 randomly selected commonly used 
                                                          
16
 Practitioners of herbal medicine are prevalent in the UK and are able to dispense herbal 
ingredients to patients following a consultation.  
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East Asian herbs) Estimates based on informal interviews with herb sourcing 
companies, suppliers and practitioners. The value of the herbs increases as the 
product moves away from the farmer and towards the consumer. The farmers are often 
the same individuals who are selling the herbs in the market. In this example there is 
no 'value addition' due to processing as the final product is still in the same form as 
when it started i.e. a crude dried herb. Therefore the price increments are due to costs 
incurred through externalities, price increases through middlemen and value added in 
terms of professional knowledge. This is in contrast to when the OTC product has 
value added additionally through different cultivation and processing methods (Fig. 49). 
 Notably there is a tenfold increase for simply encapsulating the powder for 
convenience and to give the appearance of a medicinal product.  
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Figure 48, The herbal practitioner value chain.  
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Figure 49, The value chain for OTC turmeric products found in UK retail outlets. 
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7.5 Analysis of farmer and farm / factory worker perspectives 
The majority of farms in India are small and food crops are grown primarily to provide 
food for the family. Any surplus food can be sold at local markets. A decision to replace 
food crops with medicinal plants presents the farmers with a dilemma. On one hand the 
income received from medicinal plants can be greater but on the other, the market has 
historically been unstable with prices fluctuating. This has not been so much of a 
problem for wild collection where little investment is needed but in cultivation land must 
be put aside and inputs must be bought. For some plants, the time before harvest can 
be many years. This scenario presents a substantial amount of risk for the farmer, and 
more so for the farmer with only a small farm and little capital. 
Turmeric appears to be one of the few medicinal plants commonly grown by farmers in 
India. Of course, this must partly be due to its use as a food and a cosmetic making it 
less of a risk than plants that are solely used as medicines.  
In case study 1, the Tamil Nadu chain, the farmers were aware of turmeric’s use in 
medicine but chose to sell their crop at the state-run auction house. This gave them the 
possibility of selling when the price was high and also they could take advantage of the 
storage facilities provided in the town of Erode when the market price was low. They 
expressed interest in selling directly to HMP manufacturers and especially those 
outside of India but at present did not have the necessary linkages in place. They 
accepted that there was a market for organically produced turmeric but lacked 
expertise in this area and were not prepared to undertake any changes that, in their 
view, could easily result in a loss of income. Paradoxically, they were unhappy with the 
low market value of the domestic market and their necessary but uncomfortable 
reliance on middlemen. 
Their views towards medicinal plants generally were skeptical and they considered 
them to be high-risk products. There general strategy was to watch the market carefully 
and have a cultivation strategy that would return the highest income, plant crops that 
could be harvested in the shortest period of time and use whatever external inputs 
necessary to produce the best quality, highest yielding crops. 
In case study 2, (The VIVC), the risks for the farmers have been minimised through the 
establishment of contracts that guarantee an order size and a price for the crop. The 
farmers in the integrated chain are directed through the buyer as to which plant to grow 
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and how much. If market prices should fall, the loss becomes the buyers rather than 
the farmers although if market prices substantially rise, then it is the farmer who will 
lose out and so there is still some level of risk with this system in place.  
The cultivation of medicinal plants in India (as in many other regions of the world) is 
relatively new, with wild-collection being the main source of supply. Through belonging 
to the chain, the farmers are able to access important information from the lead 
company on the optimum cultivation parameters for individual plants. The farmers are 
also engaging in their own research on how best to grow the plants organically.  
Apart from the premiums paid for different crops, the farmers (and farm workers) 
benefit from the stability and regularity of belonging to an integrated chain although for 
this to continue the manufacturers further down the chain must succeed and prosper. 
Case study 3, the Jhansi chain 
The two farms examined provided a stark contrast. The farmers on the small farm were 
the less affluent of all the chains studied. They had no means to engage with any 
outside markets and relied on selling their unprocessed turmeric for the minimal price 
at local markets. Farm workers were generally part of the family and rather than 
receive wages they worked on the farm in order to eat and have somewhere to live. 
In contrast the other Jhansi farm was the largest investigated in this study and the 
farmers (or more accurately farm managers) appeared relatively wealthy. The farm was 
a source of employment for local and sometimes migrant labourers. This farm did not 
grow food crops but focused mainly on Mentha piperita from which menthol can be 
extracted. It was not integrated into a value chain but sold its crops to a local distillation 
company who act as middlemen for pharmaceutical and cosmetic industries. 
7.6 Analysis of manufacturer perspectives 
For the manufacturer, the quality and traceability of the raw materials used to 
manufacture HMPs is a major concern, and especially when those products are 
required to be licensed e.g. the European THR.  
In India, it was observed that companies that produce HMPs for the domestic market 
often obtain their supplies through middlemen. In the case of turmeric they may buy it 
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from one of the state-run auction houses. Some companies have started to invest in 
cultivating their own crops but for others wild collection is still the main source. 
With the VIVC investigated, the primary processing company (PA) is a vital part of the 
chain. Being located in India, they are able to make contracts with farmers in order to 
fulfill the order requirements of the lead firm (PH). PA has become a major supplier of 
PH and the majority of medicinal plants processed are destined for secondary 
manufacture by PH. 
PA can plan their contracts with farmers in advance and in accordance with market 
predictions from the lead firm.  
PH do not only deal in India but have contracts with over one hundred farmers in many 
parts of the world, including Sri Lanka, China, Vietnam and Eastern Europe. Through 
making these contracts and paying a premium for organically produced crops. PH are 
able to use this to full market advantage, apart from the organic nature of their 
products, they are able to claim full traceability – down to the field the crop was grown 
in. Moreover they are able to exploit the relationships they have built with farmers and 
use their ‘fair trade’ ethic as a marketing tool. 
This represents a considerable investment for PH in terms of time and money. The 
relationships that are forged with the farmers need to be constantly attended to. In 
practice this means that the lead firm must send employees to visit the farms on a 
regular basis. Training needs to be delivered to the farmers and farm workers and the 
farms and primary processing facilities need to be audited to ensure compliance with 
the manufacturer’s product specification. 
Using the terminology of Shahidullah and Haque (2010), described in chapter 3.4, the 
relationship can be presented as an example of quasi-vertical, tapered, cost plus 
integration  (an especially close and long term relationship, where a company (PA) 
sources inputs externally from independent suppliers as well as internally within the 
same company and where the contractor is paid a negotiated amount regardless of 
incurred expenses). 
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7.7 Analysis of livelihoods 
If livelihoods are examined purely from a monetary perspective, the fieldwork 
investigations revealed that the wages earned by farm workers is approximately 
equitable throughout the different cases examined (Fig. 50). In fact the male workers in 
Tamil Nadu earn slightly more than the other two case studies.   
 
Figure 50, Comparison of wages for agricultural and factory workers 
There is evidence that the pay rates between men and women is sometimes different, 
with the male workers in Tamil Nadu (case study 1) and the VIVC (case study 2) 
earning more than their female counterparts. The pay between sexes for the Jhansi 
workers on the large farm (Case study 3), the ‘tribal’ workers at the medicinal plant 
farm at Doddabeta and the Chenchus of Andhra Pradesh is the same. (The average 
poverty line is regarded as US$2 per day in developing countries) (World-Bank, 2014). 
It can be seen that by moving from farm labouring to factory work, there are more 
opportunities for promotion in the factory and the pay for a manager is more than 
double that of a farm manager.   
For workers that develop their own skills in relation to forest products, there are further 
opportunities, a skilled craftsmen can earn up to US$8 dollars per day. However, the 
workers that stand out for their earning ability are those involved in the secondary 
processing of turmeric.  
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The agricultural workers who invested in renting machinery and provided a service to 
other farmers (boiling and polishing) are able to earn US$16 to US$20 per day during 
the harvest season, (approximately 3 months). 
The tea plantation wages are included to give a comparison to the lowest paid 
agricultural workers who work on the large tea plantations and where crop prices are 
driven down through pressures from multinational companies (see 3.8) 
Although the workers in the VIVC are generally paid less than other groups, they 
benefit from being employed on long term contracts for a year at a time and there are 
some opportunities for working in the factory (PA). 
7.8 Discussion of socio-economic findings 
Comparable to China, companies in India are also involved in forming direct 
contractual relationships with farmers although there is a greater emphasis in sourcing 
organically cultivated crops in India. In addition to sourcing herbs for export, it has been 
suggested that it is also possible to diversify and develop a product range for newly 
emerging domestic markets (Commission, 2007).  
The fieldwork investigations corroborate this view and the evidence suggests that 
consumers are willing to pay a premium for goods that are ethically sourced and that 
are produced organically (see Fig. 49). This was mainly evident in the VIVC providing 
HMPs to an international market but additional information provided by PA suggested 
that there is a new domestic Indian market emerging for these commodities. 
During the fieldwork in China and India, I discovered examples of sourcing companies, 
or individuals employed to source herbs. These were integrated into a VIVC either as 
employees within the chain, as was the case for the UK company (PH), where a 
sourcing manager and sourcing staff are sent out to different countries to find potential 
suppliers, or the sourcing company (ATHSC) who were contracted by a manufacturer 
in Taiwan to source herbs in China.  
Local companies, NGOs and government institutions are able to provide advice and 
support to farmers on market trends, planting strategies and growing techniques, 
including the correct and safe use of fertilisers and pesticides.  
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This was observed particularly in China, where there is government involvement in the 
setting up of GAP initiatives and where provincial universities (e.g. Anhui University) 
work closely with farmers on the ground (see 7.2.3).  
The fieldwork suggested that the farmers involved in the VIVC benefited from having 
regular orders and price stability with the associated premiums for individual crops. 
Other companies and primary producers investigated have shown an eagerness for 
linking into a VIVC but so far have lacked the inputs and industry connections 
necessary to make this happen (case study 1 and 3). 
My own investigation of a VIVC suggested that farm workers are not exploited but the 
benefits of belonging to a VIVC may not be immediately apparent. It initially appeared 
that the farm workers employed on the more traditional farms are better off financially 
(see Fig. 50). However, I discovered that the farm workers on the VIVC are employed 
on year-long contracts, which provides a regular income and greater job security. The 
benefits for the farmers and primary producers are greater through belonging to the 
VIVC except for those times when the market price for turmeric increases significantly, 
in which case, having access to the free market can produce higher returns. However, 
this needs to be balanced by the times that the price of turmeric drops to a low point 
and the farmer has to store the crop and incur the associated expense and inevitable 
product deterioration.  
While conducting preliminary fieldwork in Bozhou, China, I was able to witness first-
hand how Chinese herbs are traded on the open market. In China it was apparent that 
herbs were traded as commodities in a similar way to gold, silver or other items that are 
subject to price volatility (see 7.2.2). There is little evidence of GAP or GMP and once 
the herbs are dried and presented within the market, there is little opportunity to 
discover the age of the herbal material or how it has been processed. 
The supply of turmeric in India presents a similar picture and one that is unlikely to be 
appreciated by consumers in Europe. I have shown how turmeric is traded as a 
commodity and how over-planting leads to a drop in its market value, forcing farmers to 
store the dried material for sometimes long periods (see 7.3.1).  
During this storage period the product is heavily treated to prevent the growth of 
spoilage organisms (see Fig. 28).  
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Even without this spoilage, the gradual degradation of compounds in the product due to 
prolonged exposure to high climatic temperature may result in a sub-standard product. 
My fieldwork investigations reveal how it is possible for an industry to move away from 
wild collection and invest in cultivation. This is immediately apparent in the VIVC where 
the majority of herbal raw materials are cultivated but there is also evidence to support 
that this is part of a wider trend. The interviews with many of the respondents at 
secondary sites (see 7.3.4) reveal that indigenous groups, who are often regarded as 
being responsible for much of the wild collection, are engaged in projects involving the 
cultivation of medicinal plants. These projects could provide whole communities with a 
more structured and long term work outlook and their governance through NGO’s 
appears to elevate their wages to above the norm for agricultural workers (see Fig. 50). 
The fieldwork data suggests that in the case of the VIVC examined, the contractual 
obligations were honoured on both sides. In order to achieve this, the lead firm (PH) 
has to maintain regular contact with the farmers and primary producers and ensure 
through regular audits that processes and procedures were complied with. My fieldwork 
has provided evidence to show that an Indian company producing HMPs (PA) is 
capable of linking into an international value chain and this chain has shown to be both 
profitable and sustainable.  
 
8.0 Analytical analysis methods 
8.1 1H-NMR spectroscopy methods 
Solvents, reagents and chemicals 
DMSO-D6 
Curcumin reference standard (mixture of three curcuminoids) Sigma Chemicals                 
Lot 69H3457 
Tumerone reference standard Sigma Chemicals Lot 1129150 
Apparatus and instrumentation 
Bruker Avance NMR Spectrophotometer (500 MHz) with Topspin software version 1.3 
AMIX Bruker Biospin multivariate analysis software version 3.0 
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SIMCA multivariate analysis software Version 13.0 
Ependorff Minispin plus centrifuge, model 5453, Serial no. 0031564  
Fisher brand ultrasound bath, model D-78224, serial no. 004472044  
Rotamixer, rotary mixer, serial no. 8011  
Gilson micro-pipettes 200ul, serial no.AC55298 and 1000ul, serial no. AD63010  
Reaction tubes, 1.5ml eppendorf supplied by Griener Bio-One, Germany  
Wilmad LabGlass NMR sample tubes, 5mm economy, 7”Length, 100MHz 
Sample preparations for 1H-NMR spectroscopy analysis 
The method for the extraction of plant samples was developed from a method 
described by Kim et al 2010. Initial experiments were carried out using chloroform-D, 
and DMSO-D6 and methanol-D4 but it was found that DMSO-D6 was a better 
extracting solvent because the 1H-NMR spectra showed more peaks in the 0 to 10 ppm 
range than with the other solvents tried. Approximately 20 mg of all the samples were 
weighed into a 1.5 ml reaction tube and 1.0 ml of deuterated DMSO containing 0.05% 
TMS was added. The mixture was mixed on a rotary mixer for 60 seconds and 
sonicated in an ultrasound bath for 15 minutes, and allowed to stand for 1 hour. The 
solutions were centrifuged for 10 minutes at 14,000 rpm. 800 μl of the supernatant was 
added to a 5 mm diameter NMR spectroscopy tube and the samples were submitted 
for 1H-NMR spectroscopy analysis. 
1H-NMR spectroscopy
 
metabolomic analysis 
The 1H-NMR spectra spectra were acquired using 500 MHz NMR Bruker Avance 
spectrometer (Bruker BioSpin GmbH, Rheinstetten, Germany) equipped with a 5 mm 
cryoprobe head and operating at a proton frequency of 500.13 MHz. The acquisition 
parameters were: size of the spectra 64 k data points, line broadening factor = 0.16 Hz, 
pulse width (PW) = 30 degrees and the relaxation delay d1 = 1 s. The acquisition 
temperature was 298 K. TOPSPIN version 1.3 software was used for spectra 
acquisition and processing. The NMR was set up for the analysis applying diffusion-
edited 1H-NMRspectroscopy with suppression of the water signal. The scans were 
locked at zero on the TMS peak. 256 scans was the number of scans chosen for 
optimum resolution of peaks, requiring approximately 10 minutes acquisition time.  
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Statistical analysis 
TOPSPIN version 1.3 software was used for spectra acquisition and processing of the 
1H-NMR spectra which were manually corrected for phase and baseline distortions. 
The spectra were exported to Topspin Plot editor, version 3.5, Bruker and thoroughly 
examined visually for appropriate reference peaks for the identification of curcuminoids 
in the sample. The 1H-NMR spectra of all the samples were imported to the AMIX 
software, version 3.5 and simplified by using the bucketing function. The spectra in the 
range 0 to 12 ppm were divided into 301 buckets of 0.04 ppm. The residual solvent 
signals for DMSO (2.65 to 2.45 ppm) and water (3.60 to 3.10) were excluded. This data 
were imported to Microsoft EXCEL where the samples were re-labelled S1 to S 52. The 
data were then imported to SIMCA, version 13.0 software for PCA analysis. 
8.2 HPTLC methods 
Solvents, reagents and chemicals 
Reference standard no.363 Curcuminoids USP B070268 
Methanol Acros p.a. 0958514 
Ethyl acetate Acros p.a. 0963023 
Acetic acid Acros p.a. A0278887 
Toluene, Dichloromethane, 2-Propanol, Acetonitrile, Propanone 
Water In-house 
HPTLC glass 20x10 cm, Si 60 F254 Merck HX258909 
Apparatus and instrumentation 
Automatic TLC Sampler 4 CAMAG 
Twin Trough Chamber 20x10 cm CAMAG 
Chromatogram Immersion Device III CAMAG 
TLC Plate Heater III CAMAG 
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Automatic Development Chamber ADC 2 CAMAG 
Visualizer CAMAG 
Filter paper for chamber saturation CAMAG 
Ultra Centrifugal Mill ZM200 Retsch 
Analytical Balance AG245 Mettler-Toledo 
Balance DC4400 Mettler-Toledo 
Sample preparations for HPTLC analysis 
The method for the extraction of plant samples was developed from a standardised 
method used at CAMAG laboratories. Approximately 200 mg of all the samples were 
weighed into a 10 ml reaction tube and 4.0 ml of solvent was added (methanol for 
curcuminoid and dye adulterant determination, toluene for the determination of 
essential oils and water for the determination of sugars). The mixture was mixed on a 
rotary mixer for 60 seconds and shaken for 20 minutes. The solutions were centrifuged 
for 10 minutes at 14,000 rpm. The supernatant solution was transferred to a vial and 
the samples were submitted for HPTLC analysis. 
HPTLC was carried out using Merck HPTLC glass plates 20x10 cm, Si 60 F254  
HPTLC Plates. Samples were applied (4.0 µl) using the CAMAG Automatic TLC 
Sampler 4. Four developing systems were used, for curcuminoid determination 
(Toluene: acetic acid, 4:1), for essential oils (Dichloromethane) for dye adulteration 
(toluene: methanol: acetic acid, 32: 8: 10) and for sugars (acetonitrile, acetone: water, 
40:40:20). The Lab Temperature was 23°C and tank humidity within the developing 
tank was controlled at 33% using a magnesium chloride solution. The developed plates 
were derivatised by dipping with anisaldehyde reagent for the curcuminoid and 
essential oil systems and aniline-diphenylamine-phosphoric acid reagent for the sugar 
system. The plates were coated with reagent using a CAMAG chromatogram 
immersion device III and heated to 100 degrees C on a plate heater. (The adulterant 
dye plates were not derivatised). The plates were inspected using a CAMAG visualiser 
under white light and at UV, 254nm and 366nm, photographed and uploaded into the 
computer software (WinCats). 
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9.0 Analytical analysis results 
9.1 1H-NMR spectroscopy and multivariate analysis  
Curcumin reference standard Lot 69H3457 (mixture of 3 curcuminoids) minimum 80% 
curcumin, minimum 94% curcuminoids  
Curcumin (C): R, R1 = OCH3, Demethoxycurcumin (DMC): R=OCH3, R1=H, 
Bisdemethoxycurcumin (BDMC): R, R1=H 
 
 
 
 
P = Position, δ = Chemical shift, M = Multiplicity, CG = Chemical group 
Figure 51 
1H-NMR spectroscopy Curcumin reference standard (mixture of three 
curcuminoids) 
The spectra information was compared with that for pure samples of the compounds 
published in literature. The assignments of the protons responsible for these signals 
were further verified from the 1H-NMR spectra of Curcumin from the SDBS NMR 
database SDBS-1H-NMR spectroscopy Curcumin SDBSNo.2056HSP-45772 17 and 
Chemical book Curcumin reference number 458-37-718. 
 
                                                          
17
 http://riodb01.ibase.aist.go.jp/sdbs/cgi-bin/direct_frame_top.cgi 
 
18
 http://www.chemicalbook.com/SpectrumEN_458-37-7_1HNMR.htm 
 
 
P   δ M CG 
A 10.052 s OH 
(BDMC) 
A 9.659 s OH 
B 7.545 d H 
C 7.324 d H 
D 7.152 dd  H 
E 6.823 d H 
F 6.758 d H (C) 
F 6.712 d H (DMC) 
F 6.681 d H (BDMC) 
G 6.060 s H 
K 3.840 s OCH3 
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Table 6: Product description, NMR spectroscopy reference, usage and preparation 
information 
Simca
No 
Details of product NMR spectra no / 
sample 
 
Species Use 
/Preparation  
1 Tablets. 10,000mg (as 500mg of 
extract) providing 95% curcumins. 
Manufactured in UK. Supplied via 
internet. Dosage: 1 tablet daily. 
Ingredients: Turmeric root extract, 
calcium carbonate, dicalcium 
phosphate, microcrystalline cellulose. 
Tablet coating: (hydroxypropyl 
methylcellulose (HPMC), glycerine. 
Colours: Iron oxides and titanium 
dioxide), hydroxypropyl 
methylcellulose,  
carboxymethylcellulose, silicon dioxide, 
stearic acid, magnesium stearate. 
 
JUL-20-12-10      
s1 
CL M/EE 
 
2 500mg capsules manufactured in UK 
and supplied via internet. Dosage: 1 
capsule, 3 times daily. Complies with 
British Pharmacopoeia. Ingredients: 
Turmeric rhizome, hypromellose. 
JUL-20-12-20      
s3 
CZ M/PW 
3 400mg gelatine capsules, 
manufactured in USA and supplied via 
retail health food shop in UK. Dosage: 
1 capsule, twice daily. Ingredients: 
Turmeric powder (C. longa L.) 
microcrystalline cellulose, silicon 
dioxide, magnesium stearate, stearic 
acid. 
 
JUL-20-12-30      
s4 
CL M/PW 
4 500mg capsules provided by Ayurvedic 
company in Tamil Nadu, India. Dosage 
1 capsule, 3 times daily. Ingredients: 
Curcumin extract (C. longa)  
JUL-20-12-40      
s5 
CL M/EE 
5 Combination product with C. amada 
Roxb and Frangula purshiana Cooper 
Rhamnaceae (Rhamnus purshiana 
synonym on label). Tablets 
manufactured in NL. Dosage: 3-4 
tablets, 1 or 2 times daily. Ingredients: 
Curcuma rhizome extract 600mg, C. 
amada rhizome pulverized 100mg, 
Frangula purshiana Cooper cortex 
30mg, sugar 75mg. 
 
 
JUL-20-12-50      
s6 
CZ 
(mixed 
species) 
M/PW+M/EE.  
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6 400mg capsules, manufactured in USA 
and supplied via retail health food shop 
in NL. Dosage: 1 capsule, twice daily. 
Ingredients: Turmeric powder (C. 
longa), microcrystalline cellulose, 
silicon dioxide, magnesium stearate, 
stearic acid. 
 
JUL-20-12-60      
s7 
CL M/PW 
7 UK supermarket(UK) JUL-20-12-70      
s8 
CL F/PW 
(organic) 
8 Standardised 500mg tablets. 
Manufactured in UK and supplied via 
internet. Dosage: 1 to 3 tablets, daily. 
Ingredients: Curcumin powder extract 
350mg (standardised for a minimum of 
95% curcuminoids), turmeric powder 
(C. longa) 150mg, Bromelain 20mg, di-
calcium phosphate, microcrystalline 
cellulose, silicon dioxide, stearic acid. 
Coating: HPMC, propylene glycol. 
 
JUL-20-12-80      
s9 
CL M/PW+M/EE 
9 500mg capsules. Standardised for 95% 
curcuminoids. Manufactured in USA 
and supplied via internet. Dosage: 1 
capsule daily. Ingredients: Turmeric 
powder (. longa root) 450mg Turmeric 
extract (C. longa root) 50mg, gelatin, 
silica, magnesium stearate, stearic 
acid. 
JUL-20-12-90    
s10 
CL M/PW+M/EE 
10 UK supermarket. JUL-20-12-100  
s12 
CL F/PW 
11 UK retail shop. JUL-20-12-110  
s13 
CL F/PW 
12 Integrated Chain Product  JUL-20-12-120  
s14 
CL fine  
ground 
M/PW(VIC) 
(organic) 
13 Integrated Chain Product  JUL-20-12-130  
s15 
CL course 
ground 
M/PW(VIC) 
(organic) 
14 Market in Delhi, India JUL-20-12-140  
s16 
 
CL F/PW 
15 UK retail shop. JUL-20-12-150  
s17 
CL F/PW 
16 Retail shop in South India. JUL-20-12-160  
s18 
CL F/PW 
17 Retail shop in South India. JUL-20-12-170  
s19 
CL F/PW 
18 UK retail shop. JUL-20-12-180  
s20 
 
CL F/PW 
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19 Sourced in Bangalore, India JUL-20-12-190  
s21 
CA C/PW (sold 
as food) 
20 UK retail shop. JUL-20-12-200  
s22 
CL F/PW 
21 C. kwangsiensis S.G. Lee and C.F. 
Liang. Manufactured as granules in 
China and supplied by UK TCM 
company 
JUL-20-12-210  
s23 
CK M/AE 
22 C. longa. Full spectrum 5:1 herb extract 
powder. (Replenished essential oils). 
Manufactured in China and supplied by 
UK TCM company. 
JUL-20-12-220  
s24 
CL M/AE 
23 C. longa. Manufactured in Taiwan and 
supplied by UK TCM company. 
Ingredients: Curcuma longa rhizome 
concentrated extract (66%), corn starch 
(34%). 
JUL-20-12-230  
s25 
CL M/AE+ M/PW 
24 Capsules supplied by an Ayurvedic 
company in India. 
JUL-20-12-240  
s26 
CL M/PW 
25 C. aromatica. Sourced in India JUL-20-12-250  
s27 
CA C/PW 
26 Supplied by UK company JUL-20-12-260  
s28 
CL M/AE 
27 C. aromatica. Sourced in India JUL-20-12-270  
s29 
CA C/PW 
28 Supplied by retail shop in Kerala, India 
 
JUL-20-12-280  
s30 
CL DRh 
29 Manufactured in China and supplied by 
UK TCM company. 
JUL-20-12-290  
s31 
CL M/PW 
30 Cultivated in China and supplied by UK 
TCM company.  
 
JUL-20-12-300  
s32 
CL DRh 
31 Farm in Erode, India JUL-20-12-310  
s33 
CL DRh 
32 Farm in Erode, India JUL-20-12-320  
s34 
CL DRh 
(polished) 
33 Farm in Erode, India JUL-20-12-330  
s35 
CL DRT 
34 Cultivated in China and supplied by UK 
TCM company. 
JUL-20-12-340  
s36 
CL 
 
 
 
DRh 
35 500mg gelatin capsules. Standardised 
for 95% curcuminoids. Manufactured in 
USA and supplied via internet. Dosage: 
1 capsule daily. Ingredients: Turmeric 
concentrate 500mg (C. longa), 
cellulose, magnesium stearate, silicon 
dioxide. 
JUL-20-12-350  
s37 
CL M/EE 
36 Manufactured in Austria and supplied 
by retail shop in Iceland. 
JUL-20-12-360  
s38 
CL F/PW 
(organic) 
37 C. zanthorrhiza Roxb. rhizome, 
Tropilab 
APR-08-13-10   
s50 
CZ M/PW 
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38 Market in Delhi, India APR-08-13-20   
s51 
CL FRh 
39 UK supermarket APR-08-13-30   
s52 
CL FRh 
40 UK supermarket and freeze dried APR-08-13-40   
s53 
CL FRh 
41 Market in Udaipur, India APR-08-13-50   
s54 
CL DRh 
(polished) 
42 Market in Udaipur, India APR-08-13-60   
s55 
CL F/PW 
43 C. aromatica Salisb., Kasturi Manjal 
from India, sourced via internet 
APR-08-13-70   
s56 
CA C/PW 
44 C. aromatica, rhizome, Kasturi Manjal 
from India, sourced via internet 
APR-08-13-80   
s57 
CA C/PW 
45 C. aromatica, Kasturi Manjal from India 
and sourced via internet 
APR-08-13-90   
s58 
CA C/PW 
46 An Agmark certified food powder 
sourced in Hyderabad, India 
APR-08-13-100 
s59 
CL F/PW 
47 Medicinal powder. Integrated Chain 
Finished Product in 425mg capsules 
manufactured in UK and sourced via 
internet. Dosage: 2 capsules, 3 times 
daily. Ingredients:  Turmeric root (C. 
longa), HPMC. 
APR-08-13-110 
s60 
CL M/PW(VIC) 
(organic) 
48 Medicinal Super Critical Fluid (SCF) 
extract 400mg soft gel capsules. 
Manufactured in USA and sourced via 
internet. Dosage: 1 capsule daily. 
Ingredients: Turmeric (C. longa), olive 
oil, gelatine, glycerine, yellow beeswax, 
carob. 
APR-08-13-120   
s2 
CL M/SCF  
49 C. zanthorrhiza CAMAG 9765 APR-08-13-130 
9765 
CZ M/PW 
50 C. zanthorrhiza CAMAG 9767 APR-08-13-140 
9767 
CZ M/PW 
51 C. zanthorrhiza CAMAG 10565 APR-08-13-150   
10565 
CZ M/PW 
 
52 C. zanthorrhiza CAMAG 10567 APR-08-13-160  
10567 
CZ M/PW 
53 Retail shop in Greenland  CL F/PW 
54 Integrated chain product, manufactured 
and sourced in UK. Ingredients 
turmeric rhizome, ethanol. 
 CL M/EE 
(organic) 
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Species: 
CL – Curcuma longa 
CA – Curcuma aromatica 
CK – Curcuma kwangsiensis 
CZ – Curcuma zanthorrhiza 
 
Use / Preparation:  
M/AE – medicine / aqueous extract  
DRh – dried rhizome 
DRT – dried root tuber 
M/EE – medicine / ethanolic extract  
FRh – fresh rhizome 
C/PW – cosmetic / powdered drug 
F/PW – food / powdered drug  
M/PW (VIC) – medicine / powdered drug (vertically integrated chain)  
M/PW – medicine / powdered drug  
M/PW+M/EE – medicine powdered drug + ethanolic extract 
M/SCF – medicine / super critical fluid extract 
The samples (see Table 6) were analysed using 
1
H-NMR spectroscopy coupled with 
SIMCA multivariate analysis software, version 13.0. Using these coupled analytical 
platforms and using the information gathered from the products (from labels, leaflets 
and packaging), it was possible to order the products into different groups. Applying the 
SIMCA software, the groups were separated using PCA, with reference to species (Fig. 
52) and to dosage form / morphology (Fig. 53). Using this method it was possible to 
differentiate four separate species: Curcuma longa L., Curcuma aromatica Salisb., 
Curcuma zanthorrhiza Roxb., Curcuma kwangsiensis S.G. Lee and C.F. Liang and a 
range of different dosage forms, comprising ethanolic extracts, a super critical fluid 
171 
 
extract, aqueous extracts, medicinal powdered drugs, powders used as foodstuffs, 
mixed powder and extract products, dried cut rhizomes, whole dried rhizomes and 
fresh turmeric rhizomes. For comparison of individual 
1
H-NMR spectra, including 
curcumin and tumerone reference spectra (see appendix 6). 
 
 
Figure 52, Scores plot showing samples grouped according to species, PC1 VS PC2  
(n = 52)     
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Figure 53, Scores plot showing samples grouped according to form, PC1 VS PC2       
(n = 52) 
 
Figure 54, Contributions plot showing the metabolite differences between sample 1, an 
ethanol extract and the group average, n = 52 
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The contributions plot provides information on how the PCA separates the samples i.e. 
they are separated based on the presence or absence of a compound or the difference 
in concentration of a compound, which can be observed at the particular chemical 
shifts relating to that compound.  
When I compared an ethanol extract (sample 1) against the average for all samples 
(Fig. 54), sample 1 was higher than the average in the chemical shift regions 
associated with curcuminoids (6-10ppm) but lower in the carbohydrate (3-5ppm) and 
essential oil region (1-3ppm).  
The PCA was able to differentiate four different species but the initial analysis failed to 
differentiate C. aromatica and C. zanthorrhiza satisfactorily. However, when the powder 
samples were analysed without the extracts, the PCA differentiated them from C. longa 
more effectively (see Fig 55).  
 
Figure 55, Scores plot comparing all powders, roots and rhizomes, grouped by species, 
PC1 VS PC2, n = 44  
In Figure 52, sample 5 appeared to be grouped with the C. longa samples and in 
Figure 53, sample 5 was grouped with the aqueous extracts, suggesting that it was an 
aqueous extract of C. longa; however, this was not concordant with the product 
information that was held on this product. In the contributions plot, Fig. 56, sample 5 
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was high in the carbohydrate region (3-5ppm), which is consistent with high sugar 
content.  
Subsequent HPTLC analysis confirmed that this was not an aqueous extract and was 
not C. longa as the PCA suggested (see Fig. 64) and it did contain high amounts of 
sugars (see Fig. 69).  
Sample 9, a mixture of a standardised extract and powder appeared where expected      
(Fig. 53), somewhere between the powders and extracts. The other mixture of this kind 
(Sample 8), however, was placed firmly within the powder group indicating that the 
product was not high in curcuminoids as would be expected for an extract. 
 
Figure 56, Contributions plot showing the metabolite differences between sample 5 and 
the group average peak intensities for the remainder of the samples, n = 52 
   
The metabolite variability between species was chiefly in the curcuminoid region (in C. 
aromatica and C. zanthorrhiza, bis-demethoxycurcumin was absent, a phenomenon 
confirmed by HPTLC, see Fig. 64) and variation was also observed in the lower range 
of chemical shift where one would expect to see essential oils (Fig. 57). One reported 
difference between C. longa and C. aromatica / C. zanthorrhiza is that the later species 
do not to contain tumerone, the essential oil which gives C. longa its distinctive 
aromatic smell.  
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Sample 19 was interesting as although sold as C. longa it is appeared to be 
contaminated with C. aromatica or C. zanthorrhiza.  
 
Figure 57, Contributions plot showing where the main differences in metabolite 
composition occur between a sample of C. longa (sample 16) and C. zanthorrhiza 
(sample 52) 
C. aromatica samples were not well separated from C. zanthorrhiza samples (see Fig. 
58). The curcuminoid composition between C. zanthorrhiza and C. aromatica is not a 
major variable and so in order to find differences between these two species, it was 
necessary to examine different principal components.   
A pattern was observed between the species and samples 49 to 52 were particularly 
well grouped (Fig. 59). These four samples came from the same geographical location.  
Although sample 2 was labelled as complying with the British Pharmacopoeia and the 
company claimed it was C. zanthorrhiza, the data suggested that it was more similar to 
the metabolite profile of C. aromatica.  
Sample 37 was supplied, certificated as C. zanthorrhiza but had been subjected to 
fumigation which may have affected the 1H-NMR spectra.   
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Figure 58, Scores plot showing differentiation of C. aromatica and C. zanthorrhiza, PC1 VS 
PC2 ,  n = 12   
 
Figure 59, Scores plot showing differentiation of C. aromatica and C. zanthorrhiza, PC4 VS 
PC5,    n = 12    
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Foods, medicinal powders, rhizomes and a root tuber were examined, finding that   
PCA differentiated these well (Fig. 60). The fresh rhizomes (38, 39 and 40) the recently 
dried Erode samples, (31, 32 and 33) the 3 organic samples from the integrated chain 
(12 and 47), and the 2 samples from a TCM supplier (29 and 30) were mainly 
differentiated from the food powders.  
Sample 24 was interesting in that it was sold as a herbal medicinal product by a major 
Indian Ayurvedic company but according to the PCA was very similar in composition to 
the food powders. 
 
Figure 60, Comparison of all powders, dried roots, rhizomes and fresh rhizomes,              
PC1 VS PC2, n = 28 
Fig. 61, compares sample 47, the integrated chain finished product, against the 
average peak intensities for the remainder of samples shown in Figure 60. This sample 
appeared to be lower in curcuminoid content compared to the powder food samples but 
higher in the low chemical shift range, indicating that it was higher in essential oil 
content. Sample 47, the integrated chain finished product exhibited a metabolite profile 
similar to that of the fresh turmeric samples. 
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Figure 61, Contribution plot showing metabolite differences between sample 47 and the 
average peak intensities for the main group shown in Figure 60 (n = 28)     
 
Sample 47 was compared to an ethanolic turmeric extract sample 1, (Fig.62) where it 
was observed that compounds were lower in the curcuminoid region but higher in the 
essential oil region compared to the ethanolic extract.  
This may be a result of the high temperature processing employed in the ethanol/water 
extraction process, which can result in a high loss of volatile compounds, whereas 
sample 47 has not been subjected to prolonged high temperature processing but has 
only been boiled for a short time (a necessary step to prevent further plant growth and 
reduce microbial load) and then dried at ambient temperature.  
Moreover, sample 47 may be richer in these volatile compounds (compared to sample 
1), as it has been processed into a final product relatively soon after harvesting (an 
advantage of belonging to VIVC). 
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Figure 62, Contribution plot showing metabolite differences between sample 47 and an 
ethanol extract, sample 1, n = 52 
The aqueous extract of C. kwangsiensis, sample 21, contained less of the 
curcuminoids or essential oils seen in the other products but chemical shifts in the 
carbohydrate region suggested it was comparatively high in sugars (Fig. 63).  
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Figure 63, Contribution plot showing metabolite differences between sample 21, an 
aqueous extract and the main group, n = 52     
 
9.2 HPTLC analysis 
Forty samples of turmeric and turmeric products were analysed by HPTLC. A curcumin 
standard was run alongside the samples in order to identify the three major 
curcuminoids. Curcumin (Top band), demethoxycurcumin (middle band) and bis-
demethoxycurcumin (bottom band). 
In Fig. 64, Group1 includes C. aromatica and C. zanthorrhiza and group 2 consisted of 
Curcuma longa. Bis-demethoxycurcumin (Rf 0.18) was only present in C. longa.  
Group 3 are the ethanolic / SCF extracts, (35, 1, 4, 9 and 48), aqueous extracts (21, 22 
and 26) and some products (54, 34 and 8) that displayed weaker intensity zones. 
Group 1 samples exhibited strong zones at Rf 0.58 and at Rf 0.82. These zones were 
observed faintly in some of the C. longa samples indicating possible contamination or 
adulteration.  
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    Curcumin standard 
 
    Group 1                       Group 2                                                Group 3 
 
Figure 64, Derivatised plate under white light showing curcumin standard and samples 
separated into 3 groups. Mobile phase toluene, acetic acid 4:1(Curcuminoid system) 
Group 3 divulged information on some of the most diverse and interesting samples. 
Sample 48, a Super Critical Fluid (SCF) extract, appeared to contain more compounds 
than the other extracts. The samples in the last three tracks were aqueous extracts and 
no curcuminoids or essential oils were detected. Sample 23 was unusual in that it was 
an aqueous extract but contained curcuminoids. Sample 19 was sold as turmeric but 
was likely to be C. aromatica or C. zanthorrhiza. Sample 34, a TCM product was 
different to other C. longa chromatograms and may be C. kwangsiensis. The two 
products that were mixtures of ethanolic extract and powder gave differing results. 
Sample 9 showed strong bands and looked similar to the SCF extract, whereas sample 
8 exhibited weak intensity bands in comparison to the other samples. Sample 54 was a 
cold ethanolic extract and was relatively low in curcuminoids but did show a dark band 
close to the application point consistent with essential oils in this system. Sample 4 
exhibited a strong zone for curcumin but very little for either of the other two 
curcuminoids. This sample was unusual in that it was the only sample that was not 
sampled directly but was given to me by the company after a one day interval. 
HPTLC was performed to determine if there was any differences between samples that 
were sold as fresh rhizomes, the samples obtained through the integrated chain and 
those that had been boiled, dried, polished and stored (the traditional method).  
 27    2       25     5     19     23     15     6      33     31     32    24     10     28    14     16     17    18     36    53      7      11      3     20     13      3      12     29    30     35      1      4        9     48     54    34       8     21    22    26 
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My first hypothesis was that the samples obtained through the integrated chain would 
have a metabolite profile that was closer to that of a fresh rhizome as the boiling, sun-
drying, polishing and storing steps were not used. My second hypothesis was that 
samples obtained through the traditional route may be adulterated with some other 
Curcuma species. 
   
 
Figure 65, Derivatised plate under white light. Mobile phase toluene, acetic acid 
4:1(Curcuminoid system) 
 
 
Figure 66, Derivatised plate under UV 366nm. Mobile phase toluene, acetic acid 4:1 
(Curcuminoid system) 
 
More compounds were present in the freshest samples 38, 39 and 40 (figures 65 and 
66). These were fresh rhizomes that had not been boiled or dried. The integrated chain 
samples 47, 12 and 13, displayed a strong zone at Rf 0.25, which was also observed 
for 38, 39 and 40. There was also a stronger zone for the integrated chain samples and 
the fresh rhizomes at Rf 0.83. Sample 19 displayed a different pattern, having an extra 
              3        47     12       13      14       24      28      32     36       38       39      40       41      42      46      19 
            3        47       12       13      14       24     28      32      36       38      39       40       41      42      46      19 
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zone at Rf 0.65 and the bis-demethoxycurcumin zone at Rf 0.2 was missing (consistent 
with C. aromatica and C. zanthorrhiza.) indicating that this sample was not C. longa.  
 
 
Figure 67, Derivatised plate under white light. Mobile phase Dichloromethane 
(essential oil system) 
 
 
 
 
Figure 68, Derivatised plate under UV 366nm. Mobile phase Dichloromethane 
(essential oil system) 
 
In the HPTLC analysis of the essential oil system sample 19  stood out as being 
different from the rest of the group and was likely to be C. aromatica (Fig. 67 and 68). 
Sample 32 was a polished rhizome from Erode and had a band at Rf 0.5 indicating 
possible adulteration with C. aromatica. Sample 47 (track 2) showed a strong zone at 
Rf 0.86 that was also observed with the fresh rhizome samples. Moreover, for the fresh 
rhizomes, there was a zone absent at Rf 0.35 that was present in the other samples. 
This could possibly be a breakdown product caused by heating or storage.  
             3        47      13      14      19      24       28      32      36      38      39       40       41      42       46      12 
              3       47      13      14      19       24     28      32      36       38      39      40      41       42      46   12 
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Fig. 69 shows the aqueous extract samples compared against the standards, sucrose 
and fructose and a turmeric food powder. It was observed that the food powder only 
contained compounds with similar RF’s to the standard sugars whereas the aqueous 
extract products contained more sugars. From the position on the plate of these sugars 
it is likely that they are more complex polysaccharides.  
 
 
 
 
Figure 69, Derivatised plate viewed under white light. Mobile phase: Acetonitrile: 
acetone: water 40:40:20 (sugar system) 
Figure 69 confirms that the TCM aqueous extracts contain mainly sugars. Sample 5 
was not an aqueous extract but was placed with the aqueous extracts in the PCA due 
to the large amount of added sugar that it contained. Sample 7 appears only to contain 
sucrose and fructose. 
Seven samples were selected that were suspected of possible adulteration with 
artificial dyes and run against the vertical chain samples. No artificial dyes were 
detected by HPTLC in any of the samples tested (Fig. 70). There was some tailing 
which may have obscured the zone associated with fluorescein. A modified mobile 
phase could be used to make this zone clearer.  
 
 
 
 
         Sucrose  Fructose                  21       26       22      23        5         7        21    26        22      23        7     
Sample 5 contained a large amount of added sugar. 
 
185 
 
 
 
 
 
 
 
Figure 70, Plates viewed under white light19, Mobile phase: Toluene: methanol: acetic 
acid 32:8:10 (Artificial dye system) 
For further details of the HPTLC materials and methods and a fuller presentation of all 
the HPTLC analysis, see appendix 7. 
 
 
 
 
                                                          
19
 S1: Sudan I, SY: Sunset Yellow, S4: Sudan IV, AU: Auramine O, AN: Aniline,                          
FL: Fluorescein, MTY: Metanil Yellow, MNY: Menthyl Yellow, XY: Xylene 2G 
 
    S1/SY    S4/AU       AN          FL       MTY       MNY       XY                           12          13        14           19            24          28        32    
    S1/SY    S4/AU       AN          FL       MTY      MNY                                       36          38           39         40            41          42    46    
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The HPTLC data provided some evidence that there were compounds present in the 
fresh root samples that were less evident in the ground powder samples. The 
integrated chain product showed this (see figure 66).  
I hypothesised that this compound was likely to be an essential oil (I had witnessed 
during the fieldwork stage how turmeric can be stored for long periods in sub-optimal 
conditions) leading to the loss of volatile compounds. 
In order to test this hypothesis, I acquired some tumerone reference standard 
(tumerone is reportedly the main essential oil component in turmeric) and ran an NMR 
analysis on the standard and compared this to the samples of interest in the HPTLC 
chromatogram (sample 47 from the VIVC, sample 32 from the traditional route of 
supply and sample 40 obtained from the fresh root of Curcuma longa. 
Figure 71 shows the comparison between the NMR spectroscopy and HPTLC results. 
Tumerone was positively identified in the samples, giving unique peaks at 6.14 (singlet) 
and 7.08 (quadruplet). Comparing the intensity of the zones at Rf 0.25 in the HPTLC 
chromatogram against the intensity of peaks in the NMR-spectra, there is good visual 
correlation between the two techniques and it is probable that the zones at Rf 0.25 are 
caused by tumerone. This should be confirmed by running a tumerone standard during 
the HPTLC analysis. 
The NMR spectroscopy data confirms that tumerone is present in the VIVC chain 
sample (47) and at a comparatively higher level than the sample taken from case study 
1 (A polished rhizome from Erode, sample 32). 
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Figure 71, Comparison of NMR spectroscopy and HPTLC results with reference to the 
presence of tumerone. 
Sample   Number 
                   47                                                      32                                  40     
Sample 47 
Sample 32 
Sample 40 
Tumerone 
Standard 
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9.3 Discussion of analytical results 
I have shown that the chemical composition of raw materials is variable (see Fig. 55) 
and that finished products are not always of an acceptably consistent quality (e.g. 
samples 19 and 32 (Fig. 68), sample 7, (Fig. 69)). However, there are strategies that 
can be introduced that may be able to address the problems from the bottom up and 
one of these strategies is the implementation of a sustainable VIVC.   
The fieldwork investigations and laboratory analysis has demonstrated that the 
chemical composition of Curcuma longa and the resulting turmeric products can vary 
greatly (see Figs. 53 and 64). It is evident that many of the quality related problems 
associated with the product can be traced to economic factors (e.g. long term storage 
when market price is low).  
This study has shown that traditional methods of cultivating, storing and selling 
Curcuma longa can lead to adulteration of the supply chain by incorrect curcuma 
species (e.g. sample 32, Figs. 67 and 68). The adulteration often takes place at the 
polishing stage, where ground powders are added to improve the colour of the 
rhizomes. Because the VIVC product is not polished and is not destined to be sold at 
auction, (in the auction good colour is likely to have an incremental effect on the price), 
adulteration is more effectively controlled and prevented. 
I have shown that a proportion of the sampled products, the aqueous extracts, contain 
few compounds that would generally be regarded as therapeutically relevant (see Figs. 
64 and 69). Although some research has indicated that water-soluble polysaccharides 
may have some anti-inflammatory effect (Tohda et al., 2006). However, at least one of 
the aqueous extracts examined appeared only to contain the simple sugars sucrose 
and fructose (sample 7, Fig. 69).  
The main compounds accepted as being therapeutically important are the 
curcuminoids and to a lesser extent the essential oils, all of which were undetectable in 
the majority of aqueous extracts tested. The one exception being an aqueous extract 
TCM product (sample 23), where the results indicated that some of these non-aqueous 
compounds were present (see Fig. 64). On subsequent investigations with 
representatives of the manufacturing company it was discovered that crude ground 
powder is added to the extract as a filler and in order to improve its chemical 
composition and so this product cannot be regarded as a true aqueous extract. 
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I have observed and measured how some products have different chemical 
characteristics to others, how some are different species, are extracted using different 
methods, and have different ratios and concentrations of phytochemical compounds. 
With respect to the medicinal quality of Curcuma longa products, I have highlighted 
how only two of these products differ from the main group of herbal medicinal products 
and from the mass of ground turmeric available as a food ingredient. One of these is a 
Chinese medicinal product (samples 29 and 30, Fig. 60) (also obtained from a VIVC) 
and one is from the integrated chain examined during the fieldwork stage of this study 
(samples 12 and 47, Figs. 60 and 66).  
The data generated through this project suggests that this additional metabolite is likely 
to be an essential oil. From the literature I had discovered that tumerone was a major 
ingredient in Curcuma longa and was chiefly responsible for its distinctive aroma. Using 
1H-NMR spectroscopy, I compared different samples to a tumerone reference standard 
and confirmed that the integrated chain product is relatively high in this compound 
compared to a sample taken from the traditional route of supply (see Figure 71).  
It is these more volatile compounds that are likely to be lost during long term storage or 
due to the heat caused in the traditional grinding process and so this data supports the 
traditionally held view that turmeric should be stored in an air tight container and used 
within three months (Booker, 2012, fieldwork Interviews). 
I have hypothesised that by establishing a well-managed and well monitored vertically 
integrated value chain, end companies can exert a greater degree of control over 
processes and procedures that can lead to a better quality product. The analytical 
study has provided crucial evidence to support this by demonstrating that the samples 
obtained from a VIVC are free from known adulterant dyes (see Fig. 70) and that they 
are comparably closer in chemical composition to the freshest rhizomes tested, than 
other samples in the study typically representing the traditional route of supply (see 
Figs 65 to 68).  
Turmeric medicinal product samples obtained from within a vertically integrated value 
chain, show a closer resemblance to fresh samples of turmeric rhizome with respect to 
their metabolite content than samples obtained from the general market. Samples of 
turmeric obtained from a non-integrated chain have shown to be contaminated with 
curcuma species other than Curcuma longa. Most of the products sold as aqueous 
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extracts (mainly TCM products) contained little trace of compounds that were present 
in the powder and that would generally be regarded as quality indicators; some 
contained polysaccharides but the HPTLC analysis confirmed that others only 
contained simple sugars.  
 
10.0 General Discussion 
One of the main priorities of research for LCIRAH is to establish, develop and promote 
strategies that investigate the links between agriculture and health and particularly in 
connection with international development. The LCIRAH ethos has been to promote 
interdisciplinary research in order to approach and investigate areas of interest using a 
wide knowledge base and using research tools from varied disciplines.  
The central theme running through this project has been the investigation of value 
chains and how different value chains may have an impact on the livelihoods of actors 
working along the chain and how these different value chains may affect the quality of 
the finished HMPs.  
Using an interdisciplinary framework, I have investigated value chains using a variety of 
methods. I have used a socio-economic approach to discover what types of value 
chains can be discovered during a comparatively short fieldwork investigation and how 
different actors are placed within a particular chain. I have used socio-economic 
methods to assess the standard of living of different actors and how livelihoods are 
affected through participation in different value chains and what power dynamics exist 
between the companies and individuals who act as the links within the chains. I have 
then used laboratory methods to investigate the composition and aspects of quality of 
different products produced within these chains. 
For the first time it has been possible to link together the concepts of the value chain 
with analytical analysis in order to evaluate whether certain chains work better than 
others and whether the finished products produced through a VIVC are any different in 
terms of quality than those produced through more traditional methods. 
Consequently it may be possible to determine whether the additional benefits or 
financial premiums paid to actors involved at the start of the chain (i.e. the primary 
producers) can be supported through the production of analytical data of this kind. 
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10.1 Globalisation of HMPs 
Practices and attitudes to medicinal herb production in China and India have changed 
from being mainly local enterprises to being global commodities (Sharma, 2004). This 
change has particularly been prominent from a period in the mid 1980’s when China 
officially began opening its doors to world trade, and in the early 1990’s in India, 
following the introduction of liberal economic reforms, which lowered trade barriers and 
taxes, loosened the grip of state run monopolies and promoted competition within 
industries. These reforms enabled India to integrate more effectively into the global 
economy and laid the foundations for future growth (Das, 2012).  
Being the largest employment sector, employing approximately 52 per cent of the total 
number of jobs, providing over 70 per cent of rural households’ main source of income, 
and contributing 18 per cent to GDP,  agriculture and the manufacture of goods from 
agricultural raw materials has been an important area for the development of overseas 
partnerships and industrial trade (Arjun, 2013) but unlike the information technology 
industry and India’s ‘silicon valley’, the opportunities for workers have been fewer and 
the wages far less. It has been argued that agricultural workers have been unfairly 
treated by some of the major international companies that operate in India (Hilary and 
Dromey, 2010, Fairtrade, 2010).   
The economies of India and China are growing rapidly and the development of a 
medicinal plant export industry should be examined in this context. China appears 
ahead of India in many economic areas and seems to be achieving exponential growth 
but in the pharmaceutical arena, India has demonstrated that it leads China in terms of 
pharmaceutical innovation (Adams et al., 2013) and so a challenge for Indian 
companies is to apply this ethos to the medicinal plant industry. 
10.2 Trade and livelihoods 
There is a trend developing within the food industry where consumers are becoming 
more interested in the provenance surrounding food (YouGov, 2013); this can be 
readily observed by reading the descriptions of food on the shelves in most UK 
supermarkets. No longer does labelling just offer a list of ingredients or information 
about the nutritional value of the food but it is now possible to read about from which 
geographical location food originates, the environment in which an animal was kept, 
how a plant was grown, whether any pesticides were used, there is even information 
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about the farmers who reared the cattle or grew the coffee. In return for assurances 
that the food has been produced ethically, and often with added benefits to the farmers, 
consumers are required to accept that value has been added to the product through 
this philanthropy and consequently are required to pay a premium for it (Carruthers et 
al., 2013).  
This change in ethos has the potential to move into a wide variety of consumer goods, 
including food supplements, functional foods and HMPs and more so than for cultivated 
and collected plants destined for pharmaceutical extraction and conversion into single 
drug entities, where efficacy remains the main driver. 
As India’s GDP increases and a larger percentage of the population become wealthier, 
consumer demand for organic medicinal products is likely to continue to grow and will 
provide an additional market for high quality and organic medicinal plants. 
The knowledge base and expertise needed to produce these products is most crucial 
at the beginning stages of production and so it is reasonable to expect that growers will 
have a fairer distribution of revenue through the value chain. In turn consumers in 
Europe can expect to gain from having access to a wider range of Asian grown, higher 
quality and safer herbal medicinal products.  
The literature review revealed emerging evidence to indicate that farmers and pickers 
are beginning to move away from the traditional route of selling their herbs at the local 
or provincial herb markets and are beginning to form alliances with local 
pharmaceutical companies or with regional sourcing companies in order to gain access 
to the more lucrative export market (Prahalathan, 2004, Kala et al., 2006).  
The perceived benefits to the farmer to this approach are mainly market price 
stabilisation and a fixed-term contractual arrangement that allows for longer term 
planning, where the buyer is able to provide target crop yields for the farmer and agree 
a contractual price that will not be easily affected by many of the market shocks that 
may negatively impact on the market traders. Moreover the farmer has access to a 
wide range of inputs that are necessary help to cultivate medicinal plant crops 
effectively.  
This contractual approach was corroborated by my fieldwork investigations in China 
and India where by paying an agreed price for an assured quantity of herbs the buyer 
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can expect to have greater input and control over the quality of the herb material; the 
buyer or appointed sourcing company can request that crops be collected at certain 
times of the year and that they are collected, dried and stored in accordance with the 
buyer’s specification. This seems to be a logical and pragmatic approach to satisfying 
both the demands of international trade and the need to assure consistent and stable 
price structures. 
However, it is the very nature of an unstable and fluctuating market that continues to 
attract and sustain interest in the medicinal plant trade at the traditional market level 
and it appears by far to be the more common route of supply. 
It may be that there is room for both approaches; the free market for those who want to 
speculate, chiefly supplying to other traders and the Asian HMP manufacturing market, 
and those who are more inclined towards receiving a steady income with price 
guarantees and regular orders and who are amenable to modifying their working 
practices to satisfy the needs of international buyers. 
Moreover there is some evidence from the literature to suggest that VIVCs can have a 
detrimental effect on livelihoods and lead to primary producers being exploited by large 
multinational companies. Work on the effect on livelihoods from the cultivation and 
supply of Madagascan periwinkle (Neimark, 2012) serves as an illustration of this. 
However, this is not a totally new phenomena as bio-prospecting and the extraction of 
active drug substances from plants has been born from a long history of  the 
exploitation of other countries’ natural resources and the development of drugs from 
them e.g. curare, caffeine, opium.  
However, an important difference with respect to HMPs and the VIVC investigated is 
that the VIVC retail company is keen to exploit the ethno-botanical history of the use of 
these ‘medical plants’ and the socio-economic conditions that they are grown in, and so 
the cultivation practices and the livelihoods of the labour force that is involved in the 
initial stages of production become an integral factor in the successful marketing of 
such commodities. This is a very different position from drugs obtained from plants 
where the end user is unlikely to be concerned or even aware of any botanical origin a 
particular drug may have. 
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10.3 Curcuma longa 
As a case study, Curcuma longa (Turmeric) has been shown to be an important plant 
in terms of its economic significance, usage within Europe and future potential as a 
herbal medicinal product. In 2011 to 2012, Indian turmeric had an estimated total 
export value of US$120 million, exporting approximately 80,000 tonnes of turmeric 
globally (IndianSpices, 2013).  
Turmeric’s use as both food and a medicine presents an opportunity to show how a 
value chain may be different for a food and a drug and how different varieties may be 
better suited for different uses. The quality problems that are inherent within the 
turmeric market will help us to understand better the influence of quality standards on 
the value chain and how a product may be prone to adulteration, especially when 
lacking suitable controls and without a VIVC in place.  
For the farmers and collectors, changing working practices and changes in the 
governance of the regulation of medicinal plant cultivation are a priority. If higher quality 
raw materials can be produced for the export market, this may lead to a shift in equity 
towards the actors who operate at the beginning stages of the value chain. Moreover, 
by forming partnerships and alliances with well-established European companies, small 
farmers can expect greater benefits in terms of total remuneration, governance, 
training, supply of essential inputs and better business stability for the long term.  
By examining a single plant species (Curcuma longa), following it through different 
value chains, and through the laboratory analysis of selected samples, it has been 
possible to highlight the differences in chemical composition of products emanating 
from different sources and subjected to a variety of intermediary steps  before final 
manufacture. 
10.4 Standards and quality 
The cultivation and supply of medicinal plants and the manufacture of HMPs in India, 
although having a long history of trade, both domestically and internationally, has failed 
to become a major industry in terms of European exports. India has to some extent 
attempted to follow the Chinese initiative, with the globalisation of its traditional medical 
system and particularly with the export of food supplements and HMPs (Patwardhan et 
al., 2005).  
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However quality related problems inherent throughout the supply chains of 
manufacturing industries in India and China, has resulted in finished products that are 
unable to rival similar products produced within the EU. This has resulted in a poor 
export profile for these commodities. This deficiency in export trade potential has been 
further compounded by the introduction of more stringent EU regulations for herbal 
medicines and according to some industry stakeholders, pressures being exerted by 
European manufactures20, on medicines regulators to enforce these new regulations 
and standards and to close any loopholes that may have allowed for less restrictive 
trade between Europe and LEDCs (Starling, 2011).  
Although it is difficult and often unpopular to argue for less stringent standards in the 
realm of the food and medicines industries, there are some factors that may lie behind 
the decision making processes, leading to the introduction of new standards and 
regulations that are not always immediately apparent.   
It is often the companies with the most resources that are able to influence how these 
higher standards are realised, manipulated and implemented  and a counter argument 
against tighter regulation, is that the standards can be unnecessary, serving primarily 
the interests of larger companies in their desire for the oligopolisation and ultimately 
domination of the industry. A good example of this has been within the tea industry in 
India where a few major companies control most of production (Oldenziel, 2006). 
A totally Euro-centric approach, where plants are grown in the EU, and subsequently 
manufactured and distributed by European companies, may be easier to regulate and 
have less inherent dangers attached, but in an increasingly globalised market, there 
should be a means to make products of a suitable standard available from farther 
afield. This attitude would not only result in a wider variety of products for consumers, 
but also, may have a positive impact on the lives and livelihoods of primary producers 
in LEDCs.  
This is by no means a totally new concept, European consumers have already 
experienced food products, including tea, coffee and cocoa originating in these 
countries and being produced to acceptable EU standards. The difference for HMPs is 
that, not only are the requirements for testing different to that of foods, but unlike the 
food sector products, they are yet to be established as global commodities and are 
                                                          
20
 European manufacturers of registered HMPs have complained that many herbal products 
continue to be found in the retail market available as ‘food supplements’. 
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entering the market at a time of great change and uncertainty. This makes these 
products, and the companies that produce them, far more vulnerable to changes in 
legislation, increases in consumer expectations and market shocks than products 
produced by more well-established industries. 
In the global pharmaceutical industry the quality of raw materials has been an 
important factor for many years (Strother, 2012) but in the traditional medicines 
industry, the focus has been directed more towards the end product, with companies 
investing more heavily towards packaging, marketing and advertising and other end 
stage activities that are seen as a means to add value to a product. Whereas, the 
source and quality of the plant material, and the integrity of the initial processing 
stages, has in many instances, been largely ignored.  
Quality remains a concern. China has been plagued by instances of sub-standard 
quality in many of its industries, including pharmaceuticals and herbal medicines (Bate 
and Porter, 2009). Although India is regarded as a country that can produce acceptable 
quality drugs, there are major concerns regarding the production of HMPs, especially 
regarding authentication of raw materials, heavy metal content and pesticide use 
(Patwardhan et al., 2005). As found in TCM, Indian systems of herbal medicine still 
advocate the practice of ingesting heavy metals (Kumar et al., 2006), a practice that 
will never be acceptable to European medicines regulators.  
The THMPD has introduced standards that will help assure the quality and safety of 
HMPs but its implementation has so far favoured European companies who have the 
infrastructure and hard-ware analytical and manufacturing platforms in place to deliver 
this without incurring massive costs. Manufacturers and retailers have intimated that 
the introduction of the THMPD has decreased their profit margins as in order to 
achieve the standards, far more quality related expenditure is required (Patwardhan, 
2011).  
However, for the farmers and collectors, changing working practice may be more 
important than heavy investment and if high quality raw materials can be produced 
then it may lead to a shift in equity towards the beginning stages of the value chain. 
Moreover, by forming partnerships and alliances with well-established European 
companies small farmers may expect greater benefits in terms of governance, training 
and supply of essential inputs.  
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This study has demonstrated for the first time that there are differences in chemical 
composition in plants obtained from a VIVC compared with the traditional routes and 
that safety and quality can be better assured through the management of such a chain. 
Furthermore I have shown that products obtained through a VIVC are less likely to be 
spoiled or contaminated through microbial growth and paradoxically fewer chemical 
treatments are needed throughout the chain steps.   
For the end user, the customer, there are now safeguards in place to help ensure the 
safety and quality of HMPs through the introduction of the THMPD. However, apart 
from acknowledging the plausibility of a herb to treat a particular condition, the directive 
does not address efficacy.  
I have shown how, in the case of Curcuma longa, the starting material can be stored 
for long periods, resulting in deficiency of what may be important therapeutic 
compounds. Although this material would still need to pass the minimum standards 
required as determined by the relevant monograph or pharmacopoeia, this does not 
mean that it would be of optimum therapeutic quality. This is particularly relevant to 
plant species where the active ingredient(s) are unknown or unproven, as is the case 
with Curcuma longa.   
I have highlighted from the literature that although curcumin may be therapeutically 
beneficial, there are problems relating to its bio-availability and other compounds may 
also be responsible for its effects. Using 1H-NMR spectroscopy metabolomics and 
HPTLC, I have shown that the compounds present in the samples obtained from a 
VIVC are more similar to fresh material than other samples tested. This may be 
important both therapeutically but also from a general quality perspective. My argument 
is that, if it is not feasible to provide the fresh plant (as nature intended), then the 
substitute product should be as close to the plant, phytochemically, as possible. 
Ensuring that HMPs are produced through VIVCs is a strategy to accomplish this.  
10.5 Analytical analysis 
One of the central research questions of this thesis concerns the quality of HMPs and 
how this quality can be measured. Assessing the quality of a plant-based product is 
arguably somewhat different to assessing a pharmaceutical product. In the latter, the 
active ingredient, known and unknown impurities, are tested to conform to within set 
limits, whereas with the majority of plant products, active ingredients are often unknown 
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or unproven and the range of impurities that can be introduced at different stages along 
the value chain present a particular problem for analysts. 
With turmeric, the quality of the material is generally assessed with respect to the 
content of curcumin, with a stipulated limit of not less than 3.0 per cent (WHO, 1999). 
However, I have described how curcumin may not be the only compound present that 
has a therapeutic effect and that the problems associated with its lipophilicity and poor 
bio-availability have been well described (Shoba et al., 1998, Jurenka, 2009). For these 
reasons, I chose not to look at curcumin as the only quality marker but to assess the 
sampled material in terms of its whole metabolite content.  
In this study I used two analytical tools, 1H-NMR spectroscopy and HPTLC, in order to 
better understand the composition and chemical variability of the herbal medicinal 
products sampled. Both techniques provide different and complementary data and 
together they can be used to effectively differentiate between a wide variety of crude 
drug powders and herbal medicinal products. 1H-NMR spectroscopy coupled with 
multivariate analysis provides a quick method of separating different samples but is 
sometimes confused by multi-component products or by the addition of excipients. 
Comparing results against HPTLC helps to avoid this pitfall and together the two 
techniques provide a clearer picture of sample composition, offering new ways to 
understand how chemical quality may potentially be linked to local livelihoods and the 
fast developing market links of ethnopharmacological commodities.  
The metabolomic profile of a plant is generally not considered relevant in orthodox 
testing protocols, where a crude drug or product is generally assessed as suitable or 
not suitable depending on the concentration of one, or sometimes several, marker 
compounds and on the absence of impurities. Metabolomics can offer a whole new 
approach to quality assessment and one that is particularly relevant to medicinal 
plants, whereby the active ingredient is often undefined, and any therapeutic benefits 
may be due to the synergistic action of multiple plant components.   
As a case study, Curcuma longa (turmeric) has been shown to be an important plant in 
terms of its economic significance, usage within Europe and future potential as a herbal 
medicinal product. From the literature review I have shown that it has potential as a 
herbal medicinal product and particularly as an anti-inflammatory, digestive aid and for 
its use as a vulnerary.  
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However, the current literature also highlights that the supposed main active 
ingredients, the curcuminoids, are poorly absorbed even at high dosages (Jurenka, 
2009). This has led manufactures to create ‘high potency’ curcumin extracts in an 
attempt to improve bio-availability (samples 1, 4 and 35).  
The results of my study have shown that the majority of products analysed in this class, 
although higher in curcumin, lose many of the other compounds that have been 
documented as having an anti-inflammatory effect (e.g. other curcuminoids and 
essential oils). In a study by Ahmed and Gilani (2013), where different curcuminoids 
were examined for their effects on Alzheimer’s disease, the authors concluded that the 
beneficial effects were most pronounced when a curcuminoid mixture was used rather 
than the single curcumin compound and in several other studies it has been shown that 
the different chemical compounds work together synergistically .    
10.5.1 Analytical analysis limitations 
Using a metabolomics approach, where the data generated are subjected to 
multivariate analysis, can be subject to a certain amount of bias. Differing scaling 
methods can be used within the software to manipulate the data to suit the expected 
outcome. Moreover the software can only look at the variation and not any reason 
behind why a variation may exist and so the addition of excipients and differing 
extraction procedures need to be taken into account when viewing the statistical 
analysis and sometimes it is necessary to refer back to the raw NMR spectra for 
individual samples. I have minimised these biases and produced a truer picture of the 
metabolite composition through the use of HPTLC. This analytical technique gives a 
clearer view of individual compounds within the samples and allows for selective 
analysis of different groups, (e.g. sugars, essential oils), through the use of different 
solvent systems.  
10.6 The sustainable value chain 
Un-restricted growth cannot be sustainable within a contained system (Hardin, 1968) 
and the medicinal plant / herbal medicine industry is a good example of this. As plants 
are depleted in the wild, their scarcity often leads to an increase in their desirability 
which in turn results in an increase the price.  The impact at a grass roots level is that 
they become more economically attractive. This process can continue until the plant is 
endangered or even made extinct in the wild. It is often the poorest of people who 
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make their living from foraging plants from the wild, however, it is these same people 
who are most open to exploitation from middlemen and frequently only receive about 
six per cent of the retail price of a herbal medicament (Schippmann et al., 2002).  
There seems little doubt that the Indian cultivated medicinal herb industry is some way 
behind that of China with over 90 per cent of medicinal plants in India still being 
collected from the wild (Kumar et al., 2011). As demand for Indian medicinal plants 
increases it is unlikely that wild collection will be sustainable in the long term and new 
strategies will be needed if the industry is to succeed. There is already some evidence 
of strategic alliances and global partnerships manifesting but sometimes with mixed 
results (Alam and Belt, 2009, Shahidullah and Haque, 2010).  
Professionals, producers and academics should work together to share what strategies 
succeed and where the problems lie. Poor seed quality, unsuitable environment and 
lack of knowledge base have already been identified as contributory factors for failure 
and it is important that measures are taken to avoid repetition. It is interesting that 
several UK based manufacturing or distribution companies (the VIVC case study, the 
Taiwanese extract producer and a TCM company) have been working to develop this 
area and have established some very important relationships with farmers in Asia 
which appear to be successful. It is the development of these long term relationships 
which lie at the heart of building a successful value chain.  
Farmers and primary producers need incentives and guarantees if they are to invest 
finance, time and resources into the cultivation of medicinal plants. A robust regulatory 
system is needed in place that controls the manufacture and delivery of plant 
medicines through all stages of production. The European THMPD is an example of 
how a pragmatic approach can be utilised to improve the quality and safety of HMPs, 
however, one weak point is that it fails to regulate the appropriate sourcing of plants in 
a meaningful way.  
This situation is even more relevant to the Asian medicinal plant industry and if this 
industry is to develop its export capability it will be necessary for it to address issues 
such as endangered species, sustainability and economic viability in parallel to those of 
quality, safety and effectiveness. From the manufacturers’ perspective, in order to 
implement a sustainable business model, the contracts that are put in place need to be 
managed effectively from both sides. Another question arising from the literature review 
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is whether lead firms are able to manage the value chain over time and the degree to 
which the farmer will conform to the standards required by the buyer?  
10.7 Benefits for stakeholders 
There are tangible benefits to be realised by the farmer and to workers throughout the 
manufacturing stages. If the VIVC farm and company in India continues to grow and 
develops a long term relationship with the European partner, further benefits to the 
farm and factory workers may also be realised.   
However, although a VIVC may appear to be more stable and less of a risk to the 
farmer, there are some instances where the farmer may not benefit. Once contracted 
into a chain, a degree of freedom is sacrificed and the farmer is no longer free to sell 
on the open market. Large companies may be able to exert a downward pressure on 
the farmers as I have mentioned with the tea farmers whose livelihoods can become 
totally dependent on a single company. In other circumstances, as pointed out by 
Neimark (2012), on his investigation into the Vinca rosea value chain and the 
production of chemo-therapeutic agents;  although the finished product end of the 
market may be modern and well regulated, the beginning stages of the market may be 
may be quite unregulated, even when the farmer is integrated into a value chain, 
allowing the lead company to dominate the farmer.  
When selling to one or two companies, which may be the main buyers for this raw 
material, the farmer may find himself with no alternative than to make contracts with 
these big corporations who are unlikely to be interested in the livelihoods of small 
farmers. However this is a different situation to the case study I have observed, where 
traceability is evident throughout the length of the chain, farm workers are required to 
be trained in good cultivation practices, relationships between different actors in the 
chain have been built up over time and the welfare and livelihood of the farmers has 
become an integral part of the retailers marketing strategy.  
For the buyer too, some risks exist, even when under contract, there is no guarantee 
that the farmer will not sell his crop on the open market if the price is right and there is 
unlikely to be any redress for the buyer in this situation. There are also a myriad of 
economic, political, and climatic risks associated with the cultivation of medicinal plants 
and their manufacture into HMPs that need to be overcome in order to create a 
successful industry. 
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Albeit with the caveat that  there are risks in any business and that no system is fool 
proof or without its own unique set of exogenous and endogenous problems; this study 
has provided evidence that, for small to medium sized businesses, that are prepared to 
build strong relationships with farmers over time, and who are pro-active in supply 
chain management strategies, and for primary producers who are prepared to adapt 
their working practices to comply with standards of different countries than their own; 
there are mutual benefits to be attained and importantly that these benefits can be 
measured through an interdisciplinary understanding of the strategic issues.    
10.8 Future work 
Following on from the mainly qualitative investigation undertaken in the socio-economic 
section of this project concerning the livelihoods of farmers, it would be very 
enlightening to conduct a more quantitative health and well-being survey on farmer and 
farm worker households. The cultivation of medicinal plants within VIVCs is relatively 
new in India and so the information gathered from this type of survey could be used as 
a baseline from which future improvements or declines in livelihoods associated with 
MPVCs can be monitored.  
This study has focused on Curcuma longa as a case study but it is envisaged that the 
research strategies and methods described in this thesis can be reproduced to 
investigate the value chain of any medicinal plant and particularly in cases where there 
are many different products on the market of varying standards of quality.  
Total metabolite quality profiles (TMQPs) could be developed and introduced for a wide 
range of medicinal plants and their resulting products. NMR spectroscopy is a 
commonly used technique but its cost puts it out of reach of most small to medium 
sized enterprises. I have demonstrated that there is a good correlation between 1H-
NMR spectroscopy results and those produced by HPTLC, which is a system 
commonly used by HMP manufactures. The development of new methods should 
utilise new standards, using fresh plant material or pre-generated reference data 
The chosen analytical techniques have shown be effective platforms for the rapid and 
accurate determination of plant and plant product composition and future studies 
should focus on their further development and refinement. This has been the first time 
that different species of curcuma have been investigated by using a combination 
metabolomic approach using 1H-NMR spectroscopy and HPTLC and the analytical 
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investigation has shown how different information can be acquired from different 
methods of analysis. There are still some conflicting results regarding the differences in 
chemical composition of different curcuma species (e.g. C. aromatica and C. 
zanthorrhiza) and how effectively 1H-NMR spectroscopy or HPTLC can separate these 
species.  
Thorough investigation of MPVCs can provide the industry with a far more 
comprehensive picture of the cultivation, processing and storage history of a given 
HMP and this information can be used to help justify, encourage and promote the 
continued development of VIVCs together with the implementation and management of 
better contractual relationships between manufacturers of HMPs and the primary 
producers that supply them. 
 
11.0 Conclusions 
The establishment of a sustainable VIVC for the production of HMPs has had a positive 
impact on the livelihoods of the primary producers investigated in India. There is clear 
evidence to suggest that primary producers benefit from being employed on fixed-term 
contracts. 
1
H-NMR spectroscopy coupled with multivariate analysis software and HPTLC are two 
analytical platforms that can provide complementary data regarding the phytochemical 
composition of crude plant-derived raw materials and HMPs. 
HMPs that are derived from the VIVC investigated are of superior quality to those 
products analysed that derive from the free market. The reasons for this are primarily 
that products obtained through a VIVC have not been exposed to adulteration and 
have not been stored for long periods of time leading to the loss of volatile compounds. 
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13.1 Appendix 1 
Value chains of herbal medicines—Research needs and key challenges in 
the context of ethnopharmacology. 
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13.2 Appendix 2 
Chemical variability along the value chain of turmeric (Curcuma longa): A 
comparison of Nuclear Magnetic Resonance Spectroscopy and High 
Performance Thin Layer Chromatography.. 
 
Paper Published in the Journal of Ethnopharmacology (2014) 
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13.3 Appendix 3 
Templates for research objectives and semi-structured interviews used 
for fieldwork in India 
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Objective 1: To describe the value chain and assess the impact of quality on the chain 
Activity WHAT TO FIND OUT HOW TO FIND 
INFORMATION 
PRIORITY BUDGET 
Growing Where is it grown 
Who grows it 
When is it grown 
How is it grown 
What are external inputs      
(fertilizers, pesticides) 
When harvested 
Who harvests 
Farm visits 
 
 
***  
Collecting Who collects 
When collected 
Collection criteria 
Market visits ***  
Processing Who processes 
How is it processed 
Visit processor **  
Manufacturing Who manufactures 
What is the product 
Visit manufacturer ***  
Storage When is storage required Visit storage areas *  
Exporter Who is exporter Visit exporter *  
Distribution Who are distributors 
How is it distributed 
Visit distributor *  
Importer Who is importer Visit importer *  
Retailer Who are retailers 
Where are retailers 
Visit retailers **  
Regulator Who regulates 
What are the regulations 
Visit regulators 
Visit manufacturer 
**  
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Objective 2: To investigate what impact medicinal plant production has on the 
livelihoods of producers 
Activity WHAT TO FIND OUT HOW TO FIND 
INFORMATION 
PRIORITY BUDGET 
Growing Who does land belong to 
Who pays for land 
Who grows it 
How is grower paid 
Who harvests 
How is harvester paid 
Who pays for inputs 
What are other benefits 
Farm visits 
 
 
***  
Collecting Who collects 
Where are plants sold 
How is collector paid 
Other benefits 
Market visits ***  
 
 
Processing 
Who processes 
How is processor paid 
Other benefits 
Visit processor *  
Manufacturing Who manufactures 
Who are employees 
How are employees paid 
Other benefits 
Visit manufacturer ***  
Storage Where stored 
Who stores 
What are costs  
Visit storage areas *  
Exporter Who is exporter Visit exporter *  
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What are costs   
 
Distribution Who are distributors 
What are costs 
Visit distributor *  
Importer Who is importer 
What are costs 
Visit importer *  
Retailer Who are retailers 
Where are retailers 
Visit retailers **  
Regulator Who regulates 
What are costs and who 
pays 
Visit regulators  
Visit manufacturer 
**  
Community 
 
What are the living 
conditions like 
What facilities are available 
for the community 
Community visits ***  
 
* Low priority             ** Medium priority          *** High priority 
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Semi structured questionnaire for farmer 
Name of Farmer______________________ Age_______ Gender M / F 
Site______________________________                   
Date________________________ 
 
1. Have you always been a farmer 
2. Do you have any other work apart from farming 
3. How about your family – do they work on the farm 
4. What is the size of your farm 
5. Do you have many employees  
6. Are your employees all local 
7. What crops do you grow on the farm  
8. Is medicinal plant cultivation any different to food crops 
9. Are there any special requirements for growing/harvesting 
10. Do you keep any animals 
11. How do you sell your crops – who are your buyers 
12. What are your main challenges 
13. What are your biggest costs 
14. What plans do you have for the future 
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Semi structured questionnaire for farm worker 
Name of Farm worker______________________ Age_______ Gender M / F 
Site______________________________                   
Date________________________ 
 
1. Have you always been a farm worker 
2. Do you have any other work apart from working on the farm 
3. How about your family – do they work on the farm 
4. How big is the farm 
5. Are there many employees that work on the farm  
6. Are you local 
7. What crops do you grow on the farm  
8. Are there any special requirements for medicinal plants 
9. Do you look after any animals 
10. What happens to the crops once harvested 
11. What are your main challenges 
12. Do you make a living working on the farm 
13. What plans do you have for the future 
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Semi structured questionnaire for wild collector 
Name of collector______________________ Age_______ Gender M / F 
Site______________________________                   
Date________________________ 
 
1. How long have you been collecting herbs for 
2. Do you have any other work  
3. How about your family – do they collect herbs also 
4. What area do you cover 
5. Are there many people collecting plants from the wild  
6. Are you local 
7. What plants do you collect 
8. Is there any special requirements for how they are collected 
9. Is it only plants that you collect 
10. What happens to the plants after you have collected them 
11. What are your main challenges 
12. Do you make a living collecting plants 
13. What plans do you have for the future 
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Semi structured questionnaire for company representative 
Name of company representative______________________  Gender M / F 
Position__________________________________ 
Site______________________________                   
Date________________________ 
 
1. How do you obtain your plant raw materials 
2. What relationship do you have with the farmer 
3. What relationship do you have with the retailer 
4. What is your marketing area 
5. How many employees work in this company  
6. Are you local 
7. What plant products do you produce 
8. Is there any special requirements for how they are farmed/collected 
9. Is it only plant medicines you produce 
10. How are your products distributed 
11. What are your main challenges 
12. Do you think farm workers can make a living collecting plants 
13. How sustainable do you think medicinal plant production is 
14. Do you get any help from the government or NGO’s 
15. What are the regulations regarding medicinal herb products 
16. How do you think the European directive will affect you 
17. What plans do you have for the future 
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13.4 Appendix 4 
Summary of results for the on-line traditional Asian herbal medicine 
survey 
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Traditional Asian Herbal Medicine Survey  
1. This question relates to herbs from any country or tradition. Do you ever take 
medicinal herbs or herbal medicinal products for the treatment or prevention of 
illnesses or to promote good health? Include culinary herbs or spices if used 
medicinally. 
  
Response 
Percent 
Response 
Total 
1 Never   
 
14.78% 34 
2 Rarely   
 
19.57% 45 
3 Occasionally   
 
33.04% 76 
4 Yearly   
 
3.91% 9 
5 Monthly   
 
3.48% 8 
6 Weekly   
 
9.57% 22 
7 Daily   
 
15.65% 36 
  
answered 230 
skipped 5 
 
2. Have you heard of any of the following traditional medicine systems from Asia? 
  
Response 
Percent 
Response 
Total 
1 
Traditional Tibetan 
medicine 
  
 
23.85% 52 
2 
Traditional Korean 
medicine 
  
 
19.72% 43 
3 
Traditional Chinese 
medicine 
  
 
94.04% 205 
4 
Traditional Japanese 
medicine (Kampo) 
  
 
27.52% 60 
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2. Have you heard of any of the following traditional medicine systems from Asia? 
  
Response 
Percent 
Response 
Total 
5 
Traditional Indian 
medicine (Ayurveda, 
Siddha or Unani) 
  
 
63.76% 139 
6 
Traditional Thai 
Medicine 
  
 
18.81% 41 
7 
Traditional Vietnamese 
medicine 
  
 
7.34% 16 
  
answered 218 
skipped 17 
 
3. Which of these Asian countries do you think currently supplies medicinal herbs 
or medicinal herbal products to the UK? 
  
Response 
Percent 
Response 
Total 
1 China   
 
84.28% 193 
2 Japan   
 
37.12% 85 
3 Korea   
 
31.88% 73 
4 Thailand   
 
27.51% 63 
5 Tibet   
 
13.97% 32 
6 India   
 
64.63% 148 
7 Sri Lanka   
 
20.96% 48 
8 Pakistan   
 
17.90% 41 
9 Don't know   
 
12.66% 29 
10 Other: please specify   
 
3.06% 7 
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3. Which of these Asian countries do you think currently supplies medicinal herbs 
or medicinal herbal products to the UK? 
  
Response 
Percent 
Response 
Total 
  
answered 229 
skipped 6 
Answers for: Other: please specify 7 answers 
1 4/5/11 3:55PM 
2502314 
Malaysia 
Indonesia 
2 4/5/11 10:51PM 
2503470 
Malaysia 
3 10/5/11 1:35PM 
2519179 
and probably more 
4 11/5/11 10:13AM 
2521895 
Singapore; Taiwan 
5 11/5/11 1:36PM 
2523220 
I imagine all of them do - I selected those countries of which I knew from 
experience imports herbs. 
6 8/6/11 9:39AM 
2600381 
Russia 
7 17/6/11 5:43PM 
2630326 
Taiwan 
 
 
4. Do you know any herbs that are used in Asian Herbal Medicine? (maximum 10) 
You can include culinary herbs or spices if used medicinally. 
  
Response 
Percent 
Response 
Total 
1 Open-Ended Question 100.00% 139 
1 18/3/11 5:01PM 
2348112 
Ginseng 
2 18/3/11 8:51PM Ginkgo 
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4. Do you know any herbs that are used in Asian Herbal Medicine? (maximum 10) 
You can include culinary herbs or spices if used medicinally. 
  
Response 
Percent 
Response 
Total 
2348574 
3 18/3/11 9:38PM 
2348635 
eucalyptus 
4 23/3/11 8:38PM 
2367916 
garlic 
5 24/3/11 8:51AM 
2369156 
I know hundreds 
6 24/3/11 5:15PM 
2349888 
ashwaghanda 
7 31/3/11 10:30AM 
2394414 
Turmeric 
8 31/3/11 10:42AM 
2394452 
tumeric 
9 31/3/11 11:10AM 
2394989 
Cumin 
10 31/3/11 11:49AM 
2395066 
turmeric 
11 1/4/11 10:29PM 
2404783 
Ginger 
12 4/4/11 3:34PM 
2412275 
ginseng 
13 16/4/11 1:21PM 
2452394 
Turmeric 
14 23/4/11 1:51AM 
2471658 
Misai Kucing ( Orthosiphon Stamineus ) 
15 24/4/11 8:31AM 
2473499 
Ginger 
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4. Do you know any herbs that are used in Asian Herbal Medicine? (maximum 10) 
You can include culinary herbs or spices if used medicinally. 
  
Response 
Percent 
Response 
Total 
16 27/4/11 10:51PM 
2484453 
Ginger 
17 4/5/11 3:55PM 
2502311 
GINSENG 
18 4/5/11 3:55PM 
2502314 
gingko biloba 
19 4/5/11 3:57PM 
2502338 
Ginseng 
20 4/5/11 3:58PM 
2502318 
Gingko biloba 
21 4/5/11 4:04PM 
2502333 
cumin (culinary ) 
22 4/5/11 4:10PM 
2502354 
Dang gui 
23 4/5/11 4:11PM 
2502415 
Ginger 
24 4/5/11 4:14PM 
2502331 
Basil 
25 4/5/11 4:14PM 
2502336 
Garlic 
26 4/5/11 4:14PM 
2502370 
Tumeric powder - as an antiseptic 
27 4/5/11 4:23PM 
2502484 
Ginko 
28 4/5/11 4:37PM 
2502538 
ginseng 
29 4/5/11 4:53PM 
2502579 
ginseng 
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4. Do you know any herbs that are used in Asian Herbal Medicine? (maximum 10) 
You can include culinary herbs or spices if used medicinally. 
  
Response 
Percent 
Response 
Total 
30 4/5/11 5:09PM 
2502661 
None 
31 4/5/11 6:03PM 
2502796 
ginko biloba 
32 4/5/11 6:39PM 
2502950 
Aloe vera 
33 4/5/11 7:01PM 
2503057 
turmeric 
34 4/5/11 7:04PM 
2503059 
tumeric 
35 4/5/11 7:56PM 
2503159 
Ginger 
36 4/5/11 8:34PM 
2503226 
Triphala 
37 4/5/11 8:50PM 
2503265 
ginkgo biloba 
38 4/5/11 10:33PM 
2503460 
Ginseng 
39 4/5/11 10:51PM 
2503470 
Ginger 
40 4/5/11 11:08PM 
2503517 
Ginkgo biloba 
41 5/5/11 4:19AM 
2503755 
Gingseng 
42 5/5/11 7:25AM 
2503929 
tamarind 
43 5/5/11 8:54AM 
2504146 
Schizandra chinensis 
267 
 
4. Do you know any herbs that are used in Asian Herbal Medicine? (maximum 10) 
You can include culinary herbs or spices if used medicinally. 
  
Response 
Percent 
Response 
Total 
44 5/5/11 12:47PM 
2505164 
Ginseng 
45 5/5/11 2:48PM 
2505738 
cinnamon 
46 5/5/11 2:59PM 
2505767 
Abrus cantoniensis Hance 
47 5/5/11 5:41PM 
2506349 
ginseng 
48 5/5/11 5:47PM 
2502652 
None 
49 5/5/11 10:08PM 
2506994 
Panax ginseng 
50 5/5/11 10:39PM 
2507046 
Sesam Seeds 
51 5/5/11 10:56PM 
2506934 
Neem 
52 5/5/11 11:02PM 
2507080 
Tumeric 
53 6/5/11 1:44AM 
2507253 
Mint 
54 6/5/11 3:30PM 
2509062 
ginseng 
55 6/5/11 10:21PM 
2510154 
curcumin 
56 7/5/11 11:32AM 
2510888 
tumeric 
57 8/5/11 10:31PM 
2513435 
Curcuma 
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4. Do you know any herbs that are used in Asian Herbal Medicine? (maximum 10) 
You can include culinary herbs or spices if used medicinally. 
  
Response 
Percent 
Response 
Total 
58 10/5/11 8:40AM 
2517255 
Ginger 
59 10/5/11 8:41AM 
2517272 
korean ginseng 
60 10/5/11 8:52AM 
2517332 
Turmeric 
61 10/5/11 9:14AM 
2517598 
Withnia somnifera 
62 10/5/11 9:23AM 
2517780 
Ginseng 
63 10/5/11 9:29AM 
2517835 
Ginseng 
64 10/5/11 10:05AM 
2518039 
tumeric 
65 10/5/11 11:03AM 
2518335 
tian ma 
66 10/5/11 11:50AM 
2518711 
Ginseng 
67 10/5/11 12:13PM 
2518781 
Pepper 
68 10/5/11 12:47PM 
2518943 
Zingirber officinale (Ginger) 
69 10/5/11 1:05PM 
2518994 
Cumin 
70 10/5/11 1:35PM 
2519179 
tigers penis 
71 10/5/11 6:21PM 
2520317 
Ginseng 
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4. Do you know any herbs that are used in Asian Herbal Medicine? (maximum 10) 
You can include culinary herbs or spices if used medicinally. 
  
Response 
Percent 
Response 
Total 
72 10/5/11 6:47PM 
2520378 
Milk thistle  
73 11/5/11 3:13AM 
2521039 
tumeric 
74 11/5/11 10:13AM 
2521895 
100s 
75 11/5/11 11:20AM 
2522554 
Ginger 
76 11/5/11 11:36AM 
2522603 
Neem 
77 11/5/11 11:49AM 
2522752 
Gin Seng 
78 11/5/11 12:21PM 
2522941 
Ginseng 
79 11/5/11 12:37PM 
2522984 
ginseng 
80 11/5/11 1:36PM 
2523220 
Turmeric 
81 11/5/11 1:39PM 
2523240 
Jen Jen 
82 11/5/11 2:07PM 
2523340 
Neem 
83 11/5/11 3:25PM 
2523638 
Fennel 
84 11/5/11 4:05PM 
2523761 
turmeric 
85 11/5/11 6:52PM 
2524547 
Cordycep 
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4. Do you know any herbs that are used in Asian Herbal Medicine? (maximum 10) 
You can include culinary herbs or spices if used medicinally. 
  
Response 
Percent 
Response 
Total 
86 11/5/11 7:55PM 
2524742 
Acia 
87 11/5/11 11:07PM 
2525144 
turmeric 
88 12/5/11 12:15AM 
2525202 
Tumeric 
89 12/5/11 4:31AM 
2518498 
Ginseng  
90 12/5/11 4:14PM 
2527614 
turmeric 
91 12/5/11 7:31PM 
2528322 
Jasmine 
92 12/5/11 7:33PM 
2528336 
Ginger 
93 13/5/11 5:37PM 
2532239 
Yin Chao 
94 16/5/11 8:29PM 
2539486 
Gingko 
95 20/5/11 12:41PM 
2551135 
gingo biloba 
96 22/5/11 12:48PM 
2553868 
ginseng 
97 22/5/11 1:01PM 
2553864 
Turmeric 
98 22/5/11 5:00PM 
2554098 
Coriander seed 
99 24/5/11 5:21PM 
2561511 
sandal-wood 
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4. Do you know any herbs that are used in Asian Herbal Medicine? (maximum 10) 
You can include culinary herbs or spices if used medicinally. 
  
Response 
Percent 
Response 
Total 
100 1/6/11 11:35PM 
2583888 
ma huang 
101 8/6/11 9:39AM 
2600381 
rhodiola 
102 9/6/11 9:00PM 
2506564 
Garlic 
103 15/6/11 5:49PM 
2622023 
ginseng 
104 15/6/11 6:31PM 
2622163 
Jinsen 
105 15/6/11 7:00PM 
2621959 
Turmeric 
106 15/6/11 7:16PM 
2622252 
coriander 
107 15/6/11 8:07PM 
2622435 
Ginseng 
108 15/6/11 9:20PM 
2622871 
Aloe vera 
109 16/6/11 1:33AM 
2623681 
Tyrmeric 
110 16/6/11 2:22PM 
2625600 
ginseng 
111 16/6/11 2:28PM 
2625606 
Aconitum 
112 16/6/11 2:35PM 
2625659 
Tumeric 
113 16/6/11 3:21PM 
2625917 
No 
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4. Do you know any herbs that are used in Asian Herbal Medicine? (maximum 10) 
You can include culinary herbs or spices if used medicinally. 
  
Response 
Percent 
Response 
Total 
114 16/6/11 4:19PM 
2626167 
葛根湯 
115 16/6/11 10:39PM 
2627151 
Cinnamon 
116 16/6/11 10:40PM 
2627166 
Senna leaves 
117 17/6/11 7:04AM 
2627504 
Cordyceps sinesis 
118 17/6/11 10:30AM 
2628019 
ginger 
119 17/6/11 5:43PM 
2630326 
angelica sinensis 
120 18/6/11 12:40AM 
2631337 
ren shen 
121 18/6/11 5:35AM 
2631518 
Ginseng 
122 18/6/11 1:12PM 
2631956 
Dang gui 
123 19/6/11 12:53AM 
2632965 
人参 
124 20/6/11 8:17PM 
2636831 
Dang Gui 
125 21/6/11 12:45PM 
2638835 
ren shen  
126 21/6/11 4:23PM 
2639698 
Ginseng 
127 22/6/11 1:09PM 
2642313 
salvia miltiorrhiza 
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4. Do you know any herbs that are used in Asian Herbal Medicine? (maximum 10) 
You can include culinary herbs or spices if used medicinally. 
  
Response 
Percent 
Response 
Total 
128 23/6/11 10:42AM 
2645106 
Ginger 
129 27/6/11 1:16AM 
2654562 
Ginseng 
130 29/6/11 7:46AM 
2661542 
Dragon eye fruit 
131 30/6/11 6:28PM 
2667722 
Ginseng 
132 14/9/11 3:27PM 
2888486 
Cinnamon 
133 2/10/11 1:00PM 
2956324 
jin si gao 
134 3/10/11 8:55PM 
2962581 
Cinnamon 
135 13/2/12 3:10PM 
3386121 
Dang GUI 
136 8/3/12 8:28PM 
3485789 
cinnamon 
137 8/7/12 12:31PM 
4312578 
astralagus 
138 2/8/12 9:52AM 
4410632 
Ginger 
139 16/1/13 4:18PM 
5358567 
ginger 
 
2 Open-Ended Question 81.29% 113 
1 18/3/11 5:01PM 
2348112 
Milk Thistle 
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4. Do you know any herbs that are used in Asian Herbal Medicine? (maximum 10) 
You can include culinary herbs or spices if used medicinally. 
  
Response 
Percent 
Response 
Total 
2 18/3/11 8:51PM 
2348574 
Ephedra 
3 23/3/11 8:38PM 
2367916 
chilli 
4 24/3/11 5:15PM 
2349888 
ginko biloba 
5 31/3/11 10:30AM 
2394414 
ginger 
6 31/3/11 10:42AM 
2394452 
galangal 
7 31/3/11 11:10AM 
2394989 
brahmi 
8 31/3/11 11:49AM 
2395066 
amla 
9 1/4/11 10:29PM 
2404783 
Licorice 
10 4/4/11 3:34PM 
2412275 
dang gui 
11 16/4/11 1:21PM 
2452394 
Areca 
12 23/4/11 1:51AM 
2471658 
Hempedu Bumi ( Andrographis paniculata) 
13 24/4/11 8:31AM 
2473499 
Ginseng 
14 27/4/11 10:51PM 
2484453 
Ginseng 
15 4/5/11 3:55PM 
2502314 
ginger 
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4. Do you know any herbs that are used in Asian Herbal Medicine? (maximum 10) 
You can include culinary herbs or spices if used medicinally. 
  
Response 
Percent 
Response 
Total 
16 4/5/11 3:57PM 
2502338 
Echinacea 
17 4/5/11 3:58PM 
2502318 
spirulina 
18 4/5/11 4:04PM 
2502333 
pistacho (ice cream) 
19 4/5/11 4:10PM 
2502354 
Bai shao Yao 
20 4/5/11 4:14PM 
2502331 
curmin 
21 4/5/11 4:14PM 
2502336 
Ginger 
22 4/5/11 4:14PM 
2502370 
Bitter gourds juice - used by diabetics 
23 4/5/11 4:53PM 
2502579 
cinnamon 
24 4/5/11 6:39PM 
2502950 
tumeric (haldi) 
25 4/5/11 7:01PM 
2503057 
ginger 
26 4/5/11 7:04PM 
2503059 
green tea leaves 
27 4/5/11 7:56PM 
2503159 
Tumeric 
28 4/5/11 8:34PM 
2503226 
Salvia 
29 4/5/11 8:50PM 
2503265 
valerian  
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4. Do you know any herbs that are used in Asian Herbal Medicine? (maximum 10) 
You can include culinary herbs or spices if used medicinally. 
  
Response 
Percent 
Response 
Total 
30 4/5/11 10:33PM 
2503460 
Garlic  
31 4/5/11 10:51PM 
2503470 
Rhubarb 
32 4/5/11 11:08PM 
2503517 
Ginseng 
33 5/5/11 4:19AM 
2503755 
Gingko biloba 
34 5/5/11 7:25AM 
2503929 
cumin 
35 5/5/11 8:54AM 
2504146 
Ginseng  
36 5/5/11 12:47PM 
2505164 
Ginkgo 
37 5/5/11 2:48PM 
2505738 
tumeric 
38 5/5/11 2:59PM 
2505767 
Aconitum autumnale, Lindl 
39 5/5/11 5:41PM 
2506349 
ginkgo 
40 5/5/11 10:08PM 
2506994 
Alium cepa 
41 5/5/11 10:39PM 
2507046 
Ashwagandha 
42 5/5/11 10:56PM 
2506934 
tamarind 
43 5/5/11 11:02PM 
2507080 
Ginger 
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4. Do you know any herbs that are used in Asian Herbal Medicine? (maximum 10) 
You can include culinary herbs or spices if used medicinally. 
  
Response 
Percent 
Response 
Total 
44 6/5/11 1:44AM 
2507253 
ginsing 
45 6/5/11 3:30PM 
2509062 
ginko 
46 7/5/11 11:32AM 
2510888 
ginko boloba 
47 8/5/11 10:31PM 
2513435 
Ginger 
48 10/5/11 8:40AM 
2517255 
cumin 
49 10/5/11 8:41AM 
2517272 
korean royal jelly 
50 10/5/11 8:52AM 
2517332 
Ginger 
51 10/5/11 9:14AM 
2517598 
Andrographis paniculata 
52 10/5/11 9:23AM 
2517780 
Ginger 
53 10/5/11 9:29AM 
2517835 
Gingko Biloba 
54 10/5/11 11:03AM 
2518335 
jiang can 
55 10/5/11 12:13PM 
2518781 
Clove 
56 10/5/11 12:47PM 
2518943 
Ginkgo Biloba 
57 10/5/11 1:05PM 
2518994 
Turmeric 
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4. Do you know any herbs that are used in Asian Herbal Medicine? (maximum 10) 
You can include culinary herbs or spices if used medicinally. 
  
Response 
Percent 
Response 
Total 
58 10/5/11 1:35PM 
2519179 
Cordyceps caterpillar fungus 
59 10/5/11 6:21PM 
2520317 
Dang Gui 
60 10/5/11 6:47PM 
2520378 
Camphor 
61 11/5/11 3:13AM 
2521039 
cumin 
62 11/5/11 11:20AM 
2522554 
star anise 
63 11/5/11 11:36AM 
2522603 
tumeric 
64 11/5/11 11:49AM 
2522752 
Ginger 
65 11/5/11 1:36PM 
2523220 
Ginger 
66 11/5/11 2:07PM 
2523340 
turmeric 
67 11/5/11 4:05PM 
2523761 
neem 
68 11/5/11 7:55PM 
2524742 
Aloe Vera 
69 11/5/11 11:07PM 
2525144 
ginger 
70 12/5/11 12:15AM 
2525202 
Ginseng 
71 12/5/11 4:14PM 
2527614 
curcumin 
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4. Do you know any herbs that are used in Asian Herbal Medicine? (maximum 10) 
You can include culinary herbs or spices if used medicinally. 
  
Response 
Percent 
Response 
Total 
72 12/5/11 7:33PM 
2528336 
Mint 
73 13/5/11 5:37PM 
2532239 
Ginger 
74 16/5/11 8:29PM 
2539486 
ginseng 
75 20/5/11 12:41PM 
2551135 
ginsen 
76 22/5/11 12:48PM 
2553868 
opium 
77 22/5/11 1:01PM 
2553864 
Ashvagandha 
78 22/5/11 5:00PM 
2554098 
Root ginger 
79 24/5/11 5:21PM 
2561511 
angelica  
80 1/6/11 11:35PM 
2583888 
gui zhi 
81 8/6/11 9:39AM 
2600381 
cilantro aka cardamom 
82 9/6/11 9:00PM 
2506564 
Cardamom  
83 15/6/11 6:31PM 
2622163 
Garlic 
84 15/6/11 7:00PM 
2621959 
Cummin 
85 15/6/11 7:16PM 
2622252 
rosemary 
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4. Do you know any herbs that are used in Asian Herbal Medicine? (maximum 10) 
You can include culinary herbs or spices if used medicinally. 
  
Response 
Percent 
Response 
Total 
86 15/6/11 8:07PM 
2622435 
ginko biloba 
87 15/6/11 9:20PM 
2622871 
ginseng 
88 16/6/11 1:33AM 
2623681 
Ginseng 
89 16/6/11 2:28PM 
2625606 
Asarum 
90 16/6/11 2:35PM 
2625659 
Green tea 
91 16/6/11 4:19PM 
2626167 
加味逍遥散 
92 16/6/11 10:39PM 
2627151 
Ginseng 
93 16/6/11 10:40PM 
2627166 
Gouqi berry 
94 17/6/11 7:04AM 
2627504 
Astragalus membranaceus  
95 17/6/11 10:30AM 
2628019 
garlic 
96 17/6/11 5:43PM 
2630326 
ginseng 
97 18/6/11 12:40AM 
2631337 
dang gui 
98 18/6/11 5:35AM 
2631518 
Dang Gui 
99 18/6/11 1:12PM 
2631956 
Sheng di 
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4. Do you know any herbs that are used in Asian Herbal Medicine? (maximum 10) 
You can include culinary herbs or spices if used medicinally. 
  
Response 
Percent 
Response 
Total 
100 19/6/11 12:53AM 
2632965 
麻黄 
101 20/6/11 8:17PM 
2636831 
Rou Gui 
102 21/6/11 12:45PM 
2638835 
huang qi  
103 21/6/11 4:23PM 
2639698 
Gingko Biloba 
104 22/6/11 1:09PM 
2642313 
ashwagandha 
105 23/6/11 10:42AM 
2645106 
Turmeric 
106 27/6/11 1:16AM 
2654562 
Ginkgo 
107 30/6/11 6:28PM 
2667722 
Chinese Angelica Root 
108 14/9/11 3:27PM 
2888486 
Ginseng 
109 3/10/11 8:55PM 
2962581 
Curcuma  
110 13/2/12 3:10PM 
3386121 
Huang qi 
111 8/3/12 8:28PM 
3485789 
tea leaves 
112 8/7/12 12:31PM 
4312578 
fen feng 
113 2/8/12 9:52AM 
4410632 
Gingseng 
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4. Do you know any herbs that are used in Asian Herbal Medicine? (maximum 10) 
You can include culinary herbs or spices if used medicinally. 
  
Response 
Percent 
Response 
Total 
3 Open-Ended Question 67.63% 94 
1 18/3/11 5:01PM 
2348112 
Turmeric 
2 23/3/11 8:38PM 
2367916 
cumin 
3 24/3/11 5:15PM 
2349888 
dan gui 
4 31/3/11 10:30AM 
2394414 
cardamon 
5 31/3/11 10:42AM 
2394452 
ginger 
6 31/3/11 11:10AM 
2394989 
calamus 
7 31/3/11 11:49AM 
2395066 
ashwaganda 
8 1/4/11 10:29PM 
2404783 
Star Anise 
9 4/4/11 3:34PM 
2412275 
ginger 
10 16/4/11 1:21PM 
2452394 
Curry Leaves 
11 23/4/11 1:51AM 
2471658 
Tongkat Ali (Eurycoma longifolia) 
12 24/4/11 8:31AM 
2473499 
Neem 
13 27/4/11 10:51PM 
2484453 
Gingko 
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4. Do you know any herbs that are used in Asian Herbal Medicine? (maximum 10) 
You can include culinary herbs or spices if used medicinally. 
  
Response 
Percent 
Response 
Total 
14 4/5/11 3:55PM 
2502314 
garlic 
15 4/5/11 4:04PM 
2502333 
clove (culinary ) 
16 4/5/11 4:10PM 
2502354 
Sheng di huang 
17 4/5/11 4:14PM 
2502331 
garlic 
18 4/5/11 4:14PM 
2502336 
Ginseng 
19 4/5/11 4:14PM 
2502370 
neem- acne 
20 4/5/11 4:53PM 
2502579 
salvia 
21 4/5/11 6:39PM 
2502950 
holy basil 
22 4/5/11 7:01PM 
2503057 
garlic 
23 4/5/11 8:34PM 
2503226 
Magnolia Officinalis 
24 4/5/11 8:50PM 
2503265 
st johns wort 
25 4/5/11 10:33PM 
2503460 
Ginger 
26 4/5/11 10:51PM 
2503470 
Chrysanthemums 
27 4/5/11 11:08PM 
2503517 
Echinacea  
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4. Do you know any herbs that are used in Asian Herbal Medicine? (maximum 10) 
You can include culinary herbs or spices if used medicinally. 
  
Response 
Percent 
Response 
Total 
28 5/5/11 7:25AM 
2503929 
pinneapple 
29 5/5/11 8:54AM 
2504146 
Eleutherococcus senticocus 
30 5/5/11 2:48PM 
2505738 
garlic 
31 5/5/11 2:59PM 
2505767 
Adenophora verticillata, Fisch 
32 5/5/11 5:41PM 
2506349 
green tea 
33 5/5/11 10:08PM 
2506994 
Uncaria sp. 
34 5/5/11 10:39PM 
2507046 
Coriander 
35 5/5/11 10:56PM 
2506934 
ginseng 
36 5/5/11 11:02PM 
2507080 
cardamom 
37 6/5/11 1:44AM 
2507253 
cinnamon 
38 6/5/11 3:30PM 
2509062 
ginger 
39 7/5/11 11:32AM 
2510888 
ginseng 
40 8/5/11 10:31PM 
2513435 
Cayenne 
41 10/5/11 8:40AM 
2517255 
black papper 
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4. Do you know any herbs that are used in Asian Herbal Medicine? (maximum 10) 
You can include culinary herbs or spices if used medicinally. 
  
Response 
Percent 
Response 
Total 
42 10/5/11 9:14AM 
2517598 
Curcuma longa 
43 10/5/11 9:23AM 
2517780 
Cardamon 
44 10/5/11 11:03AM 
2518335 
ren shen  
45 10/5/11 12:13PM 
2518781 
Cinnamon 
46 10/5/11 12:47PM 
2518943 
Ginseng 
47 10/5/11 1:05PM 
2518994 
Garlic 
48 10/5/11 1:35PM 
2519179 
similar herbal plant medicine like in UK 
49 10/5/11 6:21PM 
2520317 
Ginger 
50 11/5/11 3:13AM 
2521039 
ginseng 
51 11/5/11 11:20AM 
2522554 
gou qi zi 
52 11/5/11 11:36AM 
2522603 
oregano oil 
53 11/5/11 11:49AM 
2522752 
Tree Bark 
54 11/5/11 2:07PM 
2523340 
ginseng 
55 11/5/11 7:55PM 
2524742 
Ginger 
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4. Do you know any herbs that are used in Asian Herbal Medicine? (maximum 10) 
You can include culinary herbs or spices if used medicinally. 
  
Response 
Percent 
Response 
Total 
56 12/5/11 12:15AM 
2525202 
Cumin 
57 12/5/11 7:33PM 
2528336 
Pepper 
58 16/5/11 8:29PM 
2539486 
cinnamon 
59 22/5/11 1:01PM 
2553864 
Neem 
60 22/5/11 5:00PM 
2554098 
Cinnamon 
61 24/5/11 5:21PM 
2561511 
dry ginger 
62 1/6/11 11:35PM 
2583888 
xi xin 
63 8/6/11 9:39AM 
2600381 
Maitake / Shitake / Reishi 
64 9/6/11 9:00PM 
2506564 
Basil 
65 15/6/11 6:31PM 
2622163 
Parsley 
66 15/6/11 7:00PM 
2621959 
Corriander 
67 15/6/11 7:16PM 
2622252 
ylang ylang 
68 15/6/11 9:20PM 
2622871 
echinacea 
69 16/6/11 1:33AM 
2623681 
Peony 
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4. Do you know any herbs that are used in Asian Herbal Medicine? (maximum 10) 
You can include culinary herbs or spices if used medicinally. 
  
Response 
Percent 
Response 
Total 
70 16/6/11 2:28PM 
2625606 
Ginger 
71 16/6/11 2:35PM 
2625659 
Ginseng 
72 16/6/11 4:19PM 
2626167 
紫朴湯 
73 16/6/11 10:39PM 
2627151 
Astragulus 
74 16/6/11 10:40PM 
2627166 
Ginseng 
75 17/6/11 7:04AM 
2627504 
Salviae miltiorrhizae 
76 17/6/11 10:30AM 
2628019 
chilli 
77 17/6/11 5:43PM 
2630326 
astragalus mebranaceous 
78 18/6/11 12:40AM 
2631337 
bai zhu 
79 18/6/11 5:35AM 
2631518 
Ban Xia 
80 18/6/11 1:12PM 
2631956 
Bai shao 
81 19/6/11 12:53AM 
2632965 
大黄 
82 20/6/11 8:17PM 
2636831 
Huang Qi 
83 21/6/11 12:45PM 
2638835 
dang gui  
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4. Do you know any herbs that are used in Asian Herbal Medicine? (maximum 10) 
You can include culinary herbs or spices if used medicinally. 
  
Response 
Percent 
Response 
Total 
84 21/6/11 4:23PM 
2639698 
Turmeric 
85 22/6/11 1:09PM 
2642313 
turmeric 
86 23/6/11 10:42AM 
2645106 
Ashwagandha 
87 27/6/11 1:16AM 
2654562 
Ginger 
88 30/6/11 6:28PM 
2667722 
Codonopsis Root (dang shen) 
89 14/9/11 3:27PM 
2888486 
Bilboa 
90 3/10/11 8:55PM 
2962581 
Rauwolfia 
91 13/2/12 3:10PM 
3386121 
He shou wu 
92 8/3/12 8:28PM 
3485789 
herbal tea 
93 8/7/12 12:31PM 
4312578 
boa zu 
94 2/8/12 9:52AM 
4410632 
Gingko 
 
4 Open-Ended Question 54.68% 76 
1 18/3/11 5:01PM 
2348112 
Ginkgo 
2 24/3/11 5:15PM 
2349888 
yi yi ren 
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4. Do you know any herbs that are used in Asian Herbal Medicine? (maximum 10) 
You can include culinary herbs or spices if used medicinally. 
  
Response 
Percent 
Response 
Total 
3 31/3/11 10:42AM 
2394452 
reishi 
4 31/3/11 11:10AM 
2394989 
ashwagandha 
5 31/3/11 11:49AM 
2395066 
guduchi 
6 1/4/11 10:29PM 
2404783 
Ginseng 
7 16/4/11 1:21PM 
2452394 
Garlic 
8 23/4/11 1:51AM 
2471658 
Mas Cotek (Ficus deltoidea)  
9 24/4/11 8:31AM 
2473499 
Tulsi/Holy basil 
10 27/4/11 10:51PM 
2484453 
Licorice 
11 4/5/11 3:55PM 
2502314 
mengkudu (malay word) 
12 4/5/11 4:04PM 
2502333 
cinnamon (for intestinal bloating) 
13 4/5/11 4:10PM 
2502354 
Chuan xiong 
14 4/5/11 4:14PM 
2502331 
andrographis 
15 4/5/11 4:14PM 
2502336 
Momordica Charantia 
16 4/5/11 4:14PM 
2502370 
Shallaki (boswellia serrata) - joint pain 
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4. Do you know any herbs that are used in Asian Herbal Medicine? (maximum 10) 
You can include culinary herbs or spices if used medicinally. 
  
Response 
Percent 
Response 
Total 
17 4/5/11 4:53PM 
2502579 
chamomile 
18 4/5/11 6:39PM 
2502950 
lemon grass 
19 4/5/11 8:34PM 
2503226 
(Green) Tea 
20 4/5/11 8:50PM 
2503265 
ginseng  
21 4/5/11 10:33PM 
2503460 
Castor 
22 4/5/11 10:51PM 
2503470 
Siraitia grosvenorii 
23 4/5/11 11:08PM 
2503517 
St John's Wort 
24 5/5/11 8:54AM 
2504146 
Goji berries 
25 5/5/11 2:59PM 
2505767 
Anisum stellatum 
26 5/5/11 5:41PM 
2506349 
kefir 
27 5/5/11 10:39PM 
2507046 
Senna 
28 5/5/11 10:56PM 
2506934 
ginger 
29 5/5/11 11:02PM 
2507080 
cinammon 
30 6/5/11 1:44AM 
2507253 
gogi berry 
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4. Do you know any herbs that are used in Asian Herbal Medicine? (maximum 10) 
You can include culinary herbs or spices if used medicinally. 
  
Response 
Percent 
Response 
Total 
31 6/5/11 3:30PM 
2509062 
cayenne 
32 7/5/11 11:32AM 
2510888 
cinamon 
33 10/5/11 8:40AM 
2517255 
green tea 
34 10/5/11 9:14AM 
2517598 
Centella asiatica 
35 10/5/11 9:23AM 
2517780 
Aloe Vera 
36 10/5/11 11:03AM 
2518335 
bai zhu 
37 10/5/11 12:13PM 
2518781 
Anise 
38 10/5/11 12:47PM 
2518943 
Artemisia Annua (sweet wormwood) 
39 10/5/11 1:05PM 
2518994 
Neem 
40 10/5/11 1:35PM 
2519179 
rhino horn 
41 10/5/11 6:21PM 
2520317 
Goji Berries 
42 11/5/11 11:20AM 
2522554 
cinnamon  
43 11/5/11 11:36AM 
2522603 
slippery elm 
44 11/5/11 11:49AM 
2522752 
Cinnamon 
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4. Do you know any herbs that are used in Asian Herbal Medicine? (maximum 10) 
You can include culinary herbs or spices if used medicinally. 
  
Response 
Percent 
Response 
Total 
45 11/5/11 2:07PM 
2523340 
green tea 
46 12/5/11 12:15AM 
2525202 
Ginger 
47 16/5/11 8:29PM 
2539486 
ginger 
48 22/5/11 1:01PM 
2553864 
Stri rasayan 
49 1/6/11 11:35PM 
2583888 
Bo He 
50 8/6/11 9:39AM 
2600381 
astragalus 
51 9/6/11 9:00PM 
2506564 
Cinnamon 
52 15/6/11 6:31PM 
2622163 
Touyaku(weeds) 
53 15/6/11 7:00PM 
2621959 
All Spice 
54 15/6/11 7:16PM 
2622252 
type of funghi 
55 16/6/11 1:33AM 
2623681 
Liquorice 
56 16/6/11 2:28PM 
2625606 
Ginseng 
57 16/6/11 10:39PM 
2627151 
Rehmannia 
58 16/6/11 10:40PM 
2627166 
Codonopsis pilosula 
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4. Do you know any herbs that are used in Asian Herbal Medicine? (maximum 10) 
You can include culinary herbs or spices if used medicinally. 
  
Response 
Percent 
Response 
Total 
59 17/6/11 7:04AM 
2627504 
Sairei-to 
60 17/6/11 10:30AM 
2628019 
liquorice 
61 17/6/11 5:43PM 
2630326 
curcuma 
62 18/6/11 12:40AM 
2631337 
chuan xiong 
63 18/6/11 5:35AM 
2631518 
Bai He 
64 18/6/11 1:12PM 
2631956 
Huang qi 
65 19/6/11 12:53AM 
2632965 
甘草 
66 20/6/11 8:17PM 
2636831 
San Qi 
67 21/6/11 12:45PM 
2638835 
bai shao  
68 22/6/11 1:09PM 
2642313 
ginger 
69 23/6/11 10:42AM 
2645106 
Pepper 
70 27/6/11 1:16AM 
2654562 
Japanese Plums 
71 30/6/11 6:28PM 
2667722 
Yu Zhu 
72 3/10/11 8:55PM 
2962581 
Pterocarpus  
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4. Do you know any herbs that are used in Asian Herbal Medicine? (maximum 10) 
You can include culinary herbs or spices if used medicinally. 
  
Response 
Percent 
Response 
Total 
73 13/2/12 3:10PM 
3386121 
Chai hu 
74 8/3/12 8:28PM 
3485789 
grasses 
75 8/7/12 12:31PM 
4312578 
kudzu 
76 2/8/12 9:52AM 
4410632 
Artemisin 
 
5 Open-Ended Question 50.36% 70 
1 18/3/11 5:01PM 
2348112 
Turpentine Oil 
2 24/3/11 5:15PM 
2349888 
corydalis 
3 31/3/11 10:42AM 
2394452 
ginseng 
4 31/3/11 11:10AM 
2394989 
coptis 
5 31/3/11 11:49AM 
2395066 
neem 
6 1/4/11 10:29PM 
2404783 
Dang Gui 
7 16/4/11 1:21PM 
2452394 
Cardamom 
8 23/4/11 1:51AM 
2471658 
Kacip Fatima (Labisa pumila) 
9 24/4/11 8:31AM 
2473499 
Black cumin 
295 
 
4. Do you know any herbs that are used in Asian Herbal Medicine? (maximum 10) 
You can include culinary herbs or spices if used medicinally. 
  
Response 
Percent 
Response 
Total 
10 27/4/11 10:51PM 
2484453 
Lotus leaves 
11 4/5/11 4:04PM 
2502333 
Elderflower (drink) 
12 4/5/11 4:10PM 
2502354 
Yi yi ren 
13 4/5/11 4:14PM 
2502331 
bitter mellon 
14 4/5/11 4:14PM 
2502336 
Green tea 
15 4/5/11 4:14PM 
2502370 
Arjuna - blood circulation 
16 4/5/11 4:53PM 
2502579 
spearmint 
17 4/5/11 6:39PM 
2502950 
garlic 
18 4/5/11 8:50PM 
2503265 
camomille  
19 4/5/11 10:33PM 
2503460 
Cinnamon 
20 4/5/11 10:51PM 
2503470 
Ginseng 
21 4/5/11 11:08PM 
2503517 
Valerian  
22 5/5/11 8:54AM 
2504146 
Mumio 
23 5/5/11 2:59PM 
2505767 
Angelica sinensis 
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4. Do you know any herbs that are used in Asian Herbal Medicine? (maximum 10) 
You can include culinary herbs or spices if used medicinally. 
  
Response 
Percent 
Response 
Total 
24 5/5/11 5:41PM 
2506349 
star anise 
25 5/5/11 10:39PM 
2507046 
Amarnath 
26 5/5/11 10:56PM 
2506934 
fennel 
27 5/5/11 11:02PM 
2507080 
clove 
28 6/5/11 1:44AM 
2507253 
ginger 
29 6/5/11 3:30PM 
2509062 
goji berry 
30 10/5/11 8:40AM 
2517255 
honey 
31 10/5/11 9:14AM 
2517598 
Bacopa monniera 
32 10/5/11 9:23AM 
2517780 
Echinacea 
33 10/5/11 11:03AM 
2518335 
dang shen 
34 10/5/11 12:13PM 
2518781 
Sage 
35 10/5/11 12:47PM 
2518943 
Willow bark 
36 10/5/11 1:05PM 
2518994 
Cardamom 
37 10/5/11 1:35PM 
2519179 
artemesin 
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4. Do you know any herbs that are used in Asian Herbal Medicine? (maximum 10) 
You can include culinary herbs or spices if used medicinally. 
  
Response 
Percent 
Response 
Total 
38 10/5/11 6:21PM 
2520317 
Aloe Vera 
39 11/5/11 11:20AM 
2522554 
dang gui 
40 11/5/11 11:36AM 
2522603 
seaweeds 
41 11/5/11 11:49AM 
2522752 
Cardamom 
42 12/5/11 12:15AM 
2525202 
Cinnamon 
43 16/5/11 8:29PM 
2539486 
rhubarb 
44 22/5/11 1:01PM 
2553864 
Trikatu 
45 1/6/11 11:35PM 
2583888 
Chan tui 
46 8/6/11 9:39AM 
2600381 
Garlic 
47 9/6/11 9:00PM 
2506564 
Clove 
48 15/6/11 6:31PM 
2622163 
kuko(Leaves) 
49 15/6/11 7:00PM 
2621959 
Chinese 5 Spice 
50 15/6/11 7:16PM 
2622252 
garlic 
51 16/6/11 1:33AM 
2623681 
Rehmannia 
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4. Do you know any herbs that are used in Asian Herbal Medicine? (maximum 10) 
You can include culinary herbs or spices if used medicinally. 
  
Response 
Percent 
Response 
Total 
52 16/6/11 2:28PM 
2625606 
Garlic 
53 16/6/11 10:39PM 
2627151 
Gastrodia 
54 16/6/11 10:40PM 
2627166 
Semen zizyphi spinosae 
55 17/6/11 7:04AM 
2627504 
angelica 
56 17/6/11 10:30AM 
2628019 
peony 
57 17/6/11 5:43PM 
2630326 
Mint 
58 18/6/11 12:40AM 
2631337 
bai shao 
59 18/6/11 5:35AM 
2631518 
Jin Yin Hua 
60 18/6/11 1:12PM 
2631956 
Dang shen 
61 19/6/11 12:53AM 
2632965 
生姜 
62 20/6/11 8:17PM 
2636831 
Huang Bai 
63 21/6/11 12:45PM 
2638835 
shu di  
64 22/6/11 1:09PM 
2642313 
ginseng  
65 23/6/11 10:42AM 
2645106 
Fennel seeds 
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4. Do you know any herbs that are used in Asian Herbal Medicine? (maximum 10) 
You can include culinary herbs or spices if used medicinally. 
  
Response 
Percent 
Response 
Total 
66 27/6/11 1:16AM 
2654562 
Goji Berry 
67 30/6/11 6:28PM 
2667722 
Cordyceps 
68 3/10/11 8:55PM 
2962581 
Terminalia 
69 13/2/12 3:10PM 
3386121 
Chen pi 
70 8/7/12 12:31PM 
4312578 
gogi berry 
 
6 Open-Ended Question 43.88% 61 
1 18/3/11 5:01PM 
2348112 
Cajuput Oil 
2 24/3/11 5:15PM 
2349888 
chen pi 
3 31/3/11 10:42AM 
2394452 
fo ti 
4 31/3/11 11:10AM 
2394989 
musta 
5 31/3/11 11:49AM 
2395066 
coriander seed 
6 1/4/11 10:29PM 
2404783 
Cinnamon 
7 16/4/11 1:21PM 
2452394 
Elaichi 
8 23/4/11 1:51AM 
2471658 
Ginger (Zingiber officinale) 
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4. Do you know any herbs that are used in Asian Herbal Medicine? (maximum 10) 
You can include culinary herbs or spices if used medicinally. 
  
Response 
Percent 
Response 
Total 
9 24/4/11 8:31AM 
2473499 
Garlic 
10 27/4/11 10:51PM 
2484453 
Astragali root 
11 4/5/11 4:04PM 
2502333 
Jasmine flowers (tea) 
12 4/5/11 4:10PM 
2502354 
Ren shen 
13 4/5/11 4:14PM 
2502331 
planotol 
14 4/5/11 4:14PM 
2502336 
Neem 
15 4/5/11 4:14PM 
2502370 
Shigru (drumstick) - joint care 
16 4/5/11 4:53PM 
2502579 
valerian 
17 4/5/11 6:39PM 
2502950 
ginger 
18 4/5/11 8:50PM 
2503265 
green tea 
19 4/5/11 10:33PM 
2503460 
Cardamum 
20 4/5/11 10:51PM 
2503470 
Cordyceps 
21 5/5/11 2:59PM 
2505767 
Poria cocos, Wolf. 
22 5/5/11 5:41PM 
2506349 
chili 
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4. Do you know any herbs that are used in Asian Herbal Medicine? (maximum 10) 
You can include culinary herbs or spices if used medicinally. 
  
Response 
Percent 
Response 
Total 
23 5/5/11 10:39PM 
2507046 
Multani Mitti 
24 5/5/11 10:56PM 
2506934 
mango 
25 5/5/11 11:02PM 
2507080 
honey 
26 6/5/11 1:44AM 
2507253 
ginko biloba 
27 6/5/11 3:30PM 
2509062 
turmeric 
28 10/5/11 8:40AM 
2517255 
nigella seeds 
29 10/5/11 9:14AM 
2517598 
Trigonella foenum-graecum 
30 10/5/11 9:23AM 
2517780 
Gingko 
31 10/5/11 11:03AM 
2518335 
huang qi 
32 10/5/11 12:13PM 
2518781 
Thyme 
33 10/5/11 1:05PM 
2518994 
Bay leaves 
34 11/5/11 11:20AM 
2522554 
huang qi 
35 12/5/11 12:15AM 
2525202 
Cardamom 
36 22/5/11 1:01PM 
2553864 
Brahami 
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4. Do you know any herbs that are used in Asian Herbal Medicine? (maximum 10) 
You can include culinary herbs or spices if used medicinally. 
  
Response 
Percent 
Response 
Total 
37 1/6/11 11:35PM 
2583888 
Dan Zhu Ye 
38 8/6/11 9:39AM 
2600381 
horehound 
39 9/6/11 9:00PM 
2506564 
Nutmeg 
40 15/6/11 7:00PM 
2621959 
garlic 
41 15/6/11 7:16PM 
2622252 
cumin 
42 16/6/11 1:33AM 
2623681 
Asrtafalus 
43 16/6/11 2:28PM 
2625606 
Tumeric 
44 16/6/11 10:39PM 
2627151 
Agastache 
45 16/6/11 10:40PM 
2627166 
White paeony root 
46 17/6/11 7:04AM 
2627504 
Rheum palmatum L 
47 17/6/11 10:30AM 
2628019 
reshi 
48 17/6/11 5:43PM 
2630326 
Ginger 
49 18/6/11 12:40AM 
2631337 
dang shen 
50 18/6/11 5:35AM 
2631518 
Yuan Wu 
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4. Do you know any herbs that are used in Asian Herbal Medicine? (maximum 10) 
You can include culinary herbs or spices if used medicinally. 
  
Response 
Percent 
Response 
Total 
51 18/6/11 1:12PM 
2631956 
Dan shen 
52 19/6/11 12:53AM 
2632965 
薄荷 
53 20/6/11 8:17PM 
2636831 
Bai Zhu 
54 21/6/11 12:45PM 
2638835 
chuan xiong  
55 22/6/11 1:09PM 
2642313 
ginkgo biloba 
56 23/6/11 10:42AM 
2645106 
Aloe vera juice 
57 27/6/11 1:16AM 
2654562 
Acai Berry 
58 30/6/11 6:28PM 
2667722 
American Ginseng (Hua Qi Shen) 
59 3/10/11 8:55PM 
2962581 
Cardamon 
60 13/2/12 3:10PM 
3386121 
Yuan zhi 
61 8/7/12 12:31PM 
4312578 
tumeric 
 
7 Open-Ended Question 38.85% 54 
1 24/3/11 5:15PM 
2349888 
ginseng 
2 31/3/11 10:42AM 
2394452 
cardamom 
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4. Do you know any herbs that are used in Asian Herbal Medicine? (maximum 10) 
You can include culinary herbs or spices if used medicinally. 
  
Response 
Percent 
Response 
Total 
3 31/3/11 11:10AM 
2394989 
amalaki 
4 31/3/11 11:49AM 
2395066 
ajwain 
5 1/4/11 10:29PM 
2404783 
Peony 
6 16/4/11 1:21PM 
2452394 
Nutmeg 
7 23/4/11 1:51AM 
2471658 
Daun Sirih (Piper betle) 
8 24/4/11 8:31AM 
2473499 
Arjun 
9 27/4/11 10:51PM 
2484453 
Angelica root 
10 4/5/11 4:10PM 
2502354 
Bai zhu 
11 4/5/11 4:14PM 
2502331 
pepper 
12 4/5/11 4:14PM 
2502370 
Shatavari (Asparagus) - women's health 
13 4/5/11 4:53PM 
2502579 
peony 
14 4/5/11 6:39PM 
2502950 
freshly ground black pepper 
15 4/5/11 10:33PM 
2503460 
Jira 
16 4/5/11 10:51PM 
2503470 
Chinese Angelica Root 
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4. Do you know any herbs that are used in Asian Herbal Medicine? (maximum 10) 
You can include culinary herbs or spices if used medicinally. 
  
Response 
Percent 
Response 
Total 
17 5/5/11 2:59PM 
2505767 
Prunella vulgaris, L. 
18 5/5/11 5:41PM 
2506349 
aloe 
19 5/5/11 10:39PM 
2507046 
Babool 
20 5/5/11 10:56PM 
2506934 
jasmine 
21 5/5/11 11:02PM 
2507080 
pepper 
22 6/5/11 1:44AM 
2507253 
cannabis 
23 6/5/11 3:30PM 
2509062 
camomile 
24 10/5/11 8:40AM 
2517255 
there is more but i dont know the name in english! 
25 10/5/11 9:14AM 
2517598 
Guggal 
26 10/5/11 11:03AM 
2518335 
huang lian  
27 10/5/11 12:13PM 
2518781 
Ginseng 
28 10/5/11 1:05PM 
2518994 
Fenugreek 
29 11/5/11 11:20AM 
2522554 
green tea 
30 12/5/11 12:15AM 
2525202 
Cloves 
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4. Do you know any herbs that are used in Asian Herbal Medicine? (maximum 10) 
You can include culinary herbs or spices if used medicinally. 
  
Response 
Percent 
Response 
Total 
31 22/5/11 1:01PM 
2553864 
Jawain 
32 1/6/11 11:35PM 
2583888 
Mu Dan Pi 
33 8/6/11 9:39AM 
2600381 
feverfew 
34 9/6/11 9:00PM 
2506564 
Peppermint 
35 15/6/11 7:00PM 
2621959 
saffron 
36 15/6/11 7:16PM 
2622252 
green tea 
37 16/6/11 1:33AM 
2623681 
Angelica 
38 16/6/11 2:28PM 
2625606 
Cinnamon 
39 16/6/11 10:39PM 
2627151 
Licorice 
40 17/6/11 7:04AM 
2627504 
Tripterygium wilfordii 
41 17/6/11 10:30AM 
2628019 
wolfberries 
42 17/6/11 5:43PM 
2630326 
Atractolodes 
43 18/6/11 12:40AM 
2631337 
wu jia pi 
44 18/6/11 5:35AM 
2631518 
Wu Wei Zi 
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4. Do you know any herbs that are used in Asian Herbal Medicine? (maximum 10) 
You can include culinary herbs or spices if used medicinally. 
  
Response 
Percent 
Response 
Total 
45 18/6/11 1:12PM 
2631956 
Ren shen 
46 19/6/11 12:53AM 
2632965 
牡丹 
47 20/6/11 8:17PM 
2636831 
Zhi Zi 
48 21/6/11 12:45PM 
2638835 
xi yang shen 
49 22/6/11 1:09PM 
2642313 
gotu kola 
50 23/6/11 10:42AM 
2645106 
Neem 
51 27/6/11 1:16AM 
2654562 
Shiitake 
52 30/6/11 6:28PM 
2667722 
Cinnamon 
53 13/2/12 3:10PM 
3386121 
Suan zao ren 
54 8/7/12 12:31PM 
4312578 
fennel 
 
8 Open-Ended Question 33.09% 46 
1 24/3/11 5:15PM 
2349888 
jimneema 
2 31/3/11 10:42AM 
2394452 
cordyceps 
3 31/3/11 11:10AM 
2394989 
schizandra 
308 
 
4. Do you know any herbs that are used in Asian Herbal Medicine? (maximum 10) 
You can include culinary herbs or spices if used medicinally. 
  
Response 
Percent 
Response 
Total 
4 31/3/11 11:49AM 
2395066 
hing 
5 1/4/11 10:29PM 
2404783 
Hoelen 
6 16/4/11 1:21PM 
2452394 
Sandalwood 
7 23/4/11 1:51AM 
2471658 
Kunyit (Curcuma longa) 
8 24/4/11 8:31AM 
2473499 
Aloe vera 
9 27/4/11 10:51PM 
2484453 
Wolfberry 
10 4/5/11 4:10PM 
2502354 
Fu ling 
11 4/5/11 4:14PM 
2502331 
lemon grass 
12 4/5/11 6:39PM 
2502950 
orange peel 
13 4/5/11 10:33PM 
2503460 
Tumeric 
14 4/5/11 10:51PM 
2503470 
Astragalus 
15 5/5/11 2:59PM 
2505767 
Saussurea involucrate 
16 5/5/11 5:41PM 
2506349 
sandalwood 
17 5/5/11 10:39PM 
2507046 
Vasaka 
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4. Do you know any herbs that are used in Asian Herbal Medicine? (maximum 10) 
You can include culinary herbs or spices if used medicinally. 
  
Response 
Percent 
Response 
Total 
18 5/5/11 10:56PM 
2506934 
tea tree 
19 5/5/11 11:02PM 
2507080 
basil 
20 6/5/11 3:30PM 
2509062 
valarian 
21 10/5/11 9:14AM 
2517598 
Cinnamon 
22 10/5/11 11:03AM 
2518335 
shu di huang 
23 10/5/11 12:13PM 
2518781 
Ginko 
24 10/5/11 1:05PM 
2518994 
Lemongrass 
25 11/5/11 11:20AM 
2522554 
shan yao 
26 12/5/11 12:15AM 
2525202 
Black Pepper 
27 22/5/11 1:01PM 
2553864 
Corriander 
28 1/6/11 11:35PM 
2583888 
Huang Qi 
29 8/6/11 9:39AM 
2600381 
bee propolis 
30 9/6/11 9:00PM 
2506564 
Thyme 
31 16/6/11 1:33AM 
2623681 
Ligusticum 
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4. Do you know any herbs that are used in Asian Herbal Medicine? (maximum 10) 
You can include culinary herbs or spices if used medicinally. 
  
Response 
Percent 
Response 
Total 
32 16/6/11 10:39PM 
2627151 
Dioscorea 
33 17/6/11 10:30AM 
2628019 
rehmannia 
34 17/6/11 5:43PM 
2630326 
cinnamon 
35 18/6/11 12:40AM 
2631337 
he shou wu 
36 18/6/11 5:35AM 
2631518 
Suan Zao Ren 
37 18/6/11 1:12PM 
2631956 
Tai Zi shen 
38 19/6/11 12:53AM 
2632965 
丹圣 
39 20/6/11 8:17PM 
2636831 
Jing Jie 
40 21/6/11 12:45PM 
2638835 
chi shao 
41 22/6/11 1:09PM 
2642313 
cinnamon 
42 23/6/11 10:42AM 
2645106 
Andrographis 
43 27/6/11 1:16AM 
2654562 
Burdock Root 
44 30/6/11 6:28PM 
2667722 
Cumin 
45 13/2/12 3:10PM 
3386121 
Gan cao 
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4. Do you know any herbs that are used in Asian Herbal Medicine? (maximum 10) 
You can include culinary herbs or spices if used medicinally. 
  
Response 
Percent 
Response 
Total 
46 8/7/12 12:31PM 
4312578 
shatavari 
 
9 Open-Ended Question 27.34% 38 
1 24/3/11 5:15PM 
2349888 
neem 
2 31/3/11 10:42AM 
2394452 
astragulas 
3 31/3/11 11:10AM 
2394989 
lotus 
4 31/3/11 11:49AM 
2395066 
cumin seeds 
5 1/4/11 10:29PM 
2404783 
Atractylodes 
6 16/4/11 1:21PM 
2452394 
Mace 
7 23/4/11 1:51AM 
2471658 
Cinnamon 
8 24/4/11 8:31AM 
2473499 
Cinnamon 
9 27/4/11 10:51PM 
2484453 
Horny goat weed 
10 4/5/11 4:10PM 
2502354 
Gan cao 
11 4/5/11 6:39PM 
2502950 
ginseng 
12 4/5/11 10:51PM 
2503470 
Wolfberry 
312 
 
4. Do you know any herbs that are used in Asian Herbal Medicine? (maximum 10) 
You can include culinary herbs or spices if used medicinally. 
  
Response 
Percent 
Response 
Total 
13 5/5/11 2:59PM 
2505767 
Plastrum testudinis 
14 5/5/11 5:41PM 
2506349 
lotus 
15 5/5/11 10:56PM 
2506934 
pomegranate 
16 5/5/11 11:02PM 
2507080 
mint leaves 
17 6/5/11 3:30PM 
2509062 
garlic 
18 10/5/11 9:14AM 
2517598 
Gymnema sylvestre 
19 10/5/11 11:03AM 
2518335 
dang gui 
20 10/5/11 1:05PM 
2518994 
Ginger 
21 11/5/11 11:20AM 
2522554 
shitaki mushrooms 
22 12/5/11 12:15AM 
2525202 
Bitter Gourd 
23 22/5/11 1:01PM 
2553864 
Tulsi 
24 1/6/11 11:35PM 
2583888 
Pu Gong Ying 
25 8/6/11 9:39AM 
2600381 
arnica 
26 16/6/11 1:33AM 
2623681 
Zingiber 
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4. Do you know any herbs that are used in Asian Herbal Medicine? (maximum 10) 
You can include culinary herbs or spices if used medicinally. 
  
Response 
Percent 
Response 
Total 
27 16/6/11 10:39PM 
2627151 
Fritilleria 
28 17/6/11 5:43PM 
2630326 
liquorice (glycerrhiza) 
29 18/6/11 12:40AM 
2631337 
wu ling xian 
30 18/6/11 5:35AM 
2631518 
Di Huang 
31 18/6/11 1:12PM 
2631956 
Fu ling 
32 19/6/11 12:53AM 
2632965 
丹参 
33 20/6/11 8:17PM 
2636831 
Yi Mu Cao 
34 21/6/11 12:45PM 
2638835 
bai zhu  
35 23/6/11 10:42AM 
2645106 
Holy basil 
36 30/6/11 6:28PM 
2667722 
Roselle 
37 13/2/12 3:10PM 
3386121 
Sang bai pi 
38 8/7/12 12:31PM 
4312578 
ashwaganda 
 
10 Open-Ended Question 25.90% 36 
1 24/3/11 5:15PM 
2349888 
bai hu 
314 
 
4. Do you know any herbs that are used in Asian Herbal Medicine? (maximum 10) 
You can include culinary herbs or spices if used medicinally. 
  
Response 
Percent 
Response 
Total 
2 31/3/11 10:42AM 
2394452 
Chrysanthemum 
3 31/3/11 11:10AM 
2394989 
satavari 
4 31/3/11 11:49AM 
2395066 
fennel seeds 
5 1/4/11 10:29PM 
2404783 
Gingko 
6 16/4/11 1:21PM 
2452394 
Cloves 
7 23/4/11 1:51AM 
2471658 
Bawang putih ( Allium sativum ) 
8 24/4/11 8:31AM 
2473499 
Kerala/Bitter gourd 
9 27/4/11 10:51PM 
2484453 
Chrysanthemum 
10 4/5/11 4:10PM 
2502354 
Mo yao 
11 4/5/11 6:39PM 
2502950 
clove 
12 4/5/11 10:51PM 
2503470 
Onion 
13 5/5/11 2:59PM 
2505767 
Panax Ginseng, C. A. Mey. 
14 5/5/11 5:41PM 
2506349 
turmeric 
15 5/5/11 10:56PM 
2506934 
cardamom 
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4. Do you know any herbs that are used in Asian Herbal Medicine? (maximum 10) 
You can include culinary herbs or spices if used medicinally. 
  
Response 
Percent 
Response 
Total 
16 5/5/11 11:02PM 
2507080 
fenugreek 
17 6/5/11 3:30PM 
2509062 
magosteen 
18 10/5/11 11:03AM 
2518335 
gan cao 
19 10/5/11 1:05PM 
2518994 
Aloe vera 
20 11/5/11 11:20AM 
2522554 
sour plum 
21 12/5/11 12:15AM 
2525202 
Fenugreek 
22 22/5/11 1:01PM 
2553864 
Fennel Seeds 
23 1/6/11 11:35PM 
2583888 
Ban Zhi Lian 
24 8/6/11 9:39AM 
2600381 
ginger 
25 16/6/11 1:33AM 
2623681 
Cinnamon  
26 16/6/11 10:39PM 
2627151 
Curcuma 
27 17/6/11 5:43PM 
2630326 
discorea 
28 18/6/11 12:40AM 
2631337 
mu xiang 
29 18/6/11 5:35AM 
2631518 
Dan Shen 
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4. Do you know any herbs that are used in Asian Herbal Medicine? (maximum 10) 
You can include culinary herbs or spices if used medicinally. 
  
Response 
Percent 
Response 
Total 
30 18/6/11 1:12PM 
2631956 
Fu shen 
31 19/6/11 12:53AM 
2632965 
茯苓 
32 20/6/11 8:17PM 
2636831 
Shu Di Huang 
33 21/6/11 12:45PM 
2638835 
gan cao  
34 30/6/11 6:28PM 
2667722 
Huang Qi  
35 13/2/12 3:10PM 
3386121 
Di gu pi 
36 8/7/12 12:31PM 
4312578 
ginseng 
 
  
answered 139 
skipped 96 
 
5. The next question relates specifically to India. Do you ever use Indian medicinal 
herbs or Indian herbal medicinal products? Include culinary herbs or spices if used 
medicinally. 
  
Response 
Percent 
Response 
Total 
1 Never   
 
52.65% 119 
2 Rarely   
 
11.95% 27 
3 Within the last 5 years   
 
3.10% 7 
4 Within the last Year   
 
7.96% 18 
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5. The next question relates specifically to India. Do you ever use Indian medicinal 
herbs or Indian herbal medicinal products? Include culinary herbs or spices if used 
medicinally. 
  
Response 
Percent 
Response 
Total 
5 Monthly   
 
3.98% 9 
6 Weekly   
 
4.42% 10 
7 Daily   
 
7.08% 16 
8 Don't know   
 
8.85% 20 
  
answered 226 
skipped 9 
 
6. Would you consider using Indian medicinal herbs or Indian medicinal herbal 
products in the future? 
  
Response 
Percent 
Response 
Total 
1 Yes   
 
48.89% 110 
2 No   
 
15.11% 34 
3 Not sure   
 
36.00% 81 
  
answered 225 
skipped 10 
 
7. What do you consider to be the most important Indian medicinal herbs? 
(maximum 10) You may include culinary herbs or spices if used medicinally. 
  
Response 
Percent 
Response 
Total 
1 Open-Ended Question 98.88% 88 
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7. What do you consider to be the most important Indian medicinal herbs? 
(maximum 10) You may include culinary herbs or spices if used medicinally. 
  
Response 
Percent 
Response 
Total 
1 18/3/11 5:01PM 
2348112 
Ginger 
2 24/3/11 8:51AM 
2369156 
triphala 
3 24/3/11 5:15PM 
2349888 
jimneema 
4 31/3/11 10:30AM 
2394414 
turmeric 
5 31/3/11 10:42AM 
2394452 
brahmi 
6 31/3/11 11:10AM 
2394989 
brahmi 
7 31/3/11 11:49AM 
2395066 
amla 
8 31/3/11 7:15PM 
2398630 
coriander 
9 1/4/11 10:29PM 
2404783 
Cumin 
10 16/4/11 1:21PM 
2452394 
Turmeric 
11 23/4/11 1:51AM 
2471658 
Kunyit (Curcuma longa) 
12 24/4/11 8:31AM 
2473499 
Neem 
13 27/4/11 10:51PM 
2484453 
n/a 
14 4/5/11 3:55PM 
2502314 
dont know 
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7. What do you consider to be the most important Indian medicinal herbs? 
(maximum 10) You may include culinary herbs or spices if used medicinally. 
  
Response 
Percent 
Response 
Total 
15 4/5/11 4:04PM 
2502333 
cinnamon 
16 4/5/11 4:10PM 
2502354 
Asafoetida 
17 4/5/11 4:11PM 
2502415 
Tumeric 
18 4/5/11 4:14PM 
2502336 
Momordica charantia 
19 4/5/11 5:09PM 
2502661 
tulsi 
20 4/5/11 6:39PM 
2502950 
holy basil 
21 4/5/11 7:01PM 
2503057 
garlic 
22 4/5/11 7:04PM 
2503059 
tumeric 
23 4/5/11 8:50PM 
2503265 
safron  
24 4/5/11 10:33PM 
2503460 
Tumeric 
25 4/5/11 11:08PM 
2503517 
kashayam 
26 5/5/11 4:19AM 
2503755 
I do not Know any 
27 5/5/11 7:25AM 
2503929 
curcumin 
28 5/5/11 12:47PM 
2505164 
N/A 
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7. What do you consider to be the most important Indian medicinal herbs? 
(maximum 10) You may include culinary herbs or spices if used medicinally. 
  
Response 
Percent 
Response 
Total 
29 5/5/11 3:22PM 
2505862 
fennel 
30 5/5/11 5:41PM 
2506349 
Ginger 
31 5/5/11 5:47PM 
2502652 
Don't know any 
32 5/5/11 10:39PM 
2507046 
Neem 
33 5/5/11 10:56PM 
2506934 
Don't know 
34 6/5/11 1:44AM 
2507253 
cannabis 
35 6/5/11 3:30PM 
2509062 
tumeric 
36 7/5/11 1:02PM 
2510981 
sanjeevni herb 
37 7/5/11 6:49PM 
2511502 
black cumin seeds 
38 8/5/11 10:31PM 
2513435 
Cayenne 
39 10/5/11 8:39AM 
2517226 
fennel seeds 
40 10/5/11 8:52AM 
2517332 
Turmeric 
41 10/5/11 9:14AM 
2517598 
Curcuma longa 
42 10/5/11 9:23AM 
2517780 
Cardamon 
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7. What do you consider to be the most important Indian medicinal herbs? 
(maximum 10) You may include culinary herbs or spices if used medicinally. 
  
Response 
Percent 
Response 
Total 
43 10/5/11 10:05AM 
2518039 
tumeric 
44 10/5/11 12:13PM 
2518781 
Sage 
45 10/5/11 1:05PM 
2518994 
Turmeric 
46 10/5/11 1:35PM 
2519179 
nil 
47 10/5/11 6:21PM 
2520317 
Turmeric 
48 10/5/11 6:47PM 
2520378 
Garlic 
49 11/5/11 3:13AM 
2521039 
tumeric 
50 11/5/11 10:13AM 
2521895 
Turmeric (Curcuma longa) 
51 11/5/11 11:20AM 
2522554 
curry 
52 11/5/11 11:36AM 
2522603 
neem 
53 11/5/11 12:21PM 
2522941 
no idea 
54 11/5/11 12:37PM 
2522984 
curcumin/turmeric 
55 11/5/11 1:36PM 
2523220 
Turmeric 
56 11/5/11 2:07PM 
2523340 
neem 
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7. What do you consider to be the most important Indian medicinal herbs? 
(maximum 10) You may include culinary herbs or spices if used medicinally. 
  
Response 
Percent 
Response 
Total 
57 11/5/11 4:05PM 
2523761 
turmeric 
58 11/5/11 6:52PM 
2524547 
Turmeric 
59 11/5/11 7:55PM 
2524742 
Aloe Vera 
60 12/5/11 12:15AM 
2525202 
Tumeric 
61 12/5/11 4:14PM 
2527614 
turmeric 
62 13/5/11 5:37PM 
2532239 
cumin 
63 22/5/11 12:48PM 
2553868 
not known 
64 22/5/11 1:01PM 
2553864 
Haldi (Tumeric) 
65 22/5/11 5:00PM 
2554098 
Coriander seed 
66 1/6/11 11:35PM 
2583888 
cardamon 
67 8/6/11 9:39AM 
2600381 
cilantro 
68 9/6/11 9:00PM 
2506564 
Aloe Vera  
69 15/6/11 7:00PM 
2621959 
garlic 
70 15/6/11 7:16PM 
2622252 
Green tea 
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7. What do you consider to be the most important Indian medicinal herbs? 
(maximum 10) You may include culinary herbs or spices if used medicinally. 
  
Response 
Percent 
Response 
Total 
71 15/6/11 9:20PM 
2622871 
Aloe vera 
72 16/6/11 1:33AM 
2623681 
Turmeric 
73 16/6/11 2:28PM 
2625606 
Ginger 
74 16/6/11 2:35PM 
2625659 
Tumeric 
75 16/6/11 3:21PM 
2625917 
N/A 
76 16/6/11 10:39PM 
2627151 
Cardamom 
77 17/6/11 10:30AM 
2628019 
ashwagandha 
78 17/6/11 5:43PM 
2630326 
Turmuric 
79 18/6/11 1:12PM 
2631956 
Tumeric 
80 20/6/11 8:17PM 
2636831 
Tumeric 
81 21/6/11 12:45PM 
2638835 
withania 
82 22/6/11 1:09PM 
2642313 
asgwagandha 
83 23/6/11 10:42AM 
2645106 
Neem 
84 30/6/11 6:28PM 
2667722 
Cumin 
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7. What do you consider to be the most important Indian medicinal herbs? 
(maximum 10) You may include culinary herbs or spices if used medicinally. 
  
Response 
Percent 
Response 
Total 
85 14/9/11 3:27PM 
2888486 
Ginseng 
86 3/10/11 8:55PM 
2962581 
Cinnamon 
87 8/3/12 8:28PM 
3485789 
tea leaves 
88 8/7/12 12:31PM 
4312578 
tumeric 
 
2 Open-Ended Question 62.92% 56 
1 18/3/11 5:01PM 
2348112 
Turmeric 
2 24/3/11 8:51AM 
2369156 
ashwaganda 
3 24/3/11 5:15PM 
2349888 
garlic 
4 31/3/11 10:42AM 
2394452 
shatavari 
5 31/3/11 11:49AM 
2395066 
turmeric 
6 31/3/11 7:15PM 
2398630 
ashwaganda 
7 1/4/11 10:29PM 
2404783 
Night Jasmine 
8 16/4/11 1:21PM 
2452394 
Amla 
9 23/4/11 1:51AM 
2471658 
Cinnamon 
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7. What do you consider to be the most important Indian medicinal herbs? 
(maximum 10) You may include culinary herbs or spices if used medicinally. 
  
Response 
Percent 
Response 
Total 
10 24/4/11 8:31AM 
2473499 
Black cumin seeds 
11 4/5/11 4:04PM 
2502333 
Anise  
12 4/5/11 4:10PM 
2502354 
Garlic 
13 4/5/11 4:14PM 
2502336 
Neem (Azadirachta indica) 
14 4/5/11 6:39PM 
2502950 
garlic 
15 4/5/11 7:01PM 
2503057 
ginger 
16 4/5/11 8:50PM 
2503265 
cammomille  
17 4/5/11 10:33PM 
2503460 
Garlic 
18 4/5/11 11:08PM 
2503517 
aloe vera 
19 5/5/11 5:41PM 
2506349 
Ginseng 
20 5/5/11 10:39PM 
2507046 
Tulsi 
21 6/5/11 3:30PM 
2509062 
cumin 
22 7/5/11 11:32AM 
2510888 
don't know 
23 7/5/11 1:02PM 
2510981 
haldi - tumeric 
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7. What do you consider to be the most important Indian medicinal herbs? 
(maximum 10) You may include culinary herbs or spices if used medicinally. 
  
Response 
Percent 
Response 
Total 
24 7/5/11 6:49PM 
2511502 
turmeric 
25 8/5/11 10:31PM 
2513435 
Curcuma 
26 10/5/11 8:39AM 
2517226 
Ginger 
27 10/5/11 9:14AM 
2517598 
Withania somnifera 
28 10/5/11 9:23AM 
2517780 
Ginger 
29 10/5/11 1:05PM 
2518994 
Garlic 
30 11/5/11 3:13AM 
2521039 
fenugreek 
31 11/5/11 10:13AM 
2521895 
Bacopa monnieri 
32 11/5/11 11:36AM 
2522603 
tumeric 
33 11/5/11 2:07PM 
2523340 
turmeric 
34 11/5/11 4:05PM 
2523761 
neem 
35 11/5/11 6:52PM 
2524547 
Cloves 
36 12/5/11 12:15AM 
2525202 
Cinnamon 
37 22/5/11 1:01PM 
2553864 
Neem 
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7. What do you consider to be the most important Indian medicinal herbs? 
(maximum 10) You may include culinary herbs or spices if used medicinally. 
  
Response 
Percent 
Response 
Total 
38 22/5/11 5:00PM 
2554098 
Cardamom pods 
39 1/6/11 11:35PM 
2583888 
cinamon 
40 8/6/11 9:39AM 
2600381 
white tea 
41 9/6/11 9:00PM 
2506564 
Datura Stramonium  
42 15/6/11 7:00PM 
2621959 
parsley 
43 15/6/11 7:16PM 
2622252 
garlic 
44 16/6/11 1:33AM 
2623681 
Garlic 
45 16/6/11 2:28PM 
2625606 
Neem 
46 16/6/11 10:39PM 
2627151 
Guggal 
47 17/6/11 10:30AM 
2628019 
turmeric 
48 17/6/11 5:43PM 
2630326 
ginger 
49 18/6/11 1:12PM 
2631956 
Coriander 
50 21/6/11 12:45PM 
2638835 
gotu cola 
51 22/6/11 1:09PM 
2642313 
ginger 
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7. What do you consider to be the most important Indian medicinal herbs? 
(maximum 10) You may include culinary herbs or spices if used medicinally. 
  
Response 
Percent 
Response 
Total 
52 23/6/11 10:42AM 
2645106 
Turmeric 
53 30/6/11 6:28PM 
2667722 
Pepper 
54 14/9/11 3:27PM 
2888486 
Corriander 
55 8/3/12 8:28PM 
3485789 
herbal tea 
56 8/7/12 12:31PM 
4312578 
aswaganda 
 
3 Open-Ended Question 50.56% 45 
1 18/3/11 5:01PM 
2348112 
Liquorice  
2 24/3/11 8:51AM 
2369156 
turmeric 
3 24/3/11 5:15PM 
2349888 
turmeric 
4 31/3/11 10:42AM 
2394452 
ashwaganda 
5 31/3/11 11:49AM 
2395066 
neem 
6 31/3/11 7:15PM 
2398630 
shatavari 
7 1/4/11 10:29PM 
2404783 
Garlic 
8 16/4/11 1:21PM 
2452394 
Neem 
329 
 
7. What do you consider to be the most important Indian medicinal herbs? 
(maximum 10) You may include culinary herbs or spices if used medicinally. 
  
Response 
Percent 
Response 
Total 
9 23/4/11 1:51AM 
2471658 
Aloe vera 
10 24/4/11 8:31AM 
2473499 
Tulsi/ Holy basil 
11 4/5/11 4:04PM 
2502333 
Peppermint  
12 4/5/11 4:10PM 
2502354 
Ginger 
13 4/5/11 4:14PM 
2502336 
Ginger 
14 4/5/11 6:39PM 
2502950 
tumeric (fresh one) 
15 4/5/11 10:33PM 
2503460 
Ginger 
16 4/5/11 11:08PM 
2503517 
ginger 
17 5/5/11 5:41PM 
2506349 
Turmeric 
18 5/5/11 10:39PM 
2507046 
Ashwagandha 
19 7/5/11 6:49PM 
2511502 
garlic 
20 10/5/11 9:14AM 
2517598 
Andrographis paniculata 
21 10/5/11 9:23AM 
2517780 
Aloe Vera 
22 10/5/11 1:05PM 
2518994 
Ginger 
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7. What do you consider to be the most important Indian medicinal herbs? 
(maximum 10) You may include culinary herbs or spices if used medicinally. 
  
Response 
Percent 
Response 
Total 
23 11/5/11 3:13AM 
2521039 
nim leaves 
24 11/5/11 10:13AM 
2521895 
Azadiracta indica (Neem) 
25 11/5/11 6:52PM 
2524547 
Fenugreek 
26 12/5/11 12:15AM 
2525202 
Ginger 
27 22/5/11 1:01PM 
2553864 
Tulsi  
28 22/5/11 5:00PM 
2554098 
Root ginger 
29 1/6/11 11:35PM 
2583888 
ginger 
30 8/6/11 9:39AM 
2600381 
fenugreek 
31 9/6/11 9:00PM 
2506564 
Hyocyamus Niger  
32 15/6/11 7:00PM 
2621959 
corriander 
33 15/6/11 7:16PM 
2622252 
funghi 
34 16/6/11 1:33AM 
2623681 
Ginger 
35 16/6/11 2:28PM 
2625606 
Garlic 
36 16/6/11 10:39PM 
2627151 
Neem 
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7. What do you consider to be the most important Indian medicinal herbs? 
(maximum 10) You may include culinary herbs or spices if used medicinally. 
  
Response 
Percent 
Response 
Total 
37 17/6/11 10:30AM 
2628019 
ginger 
38 17/6/11 5:43PM 
2630326 
garlic 
39 18/6/11 1:12PM 
2631956 
Cumin 
40 21/6/11 12:45PM 
2638835 
momordica 
41 22/6/11 1:09PM 
2642313 
gotu kola 
42 23/6/11 10:42AM 
2645106 
Ginger  
43 30/6/11 6:28PM 
2667722 
Onion 
44 14/9/11 3:27PM 
2888486 
Cinnamon 
45 8/7/12 12:31PM 
4312578 
shatavri 
 
4 Open-Ended Question 37.08% 33 
1 18/3/11 5:01PM 
2348112 
Henna 
2 24/3/11 8:51AM 
2369156 
pepper 
3 24/3/11 5:15PM 
2349888 
ashviganda 
4 31/3/11 10:42AM 
2394452 
gunduchi 
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7. What do you consider to be the most important Indian medicinal herbs? 
(maximum 10) You may include culinary herbs or spices if used medicinally. 
  
Response 
Percent 
Response 
Total 
5 31/3/11 11:49AM 
2395066 
ashwaganda 
6 31/3/11 7:15PM 
2398630 
asafoetida 
7 1/4/11 10:29PM 
2404783 
Jaquirity 
8 16/4/11 1:21PM 
2452394 
Cinnamon 
9 23/4/11 1:51AM 
2471658 
curry leaves 
10 4/5/11 4:10PM 
2502354 
Liquorice 
11 4/5/11 4:14PM 
2502336 
Garlic 
12 4/5/11 6:39PM 
2502950 
Aloe vera 
13 4/5/11 10:33PM 
2503460 
Jira 
14 5/5/11 10:39PM 
2507046 
Chandan 
15 10/5/11 9:14AM 
2517598 
Centella asiatica 
16 10/5/11 1:05PM 
2518994 
Neem 
17 11/5/11 6:52PM 
2524547 
Coriander 
18 12/5/11 12:15AM 
2525202 
Cloves 
333 
 
7. What do you consider to be the most important Indian medicinal herbs? 
(maximum 10) You may include culinary herbs or spices if used medicinally. 
  
Response 
Percent 
Response 
Total 
19 22/5/11 1:01PM 
2553864 
Ginger 
20 22/5/11 5:00PM 
2554098 
Cinnamon 
21 1/6/11 11:35PM 
2583888 
fenigreek 
22 8/6/11 9:39AM 
2600381 
astragalus 
23 15/6/11 7:16PM 
2622252 
rosemary 
24 16/6/11 1:33AM 
2623681 
Cardamon 
25 16/6/11 2:28PM 
2625606 
Cinnamon 
26 16/6/11 10:39PM 
2627151 
Nutmeg 
27 17/6/11 10:30AM 
2628019 
cayenne 
28 17/6/11 5:43PM 
2630326 
neem 
29 18/6/11 1:12PM 
2631956 
Anise 
30 21/6/11 12:45PM 
2638835 
Brahma 
31 23/6/11 10:42AM 
2645106 
Holly basil 
32 30/6/11 6:28PM 
2667722 
Garlic 
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7. What do you consider to be the most important Indian medicinal herbs? 
(maximum 10) You may include culinary herbs or spices if used medicinally. 
  
Response 
Percent 
Response 
Total 
33 8/7/12 12:31PM 
4312578 
ginger 
 
5 Open-Ended Question 30.34% 27 
1 24/3/11 8:51AM 
2369156 
cinnamon 
2 24/3/11 5:15PM 
2349888 
mint 
3 31/3/11 10:42AM 
2394452 
neem 
4 31/3/11 11:49AM 
2395066 
guduchi 
5 31/3/11 7:15PM 
2398630 
brahmi 
6 1/4/11 10:29PM 
2404783 
Long Pepper 
7 16/4/11 1:21PM 
2452394 
Sandalwood 
8 23/4/11 1:51AM 
2471658 
Clove 
9 4/5/11 4:10PM 
2502354 
Turmeric 
10 4/5/11 6:39PM 
2502950 
orange peel 
11 5/5/11 10:39PM 
2507046 
Adrak 
12 10/5/11 9:14AM 
2517598 
Gymnema sylvestre 
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7. What do you consider to be the most important Indian medicinal herbs? 
(maximum 10) You may include culinary herbs or spices if used medicinally. 
  
Response 
Percent 
Response 
Total 
13 11/5/11 6:52PM 
2524547 
Mint 
14 12/5/11 12:15AM 
2525202 
Cumin 
15 22/5/11 1:01PM 
2553864 
Ashvagandha 
16 1/6/11 11:35PM 
2583888 
cumin 
17 8/6/11 9:39AM 
2600381 
goldenseal 
18 15/6/11 7:16PM 
2622252 
Ylang Ylang 
19 16/6/11 1:33AM 
2623681 
Chili 
20 16/6/11 2:28PM 
2625606 
Nutmeg 
21 16/6/11 10:39PM 
2627151 
Holy Basil 
22 17/6/11 10:30AM 
2628019 
cinnamon 
23 17/6/11 5:43PM 
2630326 
cayenne pepper 
24 18/6/11 1:12PM 
2631956 
Pepper 
25 21/6/11 12:45PM 
2638835 
shatavari 
26 23/6/11 10:42AM 
2645106 
Andrographis 
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7. What do you consider to be the most important Indian medicinal herbs? 
(maximum 10) You may include culinary herbs or spices if used medicinally. 
  
Response 
Percent 
Response 
Total 
27 8/7/12 12:31PM 
4312578 
holy basil 
 
6 Open-Ended Question 25.84% 23 
1 24/3/11 8:51AM 
2369156 
cilantro 
2 24/3/11 5:15PM 
2349888 
black pepper 
3 31/3/11 10:42AM 
2394452 
tulsi 
4 31/3/11 11:49AM 
2395066 
cumin seeds 
5 31/3/11 7:15PM 
2398630 
trikatu 
6 1/4/11 10:29PM 
2404783 
Tumeric 
7 16/4/11 1:21PM 
2452394 
Cloves 
8 23/4/11 1:51AM 
2471658 
star anise 
9 4/5/11 4:10PM 
2502354 
Cardamom 
10 4/5/11 6:39PM 
2502950 
lime 
11 11/5/11 6:52PM 
2524547 
Cumin seed 
12 22/5/11 1:01PM 
2553864 
Jawain 
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7. What do you consider to be the most important Indian medicinal herbs? 
(maximum 10) You may include culinary herbs or spices if used medicinally. 
  
Response 
Percent 
Response 
Total 
13 1/6/11 11:35PM 
2583888 
mustard seeds 
14 8/6/11 9:39AM 
2600381 
horehound 
15 15/6/11 7:16PM 
2622252 
cumin 
16 16/6/11 2:28PM 
2625606 
Ginseng 
17 16/6/11 10:39PM 
2627151 
Gotu Kola 
18 17/6/11 10:30AM 
2628019 
cardamon 
19 17/6/11 5:43PM 
2630326 
cardamom 
20 18/6/11 1:12PM 
2631956 
Cinnamon  
21 21/6/11 12:45PM 
2638835 
turmeric 
22 23/6/11 10:42AM 
2645106 
Ashwagandha 
23 8/7/12 12:31PM 
4312578 
brami 
 
7 Open-Ended Question 21.35% 19 
1 24/3/11 8:51AM 
2369156 
etc. 
2 24/3/11 5:15PM 
2349888 
holy basil 
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7. What do you consider to be the most important Indian medicinal herbs? 
(maximum 10) You may include culinary herbs or spices if used medicinally. 
  
Response 
Percent 
Response 
Total 
3 31/3/11 10:42AM 
2394452 
aloe 
4 31/3/11 11:49AM 
2395066 
fennel seeds 
5 31/3/11 7:15PM 
2398630 
cumin 
6 1/4/11 10:29PM 
2404783 
Angelica 
7 16/4/11 1:21PM 
2452394 
Gymnaema 
8 23/4/11 1:51AM 
2471658 
curcuma longa 
9 4/5/11 6:39PM 
2502950 
clove  
10 11/5/11 6:52PM 
2524547 
Black pepper 
11 22/5/11 1:01PM 
2553864 
Fennel seeds (sauf) 
12 1/6/11 11:35PM 
2583888 
indian ginseng 
13 8/6/11 9:39AM 
2600381 
feverfew 
14 16/6/11 10:39PM 
2627151 
Ashwaganda 
15 17/6/11 10:30AM 
2628019 
neem 
16 17/6/11 5:43PM 
2630326 
thulsi 
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7. What do you consider to be the most important Indian medicinal herbs? 
(maximum 10) You may include culinary herbs or spices if used medicinally. 
  
Response 
Percent 
Response 
Total 
17 18/6/11 1:12PM 
2631956 
Nutmeg 
18 21/6/11 12:45PM 
2638835 
pepper 
19 8/7/12 12:31PM 
4312578 
triphala 
 
8 Open-Ended Question 14.61% 13 
1 24/3/11 5:15PM 
2349888 
cinnamon 
2 31/3/11 10:42AM 
2394452 
triphala 
3 31/3/11 11:49AM 
2395066 
hing 
4 31/3/11 7:15PM 
2398630 
black pepper 
5 23/4/11 1:51AM 
2471658 
ginger 
6 11/5/11 6:52PM 
2524547 
Tea 
7 22/5/11 1:01PM 
2553864 
brahmi 
8 1/6/11 11:35PM 
2583888 
seasame  
9 8/6/11 9:39AM 
2600381 
velerian 
10 16/6/11 10:39PM 
2627151 
Psyllium Husk 
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7. What do you consider to be the most important Indian medicinal herbs? 
(maximum 10) You may include culinary herbs or spices if used medicinally. 
  
Response 
Percent 
Response 
Total 
11 17/6/11 10:30AM 
2628019 
shatavari 
12 18/6/11 1:12PM 
2631956 
Betel 
13 21/6/11 12:45PM 
2638835 
neem 
 
9 Open-Ended Question 12.36% 11 
1 24/3/11 5:15PM 
2349888 
aloe vera 
2 31/3/11 10:42AM 
2394452 
turmeric 
3 31/3/11 11:49AM 
2395066 
coriander seed 
4 31/3/11 7:15PM 
2398630 
guggul 
5 23/4/11 1:51AM 
2471658 
allium sativum 
6 22/5/11 1:01PM 
2553864 
Trikatu 
7 8/6/11 9:39AM 
2600381 
tea tree 
8 16/6/11 10:39PM 
2627151 
Henna 
9 17/6/11 10:30AM 
2628019 
andrographis 
10 18/6/11 1:12PM 
2631956 
Saffron 
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7. What do you consider to be the most important Indian medicinal herbs? 
(maximum 10) You may include culinary herbs or spices if used medicinally. 
  
Response 
Percent 
Response 
Total 
11 21/6/11 12:45PM 
2638835 
gymnema 
 
10 Open-Ended Question 11.24% 10 
1 24/3/11 5:15PM 
2349888 
betal nut 
2 31/3/11 10:42AM 
2394452 
boswelia 
3 31/3/11 11:49AM 
2395066 
ajwain 
4 31/3/11 7:15PM 
2398630 
triphala 
5 22/5/11 1:01PM 
2553864 
Stri Rasayam 
6 8/6/11 9:39AM 
2600381 
garlic 
7 16/6/11 10:39PM 
2627151 
Ginger 
8 17/6/11 10:30AM 
2628019 
brahmi 
9 18/6/11 1:12PM 
2631956 
Rose 
10 21/6/11 12:45PM 
2638835 
santal 
 
  
answered 89 
skipped 146 
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8. What do you regard as the single most important Indian medicinal herb and 
why? Again, you can give a food herb if it used for a medical reason. 
  
Response 
Percent 
Response 
Total 
1 Open-Ended Question 100.00% 89 
1 18/3/11 5:01PM 
2348112 
Ginger because it's active against diarrhea, nausea, anti-inflammatory, 
arthritis, blood thinning and cholesterol 
2 24/3/11 8:51AM 
2369156 
I think the philosophy is more important than individual herbs 
3 24/3/11 5:15PM 
2349888 
Turmeric, freely available good for inflamation and as an anti microbial. 
Know people that use it internally and externally therefore can be used by 
everyone. 
4 25/3/11 11:34AM 
2373885 
all foods have an energetic quality and are therefore medicine. 
5 31/3/11 10:30AM 
2394414 
turmeric 
6 31/3/11 10:42AM 
2394452 
Neem- It can be used topically and internally for many different ailments- 
Nature's Pharmacy! 
7 31/3/11 11:49AM 
2395066 
amla - for its general body strengthening, nourishing, immune build ability 
8 1/4/11 10:29PM 
2404783 
Garlic has been widely used in many dishes, and is very popular; unlike 
many other medicinal herbs. 
9 16/4/11 1:21PM 
2452394 
Bitter Melon in the treatment of Diabetes 
10 23/4/11 1:51AM 
2471658 
Curry leaves because they eat curry everyday and they do eat it a lot !  
11 24/4/11 8:31AM 
2473499 
Neem - as its widely used for a range of illnesses and its symbolic 
significance 
12 27/4/11 10:51PM 
2484453 
n/a 
13 4/5/11 3:55PM 
2502314 
not sure 
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8. What do you regard as the single most important Indian medicinal herb and 
why? Again, you can give a food herb if it used for a medical reason. 
  
Response 
Percent 
Response 
Total 
14 4/5/11 3:58PM 
2502318 
I dont know 
15 4/5/11 4:04PM 
2502333 
Peppermint , it is very good for any intestinal problems and soothing  
16 4/5/11 4:10PM 
2502354 
I believe turmeric is regarded as a 'cleansing' herb. 
17 4/5/11 4:11PM 
2502415 
Tumeric (anti cancer properties) 
18 4/5/11 4:14PM 
2502336 
Don't know 
19 4/5/11 5:35PM 
2502728 
i dont think I can name a single indian medicinal herb, sorry 
20 4/5/11 6:39PM 
2502950 
Holy basil (Tulsi) a herb considered sacred to Hindus .And is thought to aid 
in healing of mind ,body and spirit.  
21 4/5/11 7:01PM 
2503057 
garlic, ive heard more about it 
22 4/5/11 7:04PM 
2503059 
tumeric-can be used on the skin in a paste  
also put into food and good effects 
23 4/5/11 7:56PM 
2503159 
Tumeric - cancer prevention in rat models. 
24 4/5/11 11:08PM 
2503517 
kashayam, it seems to be used a lot in Ayurvedic medicine. I went to a clinic 
in India, and a few others I knew also went, and we were all prescribed with 
kashayam.  
25 5/5/11 4:19AM 
2503755 
Don't know 
26 5/5/11 7:25AM 
2503929 
curcumin colon cancer prevention 
27 5/5/11 10:07AM 
2504473 
Garlic 
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8. What do you regard as the single most important Indian medicinal herb and 
why? Again, you can give a food herb if it used for a medical reason. 
  
Response 
Percent 
Response 
Total 
28 5/5/11 12:47PM 
2505164 
N/A 
29 5/5/11 5:47PM 
2502652 
N/A 
30 5/5/11 10:39PM 
2507046 
Neem, because it can help purify blood. 
31 5/5/11 10:56PM 
2506934 
don't know 
32 6/5/11 1:44AM 
2507253 
Cannabis - oldest and most used medicine in the world 
33 6/5/11 3:30PM 
2509062 
I dont know. 
34 7/5/11 1:02PM 
2510981 
sanjeevni herb from himalayas. can revive a person on the brink of death. 
35 10/5/11 8:39AM 
2517226 
Ginger. It can be found easilyy and it has many properties. I use it for 
digestive problems. 
36 10/5/11 8:40AM 
2517255 
nigella seed 
37 10/5/11 8:52AM 
2517332 
Turmeric- cancer 
38 10/5/11 9:14AM 
2517598 
Andrographis - really excellent for the immune system when other herbs 
don't work. Works very quickly as well 
39 10/5/11 9:23AM 
2517780 
Don't know. 
40 10/5/11 9:29AM 
2517835 
Don't know 
41 10/5/11 10:05AM 
2518039 
not sure 
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8. What do you regard as the single most important Indian medicinal herb and 
why? Again, you can give a food herb if it used for a medical reason. 
  
Response 
Percent 
Response 
Total 
42 10/5/11 12:02PM 
2518761 
Turmeric, Others as well i dont know the names 
43 10/5/11 12:13PM 
2518781 
Pepper 
44 10/5/11 1:05PM 
2518994 
Garlic - based on anecdotal evidence of the various medicinal ailments it can 
treat 
45 10/5/11 1:35PM 
2519179 
am not aware there is much evidence for efficacy of any of this 
46 10/5/11 6:21PM 
2520317 
Turmeric. Easily obtained and commonly used as food additives. Affordable 
remedies. 
47 10/5/11 6:47PM 
2520378 
Garlic 
Proven benefits 
48 11/5/11 3:13AM 
2521039 
tumeric because its used so widely for many ailments. I have seen it applied 
topically as well as ingested for healing properties. 
49 11/5/11 5:26AM 
2521091 
n/a 
50 11/5/11 10:13AM 
2521895 
Turmeric - anti-inflammatory 
51 11/5/11 11:20AM 
2522554 
Don't know 
52 11/5/11 11:36AM 
2522603 
neem, it has so many uses and is cheep and plentyfull 
53 11/5/11 12:37PM 
2522984 
Curcumin [or turmeric]. it's possibly good for overall health. 
54 11/5/11 1:36PM 
2523220 
Turmeric - I use this herb daily for anti-inflammatory properties 
55 11/5/11 2:07PM 
2523340 
Neem, for it's properties which help the immune system; skin problems; 
dental health; digestion and gut health. 
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8. What do you regard as the single most important Indian medicinal herb and 
why? Again, you can give a food herb if it used for a medical reason. 
  
Response 
Percent 
Response 
Total 
56 11/5/11 4:05PM 
2523761 
neem 
57 11/5/11 6:52PM 
2524547 
Turmeric for antiseptic treatments in general. 
58 11/5/11 7:34PM 
2523427 
Tumeric Powder applied to an inflammed area, can reduce inflammation. 
59 11/5/11 7:55PM 
2524742 
Aloe Vera for it's internal and external benefits. 
I use it to prevent prickly heat (tablets) and as a hunger supressor when 
dieting 
60 12/5/11 12:15AM 
2525202 
Tumeric 
61 12/5/11 4:31AM 
2518498 
Ginseng 
62 12/5/11 4:14PM 
2527614 
don't know 
63 12/5/11 7:33PM 
2528336 
ginger because it's warming. 
64 13/5/11 5:37PM 
2532239 
n/a 
65 22/5/11 12:48PM 
2553868 
not known 
66 22/5/11 1:01PM 
2553864 
Turmeric- can heal internal and external wounds. Very good for keeping 
good immune system. Easily ingested with food, and flavoursome! 
67 22/5/11 5:00PM 
2554098 
Cardamom  
68 1/6/11 11:35PM 
2583888 
Ashwaganda. Indian ginseng, which is not heating 
69 8/6/11 9:39AM 
2600381 
cilantro for the binding & removal of heavy metals in the liver 
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8. What do you regard as the single most important Indian medicinal herb and 
why? Again, you can give a food herb if it used for a medical reason. 
  
Response 
Percent 
Response 
Total 
70 15/6/11 7:00PM 
2621959 
Garlic because it is anti-viral and anti-inflammatory 
71 15/6/11 7:16PM 
2622252 
Garlic for cleansing blood and controlling lipids and cholesterol 
72 15/6/11 9:20PM 
2622871 
Garlic. Lowers cholesterol prevents blood clots. 
73 16/6/11 1:33AM 
2623681 
Turmeric 
Anti oxidant 
74 16/6/11 2:28PM 
2625606 
Neem 
75 16/6/11 2:35PM 
2625659 
Tumeric, good for general good health and easy to use in everyday cooking 
76 16/6/11 10:39PM 
2627151 
Ashwaganda 
The ginseng of India! 
77 17/6/11 10:30AM 
2628019 
Ashwagandha because it is very nutritive, calming yet adaptogenic and gives 
energy, cardioprotective, immonomodulatory and can be used with cancer 
patients as it is very nutritive. 
78 17/6/11 5:43PM 
2630326 
Turmuric- because i have heard it recommended by the most different 
people 
79 18/6/11 12:40AM 
2631337 
ashwangwanda? 
80 18/6/11 1:12PM 
2631956 
I don't know 
81 20/6/11 8:17PM 
2636831 
? 
82 21/6/11 12:45PM 
2638835 
gotu cola - for all its effects  
83 22/6/11 1:09PM 
2642313 
ashwagandha because it is a proven AchE inhibitor as well as an adaptogen 
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8. What do you regard as the single most important Indian medicinal herb and 
why? Again, you can give a food herb if it used for a medical reason. 
  
Response 
Percent 
Response 
Total 
84 23/6/11 10:42AM 
2645106 
Turmeric - many medicinal uses (used against cancer, digestive...). Culinary 
uses as well. 
85 30/6/11 6:28PM 
2667722 
Cumin 
86 3/10/11 8:55PM 
2962581 
Cinnamon - this is being used a lot in C. Europe and whilst it is strictly a Sri 
Lankan plant, it has potential to be further developed. 
87 13/2/12 3:10PM 
3386121 
All the aromatics 
88 8/3/12 8:28PM 
3485789 
Tea leaves - because they are very common and widely used. 
89 8/7/12 12:31PM 
4312578 
ashwaganda 
 
  
answered 89 
skipped 146 
 
9. What 5 conditions do you think would respond best to Indian herbal medicine 
treatment? 
  
Response 
Percent 
Response 
Total 
1 Colds,flu etc   
 
39.90% 81 
2 Digestive problems   
 
48.77% 99 
3 Gynaecological conditions   
 
10.84% 22 
4 Infertility   
 
6.90% 14 
5 Skin diseases   
 
32.02% 65 
6 Musculo-skeletal conditions   
 
7.39% 15 
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9. What 5 conditions do you think would respond best to Indian herbal medicine 
treatment? 
  
Response 
Percent 
Response 
Total 
7 Respiritory illnesses   
 
15.27% 31 
8 Neurological diseases   
 
4.43% 9 
9 Diabetes   
 
14.29% 29 
10 Cardio-vascular disease   
 
13.79% 28 
11 
Mental-emotional conditions 
(depression, anxiety etc) 
  
 
12.32% 25 
12 Low libido   
 
10.34% 21 
13 Tiredness, fatigue   
 
32.51% 66 
14 Poor immune system   
 
33.50% 68 
15 Poor memory and concentration   
 
17.73% 36 
16 Insomnia   
 
17.24% 35 
17 Don't know   
 
31.53% 64 
18 Other: please specify   
 
5.91% 12 
  
answered 203 
skipped 32 
Answers for: Other: please specify 12 answers 
1 25/3/11 11:34AM 
2373885 
A wide range conditions. 
2 4/5/11 4:14PM 
2502336 
Pain 
3 10/5/11 1:35PM 
2519179 
you may get a placebo effect or true effect which should be further 
investigated, as far as am aware the mechanisms put forward by 
traditionalists are without evidence 
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9. What 5 conditions do you think would respond best to Indian herbal medicine 
treatment? 
  
Response 
Percent 
Response 
Total 
4 11/5/11 3:13AM 
2521039 
cuts and bruises 
5 11/5/11 12:21PM 
2522941 
I am sceptical about any medical benefits 
6 11/5/11 12:37PM 
2522984 
cancer, alzheimer's 
7 11/5/11 1:39PM 
2523240 
I do not know any indian herbs 
8 11/5/11 2:07PM 
2523340 
dental health 
9 16/6/11 3:04PM 
2625841 
not a clue 
10 18/6/11 1:12PM 
2631956 
I don't use it 
11 23/6/11 10:42AM 
2645106 
All these conditions could be treated using Ayurvedic / Unani medicine (not 
only herbal medicine).  
12 28/6/11 9:53PM 
2660931 
never heard of these meds and treatment systems listed under question2! I 
could not say the best of trying them 
 
 
10. Which Indian medicinal herbs or Indian herbal medicinal products do you use 
regularly? You may include culinary herbs or spices if used medicinally. 
  
Response 
Percent 
Response 
Total 
1 Open-Ended Question 100.00% 78 
1 18/3/11 5:01PM 
2348112 
turmeric, ginger,  
2 18/3/11 8:51PM None 
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10. Which Indian medicinal herbs or Indian herbal medicinal products do you use 
regularly? You may include culinary herbs or spices if used medicinally. 
  
Response 
Percent 
Response 
Total 
2348574 
3 24/3/11 8:51AM 
2369156 
same as in 7) 
4 24/3/11 5:15PM 
2349888 
aloe vera 
garlic 
turmeric 
black pepper 
corydalis 
cordyceps 
5 25/3/11 11:34AM 
2373885 
all foods have an energetic quality and are therefore medicine. 
6 31/3/11 10:30AM 
2394414 
ginger and turmeric 
7 31/3/11 10:42AM 
2394452 
neem, shatavari, ashwaganda, ginger, tumeric, tulsi, shankahpushpi 
8 31/3/11 11:10AM 
2394989 
brahmi 
satavari 
ghee 
9 31/3/11 11:49AM 
2395066 
amla, ahswaganda, guduchi, neem, turmeric, cumin seeds, fennel seeds, 
hing, curry leaves, methi seeds, ajwain 
10 1/4/11 10:29PM 
2404783 
Cumin, to make curry~ 
11 16/4/11 1:21PM 
2452394 
Bitter Melon 
Gymnaema 
12 23/4/11 1:51AM 
2471658 
curry leaves, star anise , clove, ginger, curcumin 
13 24/4/11 8:31AM 
2473499 
Ginger, tulsi (as a tea) 
14 27/4/11 10:51PM 
2484453 
n/a 
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10. Which Indian medicinal herbs or Indian herbal medicinal products do you use 
regularly? You may include culinary herbs or spices if used medicinally. 
  
Response 
Percent 
Response 
Total 
15 4/5/11 4:04PM 
2502333 
cumin 
16 4/5/11 4:10PM 
2502354 
None medicinally. 
17 4/5/11 4:11PM 
2502415 
None 
18 4/5/11 4:14PM 
2502336 
None 
19 4/5/11 4:14PM 
2502370 
Tumeric powder in water - used for coughs or a paste is made and put on 
cuts to prevent infection 
20 4/5/11 5:09PM 
2502661 
pudina 
21 4/5/11 7:01PM 
2503057 
none 
22 4/5/11 11:08PM 
2503517 
Aloe vera  
23 5/5/11 4:19AM 
2503755 
I have not seen any 
24 5/5/11 7:25AM 
2503929 
curry 
25 5/5/11 12:47PM 
2505164 
None 
26 5/5/11 10:39PM 
2507046 
Tulsi 
27 5/5/11 10:56PM 
2506934 
none 
28 5/5/11 11:02PM 
2507080 
tumeric powder and salt mixed with warm water, for cold and flu symptoms  
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10. Which Indian medicinal herbs or Indian herbal medicinal products do you use 
regularly? You may include culinary herbs or spices if used medicinally. 
  
Response 
Percent 
Response 
Total 
29 6/5/11 3:30PM 
2509062 
none 
30 7/5/11 11:32AM 
2510888 
tumeric 
31 10/5/11 8:40AM 
2517255 
ginger 
32 10/5/11 8:52AM 
2517332 
None 
33 10/5/11 9:14AM 
2517598 
Withania 
Centella 
Andrographis 
34 10/5/11 9:23AM 
2517780 
None 
35 10/5/11 9:29AM 
2517835 
None 
36 10/5/11 12:13PM 
2518781 
None 
37 10/5/11 1:05PM 
2518994 
Turmeric, Garlic, Ginger, Fenugreek, Cumin, Bay leaves,  
38 10/5/11 1:35PM 
2519179 
nil 
39 10/5/11 6:47PM 
2520378 
None 
40 11/5/11 3:13AM 
2521039 
I don't use any medicinally 
41 11/5/11 5:26AM 
2521091 
n/a 
42 11/5/11 10:13AM 
2521895 
Turmeric 
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10. Which Indian medicinal herbs or Indian herbal medicinal products do you use 
regularly? You may include culinary herbs or spices if used medicinally. 
  
Response 
Percent 
Response 
Total 
43 11/5/11 11:20AM 
2522554 
none 
44 11/5/11 11:36AM 
2522603 
neem 
tumeric 
oregano oil 
45 11/5/11 12:37PM 
2522984 
Curry...ocasionally. ginger sometimes. 
46 11/5/11 1:36PM 
2523220 
turmeric 
47 11/5/11 1:39PM 
2523240 
None I use only European Herbs (Sage, St John Worth, Garlic, Onion) 
48 11/5/11 2:07PM 
2523340 
(Thought I'd just answered this question) 
Neem 
Turmeric 
49 11/5/11 4:05PM 
2523761 
neem, turmeric 
50 11/5/11 6:52PM 
2524547 
Turmeric 
51 11/5/11 7:19PM 
2524599 
I use tumeric medicinally since being diagnosed with breast cancer in Dec 
2010 
52 11/5/11 7:55PM 
2524742 
Aloe Vera 
53 12/5/11 12:15AM 
2525202 
Cinnamon and Cloves 
54 22/5/11 12:48PM 
2553868 
None 
55 22/5/11 1:01PM 
2553864 
Turmeric, ginger, neem, fennel seeds, jawain. 
56 22/5/11 5:00PM None 
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10. Which Indian medicinal herbs or Indian herbal medicinal products do you use 
regularly? You may include culinary herbs or spices if used medicinally. 
  
Response 
Percent 
Response 
Total 
2554098 
57 1/6/11 11:35PM 
2583888 
Seasame, cardaomon 
58 8/6/11 9:39AM 
2600381 
cilantro 
garlic 
59 15/6/11 7:00PM 
2621959 
garlic 
60 15/6/11 7:16PM 
2622252 
green tea, garlic, rosemary, cumin 
61 15/6/11 9:20PM 
2622871 
Garlic 
62 16/6/11 1:33AM 
2623681 
Turmeric 
63 16/6/11 2:28PM 
2625606 
None 
64 16/6/11 2:35PM 
2625659 
Tumeric 
65 16/6/11 3:04PM 
2625841 
none 
66 16/6/11 10:39PM 
2627151 
Cardamom 
Ginger 
Holy Basil 
Nutmeg 
67 16/6/11 10:40PM 
2627166 
NONE 
68 17/6/11 10:30AM 
2628019 
I use the digestive spices a lot such as cardamon and cinnamon because 
they are very goo for flatulence, for upset and aching stomach and belly and 
they taste nice. 
69 18/6/11 5:35AM None 
356 
 
10. Which Indian medicinal herbs or Indian herbal medicinal products do you use 
regularly? You may include culinary herbs or spices if used medicinally. 
  
Response 
Percent 
Response 
Total 
2631518 
70 18/6/11 1:12PM 
2631956 
N/a 
71 18/6/11 10:40PM 
2632806 
None. 
72 20/6/11 8:17PM 
2636831 
tumeric 
73 21/6/11 12:45PM 
2638835 
gotu cola  
74 22/6/11 1:09PM 
2642313 
ginger 
cinnamon 
75 23/6/11 10:42AM 
2645106 
I do not use any at the moment. 
76 30/6/11 6:28PM 
2667722 
cumin 
77 3/10/11 8:55PM 
2962581 
Curcuma! Great for my aching bones tony! 
78 8/7/12 12:31PM 
4312578 
ginger, tumeric, ashwaganda, shatavari, holy basil, triphala 
 
  
answered 78 
skipped 157 
 
11. Approximately how much do you spend per month on buying Indian medicinal 
herbs or Indian medicinal herbal products? 
  
Response 
Percent 
Response 
Total 
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11. Approximately how much do you spend per month on buying Indian medicinal 
herbs or Indian medicinal herbal products? 
  
Response 
Percent 
Response 
Total 
1 Under £20   
 
29.58% 63 
2 £20-49   
 
3.29% 7 
3 £50-79   
 
0.94% 2 
4 £80-119   0.00% 0 
5 £120-179   0.00% 0 
6 £180-250   0.00% 0 
7 Above £250   0.00% 0 
8 Not applicable   
 
63.38% 135 
9 Other: please specify   
 
2.82% 6 
  
answered 213 
skipped 22 
Answers for: Other: please specify 6 answers 
1 4/5/11 10:33PM 
2503460 
do not buy something speically, other than what may be used to cook 
normally 
2 10/5/11 12:02PM 
2518761 
I dont know, My father sends some 
3 11/5/11 10:13AM 
2521895 
None 
4 16/6/11 4:09PM 
2626169 
used vary rarely to answer 
5 23/6/11 10:42AM 
2645106 
I do not purchase Indian medicinal herbs monthly 
6 8/7/12 12:31PM 
4312578 
only familiar with us dollars 
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12. Where do you obtain your medicinal Indian herbs/spices or Indian herbal 
medicinal products? List all the places that you use. 
  
Response 
Percent 
Response 
Total 
1 Healthfood shop   
 
18.18% 38 
2 Supermarket   
 
20.10% 42 
3 General store   
 
4.78% 10 
4 Pharmacy   
 
6.22% 13 
5 Practitioner clinic   
 
6.70% 14 
6 Wholesaler   
 
3.83% 8 
7 Internet   
 
3.83% 8 
8 
Brought from India by friends 
or family. 
  
 
9.09% 19 
9 Don't use them   
 
56.46% 118 
10 Other: please specify   
 
5.26% 11 
  
answered 209 
skipped 26 
Answers for: Other: please specify 11 answers 
1 24/3/11 5:15PM 
2349888 
Practitioner friends and family 
2 31/3/11 11:49AM 
2395066 
indian shops 
3 4/5/11 6:39PM 
2502950 
home country  
4 5/5/11 2:48PM 
2505738 
indian general store/grocery shop 
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12. Where do you obtain your medicinal Indian herbs/spices or Indian herbal 
medicinal products? List all the places that you use. 
  
Response 
Percent 
Response 
Total 
5 10/5/11 12:47PM 
2518943 
Dont know 
6 11/5/11 4:05PM 
2523761 
we stock them for resale to the the dog-owning public. 
7 15/6/11 5:44PM 
2622036 
I would see a practitioner 
8 16/6/11 2:35PM 
2625659 
Indian grocery store 
9 16/6/11 3:18PM 
2625860 
I used them when I was in India for 5 years since I have moved to the UK I 
haven't used any! 
10 22/6/11 7:05AM 
2640817 
we have special Ayurvedic Pharmacy in India  
11 8/7/12 12:31PM 
4312578 
herb store 
 
 
13. In what form do you take your Indian medicinal herbs? List all forms that you 
use. 
  
Response 
Percent 
Response 
Total 
1 powders   
 
23.22% 49 
2 capsules   
 
13.74% 29 
3 tablets   
 
8.06% 17 
4 tinctures   
 
5.69% 12 
5 
dried loose herbs (including 
teabags) 
  
 
16.59% 35 
6 fresh herbs   
 
16.11% 34 
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13. In what form do you take your Indian medicinal herbs? List all forms that you 
use. 
  
Response 
Percent 
Response 
Total 
7 Not applicable   
 
58.77% 124 
8 Other: please specify   
 
4.27% 9 
  
answered 211 
skipped 24 
Answers for: Other: please specify 9 answers 
1 31/3/11 10:30AM 
2394414 
tea 
2 4/5/11 11:08PM 
2503517 
creams, facewash 
3 5/5/11 10:56PM 
2506934 
freshly prepared paste to be used topically or orally 
4 11/5/11 12:37PM 
2522984 
In Food 
5 11/5/11 2:07PM 
2523340 
toothpaste 
6 11/5/11 7:55PM 
2524742 
juice 
7 1/6/11 11:35PM 
2583888 
oil 
8 15/6/11 5:49PM 
2622023 
liquid form 
9 22/6/11 7:05AM 
2640817 
Tonics and ointments 
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14. Are you aware of any companies that supply Indian herbs or Indian medicinal 
herbal products? Please list any brand names or company names that you can 
remember. 
  
Response 
Percent 
Response 
Total 
1 Open-Ended Question 100.00% 45 
1 24/3/11 8:51AM 
2369156 
pukka herbs 
2 24/3/11 5:15PM 
2349888 
Pukka herbs 
3 31/3/11 10:30AM 
2394414 
pukka herbs 
4 31/3/11 10:42AM 
2394452 
Pukka 
5 31/3/11 11:10AM 
2394989 
pukka herbs 
6 31/3/11 11:49AM 
2395066 
pukka herbs 
7 31/3/11 7:15PM 
2398630 
himalay herbal 
8 1/4/11 10:29PM 
2404783 
Tescos 
9 16/4/11 1:21PM 
2452394 
Himalaya Herbs 
10 23/4/11 1:51AM 
2471658 
BABA'S MALAYSIA 
11 24/4/11 8:31AM 
2473499 
Pukka herbs 
12 27/4/11 10:51PM 
2484453 
PukkaHerb 
13 4/5/11 4:10PM 
2502354 
Balance healthcare? 
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14. Are you aware of any companies that supply Indian herbs or Indian medicinal 
herbal products? Please list any brand names or company names that you can 
remember. 
  
Response 
Percent 
Response 
Total 
14 4/5/11 4:14PM 
2502370 
Himalayas (available in india) 
15 4/5/11 11:08PM 
2503517 
Aloeclins 
16 5/5/11 4:19AM 
2503755 
No 
17 5/5/11 12:47PM 
2505164 
No. 
18 5/5/11 5:47PM 
2502652 
None 
19 5/5/11 10:39PM 
2507046 
Hamdard (Pakistan/India) 
20 5/5/11 10:56PM 
2506934 
none 
21 5/5/11 11:02PM 
2507080 
V.B & Sons 
22 10/5/11 9:14AM 
2517598 
Baldwins 
23 10/5/11 1:05PM 
2518994 
TRS (culinary) 
24 10/5/11 1:35PM 
2519179 
no 
25 11/5/11 10:13AM 
2521895 
Pukka herbs 
26 11/5/11 12:21PM 
2522941 
Maharishi Ayurveda used to - think they've stopped though 
27 11/5/11 12:37PM No idea... 
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14. Are you aware of any companies that supply Indian herbs or Indian medicinal 
herbal products? Please list any brand names or company names that you can 
remember. 
  
Response 
Percent 
Response 
Total 
2522984 
28 11/5/11 2:07PM 
2523340 
Mekuti 
29 11/5/11 4:05PM 
2523761 
Mekuti 
30 11/5/11 6:52PM 
2524547 
Mina Stores London (Romford Road) 
31 22/5/11 12:48PM 
2553868 
Not known 
32 22/5/11 1:01PM 
2553864 
Pukka 
33 22/5/11 4:39PM 
2554070 
Yogi tea? 
34 1/6/11 11:35PM 
2583888 
no 
35 15/6/11 7:00PM 
2621959 
No 
36 15/6/11 7:16PM 
2622252 
no 
37 16/6/11 2:35PM 
2625659 
Pukka 
38 16/6/11 3:21PM 
2625917 
N/A 
39 16/6/11 10:40PM 
2627166 
Jinay Exports International  
40 17/6/11 10:30AM 
2628019 
Pukka 
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14. Are you aware of any companies that supply Indian herbs or Indian medicinal 
herbal products? Please list any brand names or company names that you can 
remember. 
  
Response 
Percent 
Response 
Total 
41 21/6/11 12:45PM 
2638835 
pukka 
42 22/6/11 1:09PM 
2642313 
Himalaya 
43 23/6/11 10:42AM 
2645106 
Pukka 
44 3/10/11 8:55PM 
2962581 
Turmeric extra (Schwabe) 
45 8/7/12 12:31PM 
4312578 
himalayan 
 
2 Open-Ended Question 40.00% 18 
1 24/3/11 5:15PM 
2349888 
Pataks 
2 31/3/11 10:42AM 
2394452 
Organix South 
3 31/3/11 11:10AM 
2394989 
banyan botanicals 
4 31/3/11 7:15PM 
2398630 
pukka herb 
5 1/4/11 10:29PM 
2404783 
Holland and Barrett's 
6 23/4/11 1:51AM 
2471658 
ADABI MALAYSIA 
7 4/5/11 4:10PM 
2502354 
Oxford medical ? 
8 5/5/11 10:39PM 
2507046 
Safi 
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14. Are you aware of any companies that supply Indian herbs or Indian medicinal 
herbal products? Please list any brand names or company names that you can 
remember. 
  
Response 
Percent 
Response 
Total 
9 10/5/11 9:14AM 
2517598 
Herbs In A Bottle 
10 10/5/11 1:05PM 
2518994 
Divya Herbal Medicines 
11 11/5/11 2:07PM 
2523340 
Neem Genie 
12 11/5/11 4:05PM 
2523761 
NeemGenie 
13 22/5/11 1:01PM 
2553864 
Divya Pharmacy 
14 16/6/11 2:35PM 
2625659 
Solgar 
15 16/6/11 10:40PM 
2627166 
Savalia Group 
16 21/6/11 12:45PM 
2638835 
panacea 
17 23/6/11 10:42AM 
2645106 
Phyto 
18 8/7/12 12:31PM 
4312578 
bayan 
 
3 Open-Ended Question 17.78% 8 
1 24/3/11 5:15PM 
2349888 
mediherb 
2 31/3/11 10:42AM 
2394452 
Nature's formulary 
3 31/3/11 11:10AM 
2394989 
organic india 
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14. Are you aware of any companies that supply Indian herbs or Indian medicinal 
herbal products? Please list any brand names or company names that you can 
remember. 
  
Response 
Percent 
Response 
Total 
4 1/4/11 10:29PM 
2404783 
Sainsburys 
5 5/5/11 10:39PM 
2507046 
Wings Pharma 
6 10/5/11 9:14AM 
2517598 
Avicenna 
7 21/6/11 12:45PM 
2638835 
herbs in a bottle  
8 8/7/12 12:31PM 
4312578 
mountain rose herbs 
 
4 Open-Ended Question 6.67% 3 
1 24/3/11 5:15PM 
2349888 
shwabay 
2 5/5/11 10:39PM 
2507046 
Divya Pharma 
3 21/6/11 12:45PM 
2638835 
avicenna 
 
5 Open-Ended Question 2.22% 1 
1 24/3/11 5:15PM 
2349888 
siddhalemar 
 
6 Open-Ended Question 2.22% 1 
1 24/3/11 5:15PM 
2349888 
mayway 
 
7 Open-Ended Question 2.22% 1 
1 24/3/11 5:15PM 
2349888 
sunten 
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14. Are you aware of any companies that supply Indian herbs or Indian medicinal 
herbal products? Please list any brand names or company names that you can 
remember. 
  
Response 
Percent 
Response 
Total 
8 Open-Ended Question 2.22% 1 
1 24/3/11 5:15PM 
2349888 
slogar 
 
9 Open-Ended Question 2.22% 1 
1 24/3/11 5:15PM 
2349888 
bioforce 
 
10 Open-Ended Question 2.22% 1 
1 24/3/11 5:15PM 
2349888 
health pure 
 
  
answered 45 
skipped 190 
 
15. Have you had a consultation with a practitioner of traditional Indian medicine? 
  
Response 
Percent 
Response 
Total 
1 Never   
 
88.21% 187 
2 More than 5 years ago   
 
4.72% 10 
3 Within the last 5 years   
 
4.72% 10 
4 Within the last year   
 
2.36% 5 
5 Within the last month   0.00% 0 
  
answered 212 
skipped 23 
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16. If you have had a consultation with a practitioner, do you know which branch of 
Indian medicine was used? 
  
Response 
Percent 
Response 
Total 
1 Ayurveda   
 
14.37% 25 
2 Siddah   
 
0.57% 1 
3 Unani   
 
0.57% 1 
4 Don't know   
 
6.90% 12 
5 Not applicable   
 
78.16% 136 
6 Other: please specify   
 
1.15% 2 
  
answered 174 
skipped 61 
Answers for: Other: please specify 2 answers 
1 11/5/11 11:07PM 
2525144 
In English was called Neurotherapy. Can't remember Indian name. 
2 23/6/11 10:42AM 
2645106 
I do not know Siddah medicine. I find both Ayurveda and Unani interesting. 
 
 
17. If you visit a practitioner, approximately how much does it cost per visit 
including the cost of the herbs? 
  
Response 
Percent 
Response 
Total 
1 Under £20   
 
5.91% 11 
2 £20-39   
 
1.61% 3 
3 £40-59   
 
2.69% 5 
4 £60-79   
 
1.61% 3 
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17. If you visit a practitioner, approximately how much does it cost per visit 
including the cost of the herbs? 
  
Response 
Percent 
Response 
Total 
5 £80-99   0.00% 0 
6 £100-200   0.00% 0 
7 Above £200   
 
0.54% 1 
8 Not applicable   
 
84.41% 157 
9 Other: please specify   
 
3.23% 6 
  
answered 186 
skipped 49 
Answers for: Other: please specify 6 answers 
1 4/5/11 4:14PM 
2502370 
free consultation in india 
2 11/5/11 11:07PM 
2525144 
around 12 to 15 years ago 
3 22/5/11 1:01PM 
2553864 
They are based in India 
4 29/5/11 11:35PM 
2575409 
No Herbs just massage 
5 23/6/11 10:42AM 
2645106 
It depends on the cost of the prescribed herbs. £ 80 - 120 
6 8/7/12 12:31PM 
4312578 
between 80-150 us dollars 
 
 
18. Do you have any concerns regarding the safety or quality of Indian herbs or 
Indian herbal medicinal products? If so please list them. 
  
Response 
Percent 
Response 
Total 
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18. Do you have any concerns regarding the safety or quality of Indian herbs or 
Indian herbal medicinal products? If so please list them. 
  
Response 
Percent 
Response 
Total 
1 Open-Ended Question 100.00% 76 
1 18/3/11 8:51PM 
2348574 
Have they been tested to the same stringent levels as required by European 
or US Pharma companies? 
2 24/3/11 5:15PM 
2349888 
1. Plant variability 
2. Efficacy 
3. Sustainability 
4. Transport and storage conditions and spoilage 
5. contamination chemical and biological 
6. toxicology 
3 25/3/11 11:34AM 
2373885 
No 
4 31/3/11 10:30AM 
2394414 
will too much hurt u? will they have a reverse affect from the purpose. 
5 31/3/11 11:49AM 
2395066 
no 
6 1/4/11 10:29PM 
2404783 
NO 
7 4/4/11 3:34PM 
2412275 
no 
8 24/4/11 8:31AM 
2473499 
If I was to use them a lot and specifically for medical reasons I may be 
concerned as to their quality and regulation. 
9 27/4/11 10:51PM 
2484453 
They don't seem to have any quality standards or have been regulated in the 
UK. Moreover, the products should be used only under consultation. 
10 4/5/11 3:55PM 
2502314 
originality 
11 4/5/11 3:58PM 
2502318 
Not so familiar with them to be concerned 
12 4/5/11 4:04PM 
2502333 
yes, i do.  
quality, 
dose in each product may vary, 
contamination, 
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18. Do you have any concerns regarding the safety or quality of Indian herbs or 
Indian herbal medicinal products? If so please list them. 
  
Response 
Percent 
Response 
Total 
adulterant. 
13 4/5/11 4:10PM 
2502354 
Contamination 
Adulteration 
Quantification of active ingredients 
Drug/ herb interaction 
Labelling 
14 4/5/11 4:14PM 
2502370 
no 
15 4/5/11 4:37PM 
2502538 
I'd be worried that: 
a) market isn't regulated so you wouldn't know if the product was any good - 
if it contained what it said it contained 
b) don't know if they work 
16 4/5/11 6:32PM 
2502967 
I would be worried the conditions in which the medicines are produced and 
whether the medicines are hygenic. 
17 4/5/11 7:01PM 
2503057 
i dont think they work as well as conventional medicines 
18 4/5/11 7:04PM 
2503059 
no 
19 4/5/11 8:34PM 
2503226 
In most cases these herbs are not able to replace western medicine. There 
is a danger of people using these herbs instead of going for the 'true' tested 
and scientifically proven treatment. Also several reports have noted that 
some herbs used in traditional asian medicine in general are toxic, with even 
cases of liver or kidney cancer causing death. 
20 4/5/11 8:50PM 
2503265 
reproducibility  
quality of products 
safety issues  
lack of regulation  
21 4/5/11 10:33PM 
2503460 
As with anything, excessive use can be dangerous, and if individuals do opt 
for pills and the sort, purity and even placebos might be a problem. 
22 5/5/11 4:19AM 
2503755 
I' have never used any. 
23 5/5/11 7:25AM Yes, adulteration and toxicity such as hepato and renal toxicity 
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18. Do you have any concerns regarding the safety or quality of Indian herbs or 
Indian herbal medicinal products? If so please list them. 
  
Response 
Percent 
Response 
Total 
2503929 
24 5/5/11 12:47PM 
2505164 
Yes. Quality, content, side effects, clinical efficacy, drug interactions. 
25 5/5/11 5:41PM 
2506349 
- purity 
- hygene 
- ecological 
- toxilogical 
26 5/5/11 5:47PM 
2502652 
N/A 
27 5/5/11 10:39PM 
2507046 
No, its natural 
28 7/5/11 11:32AM 
2510888 
contraindications with other prescribed medicines. Safety and efficacy of the 
herbal medicines 
29 10/5/11 8:52AM 
2517332 
That they have not been tested for their toxicology or efficacy 
30 10/5/11 9:14AM 
2517598 
Would never buy anything over the Internet in case it was adulterated or 
simply not the authentic plant 
31 10/5/11 9:29AM 
2517835 
I would prefer standardised medicines with a license. 
32 10/5/11 1:35PM 
2519179 
Yes. As far as i'm aware these medicines are either unproven or need 
research to understand them further. The example of artmesin for malaria is 
a good one. 
33 10/5/11 6:21PM 
2520317 
1. Purpose of use 
2. Clinical data or evidence of efficacy 
3. Side effects/adverse reactions 
4. Possible interactions with drugs (prescriptions or over the counter) 
34 10/5/11 6:47PM 
2520378 
Unregulated and unmonitored  
35 11/5/11 5:26AM 
2521091 
n/a 
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18. Do you have any concerns regarding the safety or quality of Indian herbs or 
Indian herbal medicinal products? If so please list them. 
  
Response 
Percent 
Response 
Total 
36 11/5/11 10:13AM 
2521895 
Lack of assurance about herbal identity, adulteration and toxicity especially 
associated with the use of heavy metals and the processing of herbs such as 
Aconitum to create bashmas which apparently renders them harmless.  
37 11/5/11 11:20AM 
2522554 
not as regulated as chinese herbs 
38 11/5/11 11:36AM 
2522603 
just quality, freshness, being free of pesticides 
39 11/5/11 11:49AM 
2522752 
Whether product is genuine (i.e. health and safety) 
40 11/5/11 12:21PM 
2522941 
No 
41 11/5/11 12:37PM 
2522984 
(i) Have they been rigorously for contraindications (ii) do they contain toxins? 
42 11/5/11 1:36PM 
2523220 
I ensure that I buy organic products in the hopes of avoiding 
pest/herb/fungicides  
43 11/5/11 1:39PM 
2523240 
I have been working in Indian restaurant and their higene was unaceptable - 
I left the place 
44 11/5/11 2:07PM 
2523340 
Potency, quality and purity are based very much on trust. 
45 11/5/11 4:05PM 
2523761 
none 
46 11/5/11 7:55PM 
2524742 
Would only buy from know high street store on the assumption the quality is 
assured by that retailer. 
47 12/5/11 12:15AM 
2525202 
No as the ones I use are also used in everyday food usage and cooking 
48 13/5/11 5:37PM 
2532239 
no 
49 22/5/11 12:48PM 
2553868 
Not applicable 
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18. Do you have any concerns regarding the safety or quality of Indian herbs or 
Indian herbal medicinal products? If so please list them. 
  
Response 
Percent 
Response 
Total 
50 22/5/11 1:01PM 
2553864 
Could have better labelling. I would prefer the use of Sanskrit rather than 
Latin names Should explain on packaging uses of the herb. 
51 22/5/11 4:39PM 
2554070 
1) Lack of controlled randomised trials for testing efficacy or safety? 
52 22/5/11 5:00PM 
2554098 
No 
53 1/6/11 11:35PM 
2583888 
no 
54 7/6/11 12:46PM 
2598111 
These products are not licensed and have not been properly tested, so may 
not be safe. 
55 8/6/11 9:39AM 
2600381 
I worry about herbs mixed with metals & animal ingredients 
56 9/6/11 9:00PM 
2506564 
Might not be produced in a safe and controlled way. Could result in harm or 
side effects to the consumer.  
57 15/6/11 7:00PM 
2621959 
None 
58 15/6/11 7:08PM 
2622263 
The ingredients must be validated and must be from reliable sources 
59 15/6/11 9:20PM 
2622871 
N/a 
60 16/6/11 1:33AM 
2623681 
No 
61 16/6/11 2:22PM 
2625600 
Possible contaminants 
62 16/6/11 3:18PM 
2625860 
I was never sure about the safety and quality  
63 16/6/11 3:21PM 
2625917 
N/A 
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18. Do you have any concerns regarding the safety or quality of Indian herbs or 
Indian herbal medicinal products? If so please list them. 
  
Response 
Percent 
Response 
Total 
64 16/6/11 10:39PM 
2627151 
No 
65 16/6/11 10:40PM 
2627166 
Similar to Chinese herbal medicine, toxicology should be introduced to the 
research on Indian herbs or Indian herbal medicinal products. 
66 17/6/11 10:30AM 
2628019 
Yes, which is why I do not really use them other than teas. I would like to try 
more Indian herbs but I have to find a professional therapist who I know 
supplies quality medicines. 
67 17/6/11 5:43PM 
2630326 
no, more concerned about endangered species and environmental impact 
68 18/6/11 1:12PM 
2631956 
No 
69 18/6/11 10:40PM 
2632806 
I would be worried about the regulation of their safety, quality and origin. 
70 21/6/11 12:45PM 
2638835 
the usual ones - plant identification , freshness of samples 
71 22/6/11 1:09PM 
2642313 
adulteration 
72 23/6/11 10:42AM 
2645106 
Sanitary concerns when not manufactured or regulated by EU legislation. 
73 29/6/11 7:46AM 
2661542 
Consistency 
Purity 
Sustainability 
Traceability 
Efficacy 
74 14/9/11 3:27PM 
2888486 
Indian Not widely known. Lot of bad press about Chinese and use of steroids 
and illegal substances in their medicines 
75 3/10/11 8:55PM 
2962581 
I prefer to take a standardised product from a reputable phytopharmaceutical 
company. 
76 8/7/12 12:31PM 
4312578 
studies have shown that heavy metals have been found in herbal formulas 
imported from india 
 
376 
 
18. Do you have any concerns regarding the safety or quality of Indian herbs or 
Indian herbal medicinal products? If so please list them. 
  
Response 
Percent 
Response 
Total 
  
answered 76 
skipped 159 
 
19. Do you have any other comments about Indian herbal medicine? 
  
Response 
Percent 
Response 
Total 
1 Open-Ended Question 100.00% 49 
1 31/3/11 10:30AM 
2394414 
wish it was more widely used especially in the US. 
2 31/3/11 10:42AM 
2394452 
the most effective system i have used 
3 1/4/11 10:29PM 
2404783 
Very effective, no side effect, allows for creativity, cooking is an art and I 
happily integrate medicinal herbs in the food I prepare! 
4 23/4/11 1:51AM 
2471658 
use them a lot in cooking and not specifically for health purposes sometimes 
we are even aware of it health benefit 
5 27/4/11 10:51PM 
2484453 
n/a 
6 4/5/11 3:58PM 
2502318 
None 
7 4/5/11 4:10PM 
2502354 
I know very little about it. It must have a PR problem in the UK.  
8 4/5/11 6:32PM 
2502967 
Never really came across it. 
9 4/5/11 7:01PM 
2503057 
no 
10 4/5/11 7:04PM no 
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19. Do you have any other comments about Indian herbal medicine? 
  
Response 
Percent 
Response 
Total 
2503059 
11 4/5/11 8:34PM 
2503226 
"Herbal" is often seen as good as it comes directly from "nature", so "it must 
be good". However, botulinum toxines are natural as well and are deadly 
when not used in a scientifically proven way. The same goes for many 
poisonous plants.  
If 'nature' would really be that good, than why has human kind, pharmacists, 
doctors and scientists spent ages and ages identifying the active substance 
in plants and purifying and extracting these substances from the rest of the 
plant?  
We have done this so we can have a true cure, which is powerful enough to 
work, which does not fluctuate in percentage of substance by factors like 
amount of sunlight. We have scientifically test the western tablets to be 
completely safe, and they do not contain any more side toxins than 
necessary. 
12 4/5/11 10:33PM 
2503460 
Use them, very occasionally, allone on "made" in a home-remidy medcinal 
form. Some herbs that are a part of my everyday diet, as a part of foods do 
have "medicinal" use, or in other words, are good for ones health, normally.  
13 5/5/11 4:19AM 
2503755 
Same as number 18 
14 5/5/11 12:47PM 
2505164 
No. 
15 5/5/11 5:47PM 
2502652 
N/A 
16 5/5/11 10:39PM 
2507046 
Its effective 
17 5/5/11 10:56PM 
2506934 
On the rare occasions that i have used them where traditional western 
medicines have been less effective eg. indigestion, muscular aches and 
pains they have prooved to be very effective. 
18 7/5/11 1:02PM 
2510981 
they work better and faster than western medicine 
19 10/5/11 9:29AM 
2517835 
None 
20 10/5/11 1:35PM 
2519179 
don't know enough about it but am aware that many traditional medicine 
systems prey on the poor, uninformed and afraid. They are also a significant 
factor in the exploitation of endangered plants and animal. I would support 
efforts to enhance the evidence base for the active compounds which may 
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19. Do you have any other comments about Indian herbal medicine? 
  
Response 
Percent 
Response 
Total 
be present in some herbal medicines but would not support promotion of 
these belief systems as they currently stand 
21 10/5/11 6:21PM 
2520317 
Mysterious and powerful 
22 11/5/11 5:26AM 
2521091 
n/a 
23 11/5/11 10:13AM 
2521895 
I know little of Indian herbal medicine other than it has 3 main branches, a 
long history and philosophy and a considerable written record, but not nearly 
so extensive as that of Traditional Chinese herbal medicine. Is there a 
government -recognised set of references herbs and corresponding 
herbarium specimens that can be used as a scientific platform for 
authentication, quality control and activity research? If not, then this ought to 
be instigated in order to ensure its future scientific credibility. The use of the 
herbs in powdered form prevents the use of morphological checks for identity 
and quality; such tests need therefore to be totally reliant on lab-based 
methods. Have such test been undertaken and published?  
24 11/5/11 11:36AM 
2522603 
it's the root of Chinese medicine but don't see it much, would be nice to see 
it as much as TCM 
25 11/5/11 12:37PM 
2522984 
No. 
26 11/5/11 1:39PM 
2523240 
We have a lot of European herbs that are underused I do not see the sense 
of shipping something thousands of kilometers- especially that bacterial flora 
in our guts is quite different.  
27 11/5/11 4:05PM 
2523761 
It's underused, under-rated but so effective at so many levels. Turmeric is 
recognised by homeopathic vets as being-anti-cancer, but neem's properties 
are less well known. We wouldn't be without it - used for our dog who has 
joint problems, helped our other dog get well from cancer, and we use it for 
many, many things. 
28 11/5/11 9:49PM 
2525036 
Never used them! 
29 11/5/11 10:19PM 
2525081 
Not familiar with it at all, but know it is an ancient medicine form. 
30 12/5/11 12:15AM 
2525202 
Traditional, economically viable, therapeutically effective on its own or as an 
adjunctive to western medicine. 
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19. Do you have any other comments about Indian herbal medicine? 
  
Response 
Percent 
Response 
Total 
31 22/5/11 12:48PM 
2553868 
No 
32 22/5/11 1:01PM 
2553864 
Need a more comrehensive source of buying herbs in the UK- currently very 
dispirate distribution networks. Would like to see better labelling, more user 
friendly and explainatory. 
33 22/5/11 5:00PM 
2554098 
No 
34 29/5/11 11:35PM 
2575409 
I do not use them but I do use herbal remedies which i make myself from 
own grown plants ie: Elderberry cordial for colds 
35 1/6/11 11:35PM 
2583888 
no 
36 8/6/11 9:39AM 
2600381 
surprisingly good results so far 
37 9/6/11 9:00PM 
2506564 
No 
38 15/6/11 7:00PM 
2621959 
None except they can be used to make a lovely curry! 
39 15/6/11 7:16PM 
2622252 
I am interested in any complementary medicines so have no worries about 
using them. 
40 15/6/11 9:20PM 
2622871 
N/a 
41 16/6/11 1:33AM 
2623681 
No 
42 16/6/11 2:35PM 
2625659 
There are many others made by people in India, which are a mix of various 
products, in a combination unavailable in the UK. 
43 16/6/11 3:21PM 
2625917 
No 
44 16/6/11 10:39PM 
2627151 
No 
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19. Do you have any other comments about Indian herbal medicine? 
  
Response 
Percent 
Response 
Total 
45 17/6/11 10:30AM 
2628019 
It would be a shame if Indian and Asian herb would not be available in the 
UK or that the natives in Asia could not grow their own herbs and make their 
medicines. The role of these herbs is vital as it has been part of their cultures 
for thousands of years. 
46 18/6/11 10:40PM 
2632806 
Contrary to other types of herbal medicine, I have never heard anybody 
talking about having used Indian herbal medicine, or seen a shop selling it. 
47 22/6/11 7:05AM 
2640817 
Minor conditions like cold and allergies work better. most often the effect is 
very slow patience is important. 
48 23/6/11 10:42AM 
2645106 
We have little knowledge about it. 
49 29/6/11 7:46AM 
2661542 
My understanding is that most traditional medicines are prescribed as a 
result of a consultation. Off the shelf remedies are therefore questionable. 
 
  
answered 49 
skipped 186 
 
20. What is your gender? 
  
Response 
Percent 
Response 
Total 
1 female   
 
66.52% 149 
2 Male   
 
33.48% 75 
  
answered 224 
skipped 11 
 
21. What is your age range?  
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Response 
Percent 
Response 
Total 
1 21 and Under   
 
16.44% 37 
2 22 to 34   
 
49.78% 112 
3 35 to 44   
 
12.00% 27 
4 45 to 54   
 
14.22% 32 
5 55 to 64   
 
4.44% 10 
6 65 to 74   
 
2.67% 6 
7 75 and over   
 
0.44% 1 
  
answered 225 
skipped 10 
 
22. Where were you born? 
  
Response 
Percent 
Response 
Total 
1 
United Kingdom and 
Ireland 
  
 
45.98% 103 
2 Europe   
 
17.41% 39 
3 Asia   
 
17.86% 40 
4 Africa   
 
7.14% 16 
5 Australasia   
 
0.45% 1 
6 North America   
 
9.38% 21 
7 
Central or South 
America 
  
 
1.79% 4 
  
answered 224 
skipped 11 
382 
 
 
23. Your ethnic group 
  
Response 
Percent 
Response 
Total 
1 White   
 
58.04% 130 
2 
Black or Black British – 
Black Caribbean 
  
 
0.89% 2 
3 
Black or Black British – 
Black African 
  
 
4.46% 10 
4 
Asian or Asian British – 
Indian 
  
 
9.82% 22 
5 
Asian or Asian British – 
Pakistani 
  
 
1.79% 4 
6 
Asian or Asian British – 
Bangladeshi 
  
 
2.23% 5 
7 
Chinese or Other Ethnic 
Group – Chinese 
  
 
4.46% 10 
8 
Black or Black British – 
Other Black 
  0.00% 0 
9 
Asian or Asian British – 
Other Asian 
  
 
6.25% 14 
10 
Chinese or Other Ethnic 
Group – Other 
  
 
4.02% 9 
11 
Mixed White/Black 
Carribean 
  
 
0.89% 2 
12 Mixed White/Asian   
 
0.89% 2 
13 Mixed - other   
 
6.25% 14 
  
answered 224 
skipped 11 
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24. Your occupation group 
  
Response 
Percent 
Response 
Total 
1 Managers & Administrators    
 
7.46% 17 
2 Professional Occupations    
 
28.07% 64 
3 
Associate Professionals & 
Technical Occupations 
  
 
1.75% 4 
4 
Clerical & Secretarial 
Occupations  
  
 
0.88% 2 
5 Craft & Related Occupations    
 
1.32% 3 
6 
Personal & Protective Service 
Occupations  
  
 
0.88% 2 
7 Sales Occupations    
 
0.88% 2 
8 Plant & Machine Operatives   
 
0.44% 1 
9 Students   
 
44.74% 102 
10 Unemployed   
 
1.32% 3 
11 Retired   
 
3.51% 8 
12 Other: please specify   
 
8.77% 20 
  
answered 228 
skipped 7 
Answers for: Other: please specify 20 answers 
1 23/3/11 8:38PM 
2367916 
acupuncturist TCM style (not herbal) 
2 31/3/11 7:15PM 
2398630 
naturopath 
3 4/4/11 3:34PM 
2412275 
acupuncture 
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24. Your occupation group 
  
Response 
Percent 
Response 
Total 
4 10/5/11 8:52AM 
2517316 
Uni. Researcher 
5 10/5/11 9:14AM 
2517598 
Also - herbalist 
6 10/5/11 11:19AM 
2518458 
Health Policy Researcher 
7 10/5/11 12:02PM 
2518761 
Academic researcher 
8 11/5/11 12:23PM 
2522953 
graphic designer 
9 11/5/11 2:07PM 
2523340 
self employed 
10 11/5/11 4:05PM 
2523761 
self-employed online retail 
11 11/5/11 11:07PM 
2525144 
Graphic designer 
12 12/5/11 7:33PM 
2528336 
Acupuncturist 
13 20/5/11 12:41PM 
2551135 
research 
14 15/6/11 5:49PM 
2622023 
 
15 17/6/11 1:28PM 
2628915 
Professional Sportsperson 
16 19/6/11 12:53AM 
2632965 
Chinese Medicine Expert 
17 21/6/11 12:45PM 
2638835 
herbalist and acupuncturist 
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24. Your occupation group 
  
Response 
Percent 
Response 
Total 
18 22/6/11 7:05AM 
2640817 
PhD researcher at DKFZ Germany 
19 28/6/11 9:53PM 
2660931 
Academia 
20 16/1/13 4:18PM 
5358567 
medical doctor 
 
 
25. Where do you currently live 
  
Response 
Percent 
Response 
Total 
1 United Kingdom   
 
83.19% 188 
2 Ireland   
 
0.88% 2 
3 Other country in Europe   
 
3.98% 9 
4 North America   
 
5.75% 13 
5 Central or South America   
 
0.44% 1 
6 Asia   
 
3.10% 7 
7 Africa   
 
0.44% 1 
8 Australasia   
 
1.33% 3 
9 Other, please specify:   
 
0.88% 2 
  
answered 226 
skipped 9 
Answers for: Other, please specify: 2 answers 
1 23/4/11 1:51AM Malaysia 
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25. Where do you currently live 
  
Response 
Percent 
Response 
Total 
2471658 
2 4/5/11 8:34PM 
2503226 
Belgium 
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13.5 Appendix 5 
Price and market trends for herbs sold in Bozhou herb market, Anhui, 
PRC – obtained on 20-3-2011 
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Name 
 
Specifications  Produce Area  Price /kg 
(YUAN) 
Trend  
AJIAO FUPAI SHANGDONG 450 Stable 
AJIAO DONGA SHANGDONG 1050 Stable 
AWEI Mixed Import 350  
AIYE Mixed All over 3.5  
Anxixiang Mixed  Import 90  
BAJIAOFENG Mixed Guangxi 3.8  
BAJIAOLIAN Mixed Hubei 25  
BAIJIAOLIAN Mixed Sichuan 14  
BAYUEZHA White Anhui 20 Little 
BAYUEZHA Mixed Anhui 15  
BADOU mixed Sichuan 9  
BAJITIAN Body Guangdong 120  
BAJITIAN Mixed Guangdong 85  
BAJI Mixed Anhui 3  
BAIBEI Root Guangxi 3  
BAIBIANDOU Skin Sichuan 5.5  
BAIBIANDOU Mixed Import 9.5  
BAIBIANDOU Mixed Sichuan 10  
BAICHANHUA Mixed Zhejiang 19  
BAIDOUKOU Mixed Import 51 Increase 
BAIFAN Mixed Zhejiang 1  
BAIFUZI Mixed DOONGBEI 85 Little 
BAIGUO Mixed, Kernel All over 13  
BAIGUO Mixed, good All  10  
BAIGUO Mixed All 6.5  
389 
 
BAIGUO Kernel All 17  
BAIHUJIAO  Mixed Vietnam  46.5 Little 
BAIHUJIAO Mixed HAINAN 46.5 Increase  
BAIHUASHE Each Jiangxi 36  
Baihuasheshecao Farm Henna 8.5  
Baihuasheshecao Wild Jiangxi 12.5  
BAIJI Select Guizhou 230 Little 
BAIJI Mixed Guizhou 170 Little 
BAIJILI Mixed Neimeng 7  
BAIJILI  Neimeng 9  
BAIJIEZI Mixed Sichuan 12  
BAIJUSHENG Mixed Hebei 25  
baimaoXiakucao Mixed Dabieshan 6  
BAI LIAN Mixed ANHUI 15.5 Increase 
BAIMAOGEN Mixed Hebei 11  
BAIMAOGEN Select Anhui 12  
BAIQIAN Washed Hubei 58 little 
BAIQIAN Mixed Hubei 40  
BAISHAO Tail Anhui 14  
Baishao Grade 3/4 Anhui 19  
Baishao Mixed Anhui 18  
Baishao Grade 2/3 Anhui 22  
Baishao Grade 1/2 Anhui 24  
Baishao Black Anhui 14.5  
Baishao Cooked Anhui 10  
BAISHOUWU Mixed Jiangsu 1  
BAISHIZHI Mixed  2  
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Name Specifications  Produce Area  Price / kg 
(YUAN) 
Trend  
BAIZHU Select Anhui 43 Short 
Baizhu Mixed Zhejiang 35 Down 
Baizhu Mixed Anhui 40 Down 
Baizhu Mixed Hebei 28  
Baizhu Mixed Zhejiang 40 Little 
BAIZHU seeds Mixed Anhui 95  
Baituoweng  Mixed Dongbei 24  
Baiwei Farmed Dongbei 14  
Baiwei Mixed Gansu 9  
Baixianpi Mixed Korea 34  
Baixianpi Select Dongbei 60  
Baixianpi Mixed Dongbei 38  
Baiyaozi Mixed Hunan 8.5  
Baiying Mixed Hubei 4  
Baizhi Mixed Hebei 15  
Baizhi Mixed Sichuan 20  
Baizhi Mixed Anhui 16  
Baizhi Mixed Anhui 19  
Baibu Large Hubei 13  
Baibu Large Yunnan 13  
Baibu Small Sichuan 14  
Baihe Large Hunan 40  
Baihe Small Henan 40  
Baihe High grade Gansu 95  
Baihe Mixed Gansu 45  
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Name Specifications  Produce Area  Price / kg 
(YUAN) 
Trend  
Baihehua Mixed Hunan 22  
Bairuicao Mixed  39 Little 
Baiziren Year 98 Shandong 70  
Baiziren Mixed Shandong 68  
Baijiangcao Yellow flower Anhui 7  
Baijiangcao North Hebei 3  
Baijiangcao South  5  
Banlangen Mixed Gansu 12  
Balangen Mixed Dongbei 12  
Banlangen Mixed Henna 12  
Banbianlian Mixed Jiangsu 26 Little 
Banfenghe Mixed Guangdong 7  
Banzhilian Second cut Henna 6.5  
Banzhilian First Henna 7.5  
Baoshilian Mixed Guangdong 16  
Beidougen Mixed Dongbei 9.5  
Beishashen Mixed Neimeng 62 Little 
Beishashen Mixed Hebei  Increase 
Bibo Mixed Yunnan 42 Little 
Bibo Mixed Import 43 Little 
Beidougen Mixed Dongbei 9.5  
Beishashen Mixed Neimeng 62 Little 
Bixie   10.5  
Bixie  Anhui 11.5  
Bimazi Mixed Anhui 6  
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Name Specifications  Produce Area  Price / kg 
(YUAN) 
Trend  
Bitaogan Mixed  7  
Biandouhua Mixed  58 Little 
Bianxu Mixed  2  
Biejia Mixed  65  
Bianlang Mixed Import 9  
Binpian White Guangzhou 140  
Binqiuzi Mixed Mguizhou 180 Little 
Bohe High grade  15  
Bohe Mixed  5  
Bohe M(leaves)  12  
Bohenao  Shanghai 260  
Boheyou Plain oil  120  
Boheyou Raw oil   170  
Buguzhi Mixed Import 35  
Cansha Mixed Hainan 3  
Cangerzi Small  6.5  
Cangerzi Large  3.5  
Cangzhu Plain Neimeng 31  
Cangzhu Half skin off Neimeng 26  
Caodoukou Mixed Hainan 27  
Caoguo Seeds Yunnan 80 Little 
Caoguo Mixed Yunnan 54 Down  
Caoheche Mixed Gansu 14.5  
Caojueming High grade  7 Little 
Caojueming Mixed  4.5  
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Name Specifications  Produce Area  Price / kg 
(YUAN) 
Trend  
Caojueming Mixed Import 3.5  
Caowu Sliced Sichuan 20 Little 
Caowu Mixed Sichuan 18  
Cebeiye Mixed  2  
Chaihu Farmed Gansu 60 briskly 
&easily 
Chaihu 
 
Red Neimeng 95  
Chaihu Wild Gansu 65 briskly 
&easily 
Chaihu Wild Shanxi 70 briskly 
&easily 
Chaihu baby plants Autumn plants  3.5  
Chaihu baby pants Spring plants  4.5  
Chantui Washed Shangdong 140 Little 
Chantui Mixed Shandong 100 briskly 
&easily 
Chenpi Mixed Jianghsu 24  
Chenpi Skin/piece Jiangsu 5  
Chansu 6%  Jiangsu 3200 Little 
Changchunhua Mixed Yunnan 10  
Changshan  Sichuan 7  
Changshan  Dabieshan 5  
Cheqiancao Mixed  3  
Cheqianzi Mixed Dongbei 20  
Cheqianzi Mixed Jiangxi 21  
Chenxiang Out of standard Indonesia 150  
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Name Specifications  Produce Area  Price / kg 
(YUAN) 
Trend  
Chenxiang Mixed Indonesia 580 Little 
Chenxiang 15-20% Indonesia 1200 Little 
Chensha Mixed Guangxi 180  
Chenpi Thread Zhejiang 4.8  
Chenpi Mixed Zhejiang 3.8  
Chishao  Dongbei 21.5  
Chishao  Neimeng 26.5  
Chishizhi Mixed Shanxi 1,5  
Chixiaodou Mixed  8.5  
Chongweizi Mixed Anhui 20 Little 
Chushizi Mixed Anhui 22  
Chuanbei Blue Sichuan 1500  
Chuanbei  Sichuan 1850  
Chuanlianzi Mixed Yunnan 3.5  
Chuanlianzi Mixed Sichuan 3.5  
Chuannuxi Mixed Hubei 13  
Chuanniuxi Mixed Sichuan 15  
Chuanwu Sliced Sichuan 23 Little 
Chuanwu Mixed Sichuan 16  
Chuanxiong Mixed Sichuan 30  
Chuanposhi Mixed Hunan 3.5  
Chuanshanjia Plain scale  LAOS 2400 Little 
Chuanshanlong Mixed Dongbei 9  
Chuanxinlian Stem Guangxi 3.5  
Chuanxinlian Leaves Anhui 11 Little 
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Name Specifications  Produce Area  Price / kg 
(YUAN) 
Trend  
Chuanxinlian Whole plant Guangxi 6.5  
Chuipengcao Washed Zhejiang 9  
Chuipengcao Mixed Zhejiang 7  
Chunpi Mixed  2.2  
Name Specifications  Produce Area  Price / kg 
(YUAN) 
Trend  
Chunpi Root skin  5.5  
Cishi Mixed Jiangsu 1.5  
Cihuang Mixed  30  
Ciwei Skin/high grade  125 Little 
Ciwei Skin  90  
Ciwujia Stem Dongbei 5  
Ciwujia Root Dongbei 6.5  
Ciwujia Peel Dongbei 35 little 
Dafengzi Mixed Hainan 11  
Dafupi Hard shell Import 4.5  
Dafupi Soft shell Import 4.5  
Dahuang Water root  4.5  
Dahuang  Gansu 18 Little 
Dahuang Water root  4.5  
Dahuang  Gansu 4  
Dahuang  Gansu 7.5 Little 
Dahui Mixed Guangxi 27  
Daji Root  18  
Daji Mixed  5  
Dajiangjun Mixed Neimeng 245  
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Name Specifications  Produce Area  Price / kg 
(YUAN) 
Trend  
Daqingyan Mixed  2  
Daqingye Mixed Dongbei 2.3  
Daqingye Mixed Gansu 2.8  
Daidaihua Mixed Zhejiang 60 Little 
Daimao Mixed Import 800  
Danshen Mixed Shangdong 13  
Danshen Mixed Anhui 11.5 briskly 
&easily 
Danshen Large Jiangsu 18  
Danshen Select Anhui 15  
Danshen Second Jiangsu 11  
Dansheng Mixed Shanxi 11.5  
Danpi Mixed Tongling 35  
Danpi  Anhui 29 briskly 
&easily 
Danpi  Anhui 36 briskly 
&easily 
Danpi White, small Anhui 20.5 briskly 
&easily 
Danfan Mixed Tianjing 20  
Dandouzhi Mixed  4.5  
Danzhuye Mixed  6.5  
Danggui Box Gansu 38 briskly 
&easily 
Danggui  Gansu 25 briskly 
&easily 
Danggui  Gansu 27 briskly 
&easily 
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Name Specifications  Produce Area  Price / kg 
(YUAN) 
Trend  
Danggui Sliced Gansu 33 briskly 
&easily 
Dangshen White, medium Gansu 46  
Dangshen Veins Gansu 45 Short 
Dangshen White, small Gansu 42  
Dangshen White, large Gansu 53 briskly 
&easily 
Daodoukou Mixed Southern anhui 5.5  
Daodouzi Black  4 Little 
Daodouzi White Southern anhui 5.5  
Daokoucao Mixed Guangdong 2  
Daoya Mixed 
 
 3.5  
Dengxincao Whole package Jiangxi 153 Little 
Dengxincao Small package Jiangxi 120 Little 
Dengzhanhua Mixed Guangxi 19  
Didancao Mixed Guangxi 5.5  
Diding Redish Jiangsu 12  
Diding Bitter Hebei 7 Little 
Diding Purple flower Shanxi 6  
Difuzi Mixed Dongbei 4  
Difuzi Washed Dongbei 5  
Digupi White Shanxi 12  
Digupi Pure, Red  Shanxi 35 Little 
Digupi Red  Shanxi 21  
Dimiancao Hard Jiangxi 12  
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Name Specifications  Produce Area  Price / kg 
(YUAN) 
Trend  
Dimiancao Soft  7  
Dilong Mixed Shanghai 55  
Dilong Opened Guangxi 160 Short 
Dilong Mixed Guangxi 85  
Dilong Opened Shanghai 85 Little 
Diyu Mixed  4.5  
Diyu Select  7  
Dianqie Farmed  5  
Dinggongten Mixed Guangdong 4  
Dongchongxiacao 3500 worms Tibet  85,000  
Dongchongxiacao 2600 worms Tibet 130,000  
Dongchongxiacao 2200 worms Tibet 146,000  
Dongchongxiacao Feed Tibet 35,000  
Dongchongxiacao 4000 worms Tibet 75,000  
Dongguapi Mixed  5.5  
Dongguazi Double side  35 Little 
Dongguazi Single side  5  
Donghua Mixed Hebei 90 Increase 
Donghua High grade Gansu 150 Little 
Donghua Mixed Gansu 90 Increase 
Dongkuizi Large Guangxi 6.5  
Dongkuizi Small Anhui 8  
Donglingcao Mixed  4.5  
Douzhijiang Mixed Guangdong 4  
Duhuo Mixed Gansu 9 briskly 
&easily 
399 
 
Name Specifications  Produce Area  Price / kg 
(YUAN) 
Trend  
Duhuo Mixed Hubei 8 briskly 
&easily 
Duyiwei Leaves Sichuan 20  
Duyiwei Root Sichuan 55  
Duzhong Stem bark 1mm  15  
Duzhong Twig bark  13.5  
Duzhong Stem bark 2mm  16.5  
Duzhong leaves Mixed  3.8 Little 
Duanchangcao Mixed Guangdong 10  
Danxueliu Mixed Yunnan 3.5  
Danshuhua Mixed Yunnan 24  
Eshu Mixed Yunnan 9  
Eshu Mixed Guangxi 9.5 Little 
Ebushicao Mixed Anhui 8  
Eguanshi Mixed  6  
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13.6 Appendix 6 
NMR spectroscopy raw data with sample key. 
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Simca
No 
Details of product NMR spectra no 
/ sample 
Use  Preparation  
1 Tablets. 10,000mg (as 500mg of extract) 
providing 95% curcumins. Manufactured in UK. 
Supplied via internet. Dosage: 1 tablet daily. 
Ingredients: Turmeric root extract, calcium 
carbonate, dicalcium phosphate, microcrystalline 
cellulose. Tablet coating: (hydroxypropyl 
methylcellulose (HPMC), glycerine. Colours: Iron 
oxides and titanium dioxide), hydroxypropyl 
methylcellulose,  carboxymethylcellulose, silicon 
dioxide, stearic acid, magnesium stearate. 
JUL-20-12-10      
s1 
M EE 
 
2 500mg capsules manufactured in UK and 
supplied via internet. Dosage: 1 capsule, 3 times 
daily. Complies with British Pharmacopoeia. 
Ingredients: Turmeric rhizome, hypromellose. 
JUL-20-12-20      
s3 
M PW 
3 400mg gelatine capsules, manufactured in USA 
and supplied via retail health food shop in UK. 
Dosage: 1 capsule, twice daily. Ingredients: 
Turmeric powder (C. longa L.) microcrystalline 
cellulose, silicon dioxide, magnesium stearate, 
stearic acid. 
JUL-20-12-30      
s4 
M PW 
4 500mg capsules provided by Ayurvedic 
company in Tamil Nadu, India. Dosage 1 
capsule, 3 times daily. Ingredients: Curcumin 
extract (C. longa)  
JUL-20-12-40      
s5 
M EE 
5 Combination product with C. amada Roxb. and 
Frangula purshiana Cooper Rhamnaceae 
(Rhamnus purshiana synonym on label). Tablets 
manufactured in NL. Dosage: 3-4 tablets, 1 or 2 
times daily. Ingredients: Curcuma rhizome 
extract 600mg, C. amada rhizome pulverized 
100mg, Frangula purshiana Cooper cortex 
30mg, sugar 75mg. 
JUL-20-12-50      
s6 
M PW and EE.  
Mixed 
species 
6 400mg capsules, manufactured in USA and  
supplied via retail health food shop in NL. 
Dosage: 1 capsule, twice daily. Ingredients: 
Turmeric powder (C. longa), microcrystalline 
cellulose, silicon dioxide, magnesium stearate, 
stearic acid. 
JUL-20-12-60      
s7 
M PW 
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7 UK supermarket(UK) JUL-20-12-70      
s8 
F PW 
(organic) 
8 Standardised 500mg tablets. Manufactured in 
UK and supplied via internet. Dosage: 1 to 3 
tablets, daily. Ingredients: Curcumin powder 
extract 350mg (standardised for a minimum of 
95% curcuminoids), turmeric powder (C. 
longa)150mg, Bromelain 20mg, di-calcium 
phosphate, microcrystalline cellulose, silicon 
dioxide, stearic acid. Coating: HPMC, propylene 
glycol. 
JUL-20-12-80      
s9 
M PW and EE 
9 500mg capsules. Standardised for 95% 
curcuminoids. Manufactured in USA and 
supplied via internet. Dosage: 1 capsule daily. 
Ingredients: Turmeric powder (. longa root) 
450mg Turmeric extract (C. longa root) 50mg, 
gelatin, silica, magnesium stearate, stearic acid. 
JUL-20-12-90    
s10 
M PW and EE 
10 UK supermarket. JUL-20-12-100  
s12 
F PW 
11 UK retail shop. JUL-20-12-110  
s13 
F PW 
12 Integrated Chain Product  JUL-20-12-120  
s14 
M fine  
ground PW 
(organic) 
13 Integrated Chain Product  JUL-20-12-130  
s15 
M course 
ground PW 
(organic) 
14 Market in Delhi, India JUL-20-12-140  
s16 
F PW 
15 UK retail shop. JUL-20-12-150  
s17 
F PW 
16 Retail shop in South India. JUL-20-12-160  
s18 
F PW 
17 Retail shop in South India. JUL-20-12-170  
s19 
F PW 
18 UK retail shop. JUL-20-12-180  
s20 
F PW 
403 
 
19 Sourced in Bangalore, India JUL-20-12-190  
s21 
F PW 
20 UK retail shop. JUL-20-12-200  
s22 
F PW 
21 C. kwangsiensis S.G. Lee and C.F. Liang. 
Manufactured as granules in PRC and supplied 
by UK TCM company 
JUL-20-12-210  
s23 
M AE 
22 C. longa. Full spectrum 5:1 herb extract powder. 
(Replenished essential oils). Manufactured in 
PRC and supplied by UK TCM company. 
JUL-20-12-220  
s24 
M AE 
23 C. longa. Manufactured in Taiwan and supplied 
by UK TCM company. Ingredients: Curcuma 
longa rhizome concentrated extract (66%), corn 
starch (34%). 
JUL-20-12-230  
s25 
M AE and PW 
24 Capsules supplied by an Ayurvedic company in 
India. 
JUL-20-12-240  
s26 
M PW 
25 C. aromatica. Sourced in India JUL-20-12-250  
s27 
F PW 
26 Supplied by UK company JUL-20-12-260  
s28 
M AE 
27 C. aromatica. Sourced in India JUL-20-12-270  
s29 
C PPW 
28 Supplied by retail shop in Kerala, India 
 
JUL-20-12-280  
s30 
F DRh 
29 Manufactured in PRC and supplied by UK TCM 
company. 
JUL-20-12-290  
s31 
M PW 
30 Cultivated in PRC and supplied by UK TCM 
company.  
 
JUL-20-12-300  
s32 
M DRh 
31 Farm in Erode, India JUL-20-12-310  
s33 
F/M DRh 
32 Farm in Erode, India JUL-20-12-320  
s34 
F/M DRh 
(polished) 
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33 Farm in Erode, India JUL-20-12-330  
s35 
F/M Dried root 
tuber 
34 Cultivated in PRC and supplied by UK TCM 
company. 
 
JUL-20-12-340  
s36 
M DRh 
35 500mg gelatin capsules. Standardised for 95% 
curcuminoids. manufactured in USA and 
supplied via internet. Dosage: 1 capsule daily. 
Ingredients: Turmeric concentrate 500mg (C. 
longa), cellulose, magnesium stearate, silicon 
dioxide. 
JUL-20-12-350  
s37 
M EE 
36 Manufactured in Austria and supplied by retail 
shop in Iceland. 
JUL-20-12-360  
s38 
F PW 
(organic) 
37 C. zanthorrhiza Roxb. rhizome, Tropilab APR-08-13-10   
s50 
M PW 
38 Market in Delhi, India APR-08-13-20   
s51 
F FRh 
39 UK supermarket APR-08-13-30   
s52 
F FRh 
40 UK supermarket and freeze dried APR-08-13-40   
s53 
F FRh 
41 Market in Udaipur, India APR-08-13-50   
s54 
F DRh 
(polished) 
42 Market in Udaipur, India 
 
APR-08-13-60   
s55 
F PW 
43 C. aromatica Salisb., Kasturi Manjal from India, 
sourced via internet 
APR-08-13-70   
s56 
C PW 
44 C. aromatica, rhizome, Kasturi Manjal from 
India, sourced via internet 
 
APR-08-13-80   
s57 
C PW 
45 C. aromatica, Kasturi Manjal from India and 
sourced via internet 
 
APR-08-13-90   
s58 
C  PW 
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46 An Agmark certified food powder sourced in 
Hyderabad, India 
 
APR-08-13-100 
s59 
F PW 
47 Medicinal powder. Integrated Chain Finished 
Product in 425mg capsules manufactured in UK 
and sourced via internet. Dosage: 2 capsules, 3 
times daily. Ingredients:  Turmeric root (C. 
longa), HPMC. 
APR-08-13-110 
s60 
M PW 
(organic) 
48 Medicinal Super Critical Fluid (SCF) extract 
400mg soft gel capsules. Manufactured in USA 
and sourced via internet. Dosage: 1 capsule 
daily. Ingredients: Turmeric (C. longa), olive oil, 
gelatine, glycerine, yellow beeswax, carob. 
APR-08-13-120   
s2 
M SCF  
49 C. zanthorrhiza CAMAG 9765 APR-08-13-130 
9765 
M PW 
50 C. zanthorrhiza CAMAG 9767 APR-08-13-140 
9767 
M PW 
51 C. zanthorrhiza CAMAG 10565 APR-08-13-150   
10565 
M PW 
52 C. zanthorrhiza CAMAG 10567 APR-08-13-160  
10567 
M PW 
53 Retail shop in Greenland  F PW 
54 Integrated chain product, manufactured and 
sourced in UK. Ingredients turmeric rhizome, 
ethanol. 
 M EE 
(organic) 
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13.7 Appendix 7 
Project P399-01 HPTLC Worksheet Curcuma (AB and DAF) 
CAMAG Laboratories, Muttenz, Switzerland, March 2013 
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